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Abstract 
Background: Low birth weight (LBW) remains a major public health problem in developing 
countries, but is only one measure of size at birth. Others include small-for-gestational-age 
(SGA) and low ponderal index (PI). The objectives of the thesis were: to estimate the 
prevalence of LBW, SGA and low PI in a cohort of Nepalese infants; to identify risk factors for 
small size, and to investigate whether prediction models were useful for screening; and to 
assess the effects of size at birth on subsequent outcomes. 
Methods: Mothers enrolled in a prospective trial were followed through pregnancy and 
delivery. Child anthropometry was collected at birth and at two years of age. A range of indices 
of size at birth were described. Multivariable regression models were developed to predict 
them, and their associations with subsequent outcomes. 
Results: There was a high prevalence of LBW (25%), SGA (55%) and low PI (70%) at birth. 
None of the prediction models for size at birth was particularly good, the strongest being for 
birth weight (R
2=33%). Common predictors were parity, pre-pregnancy weight, gestational 
weight gain, gestational duration and infant sex. LBW was associated with neonatal (OR 3.5, 
95% CI 1.4-8.9), infant (3.6, 1.6-7.9) and young child (3.7, 1.7-7.8) mortality, and stunting (3.4, 
2.2-5.3), wasting (2.9, 1.5-5.6) and underweight (3.7, 2.5-5.5) at two years of age. 
Discussion: In southern Nepal, many newborn infants were classified as small, and most were 
disproportionate. The modifiable risks for small size at birth were few, even though it was 
associated with mortality and size in childhood. 
Conclusion: The previously undescribed disproportionate majority of Nepalese infants is 
worrying for public health. However, measurement of birth weight is not yet routine and it 4 
seems better to recommend LBW as a single risk measure than to add new and more 
complicated activities. 5 
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Chapter 1.  Introduction and objectives 
1.1.  Scope of the thesis 
“The category of low birth weight in particular is uninformative and seldom justified.”
1 
Size at birth is a multidimensional entity determined by the sizes of different constituents of the 
body: bone, muscle, other tissues and fluid spaces. Its dimensions include birth weight, birth 
length, head circumference, chest circumference, mid-upper arm circumference and abdominal 
circumference. Size can also be expressed by combining these primary measures into composite 
indices, of which body mass index is the most familiar. Both gestational age and rate of fetal 
growth contribute to size at birth, which is also determined by the interaction between genetic 
characteristics (maternal and paternal) and environmental factors (nutritional). Optimal fetal 
growth is achieved if the infant has achieved optimum size at birth for gestational age, sex and 
ethnicity. 
Birth size is the result of prenatal growth and the intrauterine environment. It has important 
implications for mortality, morbidity, growth and development, cognitive outcomes and 
academic achievement. Associations have also been demonstrated between small size at birth 
and coronary heart disease and its risk factors, hypertension, non-insulin dependent diabetes 
mellitus and abnormalities in lipid metabolism and blood coagulation. At the opposite end of 
the spectrum of size at birth, bigger infants are more prone to obesity, an increasing public 
health problem in developed countries and an emerging one in developing countries.  
The usual measure of size is birth weight, an easily and precisely measurable anthropometric 
parameter. Birth weight is often the only anthropometric parameter used, and has been the most 
studied. Epidemiological studies have shown it to be a determinant of infant mortality. Because 
infant mortality rates in developing countries are high, there has been a large amount of work 
on low birth weight and studies of risk factors for low birth weight and intrauterine growth 20 
retardation were a natural step forward. Low birth weight is linked adversely with morbidity, 
mortality, growth and development. A strong association of birth length with development at 12 
months has been demonstrated. Low birth length has also been related to mortality and 
hospitalization. Small head circumference indicates poor development of brain - as seen in 
symmetrically growth-retarded infants – and is associated with compromised cognitive 
development. 
Although birth weight has been used as a standard measure of size at birth, it is only one 
dimension of size and is a crude marker of fetal growth. Each dimension of size has different 
implications and should be measured at birth, but the existing literature is dominated by 
discussions of weight alone. Moreover, birth weight is the only birth parameter measured in 
many hospitals as a proxy for birth size and as an indicator of health. The patterns, associations 
and implications of the various dimensions are the subject of the thesis. 
The expression low birth weight was used interchangeably with prematurity for four decades 
between the 1920s and 1960s. In the 1970s, prematurity and intrauterine growth retardation 
were understood as two separate concepts, as were differences in mortality between them. This 
evolution of concepts over time, and the arbitrary cut-off point set on the basis of mortality 
rates and ease of measurement should make us wonder about the credibility of low birth weight 
as an entity
1. Even today, risk factor studies for low birth weight are popular among 
researchers. Because the studies conducted in different settings showed different results, the 
causal relationship between important risk factors and low birth weight is difficult to establish. 
However, the extensive previous work on risk factors can be used for better understanding and 
documentation of their usefulness.  
This thesis brings together evidence from past and current research. It will address important 
issues with regard to current work on size at birth - particularly the meaning of size at birth and 
its risk factors - and discuss its relevance. The thesis discusses the identification of research on 
birth size: past and current. It assesses the usefulness of the current pool of knowledge on size 21 
at birth. The idea is to address, in a semi-rural setting in Nepal, an important public health 
problem in relation to what is already known.  
The scope of the thesis includes: 
 (a) Describing the distribution of different indicators of size at birth in a cohort of infants in 
Nepal, which has not been done before, 
 (b) Development of prediction models for different indicators of size at birth, and assessment 
of how useful they might be.  
 (c) Looking at the outcomes in infants and young children of different classifications of size at 
birth.  
1.2.  Objectives 
1.2.1.  General objectives 
The general objectives of the work carried out for the thesis were: 
1.  To understand size at birth in order to improve child survival and prevent adverse 
outcomes in Nepal. 
2.  To understand the implications of measuring different parameters of size at birth – 
weight, length and head circumference - and using derived indices such as size for 
gestational age, body mass index and ponderal index. 
1.2.2.  Specific Objectives  
The specific objectives were: 
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1.  To describe the distribution of size at birth in a cohort in southern Nepal: birth weight, 
length, head circumference, body mass index and ponderal index.  
2.  To estimate the prevalence of low birth weight, small for gestational age and low 
ponderal index in the cohort. 
Risk factors for size at birth 
1.  To examine the independent effects of maternal demographic factors, nutritional status 
and health status on size at birth. 
2.  To identify important risk factors for abnormal size at birth. 
3.  To generate models for prediction of abnormal size at birth and to investigate whether 
known risk factors can predict size at birth adequately. 
Effects of size at birth 
1.  To assess the effects of size at birth on mortality at 1 month and in early childhood. 
2.  To assess the effects of size at birth on malnutrition at two years of age. 
3.  To assess the effects of size at birth on morbidity at two years of age. 
1.3.  Role of the investigator 
I was the clinical trial coordinator for a double blind randomized controlled trial of antenatal 
multiple micronutrient supplementation in southern Nepal from 2001 to 2007.
2;3 I was based in 
Janakpur, Dhanusha for most of the research period. For the trial, I was trained in obstetric 
ultrasonography and worked from a base at Janakpur Zonal Hospital. I supervised enrollment of 
participants, follow-up in pregnancy, measurement of infants at birth and follow-up of children 
at two years of age. I was trained in and performed the obstetric ultrasonography for the trial. I 23 
was responsible for maintaining the database, entering and cleaning data. I co-ordinated the 
follow-up study, designing the questionnaire and database and supervising piloting and field 
work. In summary, I am answerable for the data used in the thesis, from collection to analysis. 
1.4.  Sequence of the thesis 
The thesis is organized as follows. It includes 7 Chapters:  
The second and third chapters describe the literature review. Chapter two summarizes the 
Millennium Development Goals and gives a snapshot of the UN declaration of the 
responsibility of the world as a whole for human equality, equity and dignity. The thesis is 
particularly focused on the 4
th goal: reduction of child mortality. The chapter provides a general 
idea of the gravity of childhood health problems, and particularly neonatal mortality. It 
discusses low birth weight as an important public health problem in developing countries and 
an underlying factor in neonatal mortality, and therefore a major contributor to deaths of 
children under five. A number of anthropometric parameters at birth are described as a 
background to using them in later work. Gestational age and Z score are also described. This is 
followed by a detailed consideration of the classification of abnormal birth sizes and the 
identification of abnormal size. The next chapter covers the subject of what is already known 
about risk factors for low birth weight in low income countries and high income countries. This 
draws upon work on risk factors and provides a critical review of the methodological 
approaches to the research work. It gives a perspective on the risk factors relevant to the 
context of the thesis. 
The fourth chapter discusses the study design, setting and methods for the field research. It 
provides a detailed description of the setting in which the study was carried out, and the 
procedures that were followed. The stages of the studies are summarized from selection of 
participants to follow-up, and the tools used and data management are described. Ethical 
considerations and maintenance of data quality are also covered. 24 
Chapter five generally describes the data available for the study. 
Chapter six presents the basic results of an analysis of size at birth. It begins with maternal 
demographic characteristics followed by the prevalence of small size at birth using a population 
sample who did not receive multiple micronutrient supplementation. 
Chapter seven summarizes risk factor analysis, specially focusing on prediction models to draw 
on the determinants of size at birth. 
Chapter eight summarizes the investigation of the effects of size at birth on immediate and 
longer term outcome. It describes neonatal, infant and childhood mortality, morbidity and 
malnutrition represented by stunting, wasting and underweight. 
Chapter nine summarizes the key findings, discusses the limitations of the studies and goes on 
to discuss the implications of the findings. It particularly considers their generalisability. 
The final chapter attempts to draw clear and simple conclusions in this complex field. 25 
Chapter 2.  Background to the consideration of size at birth 
   
Figure 2.1. Normal birth weight and Low birth weight infant born at >37 weeks of 
gestation 
2.1.  The Millennium Development Goals 
In September 2000, heads of state of 189 countries approved the UN Millennium Declaration. 
Many member countries are committed to the Millennium Development Goals (MDGs) to 
reduce poverty and hunger, and to tackle ill health, gender inequality, lack of education, lack of 
access to clean water and environmental degradation. The goals are set to be achieved by 2015. 
Table 2.1 presents the MDGs, targets and indicators. There are eight goals, 16 targets and 48 
indicators, out of which one goal, one target and 3 indicators are related to child health. The 
fourth goal is to reduce child mortality. The target is to reduce under-five mortality by two-
thirds between 1990 and 2015. There are three health indicators to measure the progress 
towards the target: under-five mortality rate, infant mortality rate and the proportion of one-
year children immunized against measles.  
The measurement of achievement of MDG 4 over the period of 25 years will be reported by the 
degree of reduction in child mortality across countries. To review progress, an interim analysis 
was carried out. It showed an asymmetrical reduction in mortality: in urban Sub-Saharan 
Africa, only five out of 22 countries studied met the targeted reduction of 4% per year between 
1990 and 2000, and the rest of the countries showed either an increase or a nominal decline in 26 
mortality.
4 Similarly, another analysis for the year 1990 and 2004 in 60 countries with the 
highest mortality showed only 7 countries to be on track, 39 making nominal progress and 14 
off-track (serious concern category).
5 This analysis gave an overview of the progress and 
recommended country-specific and time-specific changes in efforts and coverage of 
interventions in those countries which were lagging behind. It included equitable coverage of 
interventions to all economic strata in poor countries. 
Table 2.1. Millennium development goals, targets and indicators related to health 
   
Goal 1  Eradicate extreme poverty and hunger 
Target 1  Halve, between 1990 and 2015, the proportion of people whose income is less than one dollar 
a day  
Indicators  Proportion of population below one dollar a day 
Poverty gap ratio (Incidence * depth of poverty) 
Share of poorest quintile in national consumption 
Target 2  Halve, between 1990 and 2015, the proportion of people who suffer from hunger 
Indicators  Prevalence of underweight children under five years of age 
Proportion of population below minimum level of dietary energy consumption 
Goal 2   Achieve universal primary education 
Target 3  Ensure that, by 2015, children everywhere, boys and girls alike, will be able to complete a full 
course of primary schooling 
Indicators  Net enrolment ratio in primary education 
Proportion of pupils starting grade 1 who reach grade 5 
Literacy rate of 15-24 year-olds 
Goal 3  Promote gender equality and empower women 
Target 4  Eliminate gender disparity in primary and secondary education, preferably by 2005, and at all 
levels of education no later than 2005 
Indicators  Ratio of girls to boys in primary, secondary and tertiary education 
Ratio of literate women to men, 15–24 years old 
Share of women in wage employment in the non-agricultural sector 
Proportion of seats held by women in national parliament 
Goal 4   Reduce child mortality 
Target 5  Reduce by two-thirds, between 1990 and 2015, the under –five mortality rate 
Indicators  Under-five mortality rate 
Infant mortality rate 
Proportion of one-year –old children immunized against measles 
Goal 5   Improve maternal health   
Target 6  Reduce by three-quarters, between 1990 and 2015, the maternal mortality ratio 
Indicators  Maternal mortality ratio 
Proportion of births attended by skilled health personnel 
Goal 6  Combat HIV/AIDS, Malaria and other diseases 
Target 7  Have halted by 2015 and begun to reverse the spread of HIV/AIDS 
Indicators  HIV prevalence among pregnant women aged 15-24 years 
Condom use rate of the contraceptive prevalence rate 
Condom use at last high-risk sex 
Proportion of population aged 15–24 years with comprehensive correct knowledge of 
HIV/AIDS 
Contraceptive prevalence rate 
Ratio of school attendance of orphans to school attendance of non-orphans aged 10-14 years 
Target 8  Halve halted by 2015 and begun to reverse the incidence of malaria and other major diseases 27 
Indicators 
 
 
Prevalence and death rates associated with malaria 
Proportion of population in malaria-risk areas using effective malaria prevention and treatment 
measures 
Prevalence and death rates associated with tuberculosis 
Proportion of tuberculosis cases detected and cured under DOTS (Directly observed short-
course) 
Goal 7  Ensure environmental sustainability 
Target 9  Integrate the principles of sustainable development into country policies and programs and 
reverse the loss of environmental resources 
Indicators  Proportion of land area covered by forest 
Ratio of area protected to maintain biological diversity to surface area 
Energy use (kg oil equivalent) per US$1 GDP (PPP) 
Carbon dioxide emissions per capita and consumption of ozone-depleting CFCs (ODP tons) 
Proportion of population using solid fuels 
Target 10  Halve by 2015 the proportion of people without sustainable access to safe drinking-water and 
sanitation 
  Proportion of population with sustainable access to an improved water source, urban and rural 
Proportion of population with access to improved sanitation, urban and rural  
Target 11  By 2020 to have achieved a significant improvement in the lives of at least 100 million slum 
dwellers 
  Proportion of households with access to secure tenure. 
Goal 8  Develop a global partnership for development 
Target 12  Develop further an open, rule-based, predictable, non discriminatory trading and financial 
system 
Target 13  Address the special needs of the least developed countries 
Target 14  Address the special needs of landlocked countries and small island developing states 
Target 15  Deal comprehensively with the debt problems of developing countries through national and 
international measures in order to make debt sustainable in the long term 
Target 16  In cooperation with developing countries, develop and implement strategies for decent and 
productive work for youth 
  Unemployment rate of young people aged 15–24 years, each sex and total 
Target 17  In cooperation with pharmaceutical companies provide access to affordable, essential drugs in 
developing countries 
  Proportion of population with access to affordable essential drugs on a sustainable basis 
Target 18  In cooperation with the private sector, make available the benefits of new technologies, 
especially information and communications 
Indicators  Telephone lines and cellular subscribers per 100 people 
Personal computers in use per 100 people 
Internet users per 100 people 
   
Adapted from United Nations declaration:  http://www.undp.org/mdg/basics.shtml   accessed on 18 
September 2008
6 
2.2.  Status of the world’s children 
Almost 130 million children are born every year. Approximately 11 million die before attaining 
the age of five years, out of which more than four million children die in the Asia and Pacific 
region alone.
7 Most of these deaths are in low and middle-income countries. Table 2.2 shows 
that developing countries fall into low, lower-middle and upper-middle income categories, and 
that these account for quite a range of possible incomes. 90% of the child deaths occur in just 
42 countries of the world and 50 % in just five countries.
8  28 
Table 2.2. World Bank classification of the economies of member countries 
Categories    Gross National Income per capita 
(2007) in US$ 
Low Income    935 or less 
Lower middle income  Developing countries  936 - 3,705 
Upper Middle income  Most child deaths  3,706 – 11,455 
High Income    11,456 or more 
Adapted from World Bank figures
9 
2.2.1.  Causes of Child Mortality 
The World Health Organization (WHO) presented estimates of medical causes of under-five 
deaths in geopolitical regions for the years 2000 to 2003. The estimates are shown in Figure 
2.2. The figure shows that a considerable percentage of under-five deaths (37%) occur during 
the first 28 days of life – the neonatal period.
10 The next most important categories of mortality 
are acute respiratory infections (19%), diarrhoea (17%), malaria (8%), measles (4%), and 
HIV/AIDS (3%). The majority of listed causes are preventable and treatable, such as malaria, 
measles, diarrhoea and acute respiratory infections.  
Figure 2.2. Causes of deaths in children under five, 2002 - 2003 
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11 
2.2.2.  Child Survival and Malnutrition 
Malnutrition among children still causes major public health problems in many countries.
12 In 
South Central Asia alone, 40% of preschool children were stunted (71.5 million), 41% 29 
underweight (73.4 million) in the year 2000 and 15%  wasted in the year 1995.
13,
14 In 1968, 
Scrimshaw described a synergistic effect between malnutrition and infection (Figure 2.3).
15  
Poor nutritional status makes children more susceptible to infections by lowering immune 
status. Infections in turn lower the nutritional status of the children by lowering appetite and gut 
absorption of nutrients (reduced protein absorption by 20 to 30% in diarrhoea, vitamin A 
malabsorption in systemic febrile illness); and by increasing metabolic rate (catabolism of 
musle protein for gluconeogenesis, participation of hormones regulating carbohydrate 
metabolism in host defence, anabolism of amino acids for synthesis of immunoglobulin and 
lymphokines) and by changing nutrient levels in the body - lipids, vitamin A (reduced in acute 
respiratory infection, , measles, gastroenteritis), riboflavin (reduced in sandfly fever), iron (in 
malaria) and ascorbic acid, for example.
16 Malnourished children are more likely to die from 
infectious disease
17 and undernutrition (low weight-for-age) is a leading underlying cause for 
more than half of under-five mortality among children in developing countries. Mild to 
moderate malnutrition is responsible for as much as 87% of child deaths, in comparison to 
severe malnutrition.
18 
Figure 2.3. Pathways of malnutrition and child mortality 
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Figure 2.4 shows how under-five mortality has been categorized into age groups. Since there 
has been a considerable decline in post-neonatal mortality due to vaccines, treatment of 
infections and oral rehydration therapy, there is a pressing need to address the problem of 
neonatal mortality.
19 The first seven days of life- the early neonatal period - is a crucial period. 
Three-quarters of neonatal deaths occur in this period, mainly within 24 hours of birth. A meta-
analysis from six developing countries showed preterm delivery as the leading cause of early 
neonatal death, followed by asphyxia and birth trauma, congenital anomalies, unknown causes 
and infections respectively.
20  
Figure 2.4. Categorization of under-five mortality 
 
The inclusion of stillbirths with early neonatal deaths constitutes perinatal death. It is estimated 
that for every neonatal death there is one stillbirth. Perinatal death alone is responsible for 7% 
of the total global burden of disease.
21 It is ranked third after lower respiratory tract infections 
and diarrhoeal diseases. (Table 2.3) 
Neonatal deaths account for two-thirds (64%) of infant mortality.
1;22 The main causes of death 
in the neonatal period have been identified and are depicted in Figure 2.5, which shows that 
prematurity presents the greatest risk for neonatal deaths (28%). Sepsis contributes the second 
most to neonatal death (26%), followed by asphyxia (23%). Congenital anomalies, tetanus and 31 
diarrhoea contribute a small part to the overall causes of deaths, just 16% when combined 
together.
19 
Figure 2.5. Causes of neonatal deaths 
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19 
In summary, neonatal mortality is mainly due to perinatal events, whereas post-neonatal 
mortality is mainly due to environmental factors. Early neonatal death is mainly due to 
asphyxia, preterm birth and congenital defects and late neonatal death is predominantly due to 
infections. 
Table 2.3. Leading global burden of disease, 1990 
Disease/Injury  DALYs (thousands)  % of total 
Lower Respiratory Infection  112898  8.2 
Diarrhoeal Disease  99633  7.2 
Perinatal condition  92313  6.7 
Depression  50810  3.7 
Ischemic Heart Disease  46699  3.4 
Cerebrovascular Disease  38523  2.8 
Tuberculosis  38426  2.8 
Measles  36520  2.7 
Road Traffic Accident  34317  2.5 
Congenital Anomaly  32921  2.4 
Adapted from Lopez 2005
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2.2.3.  Child survival and low birth weight 
Approximately 130 million infants are born every year. Usually, the only birth size indicator 
measured at birth is weight. Of the babies born, 14% weigh less than 2500 g – low birth weight. 
Back in 1985, McCormick and colleagues noted that low birth weight was one of the major 
causes of neonatal mortality
23. Low birth weight was responsible for 60-80% of neonatal 
deaths. It has been shown to have a strong relationship with infant mortality: the cut-off point 
of 2500 g was mortality-based.
24 
Birth weight has been demonstrated to be a sensitive indicator of neonatal and post-neonatal 
mortality as shown by birth weight specific mortality (Table 2.4). Low birth weight infants are 
more prone to sepsis due to altered immunity
25, asphyxia, hypothermia and feeding problems.
26 
Term low birth weight infants weighing 2000 – 2499 g have 4 and 2 times higher risk 
respectively of neonatal and post-neonatal mortality than infants weighing 2500 - 3000 g. 
Likewise, they have 10 times and 4 times higher neonatal and post-neonatal mortality than 
infants in the weight group 3000-3499 g.
27 
Low birth weight is a result of preterm birth, retarded intrauterine growth or a combination of 
both. The majority of low birth weight in developing countries is due to growth retardation. 
Preterm delivery is directly causal in 28% of neonatal deaths and term intrauterine growth 
retardation in 1-2% of neonatal deaths.
19 Growth retarded infants not only suffer intrapartum 
asphyxia, low apgar scores and meconium aspiration during late pregnancy, they are also prone 
to hypothermia due to reduced body fat mass, polycythemia secondary to hypoxia, 
hypocalcemia and hypoglycemia in the early neonatal period. Term growth retarded infants are 
born with low weight and less fat. They lack insulation and energy thus making them prone to 
hypothermia and poor growth. They may show catch-up growth during early infancy and attain 
a normal growth curve by one year of age. However, term growth retardation is linked with 
increased mortality, morbidity, disability, poor growth, cognitive development in children and 
morbidity in adults. 33 
Table 2.4. Relative risks of neonatal and post-neonatal mortality 
  Relative Risks 
Term birth weight (g)  Neonatal mortality 
(death within 28 days) 
Post-neonatal mortality 
(death between 28 days and 364 days) 
2000-2499  4  2 
2500-2999  1  1 
3000-3499  0.4  0.5 
3500-3999  0.3  0.5 
Adapted from 
27 
 
2.2.4.  Childhood morbidity and low birth weight 
The important consequences of low birth weight on childhood morbidity include disabilities, 
hospitalization.
28 poorer language development
29, diarrhoeal disease
30 and acute respiratory 
infections.
30 Cognitive, psychological, behavioural and educational deficits may also be seen
31. 
2.2.5.  Size is important 
The above evidence confirms the importance of birth weight to childhood and adult health and 
survival. However, there is more to birth size than just low birth weight. Very few studies have 
gone beyond low birth weight to investigate the importance of other dimensions of birth size, 
especially in developing countries, where fetal growth retardation and child mortality is 
common. Little is known about the association of other dimensions of size at birth with 
childhood and adult outcomes.  
The importance of size at birth has increased with the advent of the fetal origins hypothesis 
(now known as the Developmental Origins of Health and Adult Disease, DOHAD), which 
states that adult disease is programmed in utero through influences which alter fetal growth. 
Programming is the process of adaptation of the fetus to nutrition by altering the metabolic, 
physiological and structural parameters of the body.
32 Fetal malnutrition (adverse intrauterine 
environment) may occur in any phase of fetal development and for variable duration and 
severity (acute and chronic malnutrition). Each fetus has its own genetic potential and 
intrauterine environment, which influences fetal growth pathways. Infants with similar weights 
at birth could have other different birth dimensions - length, head circumference, body mass 
index, ponderal index, abdominal circumference, gestational duration and so on. Birth weight is 34 
the most studied anthropometric parameter among many that could describe fetal size, prenatal 
growth and birth size. It is used as a marker of the intrauterine environment. However, it is just 
a crude marker of fetal growth. 
Different anthropometric measurements have different implications. For instance, head 
circumference reflects brain size and growth.
33 Small head circumference indicates poor 
development of the brain - as seen in symmetrically growth-retarded infants – and is associated 
with compromised cognitive development and poor intellectual performance.
34 A strong 
association of birth length with development at 12 months has been demonstrated, and there 
appears to be an association with blood pressure in adulthood.
35-37 
Duration of exposure to intrauterine malnutrition manifests as proportionate growth retardation 
and disproportionate growth retardation, a feature of adaptation. Chronically malnourished 
fetuses present with proportionate growth retardation. This is manifested as visually 
appreciable change in birth size parameters especially smaller head circumference, shorter 
length and reduced weight and altered tissue mass. Similarly, acutely malnourished fetuses 
present with disproportionate growth retardation: normal birth weight and length, with wasting. 
The importance of the opposite end of the spectrum of birth weight has also been recently 
recognized. Infants who are bigger at birth are more prone to obesity
38, an increasing public 
health problem in developed countries and an emerging one in developing countries.  
2.3.  Cost of abnormal birth size  
Cost of providing care for low birth weight infants is high not only for families, but also for 
health services and communities. Because of its array of short term and long term 
complications, LBW imposes an enormous economic and emotional burden on the family 
throughout life. In developing countries where the problem is epidemic, health services and 
systems face functional difficulties. Modern technology for management of affected infants is 
next to impossible for the time being. Setting up whole health systems is a major challenge in 35 
itself. Preventive care and intervention might be more cost effective than the management of 
the problem and its complications. For example, Borghi et al recommended a participatory 
intervention with a women’s group in the rural setting of Nepal where supply side interventions 
are probably not feasible on a large scale because of the vast resource requirements.
39 The 
intervention offers an affordable means of reducing neonatal mortality and could benefit from 
expansion. Mass production of interventions like prenatal iron and folate supplements cost an 
estimated less than $1 per person throughout pregnancy, and might improve birth outcomes 
among women in developing countries. 
2.4.  Measurements of size at birth 
Anthropometry is the external measurement of the human body and is used to assess nutritional 
status, growth and development. Anthropometric measurements at birth are the easiest, quickest 
and most inexpensive method of estimating body size and identification of newborn infants at 
risk for adverse outcomes. Anthropometric measurements in common use are birth weight, 
length and head circumference, but mid-upper arm circumference, abdominal circumference 
and chest circumference are sometimes used. These anthropometric measurements can be 
assessed against gestation at birth, but this is not always done. Although it is not 
anthropometric, since gestation at birth is one of the important determinants of birth size, a 
section on it is included. 
2.4.1.  Birth weight  
Birth weight is the first weight of an infant measured after delivery. It does not take account of 
gestation, but is one of the most important and widely used anthropometric measurements. 
Weight is used for assessment of fetal growth and also to imply the maturity attained by birth. 
The newborn infant loses 10% of birth weight in the first week and, if all remains well, regains 
it in the next few days. Therefore, it is important to weigh the infant within the first hour of 
birth, preferably before significant postnatal weight loss occurs. It is essential to note the age 
and time at which birth weight is measured. Current intervention studies accept measurements 36 
of birth weight made within the first 72 hours. This is a compromise between accuracy and 
feasibility. 
2.4.1.1  Measurement 
Birth weight can be measured with a spring or beam balance or precision electronic scales. It is 
measured in grams. The measurement of birth weight is not consistent and tends to show inter-
observer and intra-observer variation. The reliability and validity of weighing scales should be 
checked and calibrated from time to time. It is problematic if the weighing scale does not have 
an infant pan. In this event, the mother is weighed with and without the infant and the 
difference is equated with the weight of the infant.  
Depending on the birth weight, newborn infants are categorized into 5 groups, low birth weight 
(<2500 g), very low birth weight (<1500 g), extremely low birth weight (<1000 g), normal birth 
weight (>2500 - <4000 g) and high birth weight (>4000 g). These strata have different survival 
rates and require different levels of care. 
2.4.1.2  Practical problems 
In developing countries, it is often not possible to achieve consistency in birth weight data for 
the following reasons. Firstly, the weighing scale used may not be up to international standards. 
Secondly, the weighing scale may not be reliable and valid because of lack of calibration at 
intervals and lack of durability. Thirdly, it may not feasible to weigh the infant within the first 
hour of birth because most deliveries occur at home. Table 2.5 shows how uncommon birth in 
hospital with a skilled attendant is in some Asian countries. In Nepal, the figure for home birth 
is 92%.
40 
As can be noted from the classification, the cut-off point used for the definition of normal and 
low birth weight infants is a fine line. Infants with birth weight of 2499 g are termed low birth 
weight while those of 2500 g are not. This is complicated by observation error and digit 37 
preference while recording birth weight. Digit preference is the tendency of the observer to 
prefer terminal digits such as 0 or 5, so that infants of fractionally less than 2.5 Kg are 
classified as 2.5 Kg. This hides the real picture of the incidence of low birth weight and should 
be avoided or corrected when analyzing data and interpreting results.
41 
Table 2.5. Place of birth 
Country  Home 
delivery 
Skilled Birth 
Attendant 
Traditional 
Birth 
Attendant 
Source 
Nepal  92%  19%  -  NFHS 1996
40  
India  65%  42%  35%  NFHS-2
42 
Bangladesh  92%  12%  64%  WHO
43 * 
Pakistan  >89%  _  80%  National health survey of Pakistan 1990-94
44 
Indonesia  90%  37%  _  Ronsmans 2001
45 
* http://www.whoban.org/skill_birth_training.html accessed on 19th September 2008 
2.4.2.  Gestation 
2.4.2.1  Definition 
Gestation is the period of development from conception to birth. The average duration of 
gestation is 280 days or 40 weeks. Gestational age and rate of fetal growth determine the size of 
an infant at birth. Clinical decisions for management and resource allocation largely depend 
upon gestational age at birth and birth weight. The importance of correct estimation of 
gestational age has been recognized for a long time and studies have been carried out to test 
methods of assessing it.
46;47 In recent years, because of the necessity to differentiate small-for-
dates infants from appropriate-for-dates infants who are born prematurely (Dubowitz), 
assessment has gained more value as small-for-dates infants are at risk from different 
conditions than appropriate-for-gestational-age infants. Furthermore, neurological behaviour in 
the neonatal period depends on gestational age and assessment helps to interpret it and the 
subsequent development of the infant.
48 38 
2.4.2.2  Measurement of gestational age 
Many parameters have been used to estimate gestational age, but none of them is error free. Of 
interest are: biological methods using basal body temperature; last normal menstrual period; 
ultrasound scan using fetal crown-rump length, biparietal diameter, femur length and abdominal 
circumference; clinical methods such as measurement of the height of the uterus per abdomen 
from the symphysis pubis (symphysio-fundal height), asking about the first movement of the 
fetus felt by the mother (quickening), fetal heart sound detection and immunological methods 
such as urine luteinizing hormone (LH) and human chorionic gonadotropin (hCG).
49,
50 The 
commonest method is a combination of reliable recall of last normal menstrual period and early 
ultrasound scans.
51-53 
In the postnatal period, gestational age can be estimated by a scoring system depending on 
physical and nervous system maturation. In practice, such systems are too time consuming and 
cumbersome to use routinely. The methods of Parkin, Ballard, Dubowitz and Robinson are all 
options which can be used if the gestational age by menstrual dates is not compatible with the 
physical and neurological appearance of the newborn infant
54-56 . Figure 2.6 gives Ballard score 
for newborn maturity rating. Gestational assessment of this type, which is usually based on a 
summary score, is presumed to be accurate to within ± 2 weeks.
48 39 
Figure 2.6. Ballard score for the assessment of gestational age in infants after birth 
 
Extracted from
57 40 
2.4.2.3  Classification 
Depending on gestation, the newborn infant is classified into one of three categories: preterm, 
term and post-term (See Table 2.6). 
Table 2.6. Classification of newborn infants depending on gestation 
Preterm  Infants born at < 37 completed weeks (up to 36 weeks + 6 days or < 259 days) 
Term  Infants born between 37 and 41 weeks of gestation (259–293 days) 
Post-term  Infants born at term: > 42 weeks or > 294 days 
2.4.2.4  Practical problems associated with gestational age assessment 
Accurate estimation of gestational age is essential for the diagnosis of abnormal birth size like 
small-for-gestational-age. Gestational age estimation by last normal menstrual period is based 
on maternal recall which depends on the memory, guess-work and intention of the respondent. 
In 1988 Kramer demonstrated a systematic underestimation of gestation up to 37 weeks and 
progressive overestimation after 40 weeks.
47 Furthermore, estimation is complicated by other 
factors: use of oral contraceptives, irregular periods, bleeding in early pregnancy, ovulation 
bleeding, delayed ovulation and use of lunar months. Ultrasound estimation of gestational age 
in the early period of gestation is correct to within 7 days, but in developing countries where 
most of the population are poor estimation by ultrasound is an expensive, non-affordable, 
sophisticated and undesirable method.  
2.4.3.  Head circumference 
Occipito-frontal head circumference is routinely measured in many countries. It provides a 
clinical indication of head growth in utero, brain volume
58 and cerebrospinal fluid space. 
Although it has no simple relationship with brain growth, deviation from normal head 
circumference suggests intracranial pathology and may be related to intelligence, growth and 
development. It is an easy, reliable and reproducible means of assessing fetal growth which can 
be measured with a simple measuring tape.  41 
2.4.3.1  Measurement 
Head circumference is measured at the level of maximum circumference over the supra-orbital 
ridge anteriorly (glabella) and the occipital protuberance posteriorly. At birth, the term head 
circumference measures 31–38 cm. 
2.4.3.2  Classification 
Depending on head circumference, head size is classified in three categories: microcephalic, 
normal and macrocephalic. Microcepaly describes a head circumference which lies below the 
10th percentile, more than 3 SD below the mean or less than the 5th centile for age, sex and 
gestation. It may imply dysmorphic syndromes, isolated microcephaly, congenital infections, or 
intrauterine growth retardation. Macrocephaly describes a head circumference above the 90th 
centile for age, sex and gestation. (see Table 2.7). It may imply hydrocephalus or macrosomia 
Table 2.7. Cut-offs used for classification of infant head size 
  Cut-offs for age, sex and gestation 
Microcephaly 
<10
th
 percentile 
  >3SD below the mean 
 
<5
th
 percentile  
  <2SD 
Macrocephaly 
>90
th
 percentile 
2.4.3.3  Practical problems 
Although measurement of head circumference with a measuring tape seems like a simple 
procedure, it needs practice to get the right position. Special care should be taken while reading 
the decimals on measuring tapes. Bartram claims that the old worn out tape tends to stretch, 
which may not be clinically significant but is statistically significant.
59 It is especially important 
in developing countries where the measuring tape may not be replaced frequently. 42 
2.4.4.  Mid-upper arm circumference 
MUAC is a standard anthropometric measurement of nutritional status. It can be used as a 
proxy for birth weight
60;61, for which it has been described as a reliable predictor.
62;63 Some 
studies have shown that there is a direct association of mid-upper arm circumference with both 
birth weight and gestational age.
64;65 It is a useful tool especially for developing countries where 
women are illiterate and recall of last normal menstrual period is difficult, and where most 
deliveries are conducted at home and reliable weighing scales are not available. It is an easy, 
quick and reproducible anthropometric measurement. Curves for MUAC have been developed 
for newborn infants.
66;67 
2.4.4.1  Measurement 
MUAC is measured at the midpoint between the acromion process and the tip of the olecranon 
process. It is measured to the nearest 1 mm. 
2.4.4.2  Classification 
MUAC can be used to classify infants as normal birth weight and low birth weight, for which a 
cut-off point of 9 cm has the best combination of sensitivity and specificity.
63;68 (see Table 2.8) 
MUAC reference data are available for ages between 6 and 60 months.
69 For children between 
2 and 20 years old, percentiles are generally used. Those less than the 5th percentile are 
underweight while those above the 95th percentile are overweight. Children between the 85th 
and 95th percentiles are at risk of becoming overweight.
70 
Table 2.8. Classification of newborn infant based on mid upper arm circumference 
Mid upper arm circumference  Classification 
<9 cm  Low birth weight 
>9 cm  Normal birth weight 
 43 
2.4.4.3  Practical problems 
Although it is suggested as a useful tool for developing countries, MUAC is almost never 
measured at birth. Like other anthropometric measurements, there are chances of intra-observer 
and inter-observer variation. MUAC should be measured when the infant is relaxed. The 
observer should be careful not to squeeze the soft tissue but place the tape firmly on the arm. 
The measurement should be taken three times. Therefore, the observer should have enough 
practice before actually starting to take measurements. 
2.4.5.  Chest circumference 
Chest circumference is measured at the time of birth in some institutions, and is a pointer to 
intrauterine fetal growth. In a normal newborn infant, chest circumference is smaller than head 
circumference by about 2.5 cm, but becomes roughly equal to head circumference by the end of 
the first year and greater thereafter. 
A 1993 WHO collaborative study conducted in 22 centers of the world on 400 consecutive 
samples found that chest circumference could be used as a proxy to identify infants at risk of 
low birth weight. It could be used in communities where the accurate early weighing of 
neonates is not feasible.
71 A cut-off point of ≤ 29 cm could be used with high predictive value, 
sensitivity (91%) and specificity (94.7%) for the identification of intrauterine growth retarded 
infants.
72 
2.4.5.1  Measurement 
Chest circumference is measured at the level of the nipples. It is simple, easy to measure and 
does not require expensive equipment. 44 
2.4.5.2  Classification 
Chest circumference is one of the parameters used to distinguish between proportionate and 
disproportionate intrauterine growth retardation, which will be discussed later.  
2.4.5.3  Practical problems 
The chest moves with inspiration and expiration, which can make a difference to measurements 
if the observer is not careful enough. Circumference should be measured at maximum 
inspiration.  
2.4.6.  Crown-heel length 
Crown-heel length is a good measure of skeletal growth. Measurement of length is a routine 
part of the clinical examination of the newborn infant in many countries and is of importance in 
detecting abnormal skeletal growth. Crown-heel length is measured for infants and children of 
length ≤ 85cm.
73 Body height is measured for children with length > 85 cm. 
2.4.6.1  Measurement 
Length can be measured on a bespoke length meter with the infant in extended position. The 
heels should be placed against the foot piece with the head touching the base of the board and 
knees in an extended position. The measurement should be accurate to 1 mm. At birth, length is 
approximately 50 cm.
48  
   
2.4.6.2  Classification 
Length has been used to classify growth-retarded infants into proportionate and 
disproportionate intrauterine growth retardation, of which more later. 45 
2.4.6.3  Practical problems 
Two observers are required to do the measurements. It may be difficult to find a flat surface to 
place the length measurer in rural areas of developing countries. 
 
2.4.7.  Waist circumference 
Waist circumference is a measure of abdominal fat distribution (abdominal obesity), and has 
been related to increased risk of cardiovascular disease
74 and type II diabetes.
75 Obesity is an 
emerging public health problem in developed and developing counties. Waist circumference 
has recently been demonstrated to have a closer correlation with obesity-related risk factors for 
health than BMI.
76 
2.4.7.1  Measurement  
Waist circumference is an easy, non-invasive method of measuring abdominal obesity and does 
not require sophisticated equipment. It is measured at the level of the narrowest part of the 
abdomen or midway between the iliac crest and lower level of the ribs in the mid-axillary line. 
2.4.7.2  Classification 
Studies have chosen various cut-off points for defining obesity-linked health risk in terms of 
waist circumference. For instance, Wildman in 2004 found that the Chinese population was at 
lower risk of developing cardiovascular disease than western populations.
77 The WHO 
recommended cut-off point is ≥94 cm for men and ≥80 cm for women.
78 This is based on a 
western population. Deurenberg demonstrated that Asian populations were at risk at lower 
levels of waist circumference and should not use the cut-off based on data from western 
subjects.
79 Cut-off points should be sex specific and ethnicity specific. A recent retrospective 
study on 2746 people aged 18-72 years with body mass index 18–60 kg/m
2 and waist 46 
circumference 65–150 cm showed that waist circumference was an independent risk factor for 
insulin resistance. Waist circumference <100 cm excluded insulin resistance.
78 
Table 2.9. Cut-off points for waist circumference 
  Increased risk  Substantially increased risk 
Men  94 cm or more  102 cm or more 
Women  80 cm or more  88 cm or more 
Adapted from
78 
2.4.7.3  Practical problems 
Different studies have used different methods of measurement. Some have used the natural 
waistline while some have used the mid-point between the highest point of the hip and lower 
ribs in the mid-axillary line. We have been unable to find internationally recommended cut-offs 
for waist circumference in newborn infants. 
2.5.  Composite indices of size at birth 
The most commonly used indices for measurements of nutritional status and growth in children 
are weight-for-age, weight-for-height, and height-for-age. However, these indices are not 
generally used for newborn infants. The commonest indices in use are body mass index and 
ponderal index.  
2.5.1.  Body Mass Index 
BMI (Quetelet’s index) is an anthropometric measurement of nutritional status based on ideal 
weight-for-height. It was first described by Adolphe Quetelet, between 1830 and 1850. BMI is 
defined as weight (in Kg) / height squared (in m
2). BMI is a validated measurement of adiposity 
in adults and probably in children and adolescents (5-20yrs)
80;81, and is a marker of 
cardiovascular risk: blood pressure, lipids and serum insulin
81;82, diabetes and heart disease and 
asthma in children.
83 47 
Although it attempts to describe size, BMI does not take into account the percentage of fat, 
muscle or bone. Again, although it is a well-known index, BMI is little used in young children. 
Different ultrasonically derived growth standards for fetal size parameters for different 
gestational ages are available to determine the optimum growth achieved: biparietal diameter
84, 
head circumference, abdominal circumference
85, femur length
86 and different growth standards 
for newborn infants are also available for gestational age, sex, and ethnic groups. It has not 
been possible to find literature that has used BMI standards or reference data for the fetus and 
newborn infant, apart from a paper by Odland, which used body mass index in newborn infants 
to compare the effects of essential trace elements in maternal serum on birth size.
87 
2.5.2.  Ponderal Index  
PI has been used as an indicator of fetal growth. It was described by Lubchenco in 1966 for the 
detection of intrauterine growth retardation.
88;89 The index is calculated by dividing birth weight 
in grams by the cube of crown-heel length in centimetres (and therefore is expressed in g/cm
3). 
PI is a gender- and gestation-independent neonatal variable which is an important indicator of 
fetal malnutrition. 
2.5.2.1  Normal values 
In general terms, a value of 2.5 g/cm
3 is considered normal in neonates
90, while a value of less 
than 2 g/cm
3 is considered low for a child. Morris has classified infants with values <2.6 as low 
PI, 2.6-2.8 as average and ≥2.8 as high.
91 
2.5.2.2  Classification of infants  
PI has been used to categorize small-for-gestational-age infants with intrauterine growth 
retardation into proportionate and disproportionate groups.
92 IUGR infants with low PI - below 
the 10th percentile - are disproportionate or asymmetrically growth retarded and wasted. Only 
the weight of the infant is compromised. This is presumed to be due to acute or subacute 48 
intrauterine malnourishment. Basically, infants are ‘longer and thinner’. It seems that this type 
of IUGR is more likely to be seen in developed countries.
93 
93 IUGR infants with PI above the 
10th percentile are proportionate. Proportionate growth retarded infants have appropriate PI and 
are assumed to have been chronically malnourished in utero. Weight and length are both 
compromised. This type is seen mostly in developing countries. Infants with PI above the 90
th 
percentile have high PI. They are ‘shorter and fatter’. Therefore, PI is also referred to as a 
measure of fatness.  
2.5.2.3  Ponderal index and outcome 
Studies have described the effect of PI on neonatal outcome. Although birth weight-for-
gestational-age and birth weight percentile are used for diagnosis of growth retardation, 
Walther and Fay’s studies found PI to be equally or more useful to predict neonatal problems 
and intrauterine growth problems respectively.
94;95 A Guatemalan study
96 showed that term 
IUGR classified by PI for gestational age (low, intermediate, high and appropriate) had 
different neonatal outcomes. Infants with low PI (below 10
th percentile) had the highest 
morbidity and those with high PI (above 90
th percentile) the lowest. There is evidence that body 
proportionality is itself related to morbidity, as shown by the higher morbidity in normal birth 
weight infants with low PI.
96;97 
2.6.  Classification of size at birth 
Birth anthropometric measurements are usually aimed at detecting an abnormality in birth size, 
especially LBW and IUGR. This section will deal with the basic concepts and causal factors of 
entities such as LBW, macrosomia, small-for-gestational-age, large-for-gestational-age, 
microcephaly, macrocephaly, proportionate and disproportionate IUGR (low PI). For the 
purposes of the thesis, we have developed the framework summarized in Figure 2.7. The 
framework allows us to classify abnormal birth size in three ways: based on a single 49 
measurement, a relation between a single measurement and gestational age, and a composite 
index based on more than one measurement. 
Figure 2.7. Classification of abnormal size at birth 
. 
2.6.1.  Single measurement: birth weight 
An anthropometric parameter may be used to describe infant size at birth, irrespective of 
gestational age, sex and ethnicity. The obvious example is birth weight, which is often 
classified into three groups: low, normal and high. High birth weight is defined as a birth 
weight of more than 4000 g. Risk factors for high birth weight include maternal obesity, 
prolonged gestational duration and gestational diabetes. High birth weight infants are prone to 
low blood glucose in the early neonatal period, shoulder dystocia, cerebral palsy, obesity and 
type 2 diabetes in later life. Low birth weight is defined as a birth weight of less than 2500 g. 
There are two main causes: prematurity and intrauterine growth retardation. Infants born before 
37 weeks of gestation are termed preterm or premature, and those born after 37 weeks of 50 
gestation are term. Most preterm infants are LBW. IUGR infants are those whose weight for 
gestational age is below the 10th percentile. 
2.6.2.  Relation between single measurement and gestational age 
Birth size for gestational age adds the time dimension, and is therefore more meaningful than a 
measurement of size alone. Separate reference standards are available for infant sex and 
ethnicity. Birth weight for gestational age is one of the most commonly used parameters to 
describe size at birth. Authors have used different cut-off points in studies to classify the 
newborn infant. These are summarized in Table 2.10.  
Table 2.10. Cut-offs used for classification of newborn infant size for gestational age 
Classification  Cut-offs used  Authors 
Small-for-gestational-age 
(Small-for-dates) 
<10th percentile for gestational age  Usher et al., 1969 
98 
Goldernberg et al., 1989 
99 
  <3rd percentile for gestational age  Starfield et al., 1982
100 
  <5th percentile for gestational age  Fitzhardinge et al., 1972
101 
Michaleis et al., 1970
102 
Appropriate-for-gestational-
age 
(Appropriate-for-dates) 
 
Between 10th and 90th percentile  Most authors 
Large-for-gestational-age 
(Large-for-dates) 
>90th percentile for gestational age  Most authors 
     
AGA infants are ‘normal’ size for gestational age. Most studies have used a cut-off of between 
the 10
th and 90
th percentiles for gestational age. SGA is a function of birth size and gestational 
age, not a diagnosis of a pathological condition.
103 It may describe a constitutionally small 
infant as well as an infant with growth retardation. Statistically, SGA also includes 10% of 
infants with normal growth if a cut off point of the 10
th percentile is used for definition. This 
means that infants can be classified as normal SGA, abnormal SGA and growth restricted.
103 
Normal SGA infants are SGA infants with no growth restriction and no fetal abnormality. 
Abnormal SGA infants are SGA infants with fetal causes - chromosomal, structural or 
infective. SGA infants who are small due to placental dysfunction are categorized as having 
fetal growth restriction. Since they represent one end of the spectrum, it is thought that normal 
SGA infants are no different neurodevelopmentally from AGA infants.
104  51 
There is no uniformity in the use of parameters and cut-off points across studies. Different cut-
off points for different fetal parameters have been used to define SGA, including birth weight, 
length and abdominal circumference.
105,
103 This brings more confusion to the detection of SGA 
and to comparison between studies. WHO has recommended the use of the sex-specific, single 
or twin-specific 10
th percentile of birth weight for the classification of SGA.
69;106 
Most studies have used a cut-off point of <10
th percentile for gestational age to define SGA. 
Some have used <3
rd percentile or >2SD below the mean or 5
th
 centile as the cut-off point. 
Similarly, the most commonly used parameter is birth weight below the 10
th percentile on a 
gestational age chart. Smith and Colleagues have used fetal abdominal circumference for the 
prediction of small-for-dates infants, since it is the best predictor of fetal weight. The cut-off 
used is 2 SD below the mean for gestational age, which corresponds with the 2.5
th percentile.
107  
2.6.2.1.1  Large-for-gestational-age 
Infants with birth weight > 90
th percentile for gestational age are categorised as large-for-
gestational-age (large-for-dates). Both ends of the spectrum of the size of newborn infants are 
associated with problems. Small-for-dates and large-for-dates infants have increased mortality 
and morbidity and more chance of developmental problems. Large-for-gestational-age infants 
are at risk of obesity and subsequent cardiovascular disease
108;109 and type 2 diabetes 
mellitus.
110 
2.6.2.2  Head circumference for gestational age 
Normally, an infant’s head circumference is about 2 cm larger than her chest circumference. 
There are two abnormal head size categories for gestational age: microcephaly and 
macrocephaly, both of which are associated with abnormal brain growth. Brain growth occurs 
during the intrauterine phase and the first 2 years of life, so that micro- and macrocephaly may 
be present at birth or develop during the early years of life. 52 
Microcephalic infants have head circumference below 2 SDs of the mean for gender, age and 
race. Microcephaly, as mentioned above, is either congenital or develops in the first few years 
after birth. Common causes include genetic problems, syndromes, chemical exposures, 
radiation, alcohol, drugs, and intrauterine infections. Later in life, microcephalic children may 
present with neurological problems such as convulsions, developmental delay, hyperactivity 
and spastic quadriplegia. 
Head circumference above 2 SDs of the mean for gender, age and race is termed macrocephaly. 
It may present at birth or develop later in life, and is often due to abnormal brain growth. Some 
infants’ heads may be constitutionally large. Macrocephaly may also be genetic (osteogenesis 
imperfecta, agenesis of corpus callosum, achondroplasia), or due to hydrocephalus or 
intracranial bleeding. There are important associations with low intelligence and learning 
difficulties. 
2.6.3.  Intrauterine growth retardation 
Intrauterine growth is a complex dynamic process determined by the interaction of maternal, 
uterine, placental and fetal factors. Each fetus has its own growth potential, which is both 
genetically determined and influenced by environmental factors such as maternal height and 
nutritional status. An infant is said to be growth retarded if she fails to reach or follow the 
genetically determined growth trajectory for a given gestational age. This may be due to 
intrauterine insult by single or multiple etiological factors, but the mechanics of the effect are 
poorly understood. Since growth is dynamic, at least two intrauterine assessments of fetal size 
are required to trace the course of growth and to diagnose IUGR.
111 It is recommended that fetal 
size be assessed at four-to-six week intervals for the correct diagnosis of IUGR.
112 
The prenatal detection of abnormal fetal growth is important. Growth retardation has been 
related to perinatal morbidity
113 and mortality
114;115 and clear distinction of growth-retarded 
infants is necessary. However, small-for-gestational-age and IUGR have been used 53 
interchangeably although they are not identical.
116 Small-for-gestational-age is simply a 
description of the size of an infant at a particular gestational age. Small-for-gestational-age 
infants may be small but not necessarily growth retarded. They may also be constitutionally 
small on the basis of ethnicity, parity, maternal weight and height. This distinction can avoid 
unnecessary intervention during pregnancy, which is directly linked to the safety of the mother 
as well as appropriate use of resources. Furthermore, the issue of small-for-gestational-age 
versus IUGR has confused clinicians as well as researchers and hampered them from a clear 
vision of the causes, consequences and clinical management of growth retarded small-for-
gestational-age infants.  
2.6.3.1  Diagnosis of intrauterine growth retardation  
In developing countries where ultrasonography is expensive and is not a routine investigation, 
diagnosis is based on clinical suspicion when there is low maternal weight gain, lag in fundal 
height by 4 cm or greater, or when there is an incidental finding on ultrasound of fetal 
measurements smaller than expected for gestational age.  
As mentioned above, the diagnosis of intrauterine growth retardation should not be based on a 
single estimate of fetal size. Customized and non-customized fetal biometric charts have been 
produced by researchers for the screening of fetuses.
117;118 Non-customized fetal growth charts 
have been used conventionally. They allow assessment of fetal size against gestational age for 
males and females. Customized charts are adapted for individual pregnancies and take into 
account physiological variables that are documented to have a significant effect on intrauterine 
growth: maternal ethnicity, parity, height, and weight at first visit. Their use reduces false 
positive diagnosis of IUGR. There are also other methods for detection of intrauterine growth 
retarded infants, such as uterine artery Doppler abnormalities, cardiotocography, and fetal 
venous Doppler, but all of these require sophisticated equipment. 54 
Chapter 3.  Knowledge of size at birth  
3.1.  Chapter summary 
This chapter describes what is already known on this area of study and reviews global and 
regional status of low birth weight. It tells us how most studies are focused on birth weight and 
underscores the dubiousness of its role in understanding adverse consequences like neonatal 
and infant mortality. It highlights the lack of investigation of other parameters of birth size.
    
3.2.  Low birth weight  
Low birth weight is a major problem and a challenge to most developing countries because of 
its high prevalence (16.5%)
119, its multiple and complex associated factors (maternal, placental, 
fetal or combination)
120, and its major contribution to the mortality and morbidity of neonates, 
infants and adults. The influence of intrauterine growth on adult health has recently developed 
into a field of study in its own right: the Developmental Origins of Health and Adult Disease 
(DOHAD). 
Table 3.1 summarizes a number of factors that have been assumed to have a causal association 
with premature low birth weight and low birth weight with growth retardation.  55 
Table 3.1. Causes of low birth weight in newborn infants born preterm and growth 
retarded 
Causes of Low Birth weight 
Prematurity  Intrauterine growth retardation 
Maternal 
Pre-eclampsia, pregnancy-induced hypertension
121 
Chronic illnesses: heart, kidney 
Acute illnesses: Urinary tract infections
122, vaginal 
infections (Group B streptococcus) 
123-125 
Drug use: cocaine, alcohol, smoking 
Uterine abnormality: unicornuate, bicornuate uterus 
Cervical incompetence 
126;127 
Previous preterm delivery
128 
Polyhydramnios 
Premature rupture of membrane 
124 
 
Chronic maternal illnesses: diabetes, 
hypertension, heart disease 
Infections - Cytomegalovirus, Rubella, 
Toxoplasmosis, Herpes 
129 
Abuse: smoking, alcohol, drugs 
Immunologic: Anti-phospholipid syndrome
130 
Metabolic: Phenylketonuria
131, Poor maternal 
nutrition 
Low socioeconomic status 
Fetal 
Infections 
Multiple pregnancies  
Congenital defects 
 
 
Multiple pregnancies 
Genetic disorders: Triploidy, Trisomy 13
132 
 
Placental 
Infections 
Structural malformation: Placenta praevia
133;134, 
Placental abruption
135 
 
Placental insufficiency: Pre-eclampsia, 
Idiopathic elevated maternal alpha-feto-
protein 
Structural malformation of placenta- 
Placental abruption
135, Placental 
praevia
136;137, Circumvallate placenta
138, 
Placenta accrete
138 
Low birth weight infants have 20 times more odds of dying than heavier infants.
119 It is 
generally believed that timely prevention, detection and intervention may improve the outcome 
of LBW. However, definite measures have not been well understood. It is the intricate nature of 
LBW that has led researchers and governments to spend much energy, resources and research 
on finding the most effective solution. It is not only a problem of poor countries but also a 
problem of the poorest groups in wealthier countries. However, differences lie in the cause of 
LBW in poor and well-off countries.  
In developed countries, prematurity of unknown cause makes a major contribution to LBW, 
while in developing countries IUGR is the most important cause.
139 This statement is supported 
by Table 3.2, published by Belizan and colleagues.
140 The information is clearly depicted by 
Figure 3.1 and Figure 3.2. This shows that both developed and developing countries have 
almost the same proportion of premature infants, but different prevalence of LBW. This implies 
that the higher percentage of LBW in less affluent societies is due to term LBW, and presumed 
IUGR. As the prevalence of LBW increases, the percentage of term LBW increases. For 
instance, in developing countries like Guatemala, especially in the less affluent areas, the 56 
percentage of LBW is high. There are higher numbers of LBW infants born at term, compared 
with preterm infants. The number of preterm infants contributing to the total prevalence of 
LBW is almost the same in developed and developing countries, supporting the fact that the 
high incidence of LBW in less affluent societies is due to term LBW, which is not the case in 
the affluent societies. 
Table 3.2. Contribution of preterm and term to LBW, by proportion of infants born LBW 
    Proportion of LBW 
infants 
Proportion of all infants 
  Proportion of 
infants born 
LBW 
Preterm 
 (%) 
Term 
 (%) 
Preterm  
(%) 
Term 
` (%) 
United States  6%
a  69.5  30.5  4.2  1.8 
Argentina (Urban Poor)  10%
b  50.0  50  5.0  5 
Guatemala (Rural Ladino)  16%
C  27  73  4.0  12 
Guratemala (Urban Poor)  23% 
d  23  77  5.0  18 
Guatemala (Rural 
indigenous) 
41.6%
e  17  83  7.2  34.4 
a: National figures from United States, b: Urban poor population, Argentina (Belizan, J.M,: unpublished 
data, 1975), c: Rural Ladino population, Guatemala (Delgado, G.: unpublished data, 1977), d: Urban poor 
population, Guatemala (Belizan, J. M., and Berganza, E.R.: unpublished data), (e) Rural indigenous 
population, Guatemala.  
Source: Belizan 1978
140 
Figure 3.1. Incidence of LBW and proportion of term and preterm infants in all infants 
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Figure 3.2. Incidence of LBW and proportion of preterm and term in LBW infants  
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3.2.1.  Epidemiology of low birth weight: a global picture  
A UNICEF and WHO report on LBW published in 2004 gives the overall picture of the 
prevalence of LBW in the world for the years 1997-2001.
119 The report, although not without 
drawbacks, claims to give a better picture of LBW than previously because of improved 
reporting systems. Table 3.3 shows that every year around 130 million infants are born in the 
world, of which more than 20 million are LBW (15.5%). The majority of LBW infants are born 
in less developed countries. Of the United Nations regions, Asia has the highest number of 
births - about 77 million - out of which approximately 40 million occur in South-central Asia, 
the world’s most populous region. Around 27% of births in South-central Asia are LBW. It is 
therefore fair to say that the global burden of LBW lies in South-central Asia.  
LBW estimates are based on the data obtained from national household surveys and routine 
reporting systems in developing countries and from service based data and national birth 
registration in developed countries. It is common knowledge, verified by studies in developing 
countries (Nepal NFHS 1996
40, India NFHS-2 1998 – 99
42), that most deliveries occur at home. 58 
They are generally not attended by skilled health personnel (doctors, nurses, midwives) and 
infants are not weighed at birth. Therefore, LBW has often been classified on the basis of 
mothers’ subjective assessments of infant size. National and regional estimates have also been 
derived using a range of data sources and methods for all the countries and territories with 
>300,000 population. 
The estimates of LBW prevalence by UNICEF and WHO are derived from surveys. Survey 
data are less reliable than birth registration especially when there is no weighing of infants at 
birth. In developing countries more than half of the infants (58%) are not weighed at birth. In 
South-central Asia, where most of the births take place, approximately 74% of infants are not 
weighed at birth. Also, there are 44 developing countries where routine service reporting is 
used as the source of information, but there is a lack of information about the completeness of 
reports. Furthermore, this analysis does not contain recent information from 18 countries. For 
the global and regional estimates, the main weakness is the low percentage of newborn infants 
weighed in populous countries with high prevalence of LBW. For example, only about 1in 3 
births in DHS surveys in India are weighed. 
Table 3.3. Percentage and number of low birth weight infants 
Regions 2000  % Low birth weight 
infants 
Number of low birth 
weight infants (1000s) 
 
Number of live births 
(1000s) 
World  15.5  20,629  132,882 
More developed  7.0  916  13,160 
Less developed  16.5  19,713  119,721 
Least developed   18.6  4,968  26,639 
       
Africa  14.3  4,320  30,305 
Asia*  18.3  14,195  77,490 
South central Asia  27.1  10,819  39,937 
South east Asia  26.2  10,069  38,452 
Europe  6.4  460  2,709 
Latin America and 
Caribbean 
10.0  1,171  11,671 
Northern America  7  343  4,479 
Oceania  10.5  27  255 
Adapted from
119 
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3.2.2.  Status of Low birth weight in South Asia  
Table 3.4 shows LBW prevalence in South Asia, and how it differs between countries. The 
table uses figures from majaor national initiatives such as Demographic and Health Surveys. 
The prevalence ranges from 15% in Bhutan to 30% in Bangladesh and India. All the South 
Asian countries have higher LBW prevalence than developed countries. For instance, the 
United Kingdom had a prevalence rate of 8% for the year 2000 (National Report on follow-up 
to World Summit for Children) and Sweden had a low birth weight prevalence as low as 4% in 
1994 (WHO database for Europe).  
Table 3.4. Prevalence of low birth weight in South Asia 
Country 
 
Year  Low birth weight %  Method of collection 
Bangladesh   1998   30   BINP, MOH, family 
welfare 1998 
India   1999   30   DHS 1999 
Maldives   2001   22  MICS 2001 
Srilanka   2000  20  DHS 
Nepal   2001   21  DHS 2001 
Pakistan  1991  19  DHS 1991 
Afghanistan   NA     
Bhutan   1999   15  WHO 1998-2000 
 
Adapted from
119, http://www.childinfo.org/areas/birthweight/database.php 
 Accessed on 18th April 08  
 
Table 3.5 presents a summary of studies of the prevalence of LBW in South Asian countries. It 
includes all published studies with data from which population estimates might be made.  The 
variation of prevalence within countries is striking. For instance, in Nepal the incidence was 
estimated to be 17% in 2001 at Patan missionary hospital, an urban hospital
141, while it was 
25% in Janakpur zonal hospital, a secondary referral hospital.
3 Christian in 2003 estimated the 
incidence of low birth weight as high as 43% in a rural setting in southern Nepal.
142 Likewise, 
Bangladesh had a low birth weight percentage ranging from 24% to 36% for the year 
2004.
143;144 This wide range could be attributed to different factors: type of population, 
socioeconomic status, settings, timings and methodology of collecting data. However, the 
internationally recommended cut-off point for public health action is a LBW proportion >15%, 
and the prevalence of LBW in all the South Asian studies exceeds this. 60 
Table 3.5. Studies of the Prevalence of low birth weight in South Asian countries 
  Country  Year  Setting  Sample   Study design  LBW 
Prevalence 
Mean birth 
weight 
(gram) (sd) 
Deshmukh  
 
 
India  1994  Urban 
community 
210 
pregnant  
Survey  
 
30.3% 
 
NA 
Hirve 
 
 
India  1994  Rural 
community 
1922 
pregnant  
Prospective  29%  NA 
Unicef 
 
 
Nepal  1999  Urban 
Hospitals 
2700 
births 
Prospective 
 
27% 
 
2800  
Bondevik  
 
 
Nepal  2000  Urban 
Hospital 
1400 
 
Case control  
Prospective  
17% 
 
NA 
Christian  
 
 
Nepal  2003 
 
Rural 
community 
 1037 
control  
Prospective   43.4%  NA 
Osrin  
 
 
Nepal  2005  Semi-rural 
Hospital 
600 
control 
Case control 
Prospective 
25% 
 
2733 (422) 
BW <72h 
Goodburn  Bangladesh 
 
 
 
1994  Rural  
community 
255 
mothers 
Prospective  51%  2420 
83% 
weighed <72 
h 
Salam  
 
Bangladesh 
 
 
2003 
– 04 
National   3843 live 
births 
National 
survey  
 
36% 
Rural 37%  
Urban 29% 
2632 (433) 
BW <72 
hours 
Hosain 
 
Bangladesh 
 
 
2005  Rural  350 
women 
Prospective 
 
24%  2961  
BW <48 
hours 
Najimi  Pakistan  2000  Hospital     Prospective  19%,  
70% preterm 
16% growth 
retarded  
14% premature 
and growth 
retarded 
2910 
 
Adapted from 
3;141-147 
 
3.2.3.  Underlying causes of low birth weight 
The maternal, fetal and placental unit should work in harmony for the fetus to reach her 
inherent growth potential. One of the underlying causes of LBW is inadequate supply of 
nutrients and oxygen to the fetus. The defect may be in the placenta, in the mother or in the 
fetus. Low blood flow to the fetus caused by vasoconstriction is seen in pre-eclampsia, use of 
alcohol and drugs, and smoking. Low levels of nutrients in the blood are seen in maternal 
undernutrition, anemia, and infections. In developing countries, maternal nutritional status is 
the major determinant of LBW.
120 61 
3.2.3.1  Studies of risk factors for low birth weight in developing countries 
Table 3.7 presents a summary of studies of risk factors for LBW in developing countries. The 
literature search included PubMed, recommendations from colleagues and hand searching of 
the literature cited in individual articles. Search terms included ‘low birth weight’, ‘risk factors’ 
and specific risk factors such as ‘weight gain’ and ‘maternal prepregnancy weight’. As the 
thesis will discuss later, there are many studies that try to examine risk factors for LBW. There 
have been many such studies, possibly because the methodology requires a number of LBW 
infants, a number of non-LBW infants and a questionnaire (or hospital records) which provides 
demographic and anthropometric information on mothers. For this reason, the studies in the 
table were chosen systematically. The reasons for including particular studies were (a) to report 
research from countries similar to Nepal, such as India and Pakistan; (b) to report key risk 
factors documented as important in large studies of multiple factors; (c) to highlight evidence 
based on studies with robust methodology; and (d) to include the major studies cited by in the 
literature. 
It includes studies that categorized cases by weight <2500 g irrespective of age and sex. 13 
articles that looked into risk factors associated with LBW were identified from developing 
(Guatemala, India, Mexico, Brazil and Pakistan) and developed countries (United Kingdom, 
United States, Sweden, Latin America and Greece). Out of these, three studies looked into a 
number of risk factors and 10 looked into a single risk factor: smoking, alcohol (1), teenage 
pregnancy (2), maternal anaemia (1), inter-pregnancy interval (3), ethnicity (1), maternal 
weight (2), hard work (1) and socioeconomic status (1). 
A study from India
145 assessed maternal risk factors in 210 pregnant women from a house-to-
house survey in an urban community between January and May 1994. The data showed a 
significant association of LBW with maternal anemia, (OR 4.8; 95% CI: 1.7-12.4), low 
socioeconomic status (4.0; 2.1-6.5), short birth interval (3.8; 2.1-8.4), tobacco use (3.1; 2.1-
4.9), maternal height (2.8; 1.9-3.9), maternal age (2.7; 1.7-3.8), maternal body mass index (2.0; 62 
1.3-3.1) and primiparity (1.6; 1.2-2.1). Since this was not a hospital-based study and the LBW 
prevalence in the community was high - 30% - it is likely to be representative of the population. 
Unfortunately, the study does not give definitions and cut-off points used for anemia, birth 
interval, maternal age, weight gain, or height, for comparison with other studies.  
Neel and colleagues
148 described maternal risk factors for LBW and IUGR in 306 hospital 
births between July and November 1988 in a regional hospital in Guatemala. Their data 
demonstrated that pregnancy related variables (parity, birth interval and prenatal care), nutrition 
related variables (maternal height, maternal triceps skinfold thickness, maternal weight) and 
sociodemographic indicators (maternal education, race and socioeconomic status) were 
significantly associated with birth weight. It is striking that the study did not show any 
association of LBW with infant sex, since this is the usual case. 
There is one recent Pakistani study that attempted to assess the influence of maternal anaemia 
on the outcome of pregnancy.
149 Comparable groups of 313 anaemic and 316 non-anaemic 
pregnant women in terms of race, language, education, economic status and family structure 
were enrolled at a tertiary hospital between Oct 2001 and 2002. There was a four-times 
increased odds of preterm delivery (95% CI: 2.5-6.3) and two-times increased odds of LBW 
(95% CI 1.0-3.4) in the anaemic compared to non-anaemic cohort. Moreover, there was two-
times more odds of low Apgar score of ≤5 at 1 minute (95% CI: 1.2-3.7) and four-times more 
odds of intrauterine death (95% CI: 0.9-14.6) in the infants of anaemic than non-anaemic 
pregnant women. Since the investigators did not mention the method of determination of 
gestational age, the reliability of the preterm delivery outcome could not be assessed. 
In a hospital-based case-control study
150 of the effect of socioeconomic factors on the incidence 
of LBW in pregnant Mexican women, the socioeconomic factors of 158 LBW infants and 474 
normal controls were adjusted for reproductive (parity, prior preterm delivery, prior LBW), 
nutritional (calcium and iron supplementation), pre-gestational weight, prenatal care, morbidity 
during pregnancy, tobacco exposure and demographic factors. The data demonstrated 63 
socioeconomic factors as the main risk factors for LBW. Women of low socioeconomic status 
were 2.7 times more likely to give birth to LBW infants, independently of other confounding 
factors. 
Lima and colleagues reported a retrospective cohort study of the influence of hard work during 
pregnancy on birth weight conducted in two maternity hospitals in a palmers district in Brazil, 
where most of the population (72%) was engaged in sugarcane production.
151 This hospital 
based study of 250 cases and 708 controls claimed that there was a significant fall in the mean 
birth weight of infants among women who worked in agriculture throughout pregnancy 
compared to housewives, by 190 g. The proportion of LBW was significantly higher among 
women who worked throughout pregnancy (10.4%) than housewives (7.1%). 
There are 4 different studies that assessed the effect of interpregnancy interval as an 
independent risk factor on pregnancy outcome. Out of them, one was conducted in Latin 
America
152 and three in developed countries. Conde-Agudelo and colleagues examined the 
perinatal outcomes of interpregnancy interval from a large sample of 1,125,430 derived from 
the database of the Latin American Centre for Perinatology (Uruguay, Peru, Argentina, 
Colombia, Honduras, Paraguay, El Salvador, Chile, Bolivia, Costa Rica, Panama, Dominican 
Republic, Nicaragua, Brazil, Ecuador, Mexico, Bahamas, Belize and Venezuela) between 1985 
and 2000.
152 Women with interpregnancy interval of > 59 months or < 12 months had 
independent risks of giving birth to LBW, SGA infants, preterm delivery and increased infant 
mortality during the intranatal and neonatal periods. Women with an interpregnancy interval of 
< 6 months had almost 100% odds of giving birth to LBW infants even after adjustment for 
other confounding factors. 
Risk factors for LBW in developing countries are summarized in Table 3.6. The risk factors 
listed are categorized as important based on positive results in previous studies, showing a 
causal relationship with birth outcome. Of all the risk factors reviewed, 15 have shown 
significant associations with LBW. They are categorized under three subheadings.  64 
Table 3.6. Summary of risk factors for low birth weight in developing countries 
Based on positive findings in studies discussed above 
 
Nutrition related  Pregnancy related 
 
Socio-demographic 
Maternal height 
 
Maternal weight 
 
Maternal BMI 
 
Maternal triceps skin-fold 
thickness 
 
Anemia 
Parity 
 
Birth interval: short and very long 
 
Prenatal care 
 
Fetal sex 
Maternal education 
 
Race 
 
Socioeconomic status 
 
Maternal hard work 
 
Tobacco 
 
Maternal age 
 
Fuel 65 
Table 3.7. Studies of risk factors for low birth weight in developing countries 
Site and date  Case definition  Sample  Methods  Results  Comment 
India, 1994
145  LBW: birth weight 
<2500 gram 
Maternal weight gain: 
weight gained from 12 
weeks till delivery 
Urban community 
Prospective 
 
N 210 pregnancies 
61 LBW and 140 normal 
birth weight newborn 
infants 
 
House to house survey 
SES Kuppuswamy’s scale 
Birth anthropometric 
measurement in <1h for 
hospital delivery and 24h for 
home delivery 
 
LBW 30.3% 
Anaemia OR: 4.81 
Low SES OR: 3.96 
Short Birth interval OR: 3.84 
Tobacco OR: 3.14 
Height OR: 2.78 
Maternal age OR: 2.68 
BMI OR: 2.02 
Primi parity OR: 1.58 
Reason and number of 
exclusion given 
Definition of anaemia, 
classification of birth 
interval, BMI, Height, age 
not mentioned 
 
Positive association with 
anemia, low SES, short 
birth interval, tobacco, 
height, age, BMI and prim 
parity 
Guatemala 
1988
148 
LBW 
Premature: birth < 37 
gestational weeks 
IUGR: term birth weight 
< 10th percentile for 
gestational age 
 
Type I IUGR : 
proportionate 
Type II UUGR: 
disproportionate  
Ponderal Index 
 
Gestational Age: A 
Ballard method 
Hospital  
July – Nov 1988 
N 306 
 
Exclusion 
Premature 
Congenital anomalies 
Twins 
Maternal illness 
Refusal 
Interview 
 
Birth anthropometric 
measurement in <36h of birth 
Nutritional, demographic, 
obstetric, socioeconomic data 
Prevalence: Type I IUGR: 27%, Type II 
IUGR: 7% of Newborn 
 
Sex: Non significant for BW and IUGR 
Race: significantly lower BW in Indians 
than Ladino even after controlling for 
SES, height 
Parity: Positive correlation up to 4th 
pregnancy; significantly higher type I & II 
IUGR from 1st pregnancy 
Maternal age: association with birth 
weight; incidence of IUGR & type I IUGR 
higher in teenager 
Anthropometry: Postpartum weight <107 
pound > IUGR & small infants; height 
<143 cm- more IUGR, type I & II  
 
Education: NS (SES controlled) 
SES: Significant (controlled for race); > 
IUGR in low SES  
Running water: > IUGR & type I 
compared to no running water 
Prenatal care: direct relationship; NS 
trends towards higher BW who had an 
early 1
st visit; NS difference in private & 
public physician 
Birth interval: BW increased up to 48m 
interval but declined after 48m 
 
 
Sex: Non significant 
 
Parity: significantly more 
IUGR in primiparous 
mothers 
 
Age: direct relationship with 
increasing age 
 
Race: Significant 
 
Private Physician: 113 g 
heavier than public health 
providers 
 
Birth interval: Heavier in 
longer birth interval,  
 
Uneducated receiving 
adequate prenatal care 
deliver significantly heavier 
babies than uneducated 
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Site and date  Case definition  Sample  Methods  Results  Comment 
Pakistan 2001-
02
153 
Anemia (WHO) 
Hb≤11g/L 
 
Anemia (Exposure) 
Hb< 11g/L in labor and 
on 2 previous 
occasions in the 
current pregnancy 
 
Hospital based  
N 629 pregnant women 
Anemic 313 
Not anemic 316 
 
Inclusion criteria 
(<16 gestational weeks, 
>16yrs, singleton 
pregnancy, complete 
medical records) 
 
Exclusion criteria 
Past history of preterm 
birth, obstetric 
complication, medical 
illness 
 
 
Interview  
2
nd day and at 1 month of 
delivery 
 
Questionnaires 
 
Hb 28-32 (1st antenatal visit, 
33-37 weeks, labour) 
 
Confounding factors: 
Age, Education. Employment 
status, family structure, monthly 
income, 
 
Most Muslims, urban, speak Urdu  
 
Risk of preterm is 4 times and low birth 
weight is 2.2 times and IUGR is 1.9 times 
with Anemia 
Gestational age estimation 
method not mentioned 
 
Well matched confounding 
factors 
Zimbabwe 
1994-99 
154 
Fuel: wood, dung, 
straw, LPG, natural gas 
and electricity 
BW to the nearest 10g 
Health card BWto the 
nearest 100g 
 
 
3559 child births 
Confounders: sex, birth 
order, education, 
nutritional status, 
prenatal care, household 
living standard, other 
potential confounders 
like residence,  
Demographic health survey (5  
years preceding 1999) 
2 stage cluster sample : first 
area selection by equal 
probability and second by 
probability proportional to size 
Questionnaire field tested 
BW recorded by trained workers 
in clinics, health cards at home 
or maternal recall  
Birth weight was 175g [95% CI:-300  - -
50] lighter for those using wood, dung or 
straw fuel than LPG, gas and electricity 
Fuel may be associated with 
birth weight 
 
Nationally representative 
sample 
Response rate 97.8% 
Taken account into 
important confounders 
except for history of 
smoking by household 
members 
 
 
Guatemala 
2002 
155 
Fuel  
LBW <2500g 
Gestational age: LMP 
corroborated by 
postnatal grading of 
somatic characteristics 
of newborn 
Socioeconomic status: 
house construction, 
floor material, literacy, 
marital status 
 
 
N 1717 women and 
newborn  
Rural and urban 
Home births 572 
Public hospital 1 145 
 
Household fuel 
Fire 
Socioeconomic 
 
 
Confounding factors:economic, 
social and maternal 
BW to the nearest 50g (home) 
and 25g (hospital) 
Maternal anthropometry to the 
nearest 0.1cm: height, calf 
circumference,  
Cooking on open fires 861, lowest mean 
birth weight 2819g [95% CI: 2 790 – 2 
848] 
Chimney intermediate BW 2 863 [2824 – 
2902] 
Cleanest fuel 2948 [2898 – 2998] 
 
LBW%: 18.8 (hospital), 17.1 (home),  
LBW % : 19.9 (open fire), 16.8 (chimney), 
16 (electricity),  
 
Wood users birth weight 63g lower 
P=0.05 
 
 
Wood fuel (carbon 
monoxide exposure) use 
reduced birth weight  67 
Site and date  Case definition  Sample  Methods  Results  Comment 
Mexico 1996
150  LBW <2500 g  Case control study 
Hospital study  
 
LBW n= 158 
Control n= 474 
Interview at delivery 
Questionnaires 
Review of newborn records 
Data 
 
Socioeconomic: Age, 
education, civil status, 
occupation, income, owning 
certain goods 
 
Reproductive: Parity, prior 
preterm, low birth weight infant 
 
Nutritional: Calcium, Iron 
pregestational weight, prenatal 
care, morbidity, tobacco 
 
 
Low socioeconomic status: significant  
OR 2.19 (CI ) than medium and high 
socioeconomic status 
 
Hypertension, Calcium: marginally 
significant OR 1.53(CI) and 1.86 (CI) 
Low socioeconomic status: 
most important risk factor 
for LBW independent of 
other factors: reproductive, 
nutrition, smoking, morbidity, 
accessibility of health 
facilities and prenatal care 
Brazil 1992  
151  GA Capurro method 
 
Retrospective study 
Hospital based 
N 958 
[Housewives 708 
2nd and 3rd trimester 
work for 3 months 250] 
Inclusion 
No congenital anomaly 
No chromosomal 
No congenital infection 
Low income 
Singleton pregnancy 
 
 
Interview 12-48h after delivery 
Anthropometry and gestation 
within 24h of delivery 
Exposed women: poorer, older, 
grandmulti, poor antenatal care, lighter, 
shorter with similar BMI, birth interval and 
prior LBW and fetal loss 
Mean BW 190 g lower in women who 
worked in field for 9 months compared to 
housewives 
Mean BW 117g lower (significant) after 
confounding factors are controlled 
Heavy work on 6, 7 or 8 months: no 
significant effect 
Hard work throughout 
pregnancy significantly 
reduces BW in low income 
population 
Latin America 
1985-2004
152 
GA: LMP and birth date 
interval 
 
Inter-pregnancy 
interval: time between 
last delivery and LMP 
for index pregnancy 
N: 1 125 430 
 
Inclusion: Parous, 
Singleton, Previous 
delivery >19w 
 
Exclusion: Multiple 
pregnancy 
Hospital data 
Records 
 
Prevalence: 7.9% LBW, 13.9% SGA, 
9.3% preterm 
 
<12 month interval: younger mothers with 
late and less prenatal care, prior 
miscarriage, LBW, fetal deaths, early 
neonatal deaths 
 
>59 months interval: older mothers with 
adequate prenatal care, greater BMI, 
heavier previous baby  
No difference: parity, education, smoking 
and marital status 
 
<6 months: 80-100% increase in LBW 
than 18-23 months interval, very LBW, 
<12 and >59 months birth 
interval has significant 
greater risk for LBW 68 
Site and date  Case definition  Sample  Methods  Results  Comment 
preterm and very preterm, 30% increase 
in SGA risk  
 
>60 months: 20% increase risk in LBW 
Maternal characteristics or infant birth 
weight and gestational age controlled: not 
much of the difference 
 
 
BW: Birth weight; GA: Gestational age; H: hour; Hb: Haemoglobin; IUGR:  Intrauterine Growth Retardation; LBW: Low Birth Weight; LMP: Last Menstrual Period;  NS: Non 
significant; OR: Odds Ratio;  SES: Socioeconomic status; SGA: Small for Gestational Age; W: weeks;  WHO: World Health Organization; Yr: Year;69 
3.2.3.2  Studies of risk factors for low birth weight in developed countries 
There have been a number of studies from industrialized countries. Some of their findings are 
relevant to a consideration of size at birth in developing countries. For the sake of clarity, only the 
larger studies, systematic reviews and meta-analyses will be discussed here. A large retrospective 
study of 134,088 births in Utah between 1970 and 1990 looked for an association of pregnancy at 
younger age with infant outcomes.
156 The risk of LBW, SGA and preterm delivery was examined in 
a limited cohort of white, educated, married primigravidae with healthy lifestyles (less prevalence 
of smoking, use of alcohol and drugs) and adequate prenatal care. The relative risk of low birth 
weight in teenage pregnancy (< 17 years of age) was 1.7 (95% CI: 1.5-2.0) compared to the 20-24 
years age group. Regarding premature delivery and SGA in younger teenage pregnancies, there was 
a relative risk of 1.9 (1.7-2.1) and 1.3 (1.2-1.4) compared with older mothers (20-24 years). The 
investigators related these adverse effects on outcome to young gynaecologic age and ongoing 
maternal growth. The data also showed that inadequate prenatal care doubled the odds of having a 
LBW infant.  
Another retrospective hospital-based case-control study conducted in the United States compared 
the incidence of LBW in 1102 teenagers and 1250 older women delivering between 1996 and 
1999.
157 The study showed a negative relationship between maternal age and LBW. Younger 
teenagers were more likely to give birth to LBW (8.6%) and growth restricted infants (2.6%) than 
older teenage (5.1% and 2.2% respectively) and older mothers (7.5% and 2.3% respectively). 
However, the published study does not present data on potential pregnancy related and 
socioeconomic confounding factors. The authors reported that teenagers were more likely to be 
nulliparous (88%), Hispanic (80%), unmarried (96%) and not having prenatal care than older 
women in the cohort. Furthermore, the study was limited by drawing its sample from a teenage care 
programme. 70 
Table 3.10 presents two studies on interpregnancy interval conducted in affluent countries: Greece 
51 and the USA
158. Dafopolous and colleagues used a six-month pregnancy interval as the cut-off 
point for looking at the incidence of preterm birth in a sample of 652 urban Christian and 578 rural 
Romany Muslims of Greece, who were socio-economically and racially different. In comparison 
with urban Christians, prevalence of preterm birth was significantly higher in rural Muslims and 
only rural Muslims demonstrated interpregnancy birth interval as an independent risk factor for 
preterm births. The prevalence of preterm birth was 16% versus 7% for birth interval <6 months 
and >6 months respectively.  
Murphy and colleagues in 2000 performed a systematic review (14 studies) and metanalysis (8 
studies) to determine the association between abuse and low birth weight.
159 They showed 
increased odds of low birth weight infants for mothers who reported physical, emotional or sexual 
abuse. The major limitation of the studies involved was the definition of the variable used to 
describe abuse. The review concluded that abuse may be interacting with other factors in the 
causation of LBW. 
Flynn and colleagues published a metaanalysis of 19 studies (all except two from industrialized 
countries) on bacterial vaginosis and risk of prematurity published between 1966 and 1999.
160 It 
showed significant associations between bacterial vaginosis and several outcomes: preterm 
delivery, LBW, preterm premature rupture of membrane and preterm labor. There was an almost 
two-fold increased risk for all outcomes.  
The study by Zhu and colleagues
158 considered seven birth interval categories, 0-5, 6-11, 12-17, 18-
23, 24-5, 60-119 and >/=120 months, in Utah, United States. The authors confessed that the 
drawback was use of retrospective data with estimation of gestational age based on different 
methods: last menstrual period and date of birth interval, clinical methods and ultrasound scans and 
low prevalence of reproductive risk factors. Interestingly, the study found that shorter 71 
interpregnancy interval of <6 months was not riskier compared to birth interval of >120 months. 
The safest interval was 18-23 months for this hospital based population. 
Brooke and colleagues in 1989 carried out a prospective hospital-based study of the effect of 
smoking, alcohol, caffeine, socioeconomic factors and psychological stress on LBW in 513 women 
in London (
161). Although smoking showed a significant association with LBW, passive smoking 
showed no effect. The study reported an equal risk of LBW in infants of ex-smokers and non-
smokers. There was no independent risk of alcohol, caffeine, socioeconomic status or 
psychological stress in the non-smoking population.  
A study from California
162 compared the incidence of LBW in a large sample of 203,815 black and 
white residents of California. Race was a significant independent risk factor for LBW and black 
infants had 1.7 times greater odds of being very low birth weight and 1.6 times greater odds of 
being moderately low birth weight (1500-2499 g). It is unclear whether the authors included both 
term and preterm LBW infants. They do not report the method of gestational age estimation. 
Moreover, the researchers mentioned that there could be a bias due to differences in missing data in 
black and white groups. Other independent risk factors included education, maternal age, prior 
history of LBW or premature baby, primigravidity, complications during pregnancy, labour and 
delivery, no insurance for prenatal care and median household income. 
Cnattingius and colleagues carried out a large retrospective study in Sweden of 167,750 singleton 
pregnancies from medical birth records registered between 1992 and 1993 and paediatric records, 
to look for an association between prepregnancy BMI and adverse pregnancy outcome (late fetal 
death, preterm delivery and small-for-gestational-age).
163 This study demonstrated that underweight 
mothers (BMI <20 kg/m2) were likely to have less late fetal death, more SGA infants compared to 
heavier mothers and less consistent association with preterm delivery. However, the findings were 72 
weakened by recall bias (maternal recall of pre-pregnancy weight) and case definition of SGA was 
not mentioned. 
Table 3.8 summarises reviewed studies of LBW in developed countries. It is possible to categorize 
them under three general headings- nutrition, pregnancy and sociodemographic. The modifiable 
and non-modifiable possible risk factors are summarized in Table 3.9. The table does not include 
the effects of sanitation and diet on birth weight. These have been suggested as potential risk 
factors, but the literature does not provide sufficient evidence for their inclusion 
Table 3.8. Summary of risk factors for low birth weight in developed countries 
Based on positive findings in studies discussed above 
 
Nutrition related  Pregnancy related  Socio-demographic 
Pre-pregnancy BMI 
 
Birth interval 
 
Prior LBW or preterm  
 
Primigravida 
 
Complications during pregnancy, 
labour or delivery 
 
Bacterial vaginosis 
Smoking 
 
Race 
 
Maternal education 
 
Insurance for prenatal care 
 
Maternal age 
 
Abuse 
Table 3.9. Summary of risk factors in terms of modifiability 
  Modifiable risk factors  Non modifiable risk factors  Uncertain 
Pregnancy 
related 
Birth interval 
Complications during 
pregnancy, labor or 
delivery 
Bacterial vaginosis 
Prior LBW  
 
Preterm delivery 
Nutrition related  Pre-pregnancy BMI  
Maternal anemia 
 
 
 
 
Socio-
demographic 
Smoking 
Teenage pregnancy 
Maternal education 
Abuse 
Fuel 
Race 
Primiparity 
Insurance for prenatal care 
Abuse 73 
 
Table 3.10. Studies of risk factors for low birth weight in developed countries 
Site and 
date 
Case definition  Sample  Methods  Result  Comment 
Utah 
1970-
90
156 
 
LBW: <2500 g 
Prematurity: <37 
weeks 
SGA- birth weight 
<10th percentile for 
gestational age and 
sex 
 
Maternal age groups- 
13-17y 
18-19y 
20-24y 
N 134 088 
 
Inclusion: White, 
singleton, first born 
infants, 13-24 years 
of age, complete data 
Records 
 
Confounders 
controlled:  
Socio-demographic 
covariates  analysis 
with comparable 
mothers 
13-17y: unmarried, poor perinatal care 
18-19y: age inappropriate education 
level 
 
Prevalence in <17y, 18-19y and >20 
LBW: 7%: 5% and 4% 
Preterm: 10%,8% and 5% 
SGA: 14%, 12% and 10% 
 
<17y mother compared to >20y 
mother (reference category) 
LBW [OR:1.7 (95% CI: 1.5-2)] 
Preterm [OR: 1.9 (1.7-2.1)] 
SGA [OR:1.3 (1.2-1.4)] 
 
Poor prenatal care: strongly 
associated with LBW, preterm, SGA 
No prenatal care: twice more likely to 
be LBW than adequate care 
 
 
Younger age is at 
increased risk of adverse 
pregnancy outcome-
LBW, preterm, SGA, 
independent of 
sociodemographic factors 
 
younger age, Unmarried 
inappropriate education, 
inadequate prenatal care 
increase the risk of LBW, 
preterm, SGA 
 
US 1996-
99
157 
Teenage: <20y 
SGA: <10th percentile 
for Gestational age 
Macrosomic: >4000g 
at term or >90th 
percentile for 
Gestational age 
 
Maternal age: years 
completed at the time 
of delivery 
<16, 16-19, >20 
 
Retrospective 
Case control study 
Hospital based 
 
N 1102 teenagers 
delivered between 
1996-99 
< 16 y (n=116) 
16-19y (n=986) 
 
>20y (control): 1250 
Records: prenatal 
and hospital 
Comparable demographic, marital 
status, mostly non-private patient 
More Hispanic, fewer Caucasians, 
more nulliparous, weighed less and 
gained less weight in the youngest 
group 
 
Birth weight increased with advancing 
maternal age 
Younger the gravida the more likely for 
her to give birth to very LBW- not 
significant 
 
Relatively high incidence of LBW 
among young gravida, not preterm but 
relatively higher IUGR 
Lower rate for macrosomia in <16y 
and significantly fewer postterm births 
 
Younger the teenager 
more likely to give birth to 
LBW or very LBW or 
IUGR infants but few 
post-term infants 74 
 
Site and 
date 
Case definition  Sample  Methods  Result  Comment 
Greece 
2002
51 
Inter-pregnancy 
interval: Interval 
between 2 
consecutive deliveries 
minus gestational age 
of the 2
nd neonate 
(13w=3months) 
Cutoffs: 6 months 
 
Gestational age: 
LMP if regular cycles 
and Ultrasound scan 
in 1st and 2nd 
trimester 
 
Preterm <37w 
 
Retrospective study 
Singleton pregnancy 
with prior single term 
pregnancy with no 
abortion 
Urban Christian 
n=652 
Rural Muslim n= 578 
 
≤6mo inter-pregnancy 
interval 
Urban n= 46 
Rural n= 87 
 
Preterm prevalence 
5.9% (primi)  
8.4% (multi) 
 
Confounders 
controlled: 
Age at delivery, 
smoking during 
pregnancy (>5/d), 
prenatal care after 1st 
trimester, few 
antenatal care visits 
(<8) 
Prevalence of preterm births was 16% 
and 7% for short and long 
interpregnancy interval in rural Muslim 
community respectively 
 
Since no significant difference in the 
risk factor among women in <6 and 
>6month pregnancy interval in both 
Rural and Urban population, it could 
not be causing preterm birth 
 
Pregnancy interval an 
independent risk factor 
and significantly more in 
<6 months 
interpregnancy interval in 
rural Muslims than Urban 
Christian  
 
Strengths: Potential 
confounders assessed 
 
Limitation 
Small sample size in 
women with <6month 
pregnancy interval so 
should be cautious while 
interpreting results 
 
 
2001
159 
Abuse: physical, 
sexual, emotional 
LBW: <2500g 
 
Case control and 
cohort studies 
178 to 1897 
Consecutive or 
selective participants 
interviewed at 
prenatal or postnatal 
period  
 
Metaanalysis:  
2 investigators 
Medline, Cochrane 
library, CINAHL 
(1966-99) 
Bracken’s guidelines 
for observational 
studies to analyse 
methodological 
quality 
OR using fixed effects 
models 
 
14 studies reviewed 
8 studies selected 
OR: 1.4 (95% CI:1.1 – 1.8) 
Significant association 
 
Strengths: methodogical 
quality assessed;  
 
Limitation: variation in the 
definition of exposure and 
outcome; reporting bias; 
low socioeconomic status 
women mostly so not 
generalisable;  
 
1999
160 
Bacterial vaginosis 
 
Premature delivery 
Preterm birth: delivery 
<37 weeks of 
gestation  
Low birth weight 
Preterm PROM 
Preterm labour 
 
Inclusion  
Case control and 
cohort studies 
Risk factor: bacterial 
vaginosis 
Outcomes: 
gestational age or 
birth weight  
Excluded: non english 
Metaanalysis 
2 investigators 
Mediline (1966-96), 
bibliographies, 
personal contact with 
leading researchers 
OR using fixed and 
random effects 
models 
 
 
19 studies selected (all except 2 were 
from developed countries) 
OR for preterm delivery: 1.85 (95% CI: 
1.62-2.11) 
OR for LBW 1.57 (1.32-1.87) 
OR for preterm PROM: 1.83 (1.39 – 
2.44) 
OR for preterm labor: 2.19(1.73-2.76) 
 
Significant risk factor for 
prematurity  
 
Limitation 
Publication bias:absence 
of studies finding that BV 
protects from delivery of 
LBW infant (funnel plot) 
Appropriateness of 
combining different 
studies 75 
 
Site and 
date 
Case definition  Sample  Methods  Result  Comment 
Utah 
1989-
96
158 
 
LBW <2500 g 
Preterm <37 weeks 
SGA Birth weight 
<10th percentile for 
gestational age and 
sex 
 
GA: LMP and date of 
birth interval or 
ultrasound scans or 
physical or 
neurological 
assessment 
 
Interpregnancy 
interval: period 
between delivery and 
conception- Interval 
between 2 
consecutive deliveries 
minus GA of 2nd 
infant 
N 173 205 
Hospital based 
 
Inclusion: Singleton, 
live, at least one live 
infant, multigravida, 
information on birth 
weight, sex, 
gestational age, date 
of previous delivery of 
a live infant 
 
Birth interval 
<6month, >120 month 
Birth certificates 
16 maternal 
reproductive risk 
factors 
 
Short interval: Young 
unmarried, Hispanic 
or non white, less 
educated, tobacco, 
poor prenatal care, 
prior infant death  
 
Long interval: Old 
unmarried, tobacco or 
alcohol, recent 
stillbirth or abortion 
No association: 
maternal height, pre-
pregnant weight, 
pregnancy weight 
gain, prior SB, 
abortion, 
pregnancies, area of 
residence 
Prevalence : (LBW: 4.3%, 
Preterm:5.7%, SGA:8.6%, <6 months 
interpregnancy interval:  
 
Risk (reference groups 18-23 mo) 
<6 months   
 LBW: [OR:1.4  
 Preterm: [OR:1.4 
 SGA [OR:1.3] 
 
>120 months longer 
  LBW: [OR:2 ] 
  Preterm: [OR:1.5] 
  SGA [OR:1.8] 
 
18-23 months interval 
  Lowest risk 
<3month: risk highest 
18-23month: risk lowest 
>23month: risk increased  
 
Strengths: 
Potential confounding 
factors assessed except 
for number of losses of 
pregnancy, Larger 
sample size 
 
Limitation: 
Different methods of 
assessment of GA, use of 
records, prevalence of 
reproductive risk factor 
relatively low (author 
confessed) 
California 
1992
162 
 
 
LBW: <2500g 
Very LBW: 500-1499g 
Moderately LBW 
1500-2499g 
 
Race: Black and white 
mothers 
 
N 203 815 
 
Exclusion 
Missing birth 
certificate 
Missing variables 
Multiple births 
 
 
  Parental, infant, community risk 
factors controlled- OR reduced from 
3.37 to 1.73 in very LBW and 2.5 to 
1.6 in moderate LBW for black parents 
 
Independent risk factors: parental 
education <13y, Primi parity, previous 
preterm or LBW, pregnancy, labour 
and delivery complications and no 
insurance for prenatal care and 
gestational age <259d 
 
Independent risk factors for 
moderately LBW: maternal and 
paternal age >34, education, 
unmarried, no previous births, >3 
previous births, previous premature or 
LBW babies, tobacco during 
Black race had increased 
risk of LBW 
 
Strength 
Large sample size 
Proxy for data on the 
SES of individuals 
validated  
 
Limitation 
Selection bias: racial 
differences in the 
proportion of cases 
excluded due to missing 
data. It may not be 
representative  
 
Underreporting of 76 
 
Site and 
date 
Case definition  Sample  Methods  Result  Comment 
pregnancy, pregnancy complications, 
labor and delivery complications, no 
insurance for prenatal care, no 
medical care, median household 
income < $20 000 per year, younger 
gestational age, female infant 
 
information 
Sweden 
1992-93 
163 
Pre-pregnancy BMI: 
weight(kg) divided by 
square of height(m) 
 
Categories of BMI: 
Lean <20 
Normal 20-24.9 
Overweight 25-29.9 
Obese ³30 
 
Very preterm ≤32w 
Preterm ≤37w 
Still birth ³28w  
ENND: death during 
the first week after 
birth 
 
N 167 750 
singleton 
Medical birth register 
Pediatric record 
Pre-pregnancy weight 
recall 
 
Preterm delivery: 
In primi, obese women had 
significantly higher risk of preterm 
delivery than lean mothers OR:1.6 
(95% CI:1.1-2.3) 
In Parous women, risk highest among 
lean mothers 
 
Small-for-gestational-age: 
Risk less with increasing BMI among 
multigravida than Primi 
Low weight gain is positively 
associated with small-for-gestational-
age but lots of missing data so should 
be interpreted with caution 
 
 
Higher pregnancy weight 
protects against SGA and 
underweight mothers 
have higher risk for SGA 
 
Association between low 
BMI and preterm delivery 
is less consistent 
Lean women had lower 
risk of adverse outcome 
 
Strength 
Large population based 
sample 
 
 
London 
1989
161 
GA: LMP or early USS 
 
Smokers 
>15 cigarettes per day 
<14 cigarettes per day 
 
 
 
Hospital 
Prospective 
N 1860 white mothers 
at booking for delivery 
 
Exclusion: insufficient 
English, booked after 
24w, insulin 
dependent diabetes, 
multiple pregnancy 
 
 
Estimated BW 
Births in Sheffield 
Interview and 
Structured antenatal 
and obstetric record 
 
At booking, 17, 28, 36 
weeks 
 
General health 
questionnaire 
Modified Paykel’s 
interview 
Eysenck personality 
questionnaire at 17w 
 
40 indicators of 
socioeconomic status 
and Psychosocial 
stress  
Smokers: strong relationship 
Passive smoking: not significant 
Ex smokers and non smokers: no 
difference 
Non smokers and smokers >15 
cigarette per day: 241g difference at 
40w, smokers <14cig/d: 140g at 40w 
 
Alcohol: significant decrease in BW  
Non smokers- no effect of alcohol 
smokers: effects  
women consuming 100g/w 0.069 or 
7% between non drinkers and drinkers 
(³) 
 
Caffeine: significant 
No significant dose response trend 
Smoking controlled: non significant 
Smoking significantly 
associated but not 
passive smoking  
 
No independent effect of 
alcohol, caffeine, few 
socioeconomic and 
stress in non smokers 
 
No independent effect of 
4 socioeconomic factors 
after smoking is controlle 
 
Social and psychological 
factors : little or no effect 
on birth weight 77 
 
Site and 
date 
Case definition  Sample  Methods  Result  Comment 
 
BW for GA adjusted 
for height, parity and 
Baby’s sex 
Smoking-BW relationship remained 
with alcohol and caffeine controlled 
 
Psychological stress:  
Missed antenatal care reduced bw 
But disappeared when smoking is 
controlled 
Bad neighbours increased bw but 
effect remained with smoking 
controlled 
Socioeconomic factors: reduce BW 
 
 
BW: Birth weight; EBW: Estimated birth weight; GA: Gestational age; IUGR: intrauterine growth retardation; LBW: Low birth weight; LMP; Last Menstrual 
Period; SGA: Small-for-gestational-age, SES socioeconomic status, S significant, NS Non significant, CI: Confidence interval; ENND: Early neonatal death; 
OR: Odds ratio78 
 
3.3.  Studies of size at birth in South Asia     
A number of studies have been carried out on size at birth other than LBW. Table 3.11 shows the 
different indicators of size considered in studies in South Asia. There are studies on prevalence
164, 
risk factors
141;165;166, consequences
36;167;168, interventions
3;142 and growth
169;170. In all the published 
studies of birth size, birth weight is the only outcome that was measured consistently. Some studies 
present data on length and head circumference
3;164;167. Interestingly, there are also studies that have 
not calculated ponderal index in spite of available data on birth weight and length
3;167;171 except for 
studies by Kumaran et al, Arifeen et al and Cheung et al.
36;169;172 A zinc supplementation study 
conducted in Bangladesh by Osendarp and colleagues measured its effects on weight, length and 
circumference - head, chest and MUAC - at birth. The authors investigated almost all except for 
abdominal circumference and skinfold thickness. The supplementation showed no effects on birth 
size. However, similar type of zinc supplementation study chose only 3 birth parameters-birth 
weight, length and head circumference.
173 The study showed that 20 g of zinc supplementation had 
no effect on size at birth. 
Anderson and colleagues’ investigation of the prevalence of early neonatal hypoglycaemia in 
uncomplicated pregnancies was stratified by birth weight (<2.5 kg, 2.5-3 kg and >3 kg). Attempts 
to consider other birth parameters as risk factors for hypoglycaemia were not seen, despite the 
evidence of strong association between birth weight and hypoglycaemia. The study suggested that 
55% of LBW infants suffered hypoglycaemia compared to 32% of normal birth weight infants. 
Christian and colleagues investigated the role of multiple micronutrient supplementation on birth 
size: weight, length, head circumference and chest circumference.
142 Multiple micronutrient 
supplementation during pregnancy was shown to reduce LBW compared to placebo, but not 
compared to government recommended supplementation with folic acid and iron. The study also 
demonstrated an effect on head and chest circumference, but not on length. Another study 
published by the same team did not investigate the effect of anthelmintic on parameters of size at 79 
 
birth other than birth weight
174 in the same sample frame of 4130 live birth infants in Sarlahi, 
Nepal. Anthelmintic increased birth weight by 59 g and reduced infant mortality at six months by 
41%. In the same cohort, Katz and colleagues investigated the hypothesis that the treatment effects 
actually varied by birth weight percentiles.
175 The authors chose only one birth weight to 
investigate the hypothesis and dropped other significant birth anthropometry, specifically chest and 
head circumference.  
Bondevik and colleagues investigated the associations of maternal characteristics with LBW and 
preterm delivery.
141 Severe maternal anemia was associated with both LBW and preterm birth. 
Karim and colleagues
170 chose weight and length at birth to measure growth in the first year of life 
at monthly intervals. The authors compared growth of infants against NCHS reference data for 
height-for-age, weight-for-age and weight-for-height. They found that the first six months of life 
involved catch-up and catch-down growth, followed by growth influenced by genetic and earlier 
intrauterine effects in the later half of infancy. Arifeen et al examined the infant growth patterns in 
relation to birth weight, SGA, proportionate SGA, disproportionate SGA, prematurity and length, 
from birth to one year of age.
169 They concluded that weight at 12 months was a function of weight 
at birth.  Finally, a multicentre hospital-based study conducted in Nepal measured weight, length 
and head circumference at birth.
164 The authors reported the prevalence of LBW.  
As expected, birth weight tended to get particular attention for research over other measurements of 
size. Given that it is such a major public health problem, it is surprising to see how few studies 
have focused on size at birth, even LBW. The exceptions are a growing number of investigations 
on the effect of size on outcomes (mortality, morbidity, growth and development). This is mainly 
due to the recently developed area of study of DOHAD. For example, Yajnik and colleagues 
recorded six birth size parameters in addition to birth weight.
176 The authors believe that birth 
weight alone does not represent intrauterine growth and body composition, which may be relevant 
to morbidity and mortality later in life. Younger, lighter, shorter Indian mothers with lower BMI 80 
 
gave birth to lighter infants with smaller abdominal circumference and mid-arm circumference 
compared to infants in Southampton, UK. Interestingly, Indian babies were longer and had more 
adipose tissue in the 2800-3300g birth weight category. The proposition was that other birth 
anthropometric parameters should be investigated along with birth weight.  
Rao and colleagues explored six birth size anthropometric parameters, including birth weight.
166 
Excessive maternal activity during pregnancy was an independent risk factor for size at birth. The 
effect was reflected in weight, head circumference and MUAC. In the Pune Maternal Nutrition 
Study, 631 term live births were investigated to look at the influence of parity on birth size.
165 
Seven neonatal anthropometric parameters were measured, out of which three were shown to have 
an association with parity: birth weight, abdominal circumference and skinfold thickness. One may 
argue that if the effects of risk factors are observed on different parameters of size at birth, why 
should other birth size parameters be given less importance than birth weight. These findings urge 
us to take our studies of size at birth beyond birth weight alone. 81 
 
Table 3.11. Studies of size at birth in South Asia 
Study and 
date 
Sample frame  BW  BL  HC  CC  AC  MUAC  PI  SFT  Birth gestation  Sample size  Comment 
Nepal                         
Anderson 
1993
177 
Kathmandu 
Urban 
Hospital 
+                Capurro method   226 infants  Hypoglycemia study 
LBW as risk factor 
Unicef 2000
164 
Kathmandu 
Urban 
Hospital 
+  +  +              2700 infants  Prevalence study 
Bondevik 
2001
141 
Patan 
Urban 
Hospital 
+                LMP  1400 infants  Risk factor study 
Maternal characteristics and LBW and 
preterm delivery 
Christian 
2003
142 
Sarlahi district 
Rural  
Community  
+  +  +  +          LMP  4130 infants  Supplementation study  
Birth size, infant mortality 
Christian 
2004
174 
Sarlahi district 
Rural  
Community  
+                LMP  4130 infants  Anthelmintic study  
Birth size, infant mortality 
Katz 2006
175 
Sarlahi district 
Rural  
Community  
+                LMP or urine test  4096 
pregnancies 
Supplementation study 
Birth weight, infant mortality 
Osrin 2005
3 
Dhanusha 
district 
Semi-rural 
Hospital  
+  +  +            Ultrasound  1200 infants  Supplementation study 
Birth weight 
India                         
Stein 1996,
167 
Mysore 
Hospital  +  +  +            No gestational age 
in records 
517 infants  Outcome study 
Coronary heart disease 
Kumaran 
2000
36 
Mysore 
Hospital 1934-
53 
+  +  +        +    Maternal weight   435 infants  Outcome study 
Small size at birth and Blood pressure 
Tripathy 
2002
178 
India 
Hospital 1998-
2000 
+        +        Ballard score + LMP  11223 infants  Outcome study 
Neonatal mortality 
Rao 2003
166 
Pune 
Rural 
Community 
+  +  +    +  +    +  LMP + Ultrasound  797 
pregnancies 
Effect of maternal activity 
Birth size, placental weight 
Yajnik 2003
176 
Maharashtra 
Community 
1994-96 
+  +  +    +  +    +  LMP  631 infants  Consequence study 
Placental weight  
Yajnik 2003 
110 
Maharashtra 
Hospital 1998  +  +  +  +  +  +    +  LMP + Ultrasound  157 infants  DOHAD 
Diabetes 
Muthayya 
2006
179 
Bangalore 
 Hospital   +  +        +    +    712 
pregnancies 
Descriptive study 
Arm fat index, arm muscle index, Birth 
weight and MUAC 82 
 
Study and 
date 
Sample frame  BW  BL  HC  CC  AC  MUAC  PI  SFT  Birth gestation  Sample size  Comment 
Bangladesh                         
Arifeen 2000
169 
Dhaka  
Urban 
community 
+  +          +    LMP + Capurro 
method 
1654 infants  Outcome study 
Growth 
Osendarp 
2000
171 
Matlab 
Hospital 
1996 
+  +  +  +    +      LMP  559 women  Supplementation study 
Zinc 
Karim 2001
170 
Dhaka,  
Poor Urban  
1993-95 
+  +              _  91 infants  Outcome study 
Growth  
Pakistan                         
Cheung 
2001
172 
Lahore 
Community  
1984-87 
+  +          +    Dubowitz method  
LMP 
1476 live born  Outcome study 
Diarrhoea 
 
Joshi 2005
165 
Pune 
Community 
1994-96 
+  +  +    +  +  +  +  LMP  814 
pregnancies 
Effect of Parity on birth size 
Hafeez 2005
173 
Pakistan 
Community  
Hospital 2003-
04 
+  +  +            _  242 women  Supplementation study 
Zinc 
BW: Birth weight; BL: Birth length; HC: Head circumference; CC: Chest circumference; AC: Abdominal circumference; LMP: Last menstrual period; MUAC: Mid-upper 
arm circumference; PI: Ponderal Index; SFT: Skinfold thickness (triceps, sub-scapular).83 
 
Chapter 4.  Study design, setting and methods 
4.1.  Chapter summary 
The thesis describes a prospective study of size at birth in a cohort of 600 infants, and 
predictors and outcomes of size at birth in a cohort of 1200 infants. This chapter describes the 
methods and processes used in the data collection of the study. The main aim was collection of 
information on birth size, its determinants and outcomes. This involved collection of 
information and measurements in sequential stages. The methods employed were short 
structured interviews, physical examination, laboratory examinations and anthropometric 
measurements.  
The study had five stages: 
1.  Enrolment of pregnant women. 
2.  Follow-up of pregnancies. 
3.  Measurement of birth size. 
4.  Assessment of neonatal morbidity and mortality. 
5.  Anthropometry, morbidity and mortality assessment at two years of age. 
4.2.  The antenatal multiple micronutrient supplementation trial 
The study was conducted within a double blind randomized controlled trial conducted in 
southern Nepal. The trial ran for 2 years from August 2002 to July 2004. 1200 pregnant women 
were randomised to receive monthly supplementation with either iron and folic acid (control 
group) or multiple micronutrients (intervention group), and followed up until delivery and one 
month post delivery.
3 The trial showed that antenatal multiple micronutrient supplementation 84 
 
was associated with a mean increase in birth weight of 77 g. We did not observe any 
association with gestational duration. At a mean 2.5 years of age, children in the intervention 
group were also 204 g heavier.
2 Publications from the trial are available in annex A and B.  
4.3.  Setting 
4.3.1.  Nepal 
Nepal is a small landlocked country in the South Asian region. It covers an area of 140,800 
square km. It is bordered by India on three sides (east, west and south) and by Tibet to the 
North. It has a varied altitude ranging from 100 m to above 8000 m above sea level, which 
contributes to large climatic variation.  
Nepal is roughly rectangular in shape, about 650 km in length from east to west and 200 km in 
width from north to south (see Figure 4.1). It is divided administratively into five development 
regions: eastern, central, western, mid-western and far western, and three distinctive regions 
topographically: mountain, hill and terai (plain). It is further divided into 14 zones and 75 
districts. The study covered the population of two districts, Dhanusha and Mahottari. These are 
part of the central development region in the plain region. 
In Nepal, there are 92 mother tongues and 103 ethnic goups based on the census of 2001.
180 The 
national language is Nepali, which is spoken and understood by most of the population. The 
other main languages are Maithili, Bhojpuri, Tharu, Tamang, Nepal Bhasa, Magar, Awadhi, 
Bantawa Rai, Limbu and Bajjika. The 11 largest ethnic groups are Chhetri, Hill Brahmin, 
Magar, Tharu, Tamang, Newar, Muslim, Kami, Rai, Gurung and Damain. Nepal has three main 
religions: Hindu, Buddhist and Muslim.  
Nepal had a population of about 23.2 million in 2001 based on the report published by the 
Central Bureau of Statistics in 2006. The population is growing at a rate of 2.25 % per year 
(1991-2001). Nepal has a population density of 157 per square km.
181 The sex ratio was 997 85 
 
males per thousand females in 2001. Nepal has a gross domestic product of US$ 39 billion, a 
per capita income of US $ 1402 and a human development index of 0.527. Life expectancy at 
birth is 60.4 yrs – 60.1 yrs for males and 60.7 yrs for females in 2001. 
Figure 4.1. Map of Nepal 
The total literacy rate was 54% in 2001 (66% for males and 43% for females). There are 
gender, household wealth and ethnic disparities in school attendance rates, though this disparity 
has narrowed over the past few years because of government scholarships for females, dalits 
(untouchables), disabled children and needy children. Females residing in rural areas, dalits and 
the poorest are less likely to go to school. 
Based on the 2006 NDHS report, which provides estimates over the five years 2001-2005, the 
neonatal mortality rate was 33 deaths per 1000 live births, post-neonatal mortality 15, infant 86 
 
mortality 48, child mortality 14 and under-five mortality 61 per 1000, and the perinatal 
mortality rate was 45 per 1000 births respectively.
182 Mortality rates have declined over the last 
10 years. More deaths are likely to occur in poor families with no education residing in the 
rural hills of the eastern region.  
4.3.2.  Dhanusha and Mahottari 
The caste system used by the locals in these areas is traditionally defined based on occupation 
and religion. There are Brahmins (priests and scholars), Kshatriya, (rulers and warriors), 
Vaishya (merchants) and Sudra (peasants and manual laborers, the untouchables). Dhanusha, a 
place of great cultural and historic value, covers an area of 1180 sq. km in the terai at a sea 
level of 61-610 m. It is bordered by India in the south, Mahottari district to the west, Sindhuli to 
the north and Siraha to the east, and is 400 km south east of Kathmandu. It has one municipality 
where Janakpur Zonal hospital is located. Dhanusha is mainly the home of the traditional 
Maithili ethnic group. The results of the 2001 census revealed that it is the 5th most populous 
district in Nepal, with 671,364 residents. The adult literacy rate is 49 % and human 
development index 0.534 (2005).
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Mahottari, a district adjoining Dhanusha, is 1002 sq. km in area at a sea level of 61-808 m. It 
has one municipality and 76 Village Development Committees (VDCs). The district 
headquarters is Jaleswor (named after the presence of the god Mahadeva in a water source), 
another spot of religious value. Mahottari has a population of 553,481 (2001 population 
census). The literacy rate of 34% is lower than that of Dhanusha and the human development 
index is 0.322. Mahottari is bounded by Dhanusha to the east, Sarlahi to the west, Sindhuli to 
the north, and the Indian state of Bihar to the south. 87 
 
Figure 4.2. Janaki temple 
 
4.3.3.  Janakpur Zonal Hospital 
The study was conducted in collaboration with the maternity and paediatric units of Janakpur 
Zonal hospital. This is a government hospital established in 1973, situated in Janakpur 
municipality of Dhanusha district. It is a secondary referral centre providing services to people 
from Dhanusha, Mahottari, and Sarlahi districts, those referred from lower level health 
institutions and also to people from the adjoining area of India. The sanctioned number of beds 
is 100, but the bed availability at the time of the study was 170, out of which 20 beds were in 
the maternity department and 20 beds in the paediatric department. Among 72 sanctioned staff 
(32 doctors and 40 nurses), most of the posts were filled. The hospital provides specialist care – 
paediatrics, obstetrics and gynecology, medicine, surgery, laboratory services, radiology, 
dermatology, ear, nose and throat, dental and emergency care. It is managed by a development 
committee and funded mainly by government, self-generation of income and donations. 
The obstetrics and gynaecology department has general, private and semi-private rooms. There 
are no separate rooms for maternity and gynaecological cases. It has one labour ward with three 
beds and two neonatal resuscitaires, There are one consultant, three medical officers, staff 88 
 
nurses, auxiliary nurse midwives and student nurses. The unit has a fairly good maternity 
recording system, supported regularly by training by the Nepal Safe Motherhood Programme.  
The total number of hospital outpatients including emergencies was 14,629 for the fiscal year 
2002/2003. There were 9930 surgical admissions. Of 1172 deliveries, no maternal deaths were 
recorded. 25% of women delivering at the hospital had made four antenatal clinic visits. 
At the beginning of the study, antenatal services existed but were provided in mixed clinics. 
There was no designated antenatal clinic. The study contributed to the setting up and support of 
an antenatal clinic, in partnership with the District Public Health Office and the hospital. The 
clinic was staffed by two auxiliary nurse midwives (ANMs) supervised by one staff nurse. 
Auxiliary nurse midwives are trained in specific obstetric care. Their qualifications and 
responsibilities are summarised in Table 4.1, along with those of Auxiliary Health Workers. 
The new antenatal clinic provided free care to pregnant mothers, distributed free iron and folic 
acid tablets, and referred to the hospital obstetricians in case of risk and complications.  
Table 4.1. Qualifications and responsibilities of health workers in the community 
  Maternal health   Child Health  Training 
Auxiliary Nurse Midwife  Antenatal care 
Postnatal care 
Delivery 
Manual removal of 
placenta 
Emergency Obstetric 
First Aid 
Family planning 
 
Immunizations 
Acute respiratory 
infection 
Diarrhoeal disease 
(treatment and referral) 
10 years of school 
18 months of training 
Auxiliary Health worker  Family planning 
Treatment of minor 
illnesses related to 
maternal health 
Referral 
 
Treatment of minor 
illnesses related to child 
health 
Referral 
10 years of school 
18 months of training 
Adapted from
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4.4.  Participants 
The cohort constituted pregnancies in the MIRA Janakpur Antenatal Multiple Micronutrient 
Supplementation Study.
3 Women were eligible to enter the cohort if they attended the hospital 
antenatal clinic.  89 
 
4.5.  Eligibility and inclusion criteria 
All women who attended the antenatal clinic were screened for eligibility for the study. Women 
were eligible to participate in the study if (1) their last menstrual period corroborated by 
physical examination showed a gestational age less than 20 completed weeks, and (2) they lived 
not too far away from Janakpur Zonal Hospital for monthly antenatal and home follow-up. 
Inclusion criteria (assessed after basic eligibility) were: 
1.  Viable fetus. 
2.  Gestational age of up to 20 completed weeks. 
3.  Singleton pregnancy. 
4.  No gross fetal anomaly detected on ultrasound examination. 
5.  No chronic maternal medical illnesses that could potentially affect birth weight. 
4.6.  Procedures 
4.6.1.  Enrolment 
In the antenatal clinic, ANMs took a short medical, obstetric, and gynaecological history and 
the date of the last menstrual period. They performed physical examination to confirm the 
pregnancy, physical health and to detect pregnancies at risk. Blood and urine were also sent for 
laboratory examination. Detailed addresses were taken to pick up those pregnant women 
residing in the area covered by the study. Eligible women were referred to a special study room 
for further discussion. 
In the study room, participants who fulfilled the eligibility criteria were screened by ultrasound 
scan for confirmation of gestational age, viability, fetal number and detection of gross 
congenital anomalies. If the ultrasound confirmed that a pregnant woman was suitable for the 90 
 
study, she was explained the objectives and process of the trial and provided an information 
sheet, which was available in Maithili, Nepali and English.  
A written consent form was prepared in English and translated into Nepali and Maithili. (see 
annex C and annex F) This was read to participants before enrollment. Participants were 
encouraged to clear all their doubts regarding the study and to take the opinion of their family 
members, especially heads of family. Well-informed written consent, preferably in the presence 
of family members, was taken. Written consent was taken by staff who were fluent in Maithili, 
Nepali and English. 
A series of detailed questionnaires were filled during antenatal clinic visits. The first 
questionnaire, (enrolment questionnaire) was filled after the participants give formal consent 
for inclusion (see enrolment form in annex C). It contained the participant’s identification 
information, socio-demographic details, dating of pregnancy, family and personal medical 
information, current general illnesses, birthing plans, clinical obstetric and anthropometric 
examination details and details of previous births.  
4.6.2.  Ultrasound screening and gestational assessment 
In order to confirm gestational age at enrolment, we obtained history of last menstrual period 
and performed ultrasound scans for dating of pregnancy. We used only ultrasound-based dating 
of pregnancy for the trial. All scans were performed with an Aloka SSD 900 ultrasound unit 
with a 5 MHz obstetric transducer probe (Aloka, Tokyo). Eligible participants were explained 
the process and purpose prior to the scan (See Annex E). It was conducted in the presence of 
the woman’s partner or mother-in-law in a quiet and private room. Verbal report of the scan 
was provided to the women in an understandable way. Hard copies of scan-reports were kept 
for evidence. The measurements were also recorded manually into the participants’ record files. 
Pregnancies with non-viable fetus or congenital anomaly were referred to the hospital 
gynaecologist or radiologist for further investigation and management.  91 
 
Most women had a single scan at enrolment. An anomaly scan was arranged at approximately 
20 weeks of gestation if the first scan was undertaken before 16–18 weeks or if gestational age 
estimation was not reliable due to fetal position. The anomaly scan involved a series of checks, 
including inspection of spine, head shape and structure, nuchal pad translucency, abdominal 
shape and content at the level of stomach, kidneys and umbilicus, thorax at the level of cardiac 
four chamber view, arms and legs numbers and bones (humerus, radius, ulna, tibia, fibula and 
femur) and face and lips. All measurements were taken by a single observer (AV) to minimize 
observational error, except nine scans (taken by another doctor).  
Crown-rump length (CRL) was used for dating of pregnancies for fetuses up to 12-14 weeks of 
gestation (Robinson and Fleming charts)
185, and biparietal diameter (BPD) for fetuses of 14-16 
weeks gestation (Chitty chart).
186 If it was difficult to measure these parameters due to unusual 
positioning of the fetus, either repeat ultrasound was performed one month later or femur length 
(FL) 
187or abdominal circumference (AC)
188 was used. CRL was measured at the longest length 
along the longitudinal axis of the fetus. BPD measurement was made from the outer margin of 
the proximal to the inner margin of the distal skull table using internal electronic calipers, at the 
level where the cross section appeared oval with a clear outline of the calvaria, and the cavum 
septum pellucidum and falx cerebri lying anteriorly and posteriorly in the midline respectively. 
Head circumference was measured along the outer margin of the calvaria at the same level as 
BPD. FL was measured from the greater trochanter to the distal metaphysis at the level where 
the longest image of the femur with sharp ends appeared. AC was measured in the axial plane 
at the level of the umbilical vein-ductus venosus complex. Measurements were taken at the 
outer perimeter of the abdomen. 
Ultrasound training and quality control were provided by the Superintendent Ultrasonographer 
of University College London Hospitals. Scan stills were printed and stored in the participant 
file, and scan videotapes were sent to the UK for regular quality control examination. 92 
 
4.6.3.  Follow-up 
We developed a system to follow participants up every two weeks: monthly at the antenatal 
clinic and monthly at home on an alternate basis. At every antenatal clinic visit, participants 
were provided with iron and folic acid and monthly physical examination as recommended by 
His Majesty’s Government, Nepal: maternal weight, blood pressure, urine stick test for pH and 
albumin, and blood tests for hemoglobin concentration, blood group, rhesus and rapid plasma 
reagin test for syphilis were taken at enrolment and 32 weeks. Blood haemoglobin was assayed 
spectrophotometrically with a HemoCue system, with daily calibration checks (HemoCue, 
Switzerland). Other tests were performed by the hospital pathology department. Participants 
were referred for any pregnancy related complications to the obstetric or medical department of 
the hospital. 
Every month, participants received a home visit. A home-visit team of four was trained to take 
birth anthropometry. The team visited participants every four weeks at home and encouraged 
them to have regular antenatal check-ups, to take the recommended iron and folic acid tablets 
regularly, and to visit the antenatal clinic for any complications. 
We defined loss to follow-up as failure to attend the antenatal clinic for three months and 
failure to meet the participant after three home visits. We defined miscarriage as the cessation 
of confirmed pregnancy before 23 weeks gestation, stillbirth as the delivery of an infant 
exhibiting no signs of life – movement, breathing or heartbeat - after 23 weeks gestation, early 
neonatal death as the death of a liveborn infant in the first seven days after birth, and late 
neonatal death as the death of a liveborn infant after seven but within 28 days. 
In the event of significant illness, we arranged for the participant to be seen by a consultant 
obstetrician or physician. There were two pre-specified deviations from protocol. If a 
participant’s enrollment blood haemoglobin level was below 7 g/dl, she was given an extra 60 
mg of iron daily, antihelminthic medication, and her blood haemoglobin was rechecked after 93 
 
one month. If a participant described night blindness at any time, she was given 2000 mg of 
vitamin A daily and referred for medical follow-up. 
4.6.4.  Measurement of birth size 
Participants were encouraged to have their delivery at the hospital or to inform the home visit 
team in case of home delivery as soon as possible. The main aim was to measure size within 72 
hours of birth. If the participant delivered in hospital, she was recognized by the study 
midwives in the obstetric ward or contacted the study midwives in case of hospital delivery. 
This was aided by a coloured enrolment card. Midwives were well trained to measure birth 
anthropometry: birth weight, birth length and head circumference were taken and a form 
containing details of the birth was completed. Measurements were taken as soon as possible 
after delivery. If the participant delivered at home, their family informed the home visit team 
(all except one AHWs). Trained team members completed birth detail forms and birth 
anthropometry as soon as they were informed and able to reach the home. 
Birth weight was measured on Seca 835 electronic scales accurate to 10 g, tared before each 
measurement (Seca, Germany). We attempted to do this as soon after birth as possible, but 
defined late birth weight as a measurement recorded after 72 hours. Infant length was measured 
on a Kiddimetre board accurate to 1 mm (Raven Equipment Ltd, UK) in hospital and at home 
births where vehicular access was possible. Some infant lengths were measured on a 
Rollametre (Raven Equipment Ltd, UK) when severe monsoon conditions made transport of the 
large, heavy Kiddimetre to the home impractical. Occipitofrontal head circumference was 
measured with a plastic length tape accurate to 1 mm, taking the central value of three 
consecutive measurements. 
4.6.5.  Follow-up at one month 
Participants were asked to come for a postnatal check-up one month after delivery (see one 
month check form in Annex C. Information was gathered on their infant’s feeding and illnesses 94 
 
(cough, fever, diarrhoea, breathlessness) and on their own postnatal illnesses. Information on 
deaths was also recorded. In the event of illness, infants were referred to the hospital 
paediatrician. In the event of death, neonatal verbal autopsies were conducted
189. 
4.6.6.  Follow-up at two years of age 
All infants were followed up at home at 2–3 years of age. A new home visit team of five was 
set up after training them in anthropometric measurements and filling forms for infant illness 
and verbal autopsy. One of them was appointed as a coordinator. The quality of measurements 
and observer variation was assessed in a sample size of 300 schoolchildren and women not 
involved in the original trial. Repeatability of the measurements was tested within observer and 
between observers. We were particularly concerned to minimise inter-observer variation since, 
for example, it accounted for 23% of the variation in head circumference, while intra-observer 
variation accounted for 8%.
2 Because of these variations, the measurement of the 
anthropometry was assigned to two members of the team with minimum inter-observer and 
intra-observer variation, and filling of forms to another two team members to keep the 
measurement bias to a minimum. Each team consisted of one measurer and one form-filler. 
Visiting schedules were set according to the ages of individual children and the need to cover 
flood-prone areas outside the monsoon season. All participants who had not relocated beyond 
the possibility of follow-up were visited at home, a process that required up to five visits. 
Participants were categorized as lost to follow-up if they could not be found after three 
attempts. The main reasons were that they moved out of the study area, moved to a new address 
which could not be traced, or withdrew from the trial. The field workers were unaware of the 
initial supplement allocation as access to the codes was restricted to principal investigators. 
They took informed verbal consent from heads of household and mothers after explaining the 
purpose of study. At first, forms were filled in to allay the child’s anxiety and to gain the 
child’s confidence by taking time to be friendly and playful. The parent was then asked to lay 
the child on her lap and measurements were carried out.  95 
 
Weight was measured with Seca 835 electronic scales (Hamburg, Germany) accurate to 10 g. 
Standing height was measured with a portable Leicester stadiometer accurate to 1 mm, barefoot 
and with the head in the Frankfurt plane. Head and mid-upper arm circumferences were 
measured with disposable insertion tapes accurate to 1 mm (Harlow Printing Ltd, South 
Shields, Tyne and Wear). Head circumference was taken at the maximum occipito-frontal 
measurement. Mid-upper arm circumference was measured at a level midway between the tip 
of the olecranon process and the acromion process. Chest, waist and hip circumferences were 
measured with a plastic measuring tape accurate to 1 mm. Chest circumference was measured 
at the level of the nipples, midway between inspiration and expiration during quiet breathing. 
Waist circumference was measured at the level of the natural waist, and hip circumference at 
the level of maximum circumference over the buttocks. Triceps skinfold thickness was 
measured with Harpenden callipers accurate to 1 mm (CEO 120, UK). The measurement was 
taken midway between the tip of the olecranon process and the acromion process, in the 
midline of the posterior surface of the extended dominant arm. All measurements except weight 
and height were made three times and the middle value recorded for analysis. 
We collected information about the number of illnesses in the first year of life and about 
specific illnesses in the 14 days preceding the interview (Annex D). Medical reports were 
examined where available and verbal autopsy questionnaires were completed in the event of 
mortality. These were analyzed for cause of death by two paediatricians, one of whom was the 
author. 
All data were entered in a relational database management system in Filemaker Pro 5.5. Data 
were rechecked manually for accuracy, with reference to the hard copy forms.. 
4.7.  Ethical considerations and funding 
The trial was funded by a project grant from The Wellcome Trust. The follow-up study was 
conducted under a grant from an anonymous charitable donor. The trial was approved by the 
Nepal Health Research Council and the ethics committee of the Institute of Child Health and 96 
 
Great Ormond Street Hospital for Children, and was conducted in collaboration with His 
Majesty’s Government Ministry of Health, Nepal. It was also approved by the Medical 
Superintendent of Janakpur Zonal Hospital and the District Public Health Officer. The approval 
covered all the data collection involved in the thesis study. Benefits to participants included the 
supply of supplements, free health care, and expedited referral in the event of complications. 
Participants were numerically coded and only the researcher and research assistants knew their 
names. Participants’ names did not appear on any documentation, analyses or outputs. All study 
documents were kept confidential and will be destroyed five years after the completion of the 
study. 97 
 
Chapter 5.  Data available for analysis and analytical methods 
5.1.  Data available for analysis 
The first participant joined the trial on 11
th August 2002 and the 1200
th on 22
nd October 2003. 
As a result of the process described in Chapter 4, a number of questionnaires and tools were 
available for examination. They are summarized in Table 5.1. Data were collected at four 
points: during pregnancy, at birth, at one month and at two years of age. As mentioned above, 
the women invited to participate were selected from a pool that included all those who attended 
the antenatal clinic. 
Table 5.1. Questionnaires providing data for analysis 
During pregnancy 
Enrolment questionnaire 
Monthly follow-up questionnaires 
At birth 
Birth questionnaire and anthropometry 
At one month 
Follow-up questionnaire 
At two years 
Maternal and child anthropometry 
Infant and child morbidity questionnaire 
Infant or child verbal autopsy (when required) 
Table 5.2 summarises the data available from all the tools combined. Of the 1985 women who 
came to the antenatal clinic, 785 were not enrolled. Inclusion was based mainly on the 
possibility of tracking the healthy woman and fetus from early pregnancy (at less than 20 weeks 
gestation) until delivery. Most of the exclusions at initial screening occurred for two reasons. 
Either participants lived outside the study area, which made it impossible to achieve monthly 
visits - at the hospital or at home - or their gestation was more than 20 completed weeks 
according to estimates based on the date of the last menstrual period, corroborated by 
symphysis-fundal height measurement. The second stage of screening involved obstetric 
ultrasound. Exclusions at this stage resulted from either a gestation confirmed to be over 20 
weeks, or from the identification of a congenital abnormality that might interfere with fetal 
growth. The third stage of screening involved medical examination. Medical conditions that 
could interfere with fetal growth were barred from the study.98 
 
Table 5.2. Data available for analysis 
  Antenatal  Birth  1 month  2 years 
  Mothers  Fetuses 
 
Infants  Infants  Children  Mothers 
Measurements  Age 
Height 
Weight at 1st visit 
Weight gain 
Parity 
BMI 
Blood pressure 
Morbidity 
Urine protein 
Urine sugar 
BPD 
HC 
AC 
FL 
EFW 
Gestation 
 
 
    Weight,  
Height 
HC  
CC 
WC 
Hip Circumference 
MUAC  
Triceps skin-fold thickness 
Blood pressure 
Mortality and Morbidity 
Weight 
Height 
BP 
WC 
HC 
MUAC 
Triceps skinfold 
thickness 
 
Outcomes      LBW 
SGA 
Low PI 
Neonatal deaths 
Morbidity 
Stunting 
Wasting 
Underweight 
Infant death 
Child death 
Morbidity 
BPD: Biparietal diameter; HC: Head circumference; AC: Abdominal circumference; FL: Femur length; EFW: Estimated fetal weight; BW: Birth weight; BL: Birth length; 
HC: Head circumference; CC: Chest circumference, WC: Waist circumference; MUAC: Mid upper arm circumference; BP: Blood Pressure 
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Most exclusions at enrollment were for gestations greater than 20 weeks. Maternal illnesses 
that led to exclusion were: recently treated recurrent cysticercosis (1), chlorpromazine (1) or 
anticoagulant (1) medication with changing doses, and symptomatic mitral stenosis (1) or 
multivalvular heart disease (1). Fetal exclusions were: twin pregnancies (6), anencephaly (1), 
occipital meningocoele (1), encephalocoele (1), duodenal atresia (1) and a grossly dilated 
pelvicalyceal system (1). 
Figure 5.1 is the study profile for the MIRA Janakpur Multiple Micronutrient Supplementation 
Trial. 20 participants enrolled in the trial but were never seen again, even after a thorough 
search in the areas they had given as their addresses. 19 participants moved out of the areas in 
which they could be tracked and we did not know their birth outcomes. Seven participants 
suffered spontaneous abortion. 14 participants withdrew from the trial because they felt it 
would not benefit them. One participant withdrew after developing generalized itching. In 
deviations from protocol, four participants received treatment for severe anaemia and three for 
night blindness. Information about 1139 deliveries was available for the analysis of gestational 
duration. Because most of the stillborn infants were not weighed, we included only liveborn 
infants in the analysis of birth weight. The birth weight outcome was available for 523 (87×2%) 
infants in the control group and 529 (88×2%) in the intervention group. 
In the childhood follow-up phase, we located and visited 917 mothers and children from 
December 2005 to December 2006: 455 in the control group and 462 in the intervention group. 
Retention rates from enrolment (after discontinuation, fetal loss, stillbirths, infant deaths, post-
infancy deaths and loss to follow-up) were 76% and 77% respectively. Retention rates of 
children who could potentially have been followed up after the neonatal period were 85% in the 
control and 86% in the intervention group.  
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The following sections describe the data handling for the three studies covered in the thesis: 
characteristics of mothers and infants, including size at birth, predictors of size at birth and 
associations of size at birth with mortality, morbidity and malnutrition in childhood.  
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Figure 5.1. Study profile for the MIRA Janakpur Trial 
 
  1200 randomised 
785 did not meet inclusion criteria 
1985 women screened for eligibility 
568 delivered 
 18 stillbirth 
 27 birth weight taken late or never 
523 birth weight analyzed 
 12 neonatal death 
538 potential follow-up 
20 lost to follow-up 
 12 could not be found 
 8 moved beyond follow-up 
12 discontinued trial 
 5 miscarriage 
 7 withdrew from trial 
19 lost to follow-up 
 8 could not be found 
 11 moved beyond follow-up 
10 discontinued trial 
 2 miscarriage 
 7 withdrew from trial 
 1 clinical problems 
600 allocated control 
 
600 allocated intervention 
 
571 delivered 
 15 stillbirth 
27 birth weight taken later or never 
529 birth weight analyzed 
 17 neonatal death 
539 potential follow-up 
75 lost to follow-up 
8 post-neonatal death 
 6 death at <1 year 
 2 death at >1 year 
72 lost to follow-up 
5 post-neonatal death 
 4 death at <1 year 
 1 death at <1 year 
455 anthropometry at >2 years  462 anthropometry at >2 years  
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5.2.  Characteristics of mothers and infants, including size at birth 
Table 5.3 presents summaries of size at birth for all infants born in the MIRA Janakpur trial. 
51% of infants were male. 
Table 5.3. Size of infants at birth 
  Available  Mean  (SD)    Frequency  (%) 
Gestational age at birth (w)  1048  39.46   (1.71)       
Weight (Kg)  1048  2.777   (0.429)  LBW  231  (22.0) 
        SGA  542  (51.9) 
Length (cm)  1035  48.89   (2.56)       
Ponderal index (g/cm
3)  1035  2.38   (0.34)  LPI  701  (67.7) 
Body mass index (Kg/m
2)  1035  11.60   (1.50)       
Head circumference (cm)  1039  33.59   (1.49)       
SGA: small for gestational age (< -1.28 z score ~ <10
th percentile); LPI: low ponderal index (<2.5 g/cm
3); 
LBW: low birth weight (<2.500 Kg) 
 
Because we wanted to describe size at birth in the general population, the overall study 
presented us with a problem. The effects of antenatal multiple micronutrient supplementation, 
though not large, could make the analysis unrepresentative of the usual situation. For this 
reason, we described size at birth for only infants in the control group. In later chapters, we 
included all the infants because we could control for the intervention in multivariable 
regression analysis.  
5.2.1.  Outcomes used in the analysis 
The primary outcome of interest was birth weight. The other measurements taken at birth were 
length and head circumference. Body mass index and ponderal index were calculated and 
small-for-gestational-age was computed using an appropriate reference. A cut-off of <2500 g 
was used to define low birth weight (29
th World health Assembly, 1976), <2.5 g/cm
3 for low 
ponderal index
190, and birth weight below the 10
th percentile of the British population (British 
reference LMSGrowth software) for SGA. The cut-off to define small for gestational age in this 
population was < -1.28 z score, which is equivalent to <10
th percentile.  
103 
 
5.2.2.  Statistical methods 
Preliminary analysis involved baseline maternal socio-demographic, nutritional, health and 
reproductive characteristics. Infant size at birth was described in terms of mean, standard 
deviation and as a percentage of all infants measured within 72 hours of birth. The Datadesk 
program was used for the detection of outliers and all analyses were performed in SPSS.  
5.3.  Predictors of size at birth 
We included infants born in both arms of the trial in this analysis. The database was restricted 
to cases with available primary outcome.  
5.3.1.  Outcomes used in the analysis 
We examined the associations of potential risk factors with a range of indicators of size at birth. 
These included weight, length, head circumference; BMI and PI; and LBW, SGA, and low PI. 
Cases without the outcomes in question were removed from the analysis. For the analysis of 
each birth size indicator, the cases without anthropometric measurements were not included in 
the analysis. Therefore, the total number of cases available for analysis varied across the birth 
size indicators analyzed. 
5.3.1.1  Statistical methods 
Based on the literature review, potential predictors of size at birth were chosen from the 
database that had been developed.
24 There were 21 variables of interest. They were categorized 
under two main headings, maternal and fetal. Maternal factors included socioeconomic status, 
illness during pregnancy, obstetric history, anthropometry and nutritional status. Fetal factors 
included infant sex and gestational age at birth. 
To describe socioeconomic status, we used an asset scoring system that was recommended for 
similar work and had been used before in Nepal.
191 It was divided into 4 categories: 0 (did not  
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own any household durables), 1 (possessing a clock, radio, iron, or bicycle), 2 (possessing a 
sewing machine, cassette player, camera, fan or bullock) and 3 (possessing a motor vehicle, 
television or refrigerator). However, since that time it has become more usual to use lists of 
assets collected in Demographic and Health Surveys. The assets are listed independently and 
then a composite score is generated using the technique of principal components analysis. 
Socioeconomic status was assessed based on land ownership, possession of household durables 
and husband’s occupation. There were eight factors and the score was generated from the first 
component of the principal components analysis according to published guidelines.
192 
For maternal morbidity, common complaints during pregnancy were abdominal pain, itching, 
dysuria, vaginal bleeding, constipation, parasite infestation, pneumonia, fever, perineal 
problems, nausea, backache, abdominal bloating, excessive vaginal discharge, weakness or 
cramp, urinary tract infection, visual problems, diarrhoea, and cough. Table 5.4 presents the 
categories of maternal morbidity during pregnancy based on time, number and nature of 
complaints. Maternal morbidities were divided into two groups based on which trimester the 
complaints were made. Second and third trimester maternal health complaints were again 
grouped under four categories: 0 (no complaints at all), 1 (abdominal complaints), 2 
(infections) and 3 (other complaints). 
Table 5.4. Categories of maternal morbidity during pregnancy based on time, number and 
nature of complaint 
Time of morbidity  Complaints   Categories of complaints    
First trimester morbidity 
 
Second trimester morbidity 
First complaints (I) 
 
Second complaints (II) 
No complaints at all  
 
Abdominal complaints 
  
Infections  
 
Other complaints 
 
(0) 
 
(1) 
 
(2) 
 
(3) 
 
Data patterns were examined through two-way scatterplots. A two-step statistical analysis was 
carried out to identify independent factors predictive of size at birth. First, univariable analysis 
was carried out to determine the association between each independent factor and the 
dependent variable. Second, multivariable analysis of all significant factors (at p <0.05) in the  
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univariable analysis was run to develop a prediction model. Some important predictors 
(maternal weight, maternal height, previous history of small birth, parity, gestational age at 
birth, infant sex, socioeconomic status and micronutrient supplementation) were included in the 
multivariable regression irrespective of significance level in the univariable analysis. R
2, the 
coefficient of determination, was used to measure the size of contribution of variables to 
outcome. We used logistic regression for dichotomous dependent variables (LBW, SGA and PI) 
and linear regression for continuous dependent variables (birth weight, length, head 
circumference). A factor was considered significant at p < 0.05. All the variables that were 
significant in the univariable analysis were entered first in continuous form into the model, 
after which they were tested in categorical versions. We looked particularly at their effects on 
the coefficients of determination and regression coefficients. The models were tested to see if 
the addition of variables previously not significantly associated made a difference, since a lack 
of association in univariable analysis may hide an association after adjustment. Third, the 
adequacy of each model was ascertained using a graph of residual values plotted against 
predicted values. The distribution of errors was examined by histogram and normal probability 
plot. 
5.4.  Associations of size at birth with mortality, morbidity and malnutrition in 
childhood 
Once again, we included infants born in both arms of the trial in this analysis. The database was 
restricted to cases with indicators of size at birth. Cases without birth size indicators were 
removed from the analysis. Therefore, the total number of cases available for analysis varied 
across the birth size indicators analyzed. 
5.4.1.1  Outcomes used in the analysis 
We examined the associations of different classifications of size at birth on the following 
outcomes: mortality (neonatal death, infant death, child death before follow-up), illness in 
infancy (cough and fever, diarrhoea and fever, rash and fever, frequency of illness), and illness  
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in the preceding two weeks (fever, cough, difficulty breathing, diarrhoea), and malnutrition 
(stunting, underweight, wasting). The definitions and cut-offs for the factors used in this 
chapter were as follows. 
Weaning was defined as the introduction of solid food to infants who were not fed something 
other than breast-milk and water. The rate of exclusive breastfeeding was defined as the 
proportion of infants who were not fed something other than breast milk. A cut-off of 2 SD 
below the median weight-for-age, height-for-age and weight-for-height in the WHO reference 
data was used for defining children as underweight, stunted or wasted. 
We asked mothers about the illnesses in the first year of life at follow-up at 2-3 years of age. 
The illnesses were classified as cough and fever (respiratory infections), diarrhoea and fever 
(gastroenteritis), rash and fever and frequency of illness. Diarrhoea was defined as passage of 3 
or more loose watery stools daily. Frequency of illness was categorized into five groups: 0-2, 3-
4, 5-7, 8-10 and >10 times. These were further coded as a dummy variable in which <4 times 
took a value of 0 and >5 times a value of 1. 
5.4.1.2  Statistical methods 
Cox proportional hazards modeling was used to explore the role of measurements at birth in the 
prediction of death from birth to the end of follow-up. The predictor variables explored were 
weight, weight z-score, ponderal index and gestational age at birth. The time from birth until 
deaths at one month, one year and at the end of follow-up were explored. We also used logistic 
regression to examine the effects of categories of size at birth on subsequent outcomes. The 
predictors evaluated represented the permutations of LBW, SGA and low PI. They are 
presented in Table 5.5.  
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Table 5.5. Newborn classification based on anthropometric parameters 
Single index  Combination of 2 indices 
 
Combination of 3 indices 
LBW 
LPI 
SGA 
Birth weight and ponderal index 
LBW-LPI 
LBW-API 
NBW-LPI 
NBW-API 
 
Birth weight and weight for gestational age 
LBW-SGA 
LBW-AGA 
NBW-SGA 
NBW-AGA 
 
Ponderal index and weight for gestational age 
LPI-SGA 
LPI-AGA 
API-SGA 
API-AGA 
LBW-LPI-AGA 
LBW-API-SGA 
LBW-LPI-SGA 
LBW-API-AGA 
NBW-LPI-AGA 
NBW-API-SGA 
NBW-LPI-SGA 
NBW-API-AGA 
There was a range of possible confounders for the effect of size at birth on health outcomes. 
These were dealt with as follows. First, univariable associations were examined between each 
outcome and possible confounders. Second, three models were developed for each outcome. 
Model I was an unadjusted logistic or linear regression of outcome on parameter of size at 
birth. Model II was an adjusted multivariable regression using only variables that showed 
significant association and that demonstrated almost significant association with the outcome in 
the first step. The confounder adjusted for neonatal death was weight at enrolment and for child 
death was gestational age at birth. Infant death has no significant confounders.  Similarly, the 
significant confounders that were adjusted for stunting were parity, education, socioeconomic 
status, weight at enrolment, gestational age at birth, age at weaning, age at follow up and 
frequency of illness. Underweight had same significant confounders. The exceptional factor 
was age at follow up. Wasting was adjusted for only two significant factors- education and 
weight at enrolment. For illness during infancy the confounders adjusted were as follows. 
Cough and fever was adjusted for maternal age and education. Diarrhoea and fever was 
adjusted for ethnicity, supplementation and age at follow up. Rash and fever was adjusted for 
maternal age and education. Frequency of illness was adjusted for parity, education, 
socioeconomic status and infants gender. Similarly, illness in the last fortnight before follow up  
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was adjusted for the following factors. Fever was adjusted for four significant factors. They 
were parity, education, socioeconomic status, weight at enrolment and age at weaning. Cough 
was adjusted for seven factors- parity, education, socioeconomic status, weight at enrolment, 
infants gender, age at weaning and age at follow up. Difficulty breathing was adjusted for 
parity, education, age at weaning and age at follow up. Diarrhoea had six significant 
confounders- parity, education, socioeconomic status, weight at enrolment, age at weaning and 
age at follow up. Systolic blood pressure was adjusted for parity and maternal age and diastolic 
blood pressure was adjusted for parity, ethnicity and education. 
Model III was an adjusted multivariable regression using all possible confounders. They were 
maternal age, parity, ethnicity, education, socioeconomic status, supplements, weight at 
enrolment, gestation at birth, infant sex and age at weaning for neonatal, infant and child 
deaths. For malnutrition, the factors adjusted were same. We also adjusted for one more factor - 
frequency of illness. For illness during infancy and in the fortnight before follow up, it is also 
same as deaths. The extra factor adjusted was age of child at follow up.   
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Chapter 6.   Results: characteristics of mothers and infants, including 
size at birth 
6.1.  Chapter summary 
This chapter describes size at birth in the infants of an initial sample of 600 pregnant women 
recruited into the control group of the MIRA Dhanusha Antenatal Multiple Micronutrient 
Supplementation Trial. The previous chapter summarized the study profile for participants and 
infants in both arms of the trial. The whole dataset was used for the analysis of predictors and 
outcomes of size at birth (described Chapters 7 and 8). However, a reduced dataset was used in 
this chapter because the objective was to describe the distribution of size at birth in Nepalese 
infants. Since the maternal multiple micronutrient supplements were associated with greater 
size at birth, it was felt that including infants whose mothers had taken them would reduce the 
external validity of the findings. After describing losses to enrollment and follow-up, the 
chapter summarises the final dataset available for analysis. It describes baseline characteristics 
of the study participants, anthropometry of newborn infants, composite indices (BMI and PI), 
and then a detailed presentation and comparison of indices of small size (LBW, low PI and 
SGA). 
6.2.  Exclusions from analysis 
Table 6.1 summarises the reasons for exclusion of participants from the main analysis. From 
the 600 women enrolled, 523 infant birth weights were analyzed. The analysis was restricted to 
mothers who completed the study and gave birth to a live infant whose anthropometry was 
taken within 72 hours of birth. Participants were defined as lost to follow-up if they failed to 
visit the antenatal clinic for three consecutive months, and if the home visit team failed to meet 
them at home after three visits in spite of rigorous attempts.  
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Table 6.1. Exclusions from analysis 
Dropped out during pregnancy 
Lost to follow-up   
12 Never found  Wrong address provided at enrolment   
8 Participants moved  Beyond study follow-up area 
Across the country 
Ceased trial   
5 Miscarriages  4 Spontaneous 
1 Induced 
 
7 Withdrew from trial  Generalized itching 
Not doing her any good 
No reason given 
Problems with birth weight ascertainment   
           18 Stillbirths  Unknown reason 
           27 Birth weight measured at >72 hours  Lack of easy communication: telephone facility, 
transport facility 
Weakness in convincing participants  
 
In general, early losses were due to miscarriage or unwillingness to take part in the study, and 
later losses were due to movement out of the study area. It is a tradition for women in Dhanusha 
to go to their maternal homes for later pregnancy and delivery. Overall, the birth weights 
available for analysis were 87% of the initial group. The mean gestation at loss to follow-up 
was 26.8 weeks (SD 7.9), equivalent to 80 days (SD 47). 
6.3.  Characteristics of mothers 
Table 6.2 summarises maternal characteristics at enrolment. It allows comparison of the women 
in the trial control group with women who were lost to follow-up. The mean gestation at 
enrollment was 16 weeks (SD 2.6). 44% of the women were in their first pregnancy. 
Approximately 86% of the cohort was of Maithili ethnic origin and the rest belonged to ethnic 
groups from Nepal’s hills (6%). Most of the participants were Hindu (95%), with half of them 
dwelling in town (53%). As expected, all the mothers were married. Mothers tended to be 
young and in their second pregnancy, with a mean age of 21.5 years (range: 15–38) and median 
parity of 1 (range: 0–6). Less than one third of the pregnant women were teenagers (171, 29%). 
More than half of the participants had some education. 
No participant said that she smoked, but the data may not be reliable due to social stigma. One 
third of participants had mild to moderate anaemia at enrollment (35%). There were no mothers  
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with severe anaemia. The mean weight at enrolment was 45.1 kg (SD 6.0) and the mean height 
was 151.0 cm (SD 5.7). Mean BMI was low (19.8, SD 2.4). 28% of pregnant women had a BMI 
lower than 18.5 Kg/m
2.  
Table 6.2. Maternal characteristics at enrollment 
  Cohort 
(n=523) 
(%)  Lost to follow-up 
(n=77) 
(%) 
         
Residence         
 Urban   273  (52.2)  43  (55.8) 
 Rural  250  (47.8)  34  (44.2) 
Religion         
 Hindu  497  (95)  71   (92.2) 
 Muslim  25   (4.8)  6  (7.8) 
 Buddhist  1   (0.2)     
Ethnicity         
 Terai Brahmin  69  (13.2)  14  (18.2) 
 Terai Chhetri  15  (2.9)  2  (2.6) 
 Terai Vaishya  360  (68.8)  46  (59.7) 
 Terai Sudra  11  (2.1)  1  (1.3) 
 Hindu Brahmin  16  (3.1)  4  (5.2) 
 Hindu Chhetri  14  (2.7)  2  (2.6) 
 Muslim  26  (5)  6  (7.8) 
 Newar, Tibeto-Burman and others  12   (2.3)  2  (2.6) 
Age (y)  21.54   (3.54)  22.39  (4.54) 
 <19   153  (29.3)  18  (23.4) 
 20-29  346  (66.2)  52  (67.5) 
 ≥30  24  (4.6)  7  (9.1) 
Education         
 None  238  (45.5)  33  (42.9) 
 Primary, class 1-5  52  (9.9)  15  (19.5) 
 Secondary, class 6 or higher  233  (44.6)  29  (37.7) 
         
Anthropometry         
 Weight (Kg) [mean, SD]  45.19   (6.00)  44.70  (5.85) 
 Height (cm) [mean, SD]  151.13   (5.77)  150.04  (4.85) 
 BMI (Kg/m
2) [mean, SD]  19.79   (2.41)  19.84  (2.27) 
 Low BMI (<18.5)  148   (28.4)     
         
Medical Status         
 Blood haemoglobin at enrolment (g/dL) 
[mean, SD] 
11.55   (1.56)  11.38  (1.48) 
  <110 g/L  177   (34.2)  24  (36.4) 
  <70 g/L  0   (0.0)  0  (0.0) 
 Blood haemoglobin at 32 w gestation (g/dL) 
[mean, SD] 
11.79  (1.35)  11.88  (1.53) 
 Systolic blood pressure (mmHg) [mean, 
SD] 
103.43   (9.66)  101.56   (10.0) 
 Diastolic blood pressure (mmHg) [mean, 
SD] 
63.18   (7.92)  61.95   (8.28) 
         
Obstetric Status         
Parity at birth of index child [median, range]  1   (0–6)  1  (0 - 6) 
0 
1 
2 
3+ 
231 
162 
70 
60 
(44.2) 
(31.0) 
(13.4) 
(11.5) 
35 
14 
15 
13 
(45.5) 
(18.2) 
(19.5) 
(16.9) 
Gestation at booking (wk) [mean, SD]  15.96  (2.55)  16  (2.51) 
Data are frequency (%) unless otherwise indicated  
112 
 
Table 6.3 presents indicators of socioeconomic status. Most of the participants had some land, 
with off-farm employment to supplement low farm income: small-scale shops (19%), waged 
employment (11%) and migration for labour (1%). Half of the participants’ families were 
ranked as having a good economic condition based on the household ownership of a set of 
consumer durables. This could be misleading because of inclusion of television ownership in 
the first rank. A small television could be procured for as little as 1000–1500 Nepalese Rupees 
(£9-14). 
Table 6.3. Indicators of socioeconomic status 
  Cohort 
(n=523) 
(%)  Lost to follow-up 
(n=77) 
(%) 
Land owned         
 None  33  (6.3)  6  (7.8) 
 ≤10 kattha  277  (53.2)  35  (45.5) 
 >10 kattha  211  (40.5)  36  (46.8) 
Husband's occupation         
 No work  59  (11.3)  2  (2.6) 
 Farming  78  (14.9)  14  (18.2) 
 Salaried  217  (41.5)  35  (45.5) 
 Small business  97  (18.5)  17  (22.1) 
 Waged labour  57  (10.9)  9  (11.7) 
 Student  8  (1.5)     
 Out of country  7  (1.3)     
Ownership of Consumer durables         
 Motor vehicle, television, refrigerator  277  (53)  24  (31.6) 
 Sewing machine, cassette player, camera, fan, 
bullock cart 
27  (5.2)  7  (9.2) 
 Clock, radio, iron, bicycle  137  (26.2)  30  (39.5) 
 None of the above  82  (15.7)  15  (19.7) 
10 kattha is about 0.3 hectares 
6.4.  Characteristics of infants  
Table 6.4 presents figures on birth characteristics. 53% of deliveries were conducted at the 
hospital. Most had no signs of birth asphyxia at five minutes after birth, and only 7% required 
resuscitation. Less than one percent suffered severe asphyxia on assessment at five minutes 
after delivery. 7% of infants were born with congenital anomalies. The physical state of a 
newborn is recorded at one minute and five minutes as a score -Apgar score- based on 
respiratory rate, heart beat, skin colour, muscle tone and reflexes. The total score is 10. 
Newborn with severe birth asphyxia has a score of three or below; moderate birth asphyxia has 
a score of four to six and mild birth asphyxia or normal newborn has a score of seven or more.  
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Table 6.4. Infant status at birth 
  Frequency  (%) 
Delivery [n=566]     
 Hospital  300  (53) 
 Home  246  (43.5) 
 Other  20  (3.5) 
Apgar Score at 1 minute [n=295]     
 Severe Asphyxia  5  (1.7) 
 Moderate Asphyxia  21  (7.1) 
 Mild Asphyxia/ Normal  269  (91.2) 
Apgar Score at 5 minutes [n=546]     
 Severe Asphyxia  4  (0.7%) 
 Moderate Asphyxia  21  (7.1%) 
 Mild Asphyxia/ Normal  269  (91.2%) 
Resuscitation [n = 555]  38  (6.8%) 
Congenital Anomaly [n =591]  38  (6.8%) 
6.5.  Infant size at birth  
6.5.1.  Distributions 
Birth anthropometry was analysed for 523 infants. One newborn, an extreme outlier in the birth 
weight distribution, due to extreme preterm delivery (900g at 28.14 weeks gestation), was 
removed from the dataset. Other anthropometric measurements which were outliers were not 
analyzed. There were four birth length outliers and one head circumference outliers.  Figure 
6.1, Figure 6.2 and Figure 6.3 illustrate the distributions of birth weight, length and head 
circumference. All were normally distributed. 
Figure 6.1. Distribution of birth weight 
 
 
Figure 6.2. Distribution of birth length 
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Figure 6.3. Distribution of birth head circumference 
 
6.5.2.  Measures of central tendency 
Measures of central tendency and spread for major anthropometric indicators are shown in 
Table 6.5. Mean birth weight of live-born singleton infants was 2736 g, mean length was 48.8 
cm, and mean head circumference was 33.5 cm. The mean gestational age at delivery was 39 
weeks and 2 days. Two composite indices are presented: PI, with a mean of 2.4 g/cm
3, and 
BMI, with a mean of 11.5 kg/m
2. 
Table 6.5. Birth anthropometry 
Birth Size  Mean (SD) [n]  95% CI  Range 
Birth Weight (g)  2736 (414) [522]  (2701–2772)   1500-4040 
Birth Length (cm)  48.77 (2.47) [513]  (48.56–48.99)  41.2-56.8 
Birth Head Circumference (cm)  33.48 (1.47) [517]  (33.35–33.60)  28.5-38.2 
Gestational Age (weeks)  39.34 (1.76) [522]  (39.19–39.50)  31.58-45.14 
Ponderal Index (g/cm
3)  2.37 (0.33) [513]  (2.34–2.39)  1.48-3.68 
Body mass index (kg/m
2)  11.50 (1.46) [513]  (11.37–11.63)  7.74-17.45 
6.5.3.  Birth size by gestation: term and preterm 
Table 6.6 presents the prevalence of “abnormal” size at birth: LBW, low PI and SGA. 133 
(25%) infants met the WHO definition of LBW. Out of these, 77% were born at term. The ratio 
of term to preterm LBW was 3.4:1 (77:23). 70% (358) of infants were born with low PI, and 
287 (55%) were classified as SGA, most being born at term (97%).   
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Table 6.6. Figures for abnormal size at birth 
Abnormal size category   Frequency  (%,   95% CI) 
LBW  132/522  (25.3,  21.6–29.2) 
   Term LBW  104/522  (19.9,  16.6–23.6) 
   Preterm LBW  30/522  (5.7,  3.9–8.1) 
Low PI   358/513  (69.8,  65.6–73.7) 
   Term low PI  328/513  (63.9,  59.6–68.1) 
   Preterm low PI  30 /513  (5.8,  4.0–8.2) 
SGA   287/520  (55.2,  50.8–59.5) 
   Term SGA  274/520  (52.7,  48.3–57.1) 
   Preterm SGA  13/520   (2.5,  1.3–4.2) 
6.5.4.  Size at birth by infant sex 
Table 6.7 summarizes size at birth stratified by infant sex. As expected, male infants had higher 
birth weight, length and head size compared to females. The mean gender differences were 128 
g, 0.76 cm and 0.59 cm, respectively. All these differences in birth anthropometry reached 
statistical significance. In spite of this, there was only a small difference in mean PI. Though 
marginally larger in males than females, this did not reach statistical significance. Male and 
female infants were both wasted at birth (PI <2.5), as shown by mean PIs of 2.37 (SD 0.36) and 
2.36 (SD 0.32) respectively. In contrast, there was a difference in BMI of 0.25 g/cm
3 between 
males and females. This was closer to statistical significance (p = 0.06). 
The table also presents the odds ratios for abnormal birth size in females compared with males. 
81 girls (31%) and 51 boys (20%) were born with LBW, irrespective of gestational age. Boys 
had almost half the odds of being born LBW than girls (OR 0.54; 95% CI 0.35–0.84). This was 
highly significant (p = 0.006). 70% of newborn infants were wasted at birth (low PI). Boys had 
14% lower odds of being born with low ponderal index than girls, but as mentioned above this 
was not significant (OR 0.86; 95% CI 0.58 – 1.29). Similarly, boys had 5% lower odds of being 
SGA than girls but the difference was not significant.  
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Table 6.7. Birth size stratified by infant sex 
Birth Sizes  Males 
Mean (SD) [n] 
Females 
Mean (SD) [n] 
Difference (95% Cl) 
       
Birth weight (Kg)  2.800 (0.419) [262]  2.672 (0.399) [260]  0.128 (0.06–0.20) 
Length (cm)  49.15 (2.51) [256]  48.40 (2.38) [257]  0.76 (0.33–1.18) 
Head circumference (cm)  33.77 (1.44) [260]  33.18 (1.45) [257]  0.59 (0.34–0.84) 
       
Composite birth indices       
PI (g/cm
3)  2.37 (0.36) [256]  2.36 (0.32) [257]  0.02 (-0.04–0.07) 
BMI (Kg/m
2)  11.62 (1.50) [256]  11.38 (1.41) [257]  0.25 (-0.01–0.50) 
Abnormal birth sizes       
LBW  51 (19.5%)  81 (31.2%)  OR = 0.54 (0.35–0.84) 
Low PI  171 (66.8%)  187 (72.8%)  OR = 0.86 (0.58–1.29) 
SGA  134 (51.5%)  153 (58.8%)  OR = 0.95 (0.64–1.39) 
 
6.5.5.  Comparison of categorizations of size at birth: birth weight and ponderal index 
Table 6.8 shows the results of combining LBW and PI classifications. The prevalence of low PI 
was 70% (n = 358) and of LBW was 25% (n = 129). A large proportion had low PI: 64% in 
normal birth weight and 88% in LBW infants.  
Table 6.8. Proportion of newborn infants based on birth weight and ponderal index 
classification 
  Normal birth weight  LBW  Total 
API 
Proportionate 
139 (36%)  16 (12%)  155 (100%) 
LPI 
Disproportionate 
245 (64%)  113 (88%)  358 (100%) 
Total  384 (75%)  129 (25%)  513 (100%) 
API: Appropriate Ponderal Index (normal or stunted); LPI: Low Ponderal Index (wasted) 
Figure 6.4 shows a scatterplot of ponderal index at birth against birth weight, with quadrants 
representing different categories of newborns. Each dot represents a single newborn. Two lines 
pass through the cut-off points of 2.5 for ponderal index and birth weight in their respective 
units. The right upper quadrant represents newborns with normal birth weight and appropriate 
PI. Out of 513 infants with available data, only 27% were normal in terms of both weight and 
PI. 22% were abnormal on both classifications (LBW-LPI). Only 3% of infants were 
proportionate but LBW. Almost half of infants were normal birth weight for their gestational 
age but had abnormal PI. If the purpose of the study was to identify normal infants in terms of 
both birth weight and PI, then only 27% of infants would be classified as normal   
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Figure 6.4. Scatterplot of Ponderal Index at birth against Birth Weight 
 
6.5.6.  Comparison of categorizations of size at birth: birth weight and weight-for-gestation 
Table 6.9 shows the results of combining birth weight and weight-for-gestational-age 
classifications. The sample available for analysis was 520. The prevalence of SGA was 55% 
and of LBW was 25%. SGA accounted for 45% of normal birth weight (173/388) and 86% of 
LBW infants. It is striking that almost 60% of SGA infants had normal birth weights. 
Table 6.9. Proportion of newborn infants based on birth weight and weight-for-
gestational-age classification 
  Normal birth weight  LBW  Total 
AGA  215 (55%)  18 (14%)  233 (100%) 
SGA  173 (45%)  114 (86 %)  287 (100%) 
Total  388 (75%)  132 (25%)  520 (100%) 
Figure 6.5 shows a scatterplot of birth weight Z-score against birth weight. As in Figure 6.4, the 
quadrants are defined by lines passing through the cut-off points for small for gestational age (-
1.28) and  low birth weight. The right upper quadrant represents newborns with normal birth 
weight and appropriate weight-for-gestational-age. 22% of infants were small in terms of birth 
weight and weight for their gestational age (LBW-SGA), whereas only 41% had appropriate 
weight for their gestational age at birth and weight >2500g (AGA-NBW). In spite of having 
weight appropriate for their gestational age, around 4% of infants had birth weight <2500 g 
(LBW-AGA). 33% of infants had normal birth weight but were SGA (NBW-SGA).  
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Figure 6.5. Scatterplot of Birth Weight Z score against Birth Weight 
 
6.5.7.  Comparison of categorizations of size at birth: weight-for-gestation and ponderal 
index 
Table 6.10 stratifies SGA and AGA infants into subgroups based on PI. The number of cases 
available was 511. The numbers differ from previous sections because of some missing data for 
birth length. The overall incidence of SGA was 56% (n=284) and of low PI was 70% (n=356). 
Most SGA infants were disproportionate (82%) and more than half of infants of normal weight-
for-gestational-age were actually wasted (n = 124, 54%) The ratio of proportionate to 
disproportionate SGA was almost 1:4.5.  
Table 6.10. Proportion of newborn infants based on weight-for-gestational-age and 
ponderal index classification 
  AGA  SGA  Total 
API 
Proportionate 
103 (20.2%)  52 (10.2%)  155 (100%) 
LPI 
Disproportionate 
124 (24.3%)  232 (45.4%)  356 (100%) 
Total  227 (44%)  284 (56%)  511 (100%) 
API: Appropriate Ponderal Index (normal or stunted); LPI: Low Ponderal Index (wasted) 
AGA: Appropriate for gestational age; SGA: Small for gestational age 
Figure 6.6 shows a scatterplot of ponderal index against birth weight Z-score. Two intersecting 
lines pass through the cut-off point of 2.5 for ponderal index and -1.28 for weight for 
gestational age. The left upper quadrant represents proportionate SGA (SGA-API), the right 
upper quadrant proportionate AGA (AGA-API), the left lower quadrant disproportionate SGA  
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(SGA-LPI) and the right lower quadrant disproportionate AGA (AGA-LPI). Only one fifth of 
infants (103) were normal for both weight-for-gestational-age and PI (AGA-API), and one tenth 
were stunted SGA (SGA-API). 45% and 24% of newborns were disproportionate SGA (SGA-
LPI) and disproportionate AGA respectively. 
Figure 6.6. Scatterplot of Ponderal Index at birth against Birth Weigh Z score 
 
6.5.8.  Comparison of categorizations of size at birth: birth weight, ponderal index and weight 
for gestation 
Table 6.11 presents categories of size based on a combination of all three classifications: birth 
weight, weight-for-gestational-age and PI. The total number of infants with data available for 
all three classifications was 513. The prevalence of LBW was 26%, of SGA 56%, and of low PI 
was 70%. The table includes a ‘composite classification’. Because the combinations of 
categories are hard to visualize, we have tried to signpost them in terms of what sort of baby 
they represent. The descriptions are not always true for each infant, but they give an idea. For 
example, an infant who is AGA-LPI-NBW is of generally of normal size but has some wasting. 
This would tend to apply to term infants with some acute growth restriction. An infant who is 
SGA-API-LBW is of generally small size, is small for gestation but is proportionate. This 
would tend to apply to preterm infants with chronic growth restriction, or to term infants with 
chronic growth restriction.  
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Table 6.11. Proportion of newborn infants based on birth weight, weight-for-gestational-
age and ponderal index classification 
Newborn Classification       
Weight for GA  PI  Birth weight  Composite classification  Frequency  % 
NBW  Term  103  20.1  API 
LBW  Preterm (chronic GR)  2  0.4 
NBW  Term (acute GR)  109  21.2 
AGA 
LPI 
LBW  Preterm (acute GR)  15  2.9 
NBW  Term (chronic GR)  38  7.4  API 
LBW  Preterm/term (chronic GR)  14  2.7 
NBW  Term (acute GR)  134  26.1 
SGA 
LPI 
LBW  Preterm/term (acute GR)  98  19.1 
Total        513  100 
GR: growth retardation; AGA: Appropriate for gestational age; SGA: Small for gestational age; API: 
Appropriate Ponderal Index (normal or stunted); LPI: Low Ponderal Index (wasted); NBW: Normal birth 
weight; LBW: low birth weight 
To visualize the relationship between classifications based on three anthropometric parameters, 
we have presented a venn diagram (see Figure 6.7). The figure shows three small rectangles 
representing LBW, SGA and LPI and a large rectangle outside them representing infants with 
all normal features in every respect (AGA-API-NBW). The figure shows all the possible 
combinations of birth anthropometric categories. One fifth of infants were born with normal 
birth anthropometry in all three classifications (AGA-API-NBW: 20%). One fifth were 
abnormal in all three classifications (SGA-LPI-LBW: 19 %). One fifth had normal birth weight 
and were appropriate for gestational age, but were wasted (AGA-LPI-NBW: 20 %). One fourth 
had normal weight but were SGA and disproportionate (SGA-LPI-NBW: 26 %). Finally, 3% of 
infants had normal weight for gestational age, but were wasted and LBW (AGA-LBW-LPI).  
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Figure 6.7. Venn diagram of newborn size based on birth weight, ponderal index and weight for dates 
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Chapter 7.  Results: Predictors of size at birth 
7.1.  Chapter summary 
It is evident from the results in Chapter 6 that the problem of small size at birth is large from a 
public health perspective in Dhanusha district. Literature review suggests that size at birth has a 
strong association with infant morbidity and mortality and the aetiology of LBW has been well 
studied over decades. However, addressing the problem of small size at birth has not been 
successful. The study provided an ideal sample for testing a series of risk factors that are 
believed to affect size at birth. This chapter describes an extensive investigation of associations 
- maternal and fetal - of size at birth. 
The objectives of the investigation were: 1) to examine the effects of known predictive factors 
of size at birth; 2) to develop models for prediction of abnormal size at birth; and 3) to 
investigate whether known risk factors predict size at birth adequately. However, the analysis 
had an ulterior motive. As suggested in the introductory chapters of the thesis, there is a feeling 
that the studies of risk factors are more about carrying out a study than achieving a public 
health change. Part of the reason for the analysis – its proposition before being carried out – 
was that we felt that it was unlikely to yield results that were either unpredictable or 
particularly useful, and that we were keen to make a statement about the redundancy of such 
approaches. 
7.2.  Relationship between variables 
The Figure 7.1, Figure 7.2 and Figure 7.3 show scatterplots of birth weight, length and head 
circumference against independent variables used for the prediction of birth size. An 
examination of the relationship between independent variables showed a few outliers in 
maternal height and weight at booking. 
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Figure 7.1. Scatterplots of outcome (birth weight) against independent variables 
    
124 
 
Figure 7.2. Scatterplot of birth length against independent variables 
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Figure 7.3. Scatterplot of head circumference at birth against independent variables 
7.3.  Characteristics of mothers 
Of 1200 subjects enrolled in the randomized controlled trial, 1052 newborn infants were 
available for weighing within 72 hours of birth. Four preterm infants, extreme outliers for birth 
weight, were removed from the data. The number of participants available for analysis was 
1048. The sample size was 1048 for birth weight and LBW, 1045 for SGA, 1035 for BMI, PI 
and low PI, and 1039 for head circumference. Participants’ characteristics at enrolment for 
1048 women are shown in Table 7.1. As mentioned in the previous section (which considered a 
sub-cohort of 600), most participants were middle-income Hindu Maithili women in their 
twenties, in their second pregnancy, with monthly antenatal visits, low mean BMI and some 
education. Around 1% said they had suffered eclampsia (as convulsions associated with 
pregnancy).    
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Table 7.1. Participants with valid infant anthropometry: characteristics at enrolment 
Variables  Frequency 
[n = 1048] 
(%) 
Residence     
 Urban  546   (52.1) 
 Rural    502   (47.9) 
Education [mean (SD)]  4.7   (4.7) 
 None  474   (45.2) 
 Primary  101   (9.6) 
 Secondary   473   (45) 
Age (y) [mean (SD)]  21.45   (3.42) 
Ethnicity     
 Terai Brahmin-Chhetri  172   (16.4) 
 Terai Vaishya  693   (66.1) 
 Terai Sudra  25   (2.4) 
 Hindu Brahmin-Chhetri  62   (5.9) 
 Muslim  65   (6.2) 
 Newar, Tibetoburman or others  31   (2.9) 
Religion     
 Hindu  978  (93.3) 
 Muslim  64   (6.1) 
 Buddhist  6   (0.6) 
Land Owned (kattha) [mean (SD)]  21.9   (44.9) 
Husband’s occupation     
 No work  122   (11.6) 
 Farming  153   (14.5) 
 Salaried  450   (42.9) 
 Small business  192   (18.3) 
 Waged labour  104   (9.9) 
 Student  13   (1.2) 
 Out of country  14   (1.3) 
Ownership of consumer durables     
 (3) Motor vehicle, television, refrigerator  554   (52.9) 
 (2) Sewing machine, cassette player, camera, fan, bullock cart  48   (4.6) 
 (1) Clock, radio, iron, bicycle  289   (27.6) 
 (0) None of the above 
 
157   (15) 
Anthropometry     
 Weight (kg) [mean (SD)]  45.26   (5.95) 
 Height (cm) [mean (SD)]  150.9   (5.6) 
 BMI (kg/m
2) [mean (SD)] 
 
19.9   (2.3) 
Nutritional status     
 Blood haemoglobin (g/dl) [mean (SD)]  11.53   (1.57) 
 Anaemia (<11 g/dl)  362   (34.9) 
 Weight gain between 15.9 wks and last visit before delivery (Kg) 
[mean (SD)] 
7.06   (3.04) 
 Multiple micronutrient supplements 
 
526   (50.2) 
Health Status     
 Systolic Blood pressure (mmhg) [mean (SD)]  103.56   (9.60) 
 Diastolic Blood Pressure (mmhg) [mean (SD)]  63.11   (7.65) 
 Eclampsia 
 
7   (0.7) 
Obstetric History     
 Primigravida  472   (45) 
 Prior miscarriage [n = 1046]  86  (9.2) 
 Prior history of LBW infant [n = 1044]  22  (2.1) 
 Prior Still Birth [n 1046]  64  (6.1) 
Data are n (%) unless otherwise indicated. 
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7.4.  Predictors of birth weight 
The corresponding results of the univariable and multivariable analysis for all the outcomes are 
presented. The final prediction models present the variables based on significance level. Among 
the likely determinants of birth weight listed in Table 7.2, the univariable analysis showed that 
the significant predictors were: ethnic group, maternal age and education; maternal parity; 
maternal height and weight; maternal weight gain and antenatal supplementation; and sex and 
gestation at birth.    
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Table 7.2. Univariable analysis of associations with birth weight  
Parameters  
n = 1048 
b   (95% CI)  P value 
Maternal factors       
Ethnicity  0.027  (0.012 – 0.043)  0.001 
Terai Brahmin   Reference     
Terai Chhetri  0.028   (-0.127 – 0.184)  0.7 
Terai Vaishya  -0.077   (-0.155 – 0.001)  0.05 
Terai Sudra  -0.176   (-0.352 -  0.003)  0.06 
Hindu Brahmin  0.061   (-0.095 – 0.216)  0.4 
Hindu Chhetri  0.028   (-0.150 – 0.206)  0.8 
Muslim  0.102  (-0.023 – 0.227)  0.1 
Newar  -0.038   (-0.288 – 0.212)  0.8 
Other small ethnic groups 
 
0.379   (-0.175 – 0.582)  0.001 
Demographic       
Education level in years  0.012   (0.006 – 0.017)  0.001 
Residence urban or rural  0.017   (-0.035 – 0.069)  0.5 
Socioeconomic status in scores   -0.013   (-0.039 – 0.013)  0.3 
Age  0.019   (0.011 – 0.026)  0.001 
Morbidity       
Systolic Blood Pressure at enrolment  0.001   (-0.001 – 0.004)  0.3 
Diastolic Blood Pressure at enrolment  0.002   (-0.001 – 0.006)  0.2 
2
nd trimester morbidity I 
‡ 
None 
Abdominal complaints 
Infections 
Other
 
0.002  
Reference 
0.050 
0.081 
-0.021 
(-0.024 – 0.028) 
 
(-0.022 – 0.122) 
(-0.047 – 0.209) 
(-0.103 – 0.062) 
0.9 
 
0.2 
0.2 
0.7 
2
nd trimester morbidity II 
† 
None 
Abdominal complaints 
Infections 
Other 
0.009  
Reference 
-0.061 
0.027 
0.037 
(-0.020 – 0.039) 
 
(-0.177 – 0.055) 
(-0.159 – 0.213) 
(-0.056 – 0.131) 
0.5 
 
0.3 
0.8 
0.4 
3
rd trimester morbidity I 
‡ 
None 
Abdominal complaints 
Infections 
Other 
0.003  
Reference 
0.025 
0.153 
-0.019 
(-0.022 – 0.028) 
 
(-0.044 – 0.094) 
(0.013 – 0.293) 
(-0.098 – 0.061) 
0.8 
 
0.4 
0.03 
0.6 
3
rd trimester morbidity II 
† 
None 
Abdominal complaints 
Infections 
Other 
0.015  
Reference 
-0.071 
0.168 
0.026 
(-0.017 – 0.048) 
 
(-0.212 -  0.071) 
(0.001 – 0.336) 
(-0.080 – 0.132) 
0.4 
 
0.3 
0.05 
0.6 
Eclampsia at birth 
 
-0.118   (-0.437 – 0.202)  0.5 
Obstetric history       
Parity  0.054   (0.0031 – 0.078)  0.001 
Prior small infant 
193;194  -0.016   (-0.186 – 0.153)  0.9 
Prior miscarriage 
195;196  0.063   (-0.006 – 0.131)  0.07 
Prior stillbirth
197  -0.042   (-0.124 – 0.041)  0.3 
Prior child death
197 
 
-0.004   (-0.052 – 0.044)  0.9 
Anthropometry       
Height  0.017   (0.012 – 0.021)  0.001 
Weight
198;199 
 
0.018   (0.014 – 0.022)  0.001 
Nutrition       
Gestational weight gain  0.042   (0.034 – 0.051)  0.001 
Hemoglobin status  0.001   (-0.017 – 0.016)  0.9 
Supplements
3 
 
0.081   (0.029 – 0.133)  0.002 
Fetal factors       
Sex  0.101   (0.049 – 0.153)  0.001 
Gestational duration  0.111   (0.098 – 0.125)  0.001 
‡
 :  First complaints of antenatal illness in the specified trimester   †: Second complaints of antenatal illness 
in the specified trimester    
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Table 7.3 presents the final prediction model and adjusted R
2 in multivariable analysis for birth 
weight. The strongest predictors of birth weight were gestation, gestational weight gain, infant 
sex, maternal weight at enrolment and parity (p = 0.001), followed by antenatal 
supplementation, maternal height and education level. 33 % of the variance in the birth weight 
was explained by these variables. 
Each Kilogram increase in gestational weight gain predicted a 27 g increase in birth weight, and 
every centimetre increase in maternal height increased birth weight by 5 g. Taking supplements 
during pregnancy translated into an increase of 58 g in birth weight. Maternal education had 
small positive effects on birth weight. A woman who had a unit more education gave birth to a 
heavier infant by 6 g. The effect of gestational duration on birth weight was the strongest. For 
every week increase in gestation a 89 g increase in birth weight was predicted. Male infants 
were a mean 118 g heavier than females. A mother who had children was more likely to give 
birth to a heavier infant than a mother who never had children before; the difference was a 
mean 109 g.  
Table 7.3. Multivariable analysis of associations with birth weight 
Predictors of birth weight (kg) 
n=1048 
b (95% CI)  T  P value  R
2 
Gestation (wks)  0.089 (0.076 – 0.102)  13.19  0.001  0.327 
Maternal weight gain (kg)  0.027 (0.020 – 0.035)  7.144  0.001   
Male sex  0.118 (0.075 – 0.162)  5.353  0.001   
Maternal weight at enrolment (kg)  0.012 (0.007 – 0.016)  5.241  0.001   
Multiparity  0.109 (0.055 – 0.164)  3.928  0.001   
Supplement   0.058 (0.014 – 0.101)  2.596  0.01   
Maternal height (cm)  0.005 (0.001 – 0.009)  2.053  0.04   
Education  0.006 (0.001 – 0.011)  1.973  0.05   
         
Figure 7.4, Figure 7.5 and Figure 7.6 show the histograms of residuals, normal probability plot 
and residual plot, respectively. The histogram of residuals produced by the model confirms a 
fairly normal distribution. The normal probability plot shows residuals lying around the 
diagonal line. The residual plot shows points scattered randomly around 0, showing no obvious 
patterns in the residual distribution. The plots indicate that the normality assumption is 
satisfied.   
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Figure 7.4. Histogram of residuals for 
birth weight 
 
Figure 7.5. Normal probability plot for birth 
weight 
 
Figure 7.6. Residual plot for birth 
weight 
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7.5.  Predictors of low birth weight 
The univariable associations between LBW and the independent variables are shown in Table 
7.4. LBW showed a positive association with maternal education, age, parity, weight, height, 
weight gain, antenatal supplementation, gestational age at birth and infant sex. Maternal age, 
education and parity explored as categorical variables also showed positive associations with 
LBW. There was no association with ethnicity, residence, socioeconomic status, antenatal 
morbidity and previous adverse obstetric history (death of children, miscarriage and birth of a 
LBW infant).    
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Table 7.4. Univariable analysis of associations with low birth weight  
Parameters  
n=1048 
b  (95% CI)  P value 
Maternal factors       
Ethnicity  0.96  (0.87 – 1.05)  0.3 
Terai Brahmin  reference     
Terai Chhetri  0.42  (0.14 – 1.29)  0.1 
Terai Vaishya  1  (0.65 – 1.55)  0.9 
Terai Sudra  2.1  (0.87 – 5.13)  0.1 
Hindu Brahmin  0.97  (0.40 – 2.34)  0.9 
Hindu Chhetri  0.62  (0.20 – 1.92)  0.4 
Muslim  0.69  (0.32 – 1.48)  0.3 
Newar  0.68  (0.14 – 3.26)  0.6 
Other small ethnic groups 
 
0.64  (0.17 – 2.32)  0.5 
Demographic factors       
Education  0.96  (0.93 – 0.99)  0.007 
Residence  0.96  (0.72 – 1.29)  0.8 
Socioeconomic status  1.07  (0.93 – 1.24)  0.4 
Age (category) 
 
0.91  (0.86 – 0.95)  0.001 
Morbidity       
Eclampsia  2.67  (0.59 – 12.04)  0.2 
Systolic Blood Pressure at enrolment  0.99  (0.98 – 1.01)  0.5 
Diastolic Blood Pressure at enrolment  0.99  (0.97 – 1.01)  0.2 
2
nd trimester morbidity I 
  None 
  Abdominal complaints 
  Infections 
  Other complaints 
1 
Reference 
0.77 
0.61 
1.12 
(0.86 – 1.15) 
 
(0.50 – 1.18) 
(0.27 – 1.38) 
(0.71 – 1.17) 
1 
 
0.2 
0.2 
0.6 
2
nd trimester morbidity II 
  None 
  Abdominal complaints 
  Infections 
  Other complaints 
0.91 
Reference 
0.94 
0.57 
0.81 
(0.76 – 1.09) 
 
(0.49 – 1.81) 
(0.17 – 1.97) 
(0.47 – 1.41) 
0.3 
 
0.9 
0.4 
0.5 
3
rd trimester morbidity I 
  None 
  Abdominal complaints 
  Infections 
  Other complaints 
0.99 
Reference 
0.72 
0.50 
1.09 
(0.86 - 1.14) 
 
(0.48 – 1.09) 
(0.19 – 1.31) 
(0.70 – 1.67) 
0.9 
 
0.1 
0.2 
0.7 
3
rd trimester morbidity II 
  None 
  Abdominal complaints 
  Infections 
  Other complaints 
 
0.86 
Reference 
0.97 
0.28 
0.73 
(0.70 – 1.05) 
 
(0.44 – 2.16) 
(0.07 – 1.21) 
(0.38 – 1.38) 
0.1 
 
0.9 
0.09 
0.3 
Obstetric history       
Parity (category)  0.76  (0.65 – 9.88)  0.001 
Prior small infant  1.81  (0.79 – 4.17)  0.2 
Prior miscarriage  0.65  (0.40 – 1.05)  0.08 
Prior stillbirth  1.35  (0.90 – 2.05)  0.2 
Prior death of child 
 
1.04  (0.80 – 1.35)  0.8 
Anthropometry       
Height   0.93  (0.91 – 0.96)  0.001 
Weight 
 
0.94  (0.91 – 0.96)  0.001 
Nutrition       
Weight gain  0.82  (0.77 – 0.86)  0.001 
Blood haemoglobin  1.02  (0.93 – 1.12)  0.6 
Supplements 
 
0.69  (0.51 – 0.92)  0.01 
Fetal factors       
Sex  0.55  (0.41 – 0.74)  0.001 
Gestation at birth  0.62  (0.56 – 0.69)  0.001    
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Table 7.5 shows significant predictors of LBW derived from multivariable logistic regression 
analysis of significant variables from univariable analysis. The final model identified six 
statistically significant predictors. Among the predictors, there was a strong negative 
association between LBW and gestation at birth, maternal weight gain and infant sex. 
Table 7.5. Multivariable analysis of associations with low birth weight, with odds ratios 
Predictors of low birth weight 
N = 1048 
Odds ratio  (95% CI)  Wald  P value 
Birth gestation (wks)  0.65  (0.58 – 0.72)  61.4  0.001 
Maternal weight gain (Kg)  0.85  (0.80 – 0.91)  24.8  0.001 
Male sex  0.45  (0.32 – 0.64)  20.5  0.001 
Maternal Weight at enrolment (Kg)  0.96  (0.92 – 0.99)  5.8  0.02 
Supplementation  0.71  (0.51 – 0.99)  3.96  0.05 
Multiparity  0.66  (0.44 – 1.00)  3.87  0.05 
         
The odds of giving birth to an infant with LBW for a mother who was 1 Kg heavier at 
enrolment and who gained 1 extra Kg of weight during pregnancy were 4% (OR 0.96; 95% CI 
0.92 - 0.99) and 15% (0.85; 0.80 -0.91) lower respectively. Increasing gestational duration by 1 
week lowered the odds by 35%. Similarly, multigravid mothers had a lower odds of giving birth 
to a LBW infant (0.66; 0.44 – 0.99) compared to mothers in their first pregnancy. Antenatal 
supplementation lowered the odds of LBW by 30%. A mother bearing a male fetus had 55% 
lower odds of delivering a LBW infant. Positive associations between LBW and maternal age, 
height and education disappeared when other variables were taken into consideration. 
7.6.  Predictors of small for gestational age 
The sample available for analysis was 1044. Four cases were removed due to missing data. The 
results of univariable analysis with regression coefficients and 95% confidence interval are 
shown in Table 7.6. Significant variables that were entered into the multivariable logistic 
regression were socioeconomic status, maternal age, parity, prior history of miscarriage, 
weight, height, weight-gain, supplementation during pregnancy and gestation at birth.     
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Table 7.6. Univariable analysis of associations with small for gestational age 
Parameters  
N = 1044 
b  (95% CI)  P value 
Ethnicity      0.1 
 Terai Brahmin  reference     
 Terai Chhetri  0.84  (0.40 – 1.76)  0.7 
 Terai Vaishya  1.12  (0.77 – 1.61)  0.6 
 Terai Sudra  1.10  (0.47 – 2.55)  0.8 
 Hindu Brahmin  0.84  (0.40 – 1.76)  0.7 
 Hindu Chhetri  1.10  (0.47 – 2.55)  0.8 
 Muslim  0.67  (0.37 – 1.22)  0.2 
 Newar  0.94  (0.29 – 3.07)  0.9 
 Other small ethnic groups 
 
0.25  (0.08 – 0.80)  0.02 
Demographic       
Education  0.99  (0.96 – 1.03)  0.6 
Residence (urban or rural)  0.98  (0.77 – 1.25)  0.9 
Socioeconomic status  0.85  (0.75 – 0.96)  0.01 
Age 
 
0.96  (0.93 – 1.0)   0.04 
Morbidity       
Eclampsia  2.33  (0.45 – 12.05)  0.3 
Systolic Blood Pressure at enrolment  1.00  (0.99 – 1.02)  0.6 
Diastolic Blood Pressure at enrolment  1.00  (0.99 – 1.02)  0.9 
2
nd trimester morbidity I 
  0 Reference category 
  1 Abdominal complaints 
  2 Infections 
  3 Other complaints 
0.99 
0.86 
0.83 
1.05 
1.11 
(0.88 – 1.12) 
(0.62 – 1.21) 
(0.46 – 1.50) 
(0.46 – 1.50) 
(0.71 – 1.54) 
0.8 
2
nd trimester morbidity II 
  0 Reference category 
  1 Abdominal complaints 
  2 Infections 
  3 Other complaints 
0.97 
 
0.85 
1.49 
0.88 
(0.85 – 1.12) 
 
(0.50 – 1.46) 
(0.61 – 3.62) 
(0.57 – 1.35) 
0.7 
3
rd trimester illness I 
  0 Reference category 
  1 Abdominal complaints 
  2 Infections 
  3 Other complaints 
0.96 
 
0.83 
0.84 
0.92 
(0.85 – 1.08) 
 
(0.60 – 1.14) 
(0.43 – 1.62) 
(0.64 – 1.33) 
0.5 
3
rd trimester illness II 
  0 Reference category 
  1 Abdominal complaints 
  2 Infections 
  3 Other complaints 
 
0.87 
 
0.75 
0.47 
0.74 
(0.74 – 1.01) 
 
(0.39 – 1.45) 
(0.21 – 1.06) 
(0.45 – 1.21) 
0.06 
Obstetric history       
Parity  0.88  (0.79 – 0.98)  0.02 
Prior LBW infant  1.20  (0.54 – 2.67)  0.7 
Prior miscarriage  0.67  (0.48 – 0.94)   0.02 
Prior stillbirth  1.11  (0.75 – 1.63)  0.6 
Prior child death 
 
0.97  (0.77 – 1.21)  0.8 
Anthropometry       
Height   0.94  (0.92 – 0.96)  0.001 
Weight 
 
0.93  (0.91 – 0.95)  0.001 
Nutrition       
Weight gain (Kg)  0.92  (0.89 – 0.96)  0.001 
Blood haemoglobin (g/dL)  1.03  (0.95 – 1.11)  0.5 
Supplements 
 
0.77  (0.60 – 0.98)   0.04 
Fetal factors       
Sex  0.84  (0.66 – 1.06)  0.1 
Gestation at birth  1.27  (1.18 – 1.38)  0.001 
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Table 7.7 shows the results of the multivariable regression analysis. The strongest predictors of 
SGA were maternal weight at enrolment, gestational weight gain and parity. Another predictor 
was antenatal supplementation. A woman who was 1 Kg heavier at enrolment and who gained 1 
Kg more weight during pregnancy had 6% lower odds of giving birth to a SGA infant (OR 
0.94; 95% CI 0.92 – 0.97 and 0.94; 0.92 – 0.98, respectively) when maternal education, parity, 
prior history of miscarriage, height, antenatal supplementation and infant sex were taken into 
consideration. With a unit increase in parity, mothers had 0.19 times lower odds of giving birth 
to a SGA infant when other factors were taken into consideration. Women who received 
supplementation had 0.29 times lower odds of giving birth to a SGA infant when other factors 
entered in the model were controlled for. 
Table 7.7. Multivariable analysis of associations with small for gestational age, with odds 
ratios 
Predictors of Small for Gestational Age 
N = 1044 
Odds 
ratio 
(95% CI)  Wald  P 
value 
Maternal weight at enrolment (Kg)  0.94  (0.92 – 0.97)  18.22  0.001 
Maternal weight gain (Kg)  0.94  (0.92 – 0.98)  7.32  0.007 
Parity  0.81  (0.69 – 0.95)  6.81  0.009 
Antenatal supplementation  0.71  (0.55 – 0.92)  6.6  0.01 
         
7.7.  Predictors of birth length 
The sample available for analysis was 1033. Six participants did not have measurements of 
birth length and nine implausible outliers were removed from the dataset. The univariable 
associations of independent variables with birth length are shown in Table 7.8. Birth length 
showed an association with systolic blood pressure at enrolment (p=0.02). An association with 
diastolic blood pressure was possible but not significant (p=0.07). No associations were 
significant in the obstetric history category except prior history of death of a child. For maternal 
anthropometry, maternal height and weight at enrolment showed strong associations. 
Gestational weight also had a significant association with birth length. Other significant 
variables were maternal age, fetal sex and gestation at birth. There was no association with 
socioeconomic status (p=0.06) but it was almost significant.    
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Table 7.8. Univariable analysis of associations with birth length 
Parameters  
N = 1033 
b  (95% CI)  P value 
Maternal factors       
Ethnicity 
 Terai Brahmin 
 Terai Chhetri 
 Terai Vishya 
 Terai Sudra 
 Hindu Brahmin 
 Hindu Chhetri 
 Muslim 
 Newar 
 Other small ethnic groups 
 
0.094 
Reference  
-0.173 
-0.386 
-1.284 
0.141 
0.265 
0.265 
-0.635 
1.498 
(0.001 – 0.186)  
 
(-1.108 – 0.762) 
(-0.852 – 0.080) 
(-2.339 - -0.229) 
(-0.794 – 1.076) 
(-0.807 – 1.338) 
(-0.487 – 1.018) 
(-2.119 – 0.848) 
(0.262 – 2.736) 
0.001 
 
0.7 
0.1 
0.02 
0.8 
0.6 
0.5 
0.4 
0.02 
Demographic       
Education  0.030  (-0.012 – 0.073)   0.2 
Residence  0.108  (-0.200 – 0.417)  0.5 
Socioeconomic status  0.148  (-0.006 – 0.302)  0.06 
Age 
 
0.058  (0.013 – 0.103)   0.01 
Morbidity       
Eclampsia  0.018  (-3.286 - 0.469)  0.1 
Systolic blood pressure at enrolment  0.018  (0.003 – 0.034)   0.02 
Diastolic blood pressure at enrolment  0.019  (-0.001 – 0.039)  0.07 
2
nd trimester morbidity 
None 
Abdominal problem 
Infection 
Other 
0.076 
Reference 
0.031 
0.728 
0.127 
(-0.077 – 0.228) 
 
(-0.394 – 0.456) 
(-0.034 -  1.489) 
(-0.362 – 0.616) 
0.3 
 
0.9 
0.06 
0.6 
2
nd trimester morbidity 
None 
Abdominal problem 
Infection 
Other 
-0.009 
Reference 
-0.403 
0.638 
-0.025 
(0.090) 
 
(-1.098 – 0.292) 
(-0.455 – 1.732) 
(-0.574 – 0.523) 
0.9 
 
0.3 
0.3 
0.9 
3
rd trimester general illness 
None 
Abdominal problem 
Infection 
Other 
0.027 
Reference 
0.285 
-0.097 
0.058 
(-0.122 – 0.177) 
 
(-0.122 – 0.692) 
(-0.945 – 0.750) 
(-0.415 – 0.531) 
0.7 
 
0.2 
0.8 
0.8 
3
rd trimester general illness 
None 
Abdominal problem 
Infection 
Other 
 
0.031 
Reference 
0.350 
0.005 
0.072 
(-0.161 – 0.222) 
 
(-0.482 – 1.181) 
(-0.982 – 0.991) 
(-0.551 – 0.695) 
0.8 
 
0.4 
1 
0.8 
Obstetric history       
Parity  0.121  (-0.018 – 0.260)   0.09 
Prior small infant  -0.375  (-1.396 – 0.647)  0.5 
Prior miscarriage  0.061  (-0.349 -  0.472)  0.8 
Prior still birth  -0.306  (-0.793 – 0.181)  0.2 
Prior death of child 
 
-0.297  (-0.581 - -0.013)   0.04 
Anthropometry       
Height   0.086  (0.059 – 0.113)   0.001 
Weight 
 
0.093  (0.067 – 0.118)   0.001 
Nutrition       
Weight gain  0.141  (0.090 – 0.193)   0.001 
Blood haemoglobin  0.016  (-0.083 – 0.114)  0.8 
Supplements 
 
0.190  (-0.118 – 0.498)   0.2** 
Fetal factors       
Sex  0.583  (0.277 – 0.890)   0.001 
Gestation at birth  0.538  (0.453 – 0.622)   0.001    
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The coefficients and standard errors of the significant variables in the multivariable linear 
regression model for this population are presented in Table 7.9. The results indicate that the 
strongest predictor of infant birth length was gestational duration. The other predictors were 
infant sex, maternal weight at enrolment and antenatal weight gain, followed by maternal 
height. Among the variables that were significant in the univariable analysis, maternal 
ethnicity, education, age, systolic and diastolic blood pressure did not remain significant when 
other variables were accounted for.  
Each week increase in gestational duration was associated with a 4.7 mm increase in infant 
birth length. Being male was likely to increase birth length by 6.6 mm. Each cm increase in 
maternal height and each Kg increase in maternal weight at enrolment was likely to increase 
birth length by 3 mm and 5 mm, respectively. Every kilogram increase in maternal weight gain 
was associated with an increase in birth length by 7 mm. Similarly, a mother with a unit 
increase in the number of children who died was associated with a decrease in the length of the 
index newborn by 2.9 mm. 
This optimal model for birth length had a low adjusted R
2 of 0.19. The model was able to 
explain about 19% of the variance in the length of an infant at birth. The tolerances for 
variables in the regression model were not close to zero and the variance inflation factors (VIF) 
were below 10 for all variables. 
Table 7.9. Multivariable analysis of associations with birth length, with odds ratios  
Predictors of birth length in cm 
N = 1033 
b  (95% CI)  t  P  R
2 
Birth gestation (weeks)  0.47  (0.38 -0.55)  10.79  0.001  0.19 
Male sex  0.66  (0.38 – 0.94)  4.64  0.001   
Maternal weight at enrolment 
(Kg) 
0.05  (0.02 – 0.08)  3.59  0.001   
Maternal weight gain (Kg)  0.07  (0.03 – 0.12)  2.95  0.003   
Maternal height (cm)  0.03  (0.00 – 0.06)  2.20  0.028   
Prior death of child  -0.29  (-0.57 - -0.02)  -2.07  0.039   
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Figure 7.7 shows a roughly normal distribution of residuals for birth length. The standardized 
normal probability plot shows residuals falling randomly across the diagonal line (Figure 7.9) 
The standardized residuals plotted against the standardized predicted values show no obvious 
patterns (Figure 7.8). All these indicate that the model is adequate.
Figure 7.7. Histogram of residuals for 
birth length 
 
Figure 7.8. Residual plot for birth 
length 
Figure 7.9. Normal probability plot for birth 
length 
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7.8.  Predictors of body mass index at birth 
The sample available for analysis was 1034. The univariable associations of BMI at birth and 
possible determinants of size at birth are shown in Table 7.10. The analysis showed that ten 
variables were significantly associated with BMI at birth: ethnicity, socioeconomic status, age, 
parity, height, weight, antenatal weight gain, antenatal supplementation, age, infant sex and 
gestational age at birth.    
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Table 7.10. Univariable analysis of associations of body mass index 
Parameters  
n = 1033 
b   (95% CI)  P value 
Maternal factors       
Ethnicity 
Terai Brahmin 
Terai Chhetri 
Terai Vishya 
Terai Sudra 
Hindu Brahmin 
Hindu Chhetri 
Muslim 
Newar 
Other small ethnic groups 
 
0.071 
Reference 
0.201 
-0.110 
-0.093 
0.154 
0.076 
0.345 
0.158 
0.840 
(0.016 – 0.126) 
 
(-0.355 – 0.758) 
(-0.388 – 0.167) 
(-0.721 – 0.535) 
(-0.402 – 0.711) 
(-0.562 – 0.715) 
(-0.103 – 0.793) 
(-0.725 – 1.041) 
(0.104 – 1.576) 
0.01 
 
0.5 
0.4 
0.8 
0.6 
0.8 
0.1 
0.7 
0.03 
Demographic       
Education  0.014  (-0.012 – 0.039)  0.3 
Residence  -0.002  (-0.185 – 0.182)  0.9 
Socioeconomic status  0.135  (0.044 – 0.226)  0.004 
Age 
 
0.050  (0.023 – 0.076)   0.001 
Morbidity       
Eclampsia  0.177  (-0.938 – 1.291)  0.8 
Systolic Blood Pressure at enrolment  -0.002  (-0.012 – 0.007)  0.7 
Diastolic Blood Pressure at enrolment  0.001  (-0.011 – 0.013)  0.9 
2
nd trimester illness I 
None 
Abdominal complaints 
Infections 
Other 
-0.011 
Reference 
0.194 
-0.031 
-0.086 
(-0.101 – 0.079) 
 
(-0.059 – 0.446) 
(-0.483 – 0.421) 
(-0.376 – 0.204) 
0.8 
 
0.1 
0.9 
0.6 
2nd trimester illness II 
None 
Abdominal complaints 
Infections 
Other 
0.041 
Reference 
-0.007 
-0.198 
0.166 
(-0.062 – 0.144)) 
 
(-0.419 – 0.405) 
(-0.847  - 0.451) 
(-0.160 – 0.491) 
0.4 
 
1 
0.6 
0.3 
3
rd trimester illness I 
None 
Abdominal complaints 
Infections 
Other 
0.015 
Reference 
-0.015 
0.629 
-0.045 
(-0.073 – 0.104) 
 
(-0.256 – 0.225) 
(0.127 – 1.130) 
(-0.325 – 0.235) 
0.7 
 
0.9 
0.01 
0.8 
3
rd trimester illness II 
None 
Abdominal complaints 
Infections 
Other 
 
0.045 
Reference 
-0.451 
0.706 
0.052 
(-0.068 – 0.159) 
 
(-0.943 – 0.040) 
(0.123 – 1.289) 
(-0.317 – 0.420) 
0.4 
 
0.07 
0.02 
0.8 
Obstetric       
Multiparity  0.455  (0.273 – 0.636)  0.001 
Prior LBW infant  0.045  (-0.561 – 0.651)  0.9 
Prior miscarriage  0.189  (-0.054 – 0.432)  0.1 
Prior stillbirth  -0.022  (-0.311 – 0.267)  0.9 
Prior death of child 
 
0.088  (-0.081 – 0.257)  0.3 
Anthropometry       
Height   0.031  (0.051 – 0.047)  0.001 
Weight 
 
0.036  (0.020 – 0.051)  0.001 
Nutrition       
Weight gain  0.111  (0.081 – 0.141)   0.001 
Blood haemoglobin  -0.012  (-0.071 – 0.046)  0.7 
Supplements 
 
0.216  (0.034 – 0.398)   0.02 
Fetal factors       
Sex  0.189  (0.007 – 0.372)   0.04 
Gestation at birth  0.222  (0.171 – 0.274)   0.001    
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All the variables with significant associations were entered in the multivariable linear 
regression. The effect of prior history of giving birth to a small infant was also explored for 
their effect on the model. These variables did not change the coefficients significantly. Table 
7.11 displays the results of the multivariable regression analysis for newborn BMI. The final 
model contained six variables, which explained 12% of the variation in BMI. The variables 
which were strongly associated with BMI at birth were gestational age at birth, gestational 
weight gain and parity. Other predictors in the model were maternal weight at enrolment, infant 
sex and antenatal supplementation. The variables that were insignificant when other variables 
were taken into account were maternal age, ethnicity and socioeconomic status. 
Each week increase in gestational duration increased BMI at birth by 0.162 Kg/m
2. Similarly, a 
unit increase in maternal weight gain translated into an increase in infant BMI by 0.082 kg/m
2. 
Multigravid mothers were more likely to give birth to bigger babies than women in their first 
pregnancy: there was an increase in infant BMI by 0.375 kg/m
2. Male infants tended to be 
bigger than female infants by 0.220 kg/m
2. Supplementation of mothers increased infant BMI 
by 0.189 kg/m
2. Similarly, heavier mothers were likely to give birth to bigger infants. A gram 
increase in maternal weight increased infant BMI by 0.022 kg/m
2. 
Table 7.11. Multivariable analysis of associations of body mass index 
Predictors of BMI (Kg/m
2)
 
N = 1033 
b (95%CI)  t-value  P-value  Adjusted R
2 
Birth Gestation (w)  0.162 (0.110 – 0.215)  6.05  0.001  0.124 
Maternal weight gain (Kg)  0.082 (0.051 – 0.112)  4.99  0.001   
Multigravida   0.375 (0.159 – 0.590)  3.42  0.001   
Maternal weight at enrolment (Kg)  0.022 (0.005 – 0.039)  2.49  0.01   
Male sex   0.220 (0.049 – 0.392)  2.52  0.01   
Antenatal supplements  0.189 (0.001 – 0.379)  1.96  0.05   
         
The tolerances were not close to 0 and Variance Inflation Factors were less than 10. Figure 7.10 
demonstrates the distribution of the residuals. It shows that the residuals were somewhat 
normally distributed. Figure 7.11 is the normal probability plot which shows no obvious 
outliers. Similarly, Figure 7.12, a plot of predicted values against residuals, shows that the 
residuals were roughly normally distributed. In summary, the residual analysis showed that the 
residuals followed the normality assumption   
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Figure 7.10. Histogram of residuals 
for body mass index 
 
Figure 7.11. Normal probability plot for 
body mass index at birth 
 
Figure 7.12. Residual plot for body 
mass index at birth 
 
 
7.9.  Predictors of ponderal index at birth 
The univariable associations of variables with PI are presented in Table 7.12. The factors 
significantly related to PI at birth in the linear regression analysis were parity, age, gestational 
age at birth and antenatal weight gain.    
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Table 7.12: Univariable analysis of associations of ponderal index 
Parameters  
N = 1033 
b  (95% CI)  P value 
Maternal factors       
Ethnicity  0.011  (-0.002 – 0.023)  0.1 
 Terai Brahmin  reference     
 Terai Chhetri  0.044  (-0.083 – 0.172)  0.5 
 Terai Vaishya  -0.006   (-0.069 – 0.058)  0.9 
 Terai Sudra  0.045  (-0.099 – 0.189)  0.9 
 Hindu Brahmin  0.020   (-0.108 – 0.147)  0.8 
 Hindu Chhetri  0.011   (-0.136 – 0.157)  0.9 
 Muslim  0.056   (-0.047 – 0.159)  0.3 
 Newar  0.060   (-0.143 – 0.263)  0.6 
 Other 
 
0.113   (-0.056 – 0.282)  0.2 
Demographic       
Education  0.001   (-0.005 – 0.007)  0.7 
Residence  -0.006   (-0.048 – 0.036)  0.8 
Socioeconomic status  0.020   (-0.001 – 0.041)  0.06 
Age 
 
0.007   (0.001 – 0.013)  0.02 
Morbidity       
Eclampsia  0.106   (-0.149 – 0.361)  0.4 
Systolic Blood Pressure at enrolment  -0.001   (-0.003 – 0.001)  0.2 
Diastolic Blood Pressure at enrolment  -0.001   (-0.003 – 0.002)  0.7 
2
nd trimester morbidity I 
None 
Abdominal problems 
Infections 
Other 
-0.006 
Reference 
0.039 
-0.043 
-0.025 
(-0.027 – 0.014) 
 
(-0.018 – 0.097) 
(-0.146 – 0.060) 
(-0.091 – 0.041) 
0.6 
 
0.2 
0.4 
0.5 
2
nd trimester morbidity II 
None 
Abdominal complaints 
Infections 
Other 
0.009 
Reference 
0.021 
-0.072 
0.035 
(-0.015 – 0.032) 
 
(-0.073 – 0.116) 
(-0.221 – 0.076) 
(-0.039 – 0.110) 
0.5 
 
0.7 
0.3 
0.4 
3
rd trimester morbidity I 
None 
Abdominal complaints 
Infections 
Other 
0.003 
Reference 
-0.017 
0.141 
-0.009 
(-0.017 – 0.023) 
 
(-0.072 – 0.038) 
(0.027 – 0.256) 
(-0.073 – 0.055) 
0.8 
 
0.5 
0.01 
0.8 
3
rd trimester morbidity II 
None  
Abdominal complaints 
Infections 
Other 
 
0.008 
Reference 
-0.104 
0.148 
0.006 
(-0.018 – 0.034) 
 
(-0.217 – 0.281) 
(0.015 – 0.281) 
(-0.078 – 0.091) 
0.5 
 
0.07 
0.03 
0.9 
Obstetric       
Parity (category)  0.026  (0.008 – 0.045)**  0.006 
Prior LBW infant  0.025   (-0.113 – 0.164)  0.7 
Prior miscarriage  0.035   (-0.021 – 0.091)  0.2 
Prior stillbirth  0.010  (-0.056 – 0.076)  0.8 
Prior death of child 
 
0.031  (-0.007 – 0.070)  0.1 
Anthropometry       
Height   0.002   (-0.002 – 0.006)  0.3 
Weight 
 
0.003   (-0.001 – 0.007)*  0.1 
Nutrition       
Weight gain  0.016   (0.009 – 0.023)  0.001 
Blood haemoglobin (g/dL)  -0.003   (-0.017 – 0.010)  0.6 
Supplements 
 
0.035   (-0.007 – 0.077)  0.1 
Fetal factors       
Sex  0.012   (-0.029 – 0.054)  0.6 
Gestation at birth  0.020   (0.008 – 0.033)  0.001    
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The significant factors were entered in the multivariable linear regression, which left three 
variables significant (see Table 7.13): maternal parity (p=0.02), antenatal weight gain 
(p=0.001) and gestational age at birth (p=0.05). 
Each unit increase in gestational weight gain was translated as an increase in PI by 0.014 g/cm
3. 
Multiparity increased PI by 0.062 g/cm3 compared to primiparous mothers. Longer gestational 
duration was associated with increased PI. A week longer gestational duration increased PI by 
0.012g/cm
3. 
Socioeconomic status, education level, and prior history of small birth were entered into the 
model, but showed no significant associations. The model explained 3.2% of the variability in 
the PI at birth. The best predictor was gestational weight gain. There was no evidence of 
collinearity: variance inflation factors were all below 10 and tolerances for all the variables 
were not close to 0. Standardized residuals were normally distributed (see Figure 7.13) 
Figure 7.14 shows the normal probability plot for standardized residuals. It shows that the 
residuals lie close to the line and no outliers are evident. Figure 7.15 shows that the residuals 
were randomly distributed around the zero line. In summary, no outliers were detected on 
examination of the residual diagnostics. 
Table 7.13: Multivariable analysis of associations of ponderal index  
PI at birth (g/cm
3) 
n = 1033 
b (95% CI)  t  P  R square 
Maternal weight gain (kg)  0.014 (0.007 – 0.021)  3.78  0.001  0.032 
Primiparity   0.062 (0.011 – 0.112)  2.40  0.02   
Gestational age at birth  0.012 (0.000 – 0.025)  1.95  0.05   
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Figure 7.13. Histogram for residuals 
for ponderal index 
 
   
 
Figure 7.14. Normal probability plot for 
ponderal index 
 
 
 
 
Figure 7.15. Residual plot for ponderal index at birth 
7.10. Predictors of low ponderal index at birth 
The univariable regression coefficients and 95% confidence interval for coefficients of the 
potential determinants of low PI are given in Table 7.14. The variables that showed significant 
association with low PI were: parity as a categorical variable, antenatal weight gain, 
socioeconomic status and gestational age at birth.     
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Table 7.14. Univariable analysis of associations of low ponderal index 
Parameters 
N = 1033 
b   (95% CI)  P value 
Maternal factors       
Ethnicity  0.93  (0.86 – 1.01)  0.08 
 Terai Brahmin  Reference     
 Terai Chhetri  0.64  (0.30 – 1.36)  0.3 
 Terai Vaishya  1.10  (0.74 – 1.64)  0.7 
 Terai Sudra  0.76  (0.32 – 1.82)  0.6 
 Hindu Brahmin  1.04  (0.47 – 2.32)  0.9 
 Hindu Chhetri  1.02  (0.41 – 2.54)  0.9 
 Muslim  0.73  (0.39 – 1.35)  0.7 
 Newar  0.34  (0.10 – 1.14)  0.08 
 Other 
 
0.60  (0.22 – 1.62)  0.3 
Demographic       
Education  0.99  (0.95 – 1.02)  0.5 
Residence  1.22  (0.94 – 1.58)  0.1 
Socioeconomic status  0.85   (0.75 – 0.97)  0.02 
Age 
 
0.98  (0.94 – 1.02)  0.3 
Morbidity       
Eclampsia  0.64  (0.14 – 2.87)  0.6 
Systolic Blood Pressure at enrolment  1.01  (0.99 – 1.02)  0.4 
Diastolic Blood Pressure at enrolment  1  (0.98 – 1.02)  0.9 
2
nd trimester illness I 
None 
Abdominal complaints 
Infections 
Other 
1.04 
Reference 
0.78 
1.04 
1.23 
(0.91 – 1.19) 
 
(0.55 – 1.10) 
(0.54 – 2.00) 
(0.80 – 1.89) 
0.6 
 
0.2 
0.9 
0.4 
2
nd trimester illness II 
None 
Abdominal complaints 
Infections 
Other 
0.90 
Reference 
0.93 
1.16 
0.68 
(0.78 – 1.04) 
 
(0.52 – 1.66) 
(0.45 – 3.02) 
(0.44 – 1.07) 
0.1 
 
0.8 
0.7 
0.09 
3
rd trimester illness I 
None 
Abdominal complaints 
Infections 
Other 
0.98 
Reference 
1.02 
0.38 
1.10 
(0.86 – 1.11) 
 
(0.72 – 1.44) 
(0.19 – 0.74) 
(0.73 – 1.66) 
0.7 
 
0.9 
0.005 
0.7 
3
rd trimester illness II 
None 
Abdominal complaints 
Infections 
Other 
 
0.89 
Reference 
1.2 
0.40 
0.80 
(0.76 – 1.04) 
 
(0.57 – 2.53) 
(0.18 – 0.87) 
(0.48 – 1.33) 
0.1 
 
0.6 
0.02 
0.4 
Obstetric history       
Parity (category)  0.71  (0.55 – 0.93)  0.01 
Prior small infant  1.27  (0.51 – 3.15)  0.6 
Prior miscarriage  0.88  (0.63 – 1.23)  0.5 
Prior stillbirth  0.93  (0.62 – 1.40)  0.7 
Prior death of child 
 
0.90  (0.71 – 1.14)  0.4 
Anthropometry       
Height   1  (0.98 – 1.03)  0.8 
Weight 
 
0.99  (0.97 – 1.01)  0.3 
Nutrition       
Weight gain  0.93  (0.89 – 0.97)  0.01 
Blood haemoglobin  1.03  (0.95 – 1.12)  0.5 
Supplements 
 
0.82  (0.63 – 0.99)  0.1 
Fetal factors       
Sex  0.88  (0.68 – 1.45)  0.4 
Gestation at birth  0.92  (0.85 – 0.99)  0.03 
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Table 7.15 shows the final model of predictors of low PI at birth. Introducing prior history of 
giving birth to a small infant into the regression did not change the model. Only two variables 
were significant: maternal weight gain during pregnancy (p = 0.005) and gestational age at birth 
(p = 0.04). 
The model showed that a unit increase in parity or in gestational weight gain decreased the 
probability of giving birth to an infant with low PI. The odds of giving birth to a low PI infant 
for a woman of higher parity were 26% lower than for lower parity mothers (OR 0.74; 95% CI 
0.57–0.98). The predicted odds for giving birth to an infant with low PI for a mother who 
gained 1 kg more during pregnancy were 6 % lower (0.94; 0.90 – 0.98). 
Table 7.15. Multivariable analysis of associations with low ponderal index, with odds 
ratios 
Factors  
N = 1033 
Odds ratio  95% CI for OR  Wald  P value 
Maternal weight gain (Kg)  0.94  0.90 – 0.98  7.89  0.005 
Multiparity  0.74  0.57 – 0.99  4.27  0.04 
 
7.11. Predictors of birth head circumference 
The univariable associations between head circumference at birth and independent variables are 
shown in Table 7.16. Variables that showed associations with head circumference at birth were 
maternal height (p=0.001), weight (p=0.001), antenatal weight gain (p=0.001), socioeconomic 
status (p=0.002), education level (p=0.01), infant sex (p=0.001), gestational age at birth 
(p=0.001), parity (p=0.04), age (p=0.02) and prior history of giving birth to small infant. The 
variable showing almost an association was antenatal supplementation (p=0.08)    
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Table 7.16 Univariable analysis of associations of head circumference 
Parameters 
N = 1038 
b b b b  (Std. Error)  P value 
Maternal factors       
Ethnicity  0.008  (-0.047 – 0.064)  0.8 
 Terai Brahmin  reference     
 Terai chhetri  -0.050  (0.600 – 0.500)  0.9 
 Terai Vaishya|  -0.193  (-0.468 – 0.083)  0.1 
 Terai sudra  -0.117  (-0.745 – 0.511)  0.7 
 Hindu Brahmin  -0.016  (-0.566 – 0.534)  1 
 Hindu chhetri  0.314  (0.325 – 0.953)  0.4 
 Muslim  -0.180  (-0.623 – 0.262)  0.4 
 Newar  -0.627  (-1.511 – 0.256)  0.2 
 Other 
 
0.476  (-0.279 – 1.232)  0.2 
Demographic       
Education  0.032   (0.007 – 0.057)  0.01 
Residence  -0.101   (-0.280 – 0.080)  0.3 
Socioeconomic status  0.147   (0.056 – 0.238)  0.002 
Age 
 
0.033   (0.006 – 0.059)  0.02 
Morbidity       
Eclampsia  -0.102   (-1.216 – 1.012)  0.9 
Systolic Blood Pressure at enrolment  0.002   (-0.007 – 0.012)  0.6 
Diastolic Blood Pressure at enrolment  0.004   (-0.008 – 0.016)  0.5 
2
nd trimester morbidity I 
None 
Abdominal complaints 
Infections 
Other 
0.074  
Reference 
-0.052 
0.423 
0.192 
(-0.015 – 0.164) 
 
(-0.304 – 0.201) 
(-0.023 – 0.869) 
(-0.097 – 0.480) 
0.1 
 
0.7 
0.1 
0.2 
 
2
nd trimester illness II 
None 
Abdominal complaints 
Infections 
Other 
-0.026  
Reference 
-0.335 
-0.034 
-0.035 
 
(-0.129 – 0.076) 
 
(-0.740 – 0.069) 
(-0.682 – 0.614) 
(-0.361 – 0.292) 
 
0.6 
 
0.1 
0.9 
0.8 
3
rd trimester illness I 
None 
Abdominal complaints 
Infections 
Other 
0.008  
Reference 
0.056 
0.119 
-0.002 
(-0.080 – 0.096) 
 
(-0.185 – 0.296) 
(-0.371 – 0.608) 
(-0.280 – 0.276) 
0.9 
 
0.7 
0.6 
1 
3
rd trimester illness II 
None 
Abdominal complaints 
Infections 
Other 
 
-0.022  
Reference 
-0.496 
0.131 
-0.042 
(-0.135 – 0.092) 
 
(-0.995 – 0.002) 
(-0.453 – 0.714) 
(-0.410 – 0.327) 
0.7 
 
0.1 
0.7 
0.8 
Obstetric history       
Parity (category)  0.195  (0.013 – 0.378)  0.04 
Prior small infant  -0.545  (-1.149 – 0.058)*  0.08 
Prior miscarriage  -0.015   (-0.259 – 0.228)  0.9 
Prior still birth  -0.099   (-0.389 – 0.191)  0.5 
Prior death of child 
 
-0.148  (-0.317 – 0.021)  0.1 
Anthropometry       
Height   0.039   (0.023 – 0.055)  0.001 
Weight 
 
0.036   (0.021 – 0.052)  0.001 
Nutrition       
Weight gain  0.102   (0.072 – 0.132)  0.001 
Blood haemoglobin  0.017   (-0.041 – 0.075)  0.6 
Supplements 
 
0.165   (-0.020 – 0.350)  0.08 
Fetal factors       
Sex  0.469   (0.289 – 0.650)  0.001 
Gestation at birth  0.305   (0.256 – 0.355)  0.001    
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Table 7.17 shows the final contributors to the prediction model for head circumference at birth. 
The multivariable analysis demonstrated gestational duration, infant sex and maternal weight 
gain as independent determinants of head circumference. The univariable analysis suggested an 
effect of maternal height, parity, education, maternal weight at enrolment, but this was 
eliminated in the multivariable analysis. Similarly, maternal age, parity and previous history of 
giving birth to a small infant did not contribute to the prediction model. The model explained 
only 19% of the variability in head circumference at birth. 
A plot of standardized residuals revealed no specific patterns; points were evenly distributed 
around a horizontal line centred on zero (see Figure 7.18). Figure 7.16 shows the histogram of 
the residuals. It revealed normal distribution of residuals with no outliers. The normal 
probability plot showed residuals distributed around a diagonal line, as seen in Figure 7.17.  
Table 7.17. Multivariable analysis of associations of head circumference 
Head circumference (cm) 
N = 1038 
b   (95% CI)  t-value  P-value  R
2 
          18.8 
Birth gestation (wks)  0.28   (9.23 – 0.33)  11.0  0.001   
Male sex  0.51   (0.35 – 0.68)  6.11  0.001   
Maternal weight gain (kg)  0.06  (0.03 – 0.09)  4.11  0.001   
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Figure 7.16. Histogram of residuals 
for head circumference 
 
 
 
Figure 7.17. Normal probability plot for 
head circumference at birth 
 
Figure 7.18. Residual plot for head circumference at birth 
7.12. Summary 
The coefficients of determination (adjusted R
2) for all prediction models for size at birth 
outcomes were not high, ranging from 2.8% to 32.7%. The highest of them was for birth weight 
(32.7%), followed by birth length (19%), head circumference (18.8%), body mass index    
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(12.4%) and PI (3.2%). Nevertheless, the residual analyses confirmed that the models were 
adequate and did not violate the assumption of normality.  
The number of parameters in the prediction models ranged from two to eight. The results of the 
multivariable regression analysis showed that most of the models contained gestation at birth, 
maternal weight at enrolment and parity as the important determinants of size at birth. 
Antenatal maternal weight gain was the strongest determinant present in the final regression 
models for all birth outcomes. Similarly, gestational age, infant sex and maternal weight at 
enrolment were present in all models except for PI and low PI. The same goes for parity, which 
was present in all models except that for head circumference and length. Prior history of child 
mortality was significant in the final regression for length at birth.  
Birth weight, LBW and SGA had generally common predictors in the final regression models. 
Birth weight had two more predictors than LBW - maternal height and education - although 
their contributions were limited in the model. The model for LBW contained six factors and 
their rank order of contribution was the same as for birth weight. Since SGA is sex and 
gestation specific, sex and gestation do not figure in its final model. Otherwise, all the 
predictors of LBW were the same as for SGA. In the prediction of birth length, parity, 
education and antenatal supplementation were not elements of the model. Head circumference 
had similar predictors as birth weight, although parity, height, weight and antenatal 
supplementation did not feature in the model. 
The contribution of known risk factors in explaining the variability in birth indices was as low 
as 3-12%, the least explained being PI. The common predictors were parity and gestational 
weight gain. The multivariable logistic regression identified only two variables as significant 
predictors of low PI - parity and maternal weight gain during pregnancy - and three variables 
for PI (parity, gestational weight gain and gestational age). Table 7.18 summarises the results of 
the various multivariable prediction models for interpretation in subsequent discussion.    
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Table 7.18. Main risk factors in the analyses 
Variable  Predicts to some degree in multivariable analyses 
Gestation (wks)  Birth weight, LBW, length, BMI, PI, head circumference 
Maternal weight at enrolment (kg)  Birth weight, LBW, SGA, length, BMI 
Maternal height (cm)  Birth weight, length 
Maternal weight gain (kg)  Birth weight, LBW, SGA, length, BMI, PI, LPI, head 
circumference 
Parity  Birth weight, LBW, SGA, BMI, PI, LPI 
Infant sex  Birth weight, LBW, length, BMI, head circumference 
Supplement   Birth weight, LBW, SGA, BMI 
Education  Birth weight 
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Chapter 8.  Results: Associations of size at birth with mortality, 
morbidity and malnutrition in childhood 
8.1.  Chapter summary 
Previous chapters used a range of birth anthropometric parameters and indices to define size at 
birth. They demonstrated overlaps between classifications of size which put different 
proportions of infants into risk categories. This chapter describes an investigation of the 
associations between different measures of size at birth and short and longer term health 
outcomes in a sample of 1048 children born to women in the antenatal multiple micronutrient 
supplementation trial. Information on outcomes was collected at two points: about 1 month 
after birth, and 2-3 years of age.  
The study profile was presented in Chapter 5, but a simplified version for this analysis is shown 
in Figure 8.1. The number of children with information available varied across different indices 
of size at birth. We included children whose birth weight was measured within 72 hours of 
birth. The sample available for the analysis of neonatal deaths was 1048. The sample available 
for analysis of infant and child deaths was 953 after losses to follow-up. Child anthropometry 
was available for 915 children after losses to follow-up, infant deaths and child deaths.    
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Figure 8.1. Study profile for outcome analysis 
1200 enrolled 
785 ineligible for study 
1139 delivered  
39 lost to follow-up 
 20 could not be found 
 19 moved beyond study 
22 discontinued trial 
 7 miscarriages 
 14 withdrew from trial 
 1 clinical problem 
1985 assessed for eligibility 
785 ineligible for study 
1052 clean birth weight 
4 extreme birth weight outliers 
1048 birth weight analyzed 
  95 lost to follow-up  
1 child not at home  
23 neonatal deaths 
14 post neonatal deaths 
 10 deaths <1 year 
 4 deaths >1 year 
 
915 child anthropometry 
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Child characteristics 
Table 8.1 presents infant nutritional and immunization status, child anthropometry and blood 
pressure of children at follow-up. 99% of mothers breastfed their infants. Infants were 
exclusively breastfed for a mean duration of six months and were given solid food at a mean 
age of eight months. The immunisation rate for measles was 97%. BCG and DPT Vaccination 
rates exceeded 98%. Around 94% of children received the hepatitis B vaccination. 
Table 8.1. Infant feeding, Immunization status, child anthropometry and blood pressure 
of children at follow-up 
Nutrition  Frequency  (%) 
Breastfed [n=926]  913  (98.6) 
Duration of exclusive breastfeeding in months [n=916] (mean [SD])  6.44   (3.24) 
Age at introduction of solids in months [n=919] (mean [SD])  8.46   (3.41) 
Immunization status [n=925]     
BCG  919  (99.4) 
DPT1  917  (99.1) 
DPT2  914  (98.8) 
DPT3  911  (98.5) 
Measles  902  (97.5) 
HBV1  868  (93.8) 
HBV2  865  (93.5) 
HBV3  858  (92.9) 
Child anthropometry and blood pressure [n=915]  Mean  (95% CI) 
Weight (Kg)  10.80   (10.70 – 10.89) 
Height (cm)  83.90  (83.59 – 84.21) 
BMI (Kg/m
2)  15.31  (15.21 – 15.40) 
Systolic blood pressure (mmHg) [n=903]  99.79  (98.90 – 100.68) 
Diastolic blood pressure (mmHg) [n=904]  62.40  (61.53 – 63.28) 
MUAC (cm)  14.30  (14.23 – 14.37) 
Head circumference (cm)  46.52  (46.43 – 46.62) 
Chest circumference (cm)  48.12  (47.96 – 48.27) 
Waist circumference (cm)  46.64  (46.46 – 46.83) 
Hip circumference (cm)  46.14  (46.00 – 46.33) 
Waist hip ratio   1.01  (1.00 - 1.02) 
Triceps skinfold thickness (mm)  7.05  (6.95 – 7.16) 
 
The mean age at follow-up of children was 2.56 years (SD 0.35) and half of them were male 
(51%). The age ranged from 1.98 to 3.85 years. Figure 8.2, 8.3 and 8.4 show scatterplots of 
weight, height and head circumference against age of children at follow-up. The association of 
age with weight was not as strong (R
2 = 0.134) as with height. (R
2 = 0.321). There was little 
association of age with head circumference (R
2 = 0.055).    
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Figure 8.2. Scatterplot of weight by age of child at 
follow up 
 
Figure 8.3. Scatterplot of height by age of child at 
follow up 
 
Figure 8.4. Scatterplot of head circumference by age of child at follow up 
 
The mean weight was 10.80 kg (SD: 1.47; range 7.00 to 16.10 kg) and mean height was 83.90 
cm (4.75; 67.2 – 99.6). The mean systolic blood pressure and diastolic blood pressure were 
99.79 (SD 13.61) and 62.40 (SD 13.38) respectively.  
Figure 8.5, Figure 8.6 and Figure 8.7 show the average annual gain in weight, height and head 
circumference agaist weight of infants at birth. These averages were derived from the 
difference between the initial and follow-up measurements, divided by the age at follow-up. In 
fact, the true growth pattern will vary from year to year and these figures are simple summaries 
based on only two measures. The average annual weight gain was around 3 kg for all levels of 
birth weight:  this absolute weight gain was quite similar irrespective of actual birth weight.  
Figure 8.6 and Figure 8.7 illustrate that the absolute annual gain in head circumference and 
length varied across the ranges of head circumference and length at birth. The annual gain in    
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length ranged from 12.5 to 15.5 cm. The annual gain in head size ranged from 7.5 cm when the 
head size was 27 cm at birth, to 3.5 cm for a head size of 38 cm at birth.  
 
Figure 8.5. . Mean annual weight gain by birth 
weight 
 
Figure 8.6. . Mean annual height gain by length at 
birth  
 
 
Figure 8.7. Mean annual gain in head 
circumference by head circumference at birth 
 
These charts have expressed growth in terms of absolute measurements. Figure 8.8, Figure 8.9 
and Figure 8.10 show the mean change in z-scores of weight, height and head circumference for 
age, relative to the WHO reference. Mean changes in z scores per year were -0.209 (SD 0.459), 
-0.770 (0.579) and -0.358 (0.501) for weight, height and head circumference respectively. The 
negative signs show that children became relatively more underweight, stunted and smaller in 
head size relative to WHO reference groups. In all the figures, the annual changes in z-score 
were greater for infants with lower z-scores at birth. The annual change in weight z-scores    
158 
 
decreased with increasing z-scores of birth weight: infants with lower size at birth gained 
relatively more weight, height and head circumference than larger infants. For most infants and 
young children, the change in z-score was negative. However, the graphs show that at the lower 
end of the distribution the change was positive. The general pattern was for a downward 
movement in z-score with time, but smaller infants tended to ‘catch up’ and larger infants 
tended to ‘catch down’. 
 
   
Figure 8.8. Mean annual change in z-score for 
weight for age, by z-score at birth 
 
 
Figure 8.9. Mean annual change in z-score for 
height for age, by z-score at birth 
 
Figure 8.10. Mean annual change in z-score for head circumference for age, by z-score at birth 
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8.2.  Adjustment for possible confounding 
We used an intuitive approach and the findings of previous studies to select confounders from 
the pool of data available. The potential confounders assessed were: maternal age at 
enrolment,
200 parity,
200 ethnicity, education level, socioeconomic status, antenatal 
supplementation status, weight at enrolment, gestational age at birth, infant sex, age of 
weaning, age of child at follow-up and frequency of illnesses. Some confounders did not apply 
to all the outcomes that were assessed. In the case of neonatal death as an outcome: age at 
weaning, age of child at follow-up and frequency of illnesses. In the case of infant and child 
deaths: age at follow-up and frequency of illnesses. In the case of morbidity outcomes: 
frequency of illnesses. Age at weaning was preferred to frequency of breastfeeding as a 
possible confounder because almost all women breastfed their newborns (99%). The month of 
introduction of solid food varied across the participants, ranging from 1 to 24 months. 
All the above mentioned confounders were assessed for univariable associations with birth 
outcomes. Table 8.2 shows the results of univariable logistic regressions of mortality from birth 
to 2.5 years of age on all confounders. Out of nine possible confounders, only maternal weight 
at enrolment showed a significant univariable association with neonatal death. Infant and child 
deaths demonstrated no association with any confounder. However, gestation at birth was 
closer to significance in its association with child death (p=0.08).  
Morbidity factors assessed during infancy were cough and fever, rash and fever, and diarrhoea 
and fever. The results of the univariable logistic regression are shown in Table 8.3. Cough and 
fever, and rash and fever showed no significant association with any of the possible 
confounders. However, maternal age and education level were closer to significant association 
(p <0.09). Diarrhoea and fever showed significant associations with ethnicity, antenatal 
supplementation and children’s age at follow-up. Frequency of illnesses was significantly 
related to maternal parity, education, socioeconomic status and age of weaning.    
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Illness during 14 days before follow-up was also assessed for its association with possible 
confounders (see Table 8.4). The particular symptoms asked were fever, cough, difficulty 
breathing and diarrhoea. Fever, difficulty breathing and diarrhoea were shown to have an 
association with maternal parity, education and age at weaning. Apart from that, fever was also 
related to socioeconomic status and weight at enrolment. Cough was also associated with 
socioeconomic status, infant sex, weight at enrolment and age at follow-up. Difficulty breathing 
was associated with age at follow-up. Diarrhoea was associated with socioeconomic status, 
weight at enrolment and age at follow-up. Systolic blood pressure was univariably associated 
with maternal age and parity. Diastolic blood pressure was associated with parity, ethnicity and 
education (SeeTable 8.5).  
Table 8.6 shows univariable associations between malnutrition and possible confounders. For 
malnutrition, all 12 confounders were examined. Stunting and underweight in children showed 
significant associations with all confounders except for maternal age, ethnicity, antenatal 
supplementation and infant sex. There was an almost significant association with age of 
children at follow-up (p=0.09) for stunting. Wasting was associated with only two factors: 
maternal education and maternal weight at enrolment. 
As described in Chapter 5, we developed three models for each outcome. The model was 
developed following identification of possible confounders for deaths, illnesses and 
malnutrition. Model I was an unadjusted logistic or linear regression of outcome on parameter 
of size at birth. Model II adjusted for confounders that were associated with the outcome in 
univariable analysis. Model III adjusted for all possible confounders by including variables that 
may not have shown univariable association, but were felt to be important.     
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Table 8.2. Univariable association between possible confounders and neonatal, infant and child mortality up to 2.5 years of age 
Possible confounders  Neonatal death (n=1048) 
OR (95% CI) 
Infant death (n=953) 
OR (95% CI) 
Child death (n=953) 
OR (95% CI) 
Maternal age  0.89 (0.77–1.02) P = 0.1  0.98 (0.89–1.09) P =0.7  0.97 (0.88–1.07) P = 0.5 
Maternal parity  0.86 (0.57–1.3) P = 0.5  1.10 (0.82–1.48) P = 0.5  1.10 (0.83–1.45) P = 0.5 
Ethnicity  1.07 (0.85–1.34) P = 0.6  0.96 (0.77–1.19) P = 0.7  1.09 (0.91–1.3) P = 0.4 
Maternal education  0.97 (0.86–1.1) P = 0.6  0.93 (0.83–1.04) P = 0.2  0.93 (0.83–1.03) P = 0.2 
Socioeconomic status  0.88 (0.59–1.33) P = 0.5  0.84 (0.60–1.18) P = 0.3  0.83 (0.60–1.14) P = 0.2 
Supplements  1.56 (0.07–3.6) P = 0.3  1.19 (0.59–2.39) P = 0.6  1.04 (0.54–2.01) P = 0.9 
Weight at enrolment  0.9 (0.85–0.99) P = 0.04  0.95 (0.89–1.01) P = 0.1  0.97 (0.91–1.03) P = 0.3 
Gestation at birth  0.88 (0.7–1.1) P = 0.2  0.87 (0.72–1.01) P = 0.1  0.86 (0.72–1.02) P = 0.08 
Infant sex  0.74 (0.3–1.7) P = 0.5  0.62 (0.31–1.26) P = 0.2  0.65 (0.33–1.27) P = 0.2 
Age at weaning  -  0.83 (0.62-1.11) P = 0.2  0.96 (0.77–1.18) P= 0.7 
 
 
Table 8.3. Univariable association between possible confounders and illnesses during infancy 
Possible confounders 
n=953 
Cough and fever 
OR (95% CI) 
Diarrhoea and fever 
OR (95% CI) 
Rash and fever 
OR (95% CI) 
Frequency of illness 
OR (95% CI) 
Maternal age  0.94 (0.81–1.01) P = 0.08  0.96 (0.93–1.00) P = 1.00  0.95 (0.89-1.01) P = 0.08  0.99 (0.95–1.03)  P = 0.5 
Maternal parity  0.99 (0.78–1.27) P = 0.9  1.07 (0.94–1.22) P = 0.3  0.98 (0.82–1.18) P = 0.8  1.13 (1.00–1.30) P = 0.04 
Ethnicity  0.99 (0.85–1.20) P = 0.9  0.92 (0.85–0.99) P = 0.04  1.07 (0.96–1.20) P = 0.2  1.05 (0.97–1.13) P = 0.3 
Maternal education  0.94 (0.88–1.01) P = 0.06  0.98 (0.94–1.02)P = 0.3  0.95 (0.89–1.01) P = 0.09  0.94 (0.90–0.97) P = 0.001 
Socioeconomic status  0.81 (0.61–1.10) P = 0.1  0.95 (0.83–1.09) P = 0.5  0.90 (0.74–1.09) P = 0.3  0.85 (0.75–0.97) P = 0.02 
Supplements  1.28 (0.73–2.22) P = 0.4  0.75 (0.57–1.00) P = 0.05  1.06 (0.71–1.58) P = 0.8  0.93 (0.71–1.21) P = 0.6 
Weight at enrolment  1.03 (0.98-1.08) P = 0.3  0.99 (0.96–1.01) P = 0.3  0.99 (0.97–1.03) P = 0.97  0.99 (0.98–1.02) P = 0.8 
Gestation at birth  0.94 (0.79–1.11) P = 0.5  1.00 (0.92–1.09) P = 0.9  1.07 (0.95–1.22) P = 0.3  0.98 (0.91–1.06) P = 0.6 
Infant sex  0.89 (0.51–1.55) P = 0.7  0.84 (0.64–1.12) P = 0.2  0.97 (0.65–1.46) P = 0.9  1.32 (1.01–1.72) P = 0.04 
Age at weaning  1.05 (0.96–1.19) P = 0.3  1.04 (0.99–1.09) P = 0.1  0.99 (0.93–1.05) P = 0.7  1.03 (0.99–1.08) P = 0.1 
Age at follow up  1.11 (0.50–2.45) P = 0.8  0.61 (0.41–0.91) P = 0.02  1.05 (0.59–1.85) P = 0.9  0.83 (0.51–1.20) P = 0.8    
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Table 8.4. Univariable association between possible confounders and illnesses in the 14 days before follow up 
Possible confounders 
n=915 
Fever 
OR (95% CI) 
Cough 
OR (95% CI) 
Difficulty breathing 
OR (95% CI) 
Diarrhoea 
OR (95% CI) 
Maternal age  1.01 (0.97–1.05) P = 0.5  1.01 (0.99–1.07)  P =0.2  1.03 (0.96–1.10) P = 0.4  0.98 (0.92–1.03) P = 0.39 
Maternal parity  1.18 (1.05–1.33) P = 0.007  1.20 (1.06–1.35) P = 0.003  1.30 (1.07–1.60) P = 0.008  1.18 (1.01–1.38) P = 0.04 
Ethnicity  1.02 (0.94–1.11) P = 0.6  0.99 (0.92–1.08) P = 0.9  0.93 (0.80–1.09) P = 0.4  1.0 (0.89–1.12) P = 1.00 
Maternal education  0.91 (0.87–0.95) P = 0.001  0.91 (0.88–0.95) P = 0.001  0.86 (0.79–0.94) P = 0.001  0.94 (0.89–0.99) P = 0.04 
Socioeconomic status  0.82 (0.72–0.94) P = 0.004  0.81 (0.71–0.92) P = 0.002  0.85 (0.67–1.08) P = 0.2  0.85 (0.71–1.02) P = 0.08 
Supplements  0.99 (0.76–1.31) P = 9  1.02 (0.78–1.33) P = 1  1.26 (0.77–2.06) P = 0.4  0.87 (0.59–1.26) P = 0.5 
Weight at enrolment  0.95 (0.93-0.98) P = 0.001  0.97 (0.95-0.99) P = 0.01  0.98 (0.93–1.02) P = 0.3  0.95 (0.92–0.98) P = 0.003 
Gestation at birth  0.96 (0.89–1.04) P = 0.9  0.94 (0.87–1.02) P = 0.1  1.05 (0.90–1.21) P = 0.6  1.01 (0.90-1.13) P = 0.9 
Infant sex  1.18 (0.90–1.55) P = 0.2  1.32 (1.00–1.73) P = 0.05  1.15 (0.70–1.87) P = 0.6  1.21 (0.83–1.77) P = 0.3 
Age at weaning  1.05 (1.01–1.10) P = 0.02  1.07 (1.03–1.12) P = 0.001  1.09 (1.01-1.17) P = 0.02  1.07 (1.01–1.13) P = 0.02 
Age at follow up  1.03 (0.70–1.52) P = 0.9  0.69 (0.47–1.03) P = 0.06  1.93 (0.99–3.75) P = 0.05  0.50 (0.28–0.88) P = 0.02 
 
 
Table 8.5. Univariable association between possible confounders and blood pressure in children at 2.5 years of age 
Possible confounders 
n=915 
Systolic Blood Pressure 
OR (95% CI) 
  Diastolic Blood Pressure 
OR (95% CI) 
 
Maternal age  -0.30 (-0.51 - 0.01)   P = 0.05  -0.16 (-0.41 – 0.09)   P = 0.2 
Maternal parity  -1.29 (-2.09 - 0.50)   P = 0.001  -0.83 (-1.62 - 0.52)   P = 0.04 
Ethnicity  -0.32 (0.85 – 0.21)   P = 0.2  -0.54 (-1.06 – 0.02)   P = 0.04 
Maternal education  0.09 (-0.15 – 0.34)   P = 0.8  0.276 (0.04 – 0.52)   P = 0.02 
Socioeconomic status  -0.02 (-0.89 – 0.86)   P = 0.9  0.23 (-0.63 – 1.1)   P = 0.6 
Supplements  -1.05 (2.83 – 0.73)   P = 0.3  -0.86 (-2.6 – 0.89)   P = 0.3 
Weight at enrolment  0.01 (-0.14 – 0.16)   P = 0.9  0.07 (-0.08 – 0.2)   P = 0.4 
Gestation at birth  -0.06 (-0.59 – 0.47)   P = 0.8  -0.4 (-0.9  – 1.12)   P = 0.1 
Infant sex  0.40 (-1.38 – 2.18)   P = 0.7  -0.89 (-2.63 – 0.86)   P = 0.3 
Age at weaning  -0.08 (-0.36 – 0.19)   P = 0.6  -0.16 (-0.43– 0.11)   P = 0.3 
Age at follow up  -0.07 (-2.61 – 2.47)   P = 1.0  1.31 (-1.18 – 3.80)   P = 0.3    
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Table 8.6. Univariable association between possible confounders and malnutrition in children at 2.5 years of age 
Possible confounders 
n=915 
Stunting 
OR (95% CI) 
Wasting 
OR (95% CI) 
Underweight 
OR (95% CI) 
Maternal age  0.99 (0.96–1.03) P = 0.7  1.03 (0.95–1.11) P = 0.5  1.02 (0.98–1.06) P = 0.2 
Maternal parity  1.33 (1.17–1.51) P = 0.001  1.17 (0.94–1.47) P = 0.2  1.35 (1.19–1.52) P = 0.001 
Ethnicity  0.98 (0.91–1.06) P = 0.6  0.89 (0.74–1.07) P = 0.3  1.03 (0.95–1.11) P = 0.5 
Maternal education  0.89 (0.85–0.92) P = 0.001  0.93 (0.85–1.01) P = 0.09  0.89 (0.85–0.93) P = 0.001 
Socioeconomic status  0.68 (0.59–0.77) P = 0.001  0.93 (0.71–1.21) P = 0.6  0.69 (0.60-0.79) P = 0.001 
Supplements  0.90 (0.68–1.16) P = 0.4  1.11 (0.64–1.92) P = 0.1  0.93 (0.71–1.21) P = 0.6 
Weight at enrolment  0.91 (0.88–0.93) P = 0.001  0.89 (0.84–0.94)  P = 0.001  0.89 (0.86–0.91)P = 0.001 
Gestation at birth  0.01 (0.84–0.99) P = 0.03  0.90 (0.77–1.05) P = 0.2  0.88 (0.82–0.96) P = 0.003 
Infant sex  0.82 (0.63–1.06) P = 0.1  1.25 (0.72–2.17) P = 0.4  1.00 (0.77–1.31) P = 0.9 
Age at weaning  1.07 (1.03-1.12) P = 0.002  1.05 (0.97–1.14) P = 0.4  1.06 (1.02–1.11) P = 0.008 
Age at follow up  0.73 (0.50-1.05) P = 0.09  1.04 (0.48–2.25) P = 0.9  1.20 (0.82–1.75) P = 0.4 
Frequency of illness  1.21 (1.08–1.35) P = 0.001  1.17 (0.94–1.45) P = 0.2  1.22 (1.09–1.36) P = 0.001 
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8.3.  Effects of birth size on outcomes 
Annex M shows associations between size at birth and morbidity, mortality and growth from 
birth to 2.5 years of age. It includes results for all the models (I, II and III). Understanding the 
relationships between 16 outcomes and 23 birth size categories in 3 models was difficult. An 
adjusted model was preferable, and model III was chosen for presentation because it did not 
differ substantially from model II and represented maximal adjustment. 
8.4.  Size at birth and mortality 
We investigated the effect of various classifications of size at birth on mortality. The numbers 
of deaths identified are shown in Table 8.7. Mortality rates were high. The neonatal mortality 
rate was 21 per 1000 live births, the infant mortality rate was 33 per 1000 live births and the 
child mortality rate was 39 per 1000 live births (denominators adjusted for losses to follow-up).  
Table 8.7. Numbers of deaths 
  Denominator  Frequency  Rate/1000 
Neonatal death <28 d  1048  22  21.0 
  Early neonatal death <7d  1048  14  13.4 
  Late neonatal death >7 to <28 d 
 
1048  8  7.6 
Post-neonatal infant death >/=28 d - <1 y 
 
953  9  9.4 
Infant death <1 year  953  31  32.5 
Child death <2.5 years  953  37  38.8 
Most deaths took place in the neonatal period (n=22). Of the neonatal deaths, nearly two-thirds 
occurred in the first seven days of life. Neonatal deaths were due to preterm birth (two), 
infection (seven), birth asphyxia (five), congenital anomaly (one), sudden unexplained death 
overnight (six) and aspiration during feeding (one). Post-neonatal deaths less than one year of 
age were due to pneumonia (two), meningitis (one), measles (one), infection (one), a hepatic 
syndrome (one), complications of cleft palate (one), and sudden unexplained death overnight 
(two). Child deaths below 2.5 years of age were due to measles followed by tuberculosis (one), 
a bleeding disorder (one), convulsion (two) and diarrhoea (two).     
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 Table 8.8 shows the number of deaths and death rates per 1000 live births by gestation of 
infants at birth.  Infant mortality was highest at the very low gestational age at birth, 250 deaths 
per 1000 live births at 31 weeks of gestation and 125 deaths per 1000 live births at 34 weeks of 
gestation. Mortality rate decreased until 40 weeks of gestation (18 deaths per 1000 live births) 
but rose again in infants born post-term (77 per 1000 live births)  
 
Table 8.8. Live births and child deaths by gestational age 
    Numbers  Rates per 1000 live births 
Gestatio
n 
 at Birth  
(Week) 
Live 
Birth  Early  
Neonatal  
Deaths 
 
Late  
Neonatal  
Deaths 
 
Post  
Neonatal  
Deaths 
 
Post 
Infancy 
Deaths 
Early 
Neonatal 
(<7d) 
Late 
Neonatal 
(>7 – 
28d) 
Post 
Neonatal 
(>28d - 
<1y) 
Infan
t 
(<1y) 
Post 
Infanc
y 
(>1 y – 
2.5 y) 
 
31  4  0  1  0  0  0  250  0  250  0 
32  2  0  0  0  0  0  0  0  0  0 
33  2  0  0  0  0  0  0  0  0  0 
34  8  1  0  0  0  125  0  0  125  0 
35  21  1  1  0  0  47.6  47.6  0  95.2  0 
36  39  1  1  1  1  25.6  25.6  25.6  76.8  25.6 
37  83  0  0  2  1  0  0  24.1  24.1  12.0 
38  195  3  0  2  2  15.4  0  10.3  25.7  10.3 
39  313  3  2  2  0  9.6  6.4  6.4  21.4  0 
40  228  2  1  1  2  8.8  4.4  4.4  17.6  8.8 
41  101  1  1  0  0  9.9  9.9  0  19.8  0 
42 and 
over 
52  2  1  1  0  38.5  19.2  19.2  76.9  0 
The mean follow up age was 2.26 years and the minimum and maximum follow up time was 
from 0 years to 3.85 years. Cox proportional hazards modeling was used to explore the role of 
measurements at birth in the prediction of death from birth to the end of follow-up. Figure 8.11 
illustrates graphically the survival rate from birth to an average 2.5 years of age. It shows that 
there were more deaths in the first two weeks after which there was a sharp decline. This is 
entirely predictable from known patterns of neonatal and infant mortality. The overall survival 
rates at 1 year and at the end of follow-up were 97% and 96% respectively.     
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Figure 8.11. Predicted survival for children born in the study from birth to 2.5 years of age 
 
Table 8.9 shows estimates of hazard ratio for neonatal, infant and child deaths, with 95% 
confidence intervals calculated for different anthropometric parameters measured at birth. None 
of the anthropometric measurements was a significant determinant of survival.  
Table 8.9. Estimates of hazard ratio for anthropometric measurements at birth 
  Predicted  1 mo survival    Predicted 1 yr survival    Predicted 2.5  yr survival 
  HR   (95% CI)  P 
value 
  HR   (95% CI)  P 
value 
  HR   (95% CI)  P 
value 
G  0.87  (0.43 – 2.05)  0.9    0.84  (0.45 – 1.57)  0.6    0.82  (0.47 – 1.43)  0.5 
BW  0.40  (0.00- 35.00)  0.7    0.91  (0.03 – 32.45)  1.0    1.10  (0.05 – 26.90)  0.9 
BWZ  0.82  (0.13 – 5.38)  0.8    0.66  (0.15 – 3.00)  0.6    0.56  (0.17 – 2.56)  0.6 
PI  1.19  (0.28 – 5.12)  0.8    0.76  (0.21 – 2.73)  0.7    0.67  (0.17 – 1.83)  0.3 
                       
BW: Birth weight; BWZ: Birth weight Z score; G: Gestation; HR: Hazard ration; mo: month; PI: Ponderal 
Index; yr: year 
Table 8.10 shows associations between different classifications of size at birth and mortality. 
Three groups of findings are shown: predictors comprising a single index (LBW, SGA or LPI), 
predictors based on a combination of two indices, and predictors based on a combination of 
three indices 
8.4.1.  One anthropometric index as a predictor of mortality 
In a model adjusted for the potential confounding factors, LBW was strongly associated with 
neonatal, infant and child mortality (Table 8.10). The prevalence of LBW was 22%. 5% of    
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LBW infants died in the first month, compared with 1% of normal birth weight infants. 
Similarly, 7% of LBW infants died in the first year, compared with 2% of normal birth weight 
infants. 8% of LBW infants died before their 3
rd birthday, compared with 2% of normal birth 
weight infants. The odds of dying during the neonatal period for a LBW infant were 3.5 times 
higher than for an infant with normal birth weight. The odds of infant death and childhood 
death were also higher (3.6 and 3.7, respectively). In contrast with LBW, LPI and SGA were 
not by themselves associated with increased risk of mortality at any of the three time points. 
8.4.2.  Two anthropometric indices as a predictor of mortality 
When LBW was combined with PI, proportionate LBW infants were at highest risk of neonatal, 
infant and childhood mortality (API-LBW) but none were significant. As a group, 
disproportionate LBW infants were only marginally more likely to die in the neonatal period 
than other infants. When LBW was combined with weight-for-gestational-age, appropriately 
grown LBW infants were at highest risk of neonatal mortality (LBW-AGA), but not at 
increased risk of later death. LBW infants who were SGA were at increased risk of mortality in 
all three age bands, although the association was not significant in the neonatal period. When PI 
was combined with weight-for-gestational-age, no significant increases in odds were seen. 
8.4.3.  Three anthropometric indices as a predictor of mortality 
Two combinations were not analysed as no deaths were seen, a limitation of the sample size. 
There were no deaths in LBW infants who were appropriate for their gestational age and had 
normal PI and normal birth weight infant who were small for their gestational age and had 
appropriate PI. Three combinations of indices appeared to increase the risk of mortality, 
although none achieved significance in all three age bands. The highest risk appeared to be to 
infants who were LBW, proportionate and SGA (LBW-API-SGA) but association was only 
significant for infant deaths. Infants who were LBW, disproportionate and AGA (LBW-LPI-
AGA) had significant risk for neonatal deaths.    
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Table 8.10. Mortality in children of different birth sizes 
Adjusted models  Neonatal death 
OR (95% CI) 
Infant death 
OR (95% CI) 
Child death 
OR (95% CI) 
Single index       
LBW  3.46 (1.36 – 8.85)*
   3.60 (1.63 – 7.93)*
   3.66 (1.73 – 7.75)*
  
SGA  1.11 (0.45 – 2.73)   1.34 (0.63 -2.85)   1.67 (0.81 – 3.45)  
LPI  1.26 (0.48 – 3.32)   0.98 (0.45 – 2.12)  1.03 (0.49 – 2..16)  
       
2 index combination     
LBW-LPI  2.65 (1.03 – 6.79)*   2.26 (0.90 – 1.03)*  2.13 (0.98 – 4.59)* 
LBW-API  6.95 (2.45 – 19.70)  5.98 (2.06 – 17.41)  7.04 (2.31 – 21.44)
  
NBW-LPI  0.55 (0.22 – 1.40)  0.51 (0.24 – 1.12)   0.57 (0.28 – 1.19)  
NBW-API  0.53 (0.17 – 1.61)  0.60 (0.24 – 1.51)  0.50 (0.20 – 1.24) 
       
LBW-SGA  2.15 (0.86 – 5.38)   2.79 (1.31 – 5.96)
   3.07 (1.50 – 6.30)
  
LBW-AGA  5.69 (1.02 – 31.83)*  2.30 (0.47 – 11.24)  1.64 (0.35 – 7.85)  
NBW-SGA  0.45 (0.14 – 1.44)   0.40 (0.14 – 1.10)
   0.49 (0.19 – 1.25)  
NBW-AGA  0.60 (0.23 – 1.53)   0.63 (0.29 – 1.37)   0.54 (0.26 – 1.14)  
       
LPI_SGA  1.15 (0.48 – 2.75)   1.15 (0.55 – 2.38)  1.29 (0.64 - 2.58)  
LPI_AGA  1.1 (0.40 – 2.98 )  0.86 (0.36 – 2.06)  0.79 (0.35 – 1.80) 
API_SGA  0.92 (0.20 – 4.17)   1.46 (0.48 – 4.43)   1.87 (0.67 – 5.16)  
API_AGA  0.76 (0.25 – 2.37)   0.85 (0.34 – 2.17)   0.67 (0.27 – 1.70)  
       
3 index combination     
LBW-LPI-AGA  6.55 (1.16 – 37.06)*  2.52 (0.51 – 12.38)   1.82 (0.38 – 8.75)  
LBW-API-SGA  4.08 (0.82 – 20.19)
   6.46 (1.93 – 21.60)*
   8.09 (2.64 – 24.78)  
LBW-LPI-SGA  1.66 (0.63 – 4.36)   1.82 (0.81 – 4.08)   1.87 (0.87 – 4.03) 
LBW-API-AGA  -  -  - 
NBW-LPI-AGA  0.58 (0.17 – 2.02)   0.61 (0.23 – 1.63)   0.62 (0.25 – 1.55)  
NBW-API-SGA  -  -  - 
NBW-LPI-SGA  0.70 (0.22 – 2.23)   0.62 (0.26 – 1.68)   0.72 (0.28 – 1.83)  
NBW-API-AGA  0.78 (0.25 – 2.44)   0.87 (0.34 – 2.22)   0.69 (0.27 – 1.75)  
* Significant at p<0.05 
8.5.  Size at birth and morbidity 
8.5.1.  Size at birth and morbidity in the first year of life 
The association of categories of size at birth with illness in the first year of life is shown in 
Table 8.11. More than 90% (860) of infants were reported as having had an episode of cough 
and fever during infancy. 70% (636) suffered diarrhoea and fever. Only 11% had a bout of 
illness with rashes and fever. Around 28% (307) of infants had more than five episodes of 
illness. In the 14 days before follow-up at 2.5 years of age, 14% were reported as having 
diarrhoea, 36% had cough and <1% had measles. The table does not suggest any associations 
between different classifications of size at birth and illness in infancy. The exceptions were 
LPI, LBW-AGA and LBW-LPI-AGA. It reduced the risk of cough and fever.    
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Table 8.11. Summary of association between size at birth and illnesses in infancy 
Adjusted 
models 
Cough and fever 
OR (95% CI) 
Diarrhoea and fever 
OR (95% CI) 
Rash and fever 
OR (95% CI) 
Frequency of illness 
OR (95% CI) 
Single index         
LBW  0.83 (0.40 – 1.72)   0.88 (0.60 – 1.29)   0.65 (0.36 – 1.17)   1.31 (0.92 – 1.87)  
LPI  0.42 (0.20 – 0.88)*  0.96 (0.70 – 1.32)  1.10 (0.70 – 1.72)   1.18 (0.88 – 1.59)  
SGA  1.10 (0.61 – 2.00)   0.94 (0.69 – 1.29)   1.23 (0.79 – 1.93)   1.31 (0.98 – 1.75) 
 
2 index combination       
LBW-LPI  0.69 (0.34 – 1.42)   0.93 (0.63 – 1.38)   0.58 (0.31 – 1.07)  1.35 (0.93 – 1.95)  
LBW-API  -  0.68 (0.26 – 1.79)   1.63 (0.45 – 5.89)  0.92 (0.36 – 2.36)  
NBW-LPI  0.65 (0.36 – 1.17)   1.01 (0.75 – 1.36)   1.45 (0.95 – 2.21)  0.96 (0.74 – 1.29)  
NBW-API  2.18 (1.03 – 4.62)  1.06 (0.76 – 1.48)  0.90 (0.56 – 1.44)  0.86 (0.63 – 1.16) 
         
LBW-SGA  1.14 (0.52 – 2.47)   0.99 (0.67 – 1.47)   0.80 (0.45 – 1.41)   1.39 (0.97 – 1.99) 
LBW-AGA  0.18 (0.04 – 0.79)*  0.45 (0.17 – 1.19)   -----  0.66 (0.25 – 1.73)  
NBW-SGA  1.02 (0.54 – 1.93)   0.94 (0.67 – 1.31)   1.48 (0.93 – 2.35)  1.07 (0.78 – 1.46)  
NBW-AGA  1.10 (0.61 – 1.99)  1.14 (0.84 – 1.56)  0.92 (0.59 – 1.43)  0.80 (0.60 – 1.07) 
         
LPI-SGA  0.85 (0.47 – 1.52)   0.96 (0.70 – 1.30)  0.95 (0.61 – 1.46)  1.30 (0.97 – 1.73) 
LPI-AGA  0.53 (0.28 – 1.00)  1.05 (0.74 – 1.48)  1.12 (0.69 – 1.82)  0.85 (0.62 – 1.18) 
API-SGA  3.18 (0.75 – 13.52)  0.99 (0.59 – 1.65)   1.81 (0.97 – 3.39)  1.05 (0.66 – 1.68)  
API-AGA  1.86 (0.81 – 4.29)  1.02 (0.71 – 1.47)  0.64 (0.36 – 1.12)  0.81 (0.57 – 1.13) 
 
3 index combination       
LBW-LPI-AGA  0.15 (0.03 – 0.68)*  0.48 (0.18 – 1.31)  -  0.66 (0.24 – 1.81)  
LBW-API-SGA  -  0.73 (0.26 – 2.06)   1.88 (0.51 – 6.89)   0.93 (0.35 – 2.50)  
LBW-LPI-SGA  0.97 (0.45 – 2.10)   1.02 (0.68 – 1.54)   0.70 (0.38 – 1.29)  1.44 (0.99 – 2.09) 
LBW-API-AGA  -  0.34 (0.02 – 5.88)   -  0.87 (0.05 – 14.93)  
NBW-LPI-SGA  0.86 (0.45 – 1.64)   0.90 (0.63 – 1.27)   1.18 (0.73 – 1.91)   1.06 (0.76 – 1.47)  
NBW-LPI-AGA  0.68 (0.36 – 1.29)   1.08 (0.76 – 1.54)  1.34 (0.84 – 2.16)  0.90 (0.65 – 1.25) 
NBW-API-SGA  2.55 (0.59 – 10.97)   1.06 (0.60 – 1.89)   1.73 (0.87 – 3.46)   1.08 (0.64 – 1.82)  
NBW-API-AGA  1.83 (0.79 – 4.23)  1.04 (0.72 – 1.50)  0.65 (0.37 – 1.14)  0.81 (0.57 – 1.14) 
* Significant at p<0.05 
8.5.2.  Size at birth and morbidity in the fortnight before follow-up 
Mothers were asked about illness in the 14 days before follow-up. No association was seen 
between size at birth and diarrhoea, cough or difficulty in breathing. The exception was 
disproportionate NBW (NBW-LPI), normal birth weight AGA (NBW-AGA) and 
disproportionate AGA (LPI-AGA). They have significant reduced risk. Table 8.12 gives the 
impression that LBW might have been associated with an increased likelihood of fever in the 
last fortnight, since the association appears to recur in several categorisations.     
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Table 8.12. Summary of associations between size at birth and illnesses in last 14 days 
before follow-up at 2.5 years of age 
Adjusted models  Fever  
OR (95% CI) 
Diarrhoea  
OR (95% CI) 
Cough 
OR (95% CI) 
Difficult breathing 
OR (95% CI) 
LBW  1.57 (1.09 – 2.25)*  1.05 (0.64 – 1.73)  1.43 (0.99 – 2.05)  1.29 (0.68 – 2.46)  
LPI  0.88 (0.65 – 1.20)   0.82 (0.54 – 1.24)   0.83 (0.61 – 1.13)   0.97 (0.56 – 1.66)  
SGA  1.10 (0.61 – 2.00)   0.94 (0.69 – 1.29)   1.23 (0.79 – 1.93)   1.31 (0.98 – 1.75) 
 
2 index combination         
LBW-LPI  1.46 (1.01 – 2.12)*  1.00 (0.60 – 1.68)  1.34 (0.92 – 1.94)   1.38 (0.71 – 2.65) 
LBW-API  1.62 (0.62 – 4.19)   1.07 (0.29 – 3.93)   1.55 (0.60 – 3.99)   - 
NBW-LPI  0.71 (0.53 – 0.95)*  0.72 (0.54 – 0.96)*  0.81 (0.48 – 1.35)   0.84 (0.56 – 1.25)  
NBW-API  1.09 (0.79 – 1.49)  1.16 (0.85 – 1.59  1.22 (0.80 – 1.86)  1.13 (0.66 – 1.96) 
         
LBW-SGA  1.73 (1.20 – 2.49)*
   1.12 (0.68 – 1.85)   1.43 (0.99 – 2.06)  1.36 (0.72 – 2.58)  
LBW-AGA  0.51 (0.18 – 1.44)   1.02 (0.39 – 2.66)   0.61 (0.07 – 5.18)   0.56 (0.12 – 2.70)  
NBW-SGA  1.10 (0.80 – 1.52)   1.00 (0.72 – 1.39)   1.62 (0.93 – 2.82)  1.12 (0.72 – 1.74)  
NBW-AGA  0.69 (0.51 – 0.92)*  0.88 (0.59 – 1.33)  0.80 (0.59 – 1.07)  0.54 (0.31 – 0.94)* 
         
LPI-SGA  1.37 (1.02 – 1.84)*  1.05 (0.70 – 1.57)   1.11 (0.83 – 1.50)   1.46 (0.87 – 2.46)  
LPI-AGA  0.57 (0.40 – 0.81)  0.54 (0.27 – 1.06)  0.71 (0.50 – 1.00)*  0.71 (0.43 – 1.18)  
API-SGA  1.31 (0.81 – 2.11)   1.25 (0.67 – 2.32)  1.31 (0.81 – 2.11)  1.49 (0.71 – 3.15)  
API-AGA  1.01 (0.71 – 1.44)  1.16 (0.72 – 1.86)  1.09 (0.77 – 1.55)  0.80 (0.41 – 1.57) 
 
3 index combination         
LBW-LPI-AGA  0.44 (0.15 – 1.34)   0.67 (0.14 – 3.27)   1.25 (0.46 – 3.38)   0.63 (0.07 – 5.43)  
LBW-API-SGA  1.59 (0.58 – 4.31)   1.98 (0.73 – 5.37)   1.26 (0.34 – 4.70)  --- 
LBW-LPI-SGA  1.66 (1.14 – 2.42)*
   1.05 (0.62 – 1.77)   1.31 (0.90 – 1.93)   1.43 (0.74 – 2.76)  
LBW-API-AGA  1.94 (0.12 – 32.87)   -  -  - 
NBW-LPI-SGA  1.02 (0.73 – 1.43)   1.03 (0.65 – 1.62)   0.94 (0.67 – 1.32)   1.23 (0.70 – 2.18) 
NBW-LPI-AGA  0.61 (0.43 – 0.88)*
   0.72 (0.43 – 1.20)   0.68 (0.48 – 0.96)  0.54 (0.27 – 1.08) 
NBW-API-SGA  1.23 (0.73 – 2.10)   1.24 (0.62 – 2.48)   1.16 (0.68 – 1.98)   1.92 (0.89 – 4.16)  
NBW-API-AGA  1 (0.70 – 1.42)  1.11 (0.78 – 1.58)  1.18 (0.73 – 1.90)  0.81 (0.41 – 1.58) 
* Significant at p<0.05 
8.6.  Size at birth and malnutrition 
Table 8.13 shows the associations of different classifications of size at birth with malnutrition 
at 2.5 years of age. The prevalence of malnutrition was high. 538 children (58.8%) were stunted 
(chronic malnutrition), 55 (6%) were wasted (acute malnutrition) and 344 (37.6%) were 
underweight (stunted, wasted or both).    
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Table 8.13. Summary of associations between size at birth and malnutrition at 2.5 years 
of age 
All confounders  Stunting 
OR (95% CI) 
Wasting 
OR (95% CI) 
Underweight 
OR (95% CI) 
Single index       
LBW  3.40 (2.19 – 5.30)*
   2.93 (1.53 – 5.59)*
   3.69 (2.47 – 5.50)*
  
SGA  2.42 (1.75 – 3.36)*
   1.56 (0.83 – 2.92)   3.05 (2.18 – 4.27)*
  
LPI  1.05 (0.76 – 1.45)  2.16 (1.05 – 4.44)*  1.30 (0.94 – 1.82)  
2 index 
combination 
     
LBW-LPI  2.95 (1.89 – 4.63)*  2.63 (1.37 – 5.07)*  3.15 (2.09 – 4.75)* 
LBW-API  5.29 (1.11 – 25.34)*  2.10 (0.54 – 8.17)   5.72 (1.70 – 19.21)* 
NBW-LPI  0.59 (0.43 – 0.80)*  0.91 (0.50 – 1.65)  0.64 (0.47 – 0.88)* 
NBW-API  0.85 (0.61 – 1.18)  0.35 (0.15 – 0.79)  0.64 (0.45 – 0.90) 
       
LBW-SGA   3.01 (1.92 – 4.70)*  2.63 (1.39 – 4.97)*  4.08 (2.71 – 6.15)*
 
LBW-AGA  3.28 (0.85 – 12.69)  2.18 (0.49 – 9.72)   0.65 (0.23 – 1.81)  
NBW-SGA  1.31 (0.93– 1.85)  0.65 (0.32 – 1.28)   1.20 (0.85 – 1.69)  
NBW-AGA  0.39 (0.28 – 0.54)  0.57 (0.30 – 1.08)  0.35 (0.25 – 0.49) 
       
LPI-SGA  1.92 (1.39 – 2.66)*  1.99 (1.10 – 3.61)*  2.13 (1.54 – 2.93)* 
LPI-AGA  0.47 (0.33 – 0.67)  0.89 (0.44 – 1.79)  0.49 (0.34 – 0.72) 
API-SGA  1.85 (1.05 – 3.24)*  0.41 (0.12 – 1.40)   2.27 (1.34 – 3.82)* 
API-AGA  0.72 (0.50 – 1.03)  0.58 (0.25-1.34)  0.45 (0.30 – 0.68) 
       
3 index 
combination 
     
LBW-LPI-AGA  5.17 (1.06 – 25.16)*  1.25 (0.23 – 6.73)     0.63 (0.21 – 1.85) 
LBW-API-SGA  11.26 (1.35 – 93.71)*  1.47 (0.30 – 7.11)   7.82 (1.99 – 30.74)* 
LBW-LPI-SGA  2.58 (1.64 – 4.07)*
   2.56 (1.34 – 4.90)*
   3.59 (2.35 – 5.48)*
  
LBW-API-AGA  0.36 (0.02 – 6.14)   10.27 (0.49 – 215.12)  0.92 (0.05 – 15.99)*  
NBW-LPI-AGA  0.42 (0.29 – 0.60)*
   0.81 (0.39 – 1.69)   0.53 (0.36 – 0.78)*
  
NBW-API-SGA  1.40 (0.77 – 2.56)   0.17 (0.02 – 1.25)  1.65 (0.92 – 2.95) 
NBW-LPI-SGA  1.22 (0.85 – 1.75)   0.99 (0.50 – 1.96)  1.00 (0.70 – 1.44) 
NBW-API-AGA  0.73 (0.51 – 1.05)   0.49 (0.20 – 1.19)   0.45 (0.30 – 0.68) 
* Significant 
8.6.1.  One anthropometric index as a predictor of malnutrition 
There was a significantly increased odds of malnutrition among children who were born with 
LBW. The odds was highest for underweight (OR 3.7), followed by stunting (3.40) and wasting 
(2.93) at 2.5 years of age. Low PI in newborn infants by itself had no significant association 
with stunting or underweight in children. However, low PI was associated with wasting (OR 
2.2). SGA infants had increased odds of being stunted and underweight in childhood. The odds 
was 3-fold for underweight (OR 3.05) and 2-fold for stunting (2.42). Children who were born 
SGA were not more at risk for wasting. 
8.6.2.  Two anthropometric indices as a predictor of malnutrition 
The greatest risk of subsequent malnutrition was in children born LBW. Proportionate LBW 
infants had a five-fold increased odds of stunting and underweight at 2.5 years of age. 
Disproportionate LBW carried significant risks of stunting, wasting and underweight during    
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childhood, although the odds ratios were in the region of 2. LBW infants born SGA were more 
likely to be malnourished in all three categories at 2.5 years of age. There was not much effect 
of combining PI with weight-for-gestational-age: SGA infants were more likely to be 
malnourished at 2.5 years of age, and this association was not modified much by 
proportionality for stunting and underweight.  
8.6.3.  Three anthropometric indices as a predictor of malnutrition 
The most striking risk groups were the combination of LBW with SGA (LBW-API-SGA or 
LBW-LPI-SGA), which was significantly associated with stunting and underweight at 2.5 years 
of age. Proportionality did not seem to play a major part in the risk. LBW with AGA and low PI 
showed increased risk for stunting (LBW-LPI-AGA). 
The sensitivity, specificity and positive predictive value of different categories of size at birth 
in predicting the outcomes is given in Table 8.14. It shows the results only for those categories 
which had a significant association with mortality and malnutrition.     
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Table 8.14. Sensitivity, specificity and positive predictive value for a range of possible 
risk groups and outcomes 
               
  
Risk + 
Outcome + 
Risk + 
Outcome - 
Risk - 
Outcome + 
Risk – 
Outcome - 
Sensitivity 
(%) 
 
Specificity 
(%) 
 
Positive predictive 
value 
(%) 
             
Neonatal mortality             
LBW  12  219  11  806  52.2  78.6  5.2 
LBW-LPI  10  191  13  819  43.5  81.1  5.0 
LBW-AGA  3  27  20  994  13.0  97.4  10.0 
LBW-LPI-AGA  3  24  20  986  13.0  97.6  11.1 
               
Mortality under 2.5 y             
LBW  19  212  18  799  51.4  79.0  8.2 
LBW-LPI  14  187  22  810  38.9  81.2  7.0 
LBW-API  4  21  32  976  11.1  97.9  16.0 
LBW-SGA  16  185  21  822  43.2  81.6  8.0 
LBW-API-SGA  4  19  32  978  11.1  98.1  17.4 
               
Stunting               
LBW  151  43  387  334  28.1  88.6  77.8 
SGA  321  147  216  228  59.8  60.8  68.6 
LBW-LPI  132  40  401  331  24.8  89.2  76.7 
LBW-API  17  3  516  368  3.2  99.2  85.0 
LBW-SGA  133  38  404  337  24.8  89.9  77.8 
LPI-SGA  258  119  274  250  48.5  67.8  68.4 
API-SGA  61  27  471  342  11.5  92.7  69.3 
LBW-LPI-SGA  115  36  418  335  21.6  90.3  76.2 
LBW-API-SGA  16  2  517  369  3.0  99.5  88.9 
LBW-LPI-AGA  17  4  516  367  3.2  98.9  81.0 
               
Wasting               
LBW  23  171  32  689  41.8  80.1  11.9 
LPI  44  572  11  277  80.0  32.6  7.1 
LBW-LPI  20  152  35  697  36.4  82.1  11.6 
LBW-SGA  20  151  34  707  37.0  82.4  11.7 
LPI-SGA  31  346  23  501  57.4  59.1  8.2 
LBW-LPI-SGA  18  133  37  716  32.7  84.3  11.9 
               
Underweight               
LBW  118  76  226  495  34.3  86.7  60.8 
SGA  227  241  115  329  66.4  57.7  48.5 
LBW-LPI  102  70  240  492  29.8  87.5  59.3 
LBW-API  15  5  327  557  4.4  99.1  75.0 
LBW-SGA  109  62  34  707  76.2  91.9  63.7 
LPI-SGA  179  198  161  363  52.6  64.7  47.5 
API-SGA  47  41  293  520  13.8  92.7  53.4 
LBW-LPI-SGA  94  57  248  505  27.5  89.9  62.3 
LBW-API-SGA  14  4  328  558  4.1  99.3  77.8 
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Chapter 9.  Discussion 
9.1.  Key findings 
Examination of size at birth showed that there was a high prevalence of LBW (25%), SGA 
(55%) and LPI (70%) in the infants of women from Dhanusha and Mahottari districts involved 
in the trial. Low PI was particularly common.  
As expected, none of the prediction models for size at birth was particularly strong. The most 
common predictors of size at birth were gestational duration, infant sex, maternal pre-
pregnancy weight, gestational weight gain, and parity. PI and low PI were the least explained 
by potential risk factors. 
LBW and LBW-LPI were associated with neonatal, infant and young child mortality and 
indicators of malnutrition. LBW had higher odds ratios than LBW-LPI. LBW-SGA was the 
category with highest sensitivity and specificity as a predictor across the board. 
9.2.  General limitations 
As mentioned earlier, the study was based on a cohort of pregnant women enrolled in a trial of 
antenatal multiple micronutrient supplementation. The intervention group showed effects on 
size at birth that could have made the overall findings unrepresentative of the population. We 
tried to reduce bias by using only the control group for quantification of the size at birth and 
prevalence, whereas we adjusted for the supplementation in risk factor and outcome analysis. 
However, the effects of multiple micronutrients on size at birth cannot be ruled out completely. 
The sample size was calculated to evaluate the birth weight difference for the multiple 
micronutrient supplementation trial. We did not have independent sample size estimation for 
other birth size indicators. The sample size was slightly reduced for subsequent analysis 
because of some missing measurements.     
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Although participants came from both rural and urban areas in two districts, the core activities 
of the study were hospital-based and, although the findings are likely to be generalizable, we 
cannot be sure of this. National figures suggest that 26% of pregnant women do not make 
antenatal care visits (NDHS 2006).
182 Conversely, though hospital-based, the study did not 
exactly reflect the obstetric case-mix of the hospital because many pregnant women came to the 
hospital specifically to be enrolled in the study. This was because the study provided free 
antenatal care and ultrasound evaluation, which attracted a wide range of women from better-
off to poor, ‘higher’ ethnic groups to untouchables, and students to business families.  
Another potential limitation could be measurement error. Although we trained, randomly 
visited and checked the measurement technique, measurement error cannot be ruled out 
completely, especially for the measurement of size at birth because of involvement of a number 
of observers for hospital and home delivery cases.  
Other factors that might limit the generalisability of the findings were the characteristics of the 
study population. In general, the area is inhabited by maithili ethnic groups and some other 
groups who have migrated from other regions of Nepal. The relative proportions of ethnic 
groups were not ‘representative’ of Nepal, although it is hard to see how this could be possible 
without a national sample. The national figure for 2006 reported female education in the 
reproductive age group (15-49 years) as 29% for secondary schooling or higher. The nutrition 
statuses documented were: a mean BMI of 20.6 Kg/m
2, a prevalence of low BMI of 24%, and 
an anemia level (<110g/L) of 36%. The prevalence of LBW was 14.3%.  Comparison with this 
study gives the impression that our sample consisted of relatively privileged groups with more 
schooling (44%). It was felt that this was a result of the case-mix of urban and rural women 
with easy access to health facilities, and a moderately poor population, rather than extremely 
poor or wealthy groups.  However, women in the study were more likely to be thin (mean BMI 
19.79 Kg/m
2) and anaemic (35%), and more likely to give birth to LBW infants.    
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9.3.  Limitations of the individual studies 
9.3.1.  Characteristics of mothers and infants, including size at birth 
Most of the limitations of this part of the study fell under the general heading. The other 
limitations were sample size and the cut-offs used to define abnormal size. The sample 
available for describing size at birth was limited. We omitted newborns born to mothers who 
had taken multiple micronutrient supplements to avoid possible contamination of the data. 
Another drawback was the lack of a gold standard cut-off point to assess the proportionality of 
infants based on PI. Different studies have used different cut-offs to define proportionality in 
the newborn infant. We used a cut-off of 2.5 g/cm
3 to categorize infants into proportionate and 
disproportionate groups.
90;201 This makes comparison with other studies difficult in some cases. 
Similarly, another weakness of the methodology was the use of British reference standards to 
define SGA due to lack of a reference standard for the Nepalese population. SGA was defined 
as birth weight below the 10
th percentile of the British population (British reference 
LMSgrowth programme; T Cole, personal communication). We used a cut-off of < -1.28 z 
scores, which is equivalent to < 10
th percentile. A further limitation was the classification of 
SGA rather than IUGR, because of lack of diagnosis antenatally through continuous monitoring 
of growth trajectory. Although we did track some pregnancies with serial ultrasound, 
continuous monitoring of intrauterine growth was not feasible in the study setting. Individual 
identification, clinical case management and prevention of complications do not tend to be a 
priority in this population.
202 Bakketeig’s approach is to identify each and every growth 
retarded infant in a clinical setting, but this applies in high-income countries. Finally, we were 
unable to investigate low BMI in newborns, because we could not find studies that have used 
low BMI to define abnormal size at birth.  
9.3.2.  Predictors of size at birth 
The variables used to build the models included documented potential risk factors in low-
income countries. This may mean that relevant variables found to be risk factors in developed    
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countries were omitted. However, these would not have been significant in our population. For 
example, health insurance is rare in Nepal. Psychological stress and hard work during 
pregnancy might have an influence, but were not measured. Regarding the investigation of an 
independent relationship with the outcome, one might argue that our failure to adjust for 
maternal smoking was problematic, since maternal smoking has been shown to have an 
independent effect on fetal growth and infant mortality.
1;203 No participants reported smoking, 
but we have the impression that this was not the case. 
We used an ethnic group classification that was used locally rather than nationally. The locally 
prevalent ethnic groups were based on Hinduism, with Brahmins highest and Sudras lowest. 
The NDHS survey used a broad classification and put most of the ethnic groups in the region 
under two categories: Yadav and other Terai origin.  This would have been simpler, but we feel 
that it might not have much real meaning. 
The obstetric history obtained from mothers was based on maternal recall, which might not be 
accurate. Reports of miscarriages could be unreliable due to the prevalent practice of female 
feticide.
204 Mothers’ recall of giving birth to a small infant was used as a surrogate for previous 
infants with LBW.   
Generally, gestational age is determined based on date of last menstrual period (LMP). 
Estimation of gestational age by ultrasound does not reflect the usual practice in the general 
population. Analysis of the difference in the mean gestational age by LMP and ultrasound 
showed underestimation of gestational age by 0.43 weeks in  LMP-based gestational age (16.30 
versus 15.87), which is equivalent to less than one day. However, 29% of the mothers could not 
recall the date of their LMP. Accurate estimation was especially important to quantify the 
proportion of SGA and to classify size at birth for gestational age.  
Another limitation might be our description of socioeconomic status. This is difficult in a 
context where more than one family member’s income sources (farming and off-farming    
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income like small business and labour) are involved and the government tax system is not 
properly established. The indicators collected were not comprehensive because they failed to 
quantify the total household wealth and cash income and expenditure. The asset score that we 
used for the study was rough, and we have already pointed out that the inclusion of a television 
in the top group was probably unwise.  Socioeconomic status score was based on principal 
components methods used by the World Bank, which used only the first component as an 
indicator.  
9.3.3.  Associations of size at birth with mortality, morbidity and malnutrition in childhood 
The age of children at follow-up ranged from 1.98 years to 3.85 years. There were a number of 
reasons for this: follow-up was started late due to funding pressures; duration of follow up was 
limited for the same reason and follow-up was dictated by the age of children and necessity of 
covering flood-prone areas ahead of the monsoon season.   
A question of particular interest is whether the outputs investigated were comparable to 
international norms. We considered all outcomes in the context of international acceptability, 
except for child mortality. The norm is to report under-five child mortality rates, but the study 
reported for children under about 2.5 years of age. This was an unavoidable result of the 
follow-up timing.  
The morbidity data were entirely dependent on maternal reporting of illnesses. We failed to 
compare the maternal reports with physician reports. The bias in the result depends on the time 
span that had elapsed between recall and illness. Based on this, morbidity data for the first year 
of life was probably less reliable than that of illness in the last 14 days before the interview. We 
did collect information on physicians’ prescriptions for recent morbidity if available, but we 
could not rely on them because of haphazard use of medicines (including antibiotics) for the 
illness. The major limitation of morbidity data in the first year of life was that it was based on 
retrospective maternal interviews at 2-3 years of age. The possibility of misdiagnosis was high.    
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Firstly, data were collected using closed-questions. Secondly, the illnesses were not properly 
defined. No rigorous attempts were made to differentiate between upper and lower respiratory 
tract infections or severity of illness. Lower respiratory tract infections are usually of a more 
serious nature than upper respiratory tract infections. Cough and fever due to the common cold 
is common in children and estimates are up to 6-10 illnesses per year. No attempts were made 
to exclude other causes like allergies. Although symptoms were recalled better for the last 14 
days, collection of only specific symptoms of illness made it difficult to diagnose cases with 
certainty. Physician’s prescription was not utilized for the diagnosis for the reasons mentioned 
above. For these reasons, we find the models with morbidity outcomes unconvincing. There 
were some possible associations, but they could have arisen from a ‘fishing expedition’, as a 
many associations were tested. We do not make much of the morbidity findings in either the 
results or discussion chapters. 
We compared our cohort with international WHO references for describing child malnutrition 
using z-scores (standard deviation scores).  How appropriate the international reference was to 
the study setting is a matter for investigation.  
9.4.  Strengths 
The study was based in a population where small size at birth is a public health problem. The 
major strength of the study was its use of prospective data. National birth data are based on the 
DHS
182, which uses maternal reports of small size at birth. Blanc and colleagues reported 
pitfalls in DHS data such as digit preference and the influence of cultural preferences on 
maternal reporting of size at birth.
205 
I am not aware of any prospective studies in Nepal that have followed up pregnancies from 
early gestation to delivery, and have then followed up children. The study was novel in 
investigating anthropometric indices at birth - PI, BMI and SGA - and in examining newborn 
classification using combined anthropometric parameters and indices. We have found only two 
studies which have reported similar indices (Pal et al and manandhar et al).
206;207 To our    
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knowledge, this is the first time that the prevalence of SGA has been derived using reliable 
estimates of gestational age. Furthermore, the retention rate of the participants was high (94%). 
The sample available for follow-up of children was 953 out of 1200.  
The study used ultrasound based gestational age estimates. This is more appropriate than LMP 
in this context for the following reasons. First, recall of LMP was confusing because it was 
based on recall of important events like festivals and full moon days. Second, since the study 
was aimed at size at birth, it was important to use ultrasound-based gestational age for 
consistency across the study participants and for reliability. Since it was performed by a single 
observer except for nine cases, this reduced the possible inter-observer error. Another clear 
advantage was that it allowed the quantification of SGA and the accurate assessment of term 
LBW.  
Data on birth anthropometry were available within 72 hours of birth. This timing of evaluation 
of size at birth is internationally accepted. Another strength of the study was that 
anthropometric measurements were made by trained observers using accurate scales: electronic 
weighing scales accurate to 10 g, rollameters accurate to 1 mm and measuring tapes accurate to 
1 mm. One of the major strengths of the outcome study is the use of the median of three 
anthropometric measurements. The observers were trained in child and maternal anthropometry 
at follow-up. A pilot study was conducted to train the field workers, to assess the inter-observer 
and intra-observer variability among eligible observers, and for practice. We employed only 
two observers for measurements to reduce intra-observer and inter-observer variation, and two 
for interviews.
2 Morbidity data were collected by ANMs and CMAs from the local community, 
who had been trained in IMCI. We believe that they had a better understanding of local 
communities, health perceptions and medical knowledge. We did not offer free medical 
treatment which could have prevented mothers from over-reporting illnesses.     
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The prediction study was able to take account of most of the well-known determinants of size at 
birth applicable to Nepal. Apart from gestational age, maternal characteristics used were readily 
available and measurable at the time of booking in the antenatal clinic.  
9.5.  Characteristics of mothers and infants, including size at birth 
The purpose of this part of the study was to investigate the distribution of normal and abnormal 
size at birth in a southern Nepalese population and to evaluate the implications of using 
different classifications to define size at birth. The special interest lay in what birth weight 
really means in the prevention of morbidity and mortality, and in its implications for adult 
health. The sample of women involved in the study mainly constituted middle-income, 
multigravid Maithili women in their twenties with some education. Substantial percentages of 
women were undernourished with low BMI at enrolment and anaemia (28% and 35% 
respectively). For the derivation of mean birth anthropometric parameters for this population, 
the analysis was restricted to healthy mothers who were on government recommended iron and 
folic acid supplements. Conditions which were likely to affect fetal growth were excluded at 
the time of enrolment. The data were therefore fairly representative of healthy mothers in this 
population. 
9.5.1.  General findings 
As expected, the size of infants at birth was small compared to infants in high-income 
countries.
208;209 It is striking to note that the mean PI was low for the population, indicating that 
most infants born in the area have disproportionate body size at birth. This probably means that 
the majority suffer acute or sub-acute malnutrition in utero. Table 9.1 provides a comparison of 
studies that have reported results on birth size distribution for Nepal. The evidence from these 
studies confirms the smallness of infants at birth. Standard deviations were similar across all 
studies.   
182 
 
Table 9.1. Studies reporting the distribution of infant size at birth in Nepal 
Study 
(year) 
Place   N  Sex 
 
Weight (kg)  Length 
(cm) 
HC (cm)  PI (g/cm
3 )  BMI (kg/m
2)  Comment 
Present 
study 2002 - 
03 
Hospital 
Janakpur 
Prospective 
522   
 
2.736 (0.414)  
 
48.7 (2.47)  
 
33.48 (1.47)  
 
2.37 (0.33) 
 
11.50 (1.46) 
 
Strengths: scale accurate to 1g; anthropometry 
measured within 72 h; abnormal conditions that affect 
pregnancy not included; included term and preterm, 
singleton; ultrasound based gestation 
      M  2.800 (0.419)  49.15 (2.51)  33.77 (1.44)  2.37 (0.36)  11.62 (1.49)   
      F  2.672 (0.399)  48.40 (2.38)  33.18 (1.45)  2.36 (0.32)  11.37 (1.41)  Limitations: hospital based 
      P value 
 
0.001  0.001  0.001  0.6  0.06   
 
Christian et 
al. 1998-01 
142 
Community 
Sarlahi 
Prospective
   
 
685    2.587 (0.445)  
 
 
 
 
 
 
47.2 (2.32)  32.5 (0.46)      Strengths: Community based; included term and 
preterm; scale accurate to 1g; anthropometry obtained 
within 72 h; LMP checked against week of positive 
pregnancy test 
 
Limitations: inclusion of twins; all mothers (healthy, 
unhealthy) included 
 
UNICEF 
1998
164 
Hospital 
Biratnagar, 
Pokhara, 
Nepalgunj, 
Kathmandu 
Cross-
sectional 
3636   
 
M 
F 
P value 
 
2.810 (0.4)  
 
2.850 (0.47) 
2.770 (0.44) 
< 0.05 
 
 
 
 
      Strengths: more diverse hospital population; scale 
accurate to 10g; gestation by LMP; included term and 
preterm singletons 
 
Limitations: inclusion criteria not mentioned for mothers 
and time of measurement 
                   
 
Manandhar 
et al. 1997 
210 
Hospital  
Kathmandu 
Cross-
sectional 
 
1499   
M 
F 
P value 
2.800 (0.400)  
2.800 (0.200)  
2.700 (0.100) 
0.001 
 
        Strength: Live singleton healthy newborns; gestation by 
Ballard method; healthy mothers; weighed within 24 h; 
 
Limitations: Scale accurate to 100g; only term infants 
Manandhar 
et al. 1993-
94
207 and 
Pal 2000 
206 
Hospital  
Kathmandu 
Cross-
sectional 
 
578   
M 
F 
P value 
2.690 (0.390)  
2.710 (0.390) 
2.660 (0.390) 
>0.05 
47.2 (2.1)  
47.5 (2.1) 
46.9 (2.0) 
0.001 
32.6 (1.3)  
32.8 (1.4) 
32.4 (1.2) 
0.001 
2.5 (0.29)   12 (1.3)  
12 (1.3) 
12.1 (1.4) 
> 0.05 
Hypoglycemia study 1993-94 
Strengths: Live singleton healthy newborns; healthy 
mothers; scale accurate to 10g; weighed within 24 h; 
gestation by Capurro method 
 
Limitations: Only term infants 
 
Data presented are mean (SD) 
M: Male; F: Female, S: Significance, +: significant difference between male and female infant (p <0.05); 
HC: Head circumference; PI: Ponderal index, BMI: Body mass index   
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Out of five studies, only one study by Christian and colleagues was based in the community.
142 
The others were from zonal, regional or urban hospitals located in different parts of Nepal. As 
expected, the community-based study showed lower mean birth size than the present study: 149 
g lower for birth weight, 1.57 cm for birth length and 0.98 cm for head circumference. Given 
the expense involved in hospital care, including transport expenditure, users of public hospitals 
are not necessarily representative of the general population. The poorest and richest groups tend 
to be less represented in hospital samples. As observed in our study, richer people prefer to use 
the private sector over government hospitals, and poor families tend to access less antenatal and 
delivery care. 
Comparison of maternal anthropometric parameters at enrolment showed that despite having a 
similar mean height of 150.1 cm, mothers from the study in Sarlahi were 2.23 kg lighter and 
0.79 kg/m
2 lower in BMI than mothers in our study.
142 This could be a truer representation of 
the general population, and the lower mean birth size in Sarlahi could be partly explained by 
maternal nutritional status. On the other hand, the methodology used in Sarlahi for the selection 
of participants was different from our study: twins and all mothers were included, irrespective 
of their health status. This may have brought down mean estimates of birth size. 
The four studies that investigated birth size in hospitals had a range of findings. The 
methodologies used differed in terms of sample size, inclusion and exclusion criteria and scales 
used for measurement. Hence, they are not directly comparable. The figures from the urban 
maternity hospital in 1999 had a mean birth weight for males similar to our study, but 28 g 
lower for females.
210 Mean birth weight was 64 g greater. The drawback of the urban hospital 
study is that birth weight was reported to one decimal place, making comparison difficult. 
Moreover, exclusion of preterm births from the study made comparison difficult and 
presumably inflated mean birth size.    
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The 1993 maternity hospital data showed lower birth size.
206;207 The findings were derived from 
an urban hospital population of healthy infants with uncomplicated deliveries. The mean values 
are of interest in that male infants were 90 g lighter than in our study, and female infants 12 g 
lighter. Overall mean birth weight was 46 grams lower. The study did not show a significant 
difference in mean birth weight between sexes. Similarly, mean length and head circumference 
at birth were lower than the current study: 1.5 cm lower for birth length and 0.8 cm lower for 
head circumference. There were significant sex differences in length and head circumference, 
as in our study, but the study demonstrated insignificant sex difference, in contrast to our study. 
The differences in the two populations are that our study sample was not purely hospital-based, 
and that the Kathmandu statistics did not include preterm infants. The data are also a decade 
old. Birth anthropometry for the same urban maternity hospital with the same study design 
showed higher birth size in 1997 than 1993. However, comparison was made difficult by the 
reporting of measurements to one decimal place. It is possible that during the intervening four 
years there had been an improvement in birth anthropometric status. This finding may reflect a 
trend towards increasing birth weight over time due to improvement in nutrition and 
intergenerational effects. In the larger multicentre study,
164 however, infants were larger despite 
the fact that the data were collected five years earlier than ours. The methods were quite similar 
to our study, but involved diverse hospital samples across the country. 
None of the studies discussed above reported mean PI, except that of Pal and colleagues, 
206or 
BMI, except that of Manandhar and colleagues.
207 Both of these studies reported data for a 
tertiary hospital sample with a sample size similar to ours, but without preterm infants. The 
mean BMI was also lower in our study. All the studies reported similar smaller mean birth 
lengths (47.2 cm) and head circumferences (32.5 to 32.6 cm). Interestingly, the infants born in 
our study were heavier, longer and had larger head circumferences. Possible reasons for this 
include differences in methodology, the years of study and the inclusion criteria. 
Overall, the existing studies had a number of weaknesses. They tended to exclude preterm 
infants, and were therefore documenting birth size at term; they tended to be drawn from    
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hospital deliveries, and included women with illnesses; they tended to measure birth size to the 
nearest hundred grams, which causes problems when trying to classify infants measured as 2.5 
Kg as normal or LBW; and few studies reported PI or size for gestational age. 
We still lack representative studies that document the prevalence of LBW country-wide. Our 
study reported a prevalence of LBW (25%) similar to other Nepalese studies.
164 The estimate 
reported by the DHS was 21% for 2001, but this was based on maternal recall of rough infant 
size.
182 The best existing estimate was probably 27%, based on the multi-hospital study of 
1998.
164 There is a similarity in the prevalence in spite of the different methodologies used. The 
prevalence is well above the cut-off for public health intervention (>15 %). 
9.5.2.  Specific findings 
The high incidence of LBW in Nepal is mainly due to intrauterine growth retardation.
92 As 
expected, the ratio of term to preterm LBW showed that most of the infants born in this part of 
the country were smaller due to intrauterine insult and not due to shorter gestational duration. 
The UNICEF study also demonstrated similar larger proportions of term LBW contributing to 
the total LBW incidence.
164 
Having mentioned that SGA was based on a British reference, the actual prevalence might be 
lower than observed in our study. The study classified 55% of infants as SGA. Table 9.2 
summarises previous breakdowns of birth dimensions along these lines. As observed previously 
among Nepalese infants, the incidence of SGA was considerably higher than in high-income 
countries.
211 However, the previous calculation was based on indirect methods and the 
observations seem unrealistic. Evidence is that the incidence was relatively lower. We have 
calculated the prevalence of SGA for the first time in southern Nepal, with precise dating. As 
documented, most infants suffered SGA at term.     
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Table 9.2. Studies describing abnormal birth sizes in Nepal 
Study (year)  Birth anthropometry  Site  Mean (SD) [n] 
de Onis (1988) 
211  LBW  Rural  14.3 % 
  LBW  Urban  22.3 % 
  IUGR-LBW  Rural  11.8 %  
  IUGR-LBW 
 
Urban  18.2 % 
Pal 2000 
206  LBW  Urban  32 % [577] 
The fact that so many infants had low PI merits more discussion. The pattern of compromised 
growth was seen in most infants, including those of normal birth weight and appropriate for 
gestational age.  It is difficult to interpret this large discrepancy between PI and birth weight 
and weight-for-gestational-age. There are four possibilities.. First, this is perhaps just the use of 
the wrong index for defining size at birth. Second, it could be due to selection of an arbitrary 
cut-off point. It is possible that the cut-off should be set higher for this population. To my 
knowledge, there is no standard cut-off available to define low PI. The only reason for our 
choice was that it has been used in India, a country similar to ours,
90 and that the cut-off used in 
other countries is not that different. For instance, Morris used a cut-off of <2.6 g/cm
3 for a 
population in Brazil.
91 Third, the observation may be just a fluke and incorrect. In my opinion, 
this is unlikely because the anthropometric measurements are the main outcome of our study, 
and were carried out within 72 hours of birth after rigorous training with constant checking 
throughout the study using accurate scales. Finally, the estimation may be a true picture of 
newborn size. I believe that this is the most likely possibility because of the quality of the 
study. It is quite possible that most Nepalese infants are disproportionate as a result of some 
growth restriction. 
9.5.3.  Wider implications 
What is the likely implication if most Nepalese infants are disproportionate? If most infants are 
born after suffering fetal under-nutrition, the rapidly increasing epidemic of diabetes and 
coronary heart disease in developing countries might be partially accounted for. The fetal    
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origins hypothesis states that disproportionate fetal growth programmes later adult onset 
diseases.
32;212 Low PI alone has been demonstrated to have an independent association with 
adult coronary heart disease
213;214, diabetes
215 and microalbuminuria, in turn related to insulin 
resistance and cardiovascular disease
216. If our hypothesis is correct, the previously 
undiagnosed wasting in newborns would be a time bomb set to explode in the near future. 
Furthermore, a positive association with later morbidity has also been described.
96;97  These 
ideas raise questions regarding the use of PI in hospitals as a standard practice and regarding 
what can be done towards minimizing the risk of adult disease.  
Different methods of classifying newborn infants based on anthropometry might allow us to 
develop a new classification. Small (LBW) infants are at substantial risk of morbidity and 
mortality whether due to preterm or to intrauterine growth retardation (represented by SGA). 
Studies have shown that sub-categories of birth size may be associated with mortality, 
morbidity and size in later life. For example, disproportionate SGA infants are more at risk of 
mortality than AGA infants compared to proportionate SGA infants.
217 
Most LBW infants in our study were SGA. This is an important public health problem. The 
prevalence of LBW was as high as 25% and of SGA as high as 55%. If so many infants are 
judged to be at risk on the basis of simple classification, it might be useful to sub-classify 
infants to focus on particular groups at greatest risk. Wasted SGA infants constituted nearly 
80% of total SGA. Cuttini reported a considerable increase in neonatal deaths among stunted 
SGA infants compared with wasted SGA infants
218,but disproportionate SGA infants have been 
shown to have more early postnatal morbidity than proportionate SGA infants.
96;97;219 Our 
results support the previous findings of low mean birth weight in wasted infants.
219  
There is a tendency to underestimate the proportion of infants at risk when a single method is 
used. Only one fifth of infants were normal in terms of weight, PI and weight-for-gestational-
age. It is noteworthy that a considerable proportion of SGA infants had normal weight at birth 
(>= 2500 g), and that a substantial proportion of LBW infants suffered SGA, the majority of    
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them being wasted. The importance of this finding is at the clinical level where the use of 
growth charts and serial ultrasound scans for detecting intrauterine growth retardation is not the 
usual practice, and where weight at birth is the only indicator available. For instance, the most 
popular category in use in developing countries is LBW. Table 9.3 demonstrates how other 
abnormal categories are hidden in this single anthropometric category. Only 27% of NBW 
infants have normal PI and weight adequate for their gestational age 
Table 9.3 Subcategories of LBW and NBW 
  LBW (%)  NBW (%) 
SGA-LPI  76  35 
SGA-API  10  11 
AGA-LPI  12  29 
AGA-API  2  27 
     
In summary, we found levels of LBW similar to those described in previous studies, but added 
to this a clear understanding that many more infants were small for their gestational ages, and 
still more were disproportionate. These findings have implications for both early survival and 
long term health.  
9.6.  Predictors of size at birth 
The purpose of this study was to deepen existing knowledge of factors associated with size at 
birth and to provide information on how well the potential risk factors found in previous studies 
explain size at birth. The hypothesis was that known risk factors for LBW could be used to 
predict size at birth in other dimensions. As mentioned earlier in the thesis, although this 
hypothesis was reasonable, I had a second reason for asking the question. There have been 
many risk factor studies, but I was not convinced that they could be translated into actual 
practice in low-income countries. Not many of the risk factors seemed modifiable and, because 
small size at birth is so common, I wondered if a careful analysis could argue that we have 
reached the limit of usefulness. Of particular interest was the question ‘do we need more risk 
factor studies?’    
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9.6.1.  General findings 
In this cohort of healthy mothers, we found that known risk factors did not seem to explain size 
at birth outcomes convincingly. The hypothesis was tested through a prospective cohort with 
normal pregnancy outcomes (live, singleton newborn infants with no gross congenital 
anomalies). The cohort of mothers was of low-to-middle income, in their twenties and mostly in 
their second pregnancies. They had low mean BMI and no chronic illnesses. The study was 
conducted in a semi-rural setting in Nepal with a high prevalence of LBW, low PI, SGA and 
malnutrition in children, as illustrated in the preceding chapter. In short, the situation was a 
good one for addressing the question. Table 9.4 summarises the findings of all of the analyses 
in schematic form.     
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Table 9.4. Summary of significant associations of size at birth in the study 
Birth 
Size 
Ethnicity  Education  Rural 
or 
urban 
SES  Poor 
obstetric 
history 
Maternal 
age 
Parity  Maternal 
height 
Maternal 
weight 
Weight 
gain 
Maternal 
illness 
Blood 
haemoglobin 
Supplement  Gestation 
at birth 
Infant 
sex 
W 
 
+  + +      ‡ 
miscarriage 
+  + +  + +  + +  + +      + +  + +  + + 
LBW 
 
  +        +  + +  +  + +  + +      + +  + +  + + 
SGA 
 
      +  + 
miscarriage 
+  + +  +  + +  + +      + +  NA   
L 
 
+     
‡  ++ 
death 
+  ‡   + +  + +  + +  + SBP  
‡ DBP 
    + +  + + 
BMI 
 
+       +    +  + +  +  + +  + +      + +  + +  + + 
PI 
 
      ‡    +  + +      + +        + +   
LPI 
 
      +       + +      + +        +   
HC 
 
  +     +     +  +   +  +   + +        + +  + + 
W: weight; L: length; LBW: Low birth weight; SGA: Small for gestational age; BMI: Body mass index; PI: Ponderal index; LPI: Low ponderal index; SES: socioeconomic 
status; Poor obstetric history: prior history of stillbirth, LBW or dead child; NA: Not applicable- small for gestational age is sex and gestation specific. 
+ significant in univariable analysis ++ significant in univariable and multivariable analysis ‡ almost significant in univariable analysis but not significant in multiivariable 
analysis 
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9.6.2.  Specific findings 
Table 9.5 is presented again here, since it summarises the same findings as Table 7.18 but in a 
different way. 
Table 9.5. Main risk factors identified in the analyses 
Variable  Predicts to some degree in multivariable analyses 
Gestation (wks)  Birth weight, LBW, length, BMI, PI, head circumference 
Maternal weight at enrolment (kg)  Birth weight, LBW, SGA, length, BMI 
Maternal height (cm)  Birth weight, length 
Maternal weight gain (kg)  Birth weight, LBW, SGA, length, BMI, PI, LPI, head circumference 
Parity  Birth weight, LBW, SGA, BMI, PI, LPI 
Infant sex  Birth weight, LBW, length, BMI, head circumference 
Supplement   Birth weight, LBW, SGA, BMI 
Education  Birth weight 
Evaluation of associations with 21 potential determinants of size at birth showed that only a 
few had an independent and significant association in our sample (see Table 9.4). Maternal 
characteristics that had no significant influence on various dimensions of size at birth included 
rural/urban residence, antenatal general illness and blood haemoglobin level. When these 
potential factors were forced into the regression, none of them demonstrated any effect in the 
final model. There was no effect of maternal residence on birth size parameters in this 
population univariably or multivariably. This goes against the general perception that the urban 
population are a more economically stable, more advantaged group and are more likely to give 
birth to bigger infants. None of the birth size indicators had any association with maternal 
general illness except for birth length. Systolic and diastolic blood pressure showed a 
univariable association but showed no independent association. Surprisingly, blood 
haemoglobin status of women at enrolment showed no association. The lack of effect of 
maternal illness, blood pressure and blood haemoglobin level on size at birth is difficult to 
interpret. Compromise in blood pressure or haemoglobin level during pregnancy could affect 
the supply of nutrients and oxygen to the fetus. The fact that maternal eclampsia also had no 
significant effect could be explained by the limited sample size.     
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Despite significant univariable association, some risk factors lost significance in the multiple 
regression analysis. These were categorized as having doubtful association, and included 
maternal socioeconomic status, age, education, obstetric history and ethnicity. It is interesting 
to note that maternal socioeconomic status appeared to have no effect on size at birth in our 
sample. It showed significant univariable association with almost all birth size indicators except 
for weight and LBW, but no independent association. For length and PI, the univariable 
association was almost significant. Similarly, no association was observed between 
socioeconomic status and maternal nutritional status. Mothers residing in urban areas were 
better off than those from rural areas. The socioeconomic status of the urban population is 
boosted by the availability of non-agricultural work. To our surprise, despite mothers from 
Janakpur municipality having significantly higher socioeconomic status, maternal nutritional 
status (anthropometry and hemoglobin level) remained the same. The only reason for this (and 
here I speculate) is the possibility that women had similar dietary patterns driven by culture and 
religion. Perhaps fasting, the hierarchy of food distribution in the family, and readily available 
and affordable foods are driven more by culture than by socioeconomic status. 
With the exception of low PI, maternal age showed univariable associations with all parameters 
of size at birth, but the significance was not sustained when other risk factors were adjusted for. 
This suggests that maternal age does not have an independent effect on size at birth. It is 
consistent with the findings of the systematic review by Kramer
24: high quality studies based on 
criteria set out by the author showed no effect of age on size at birth 
220-222 (except one by 
Yudkin
223). Teenage pregnancy has been linked with size at birth, but our study did not support 
this argument. It is possible that maternal age affects size at birth by affecting maternal height. 
There was no significant difference in maternal height (<150 cm versus >150.1cm) between 
teenage and older mothers (<19 years versus ≥ 20 years). There were also few mothers of 
extreme ages at either end of the distribution: there were no participants with age >35 years and 
only 38 (0.9 %) with age <16 years. It is interesting that extreme teens (<16 years) were taller 
than older mothers (>16years) (151.58 versus 150.87cm). Two possible explanations could be    
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that maturity occurs earlier in this sample of extreme teenagers, or that teenagers are becoming 
taller than older women due to a reduction in stunting. Since height has a positive effect on 
birth weight, teenage mothers may end up more likely to give birth to heavier and longer 
infants. It is possible that the next generation may have less LBW problems. 
An issue that might have affected the findings is that information on past obstetric history was 
based on maternal self-report. This may be subject to recall bias. Furthermore, it is likely that 
reports of previous miscarriages were under-represented due to preference for male over female 
children. Deep interrogation on this subject was not attempted, especially for previous history 
of stillbirth, miscarriage and total number of child deaths. Similar findings were observed for 
maternal education level. It had no significant univariable association with all birth outcomes 
except for birth weight, LBW and head circumference. The effect became insignificant in all 
cases when confounding factors were adjusted for, except for birth weight. The effect of 
maternal education on birth weight could operate in two ways. Firstly, maternal education 
might improve health care seeking behavior. However, all the participants experienced similar 
free monthly antenatal care facilities and monthly home visits and consultation on health 
problems. Secondly, education might improve understanding and support within the family, 
with a more liberal and healthy psychosocial environment. This is reflected in the parity and 
significantly higher antenatal weight gain in educated mothers. For instance, Terai Vaishya, 
Sudra and Muslim women were less likely to be literate and tended to have significantly more 
children than literate mothers. These ethnic groups generally occupy lower social classes and 
are more conservative. Thirdly, education might reflect socioeconomic status. However, 
socioeconomic status itself did not have an independent relationship with size at birth 
(including birth weight). There are a number of possible reasons for this. The socioeconomic 
status score based on land and asset ownership and husband’s occupation may not be a true 
indicator of socioeconomic differences in our sample. Maternal education may be a better 
indicator of the socioeconomic status in a woman’s maternal home, which would in turn affect 
her nutritional status. Although it is fair to say that marriage usually takes place between    
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couples of similar socioeconomic status, educated women had husbands with higher 
occupational status. The majority of farmers, laborers or those who were working abroad had 
wives with no education. Similarly, most salaried workers, students, and businessmen had 
wives with secondary or higher education. This supports the idea of a healthier family 
environment, compared to women with no education. 
In our sample, ethnicity showed significant univariable associations with birth weight, length 
and BMI, but this association disappeared when other potential risk factors were taken into 
consideration. The absence of effect of ethnic groups residing in this area on size at birth 
implies that there is no significant independent effect of ethnicity in this sample.  
With few exceptions, the risk factors that had independent associations with most measures of 
size at birth were maternal weight at enrolment, infant sex, parity, weight gain over pregnancy 
and gestation at birth. Birth weight, length and BMI were independently associated with all 
these risk factors. The exceptional variables were as follows: length and head circumference 
had no independent association with parity; PI had no association with infant sex and pre-
pregnancy weight; and low PI had no association with infant sex, maternal weight at enrolment 
and gestational age at birth. Similarly, parity was associated with all birth size parameters 
except for PI and low PI. Maternal weight gain was the single risk factor which had a 
significant association with all birth outcomes. Pre-pregnancy weight and maternal weight gain 
during pregnancy represent the nutrition of a growing fetus.
24 In this study, mean maternal 
weight gain was around 7.1 kg. The optimal weight gain required over pregnancy is 11 kg.
224 
Some potential risk factors showed an independent association with fewer birth sizes. They 
were maternal height, antenatal supplementation, prior history of child death and maternal 
education. Maternal education has been discussed under potential risk factors with no 
association. Apart from birth weight, it showed no association with other birth sizes. The 
exception is for birth length for which it showed only a univariable association.     
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Maternal height was an independent risk factor for only weight and length at birth. Kramer 
described it as the reflection of genetic potential, environmental influence and maturity.
24 
Although significant univariably with LBW, SGA, BMI and head circumference, it showed no 
independent association. It was not related PI and low PI univariably or multivariably. 
Antenatal supplementation showed an independent association with weight, BMI, LBW and 
SGA. It did not show any effects on length, head circumference, PI and low PI. Since the 
sample was derived from the antenatal multiple micronutrient supplementation trial, half of the 
participants received iron and folic acid and half of them received multiple micronutrients. 
Surprisingly, of all the adverse obstetric history variables, death of previous offspring showed 
an independent effect on the size of the newborn. The rest showed no association.  
Factors that were not investigated included paternal height and weight, maternal psychological 
factors, pregnancy interval, caloric intake and energy expenditure. Other factors like antenatal 
care, number of antenatal care visits, quality of care, smoking, caffeine and drug intake, other 
toxic exposures, malaria, urinary tract infection, genital tract infection, and prior infertility 
were not thought to be important features of the sample. The women involved were healthy and 
received monthly antenatal care and health check-ups, with no self-reporting of smoking, 
caffeine or drug use.  
Prediction of size at birth is important from the management point of view at delivery and 
postnatally. A number of studies have considered the prediction of birth weight. The methods 
used can be categorized into three groups: (1) abdominal palpation, (2) ultrasound biometry, 
and (3) maternal characteristics. The most common method in developing countries has been 
palpation, the most sophisticated method is ultrasound and a promising method is the use of 
maternal risk factors. The abdominal palpation method involves estimation of fetal weight by 
clinicians by measurement of fundal height and integrating the clinician’s experience with 
obstetric histories. Maternal characteristics-based prediction uses routine antenatal 
measurements like height, weight, parity and age.    
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Prediction of size at birth, especially through equations to estimate birth weight, has been 
central to the development of obstetric ultrasonography. Fetal biometric parameters have been 
used to develop prediction models for birth weight, particularly using biparietal diameter, head 
circumference, abdominal circumference, femur length, and fractional limb volume.
225 Several 
equations have been published, and are used in ultrasound machines worldwide to estimate 
fetal weight, but all are based on data from high-income countries. Common examples are the 
Hadlock formula for biparietal diameter and the Robinson formula for crown-rump length. 
Nahum demonstrated that most of the equations were equally accurate (except Warsof’s 
equation)
226, but the most accurate of all was an equation that used only abdominal 
circumference, developed by Campbell and Wilkin in 1975.
227 Moreover, the prediction of fetal 
weight is of limited value because 20–44% of estimates lie outside the band of 10% on either 
side of the actual birth weight.
228;229 
In the setting of semi-rural Nepal, ultrasonographic screening remains a sophisticated procedure 
inaccessible to the majority of the population. Ultrasound machines are expensive to procure 
and maintain, and require skilled operators and maintenance teams. Ultrasound-based 
prediction is further challenged by intra-observer and inter-observer variation in fetal 
measurement. In this situation, the best solution is to develop an inexpensive method of 
prediction. Annex L summarizes a comparison of predictability based on birth weight 
estimation methods. It shows that maternal characteristic methods are comparable to ultrasound 
methods, and that clinical methods of estimation at term are more accurate than ultrasound. If 
one has to choose one method over another despite its poor predictability, it is economical and 
practical to use maternal characteristics-based birth weight prediction. 
9.6.3.  Wider implications 
Although their effects were limited, key potential risk factors identified in the study were 
maternal weight at enrolment, infant sex, parity, weight gain over pregnancy and gestation at 
birth. Individuals with modifiable risk factors are the targets of public health action. (see Table    
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9.6 ). Only two factors in our list are easily and ethically modifiable: maternal pre-pregnancy 
weight and weight gain during pregnancy. 
Table 9.6. Risk factors established in the study, according to potential for modification 
Birth anthropometry 
assessed 
Modifiable determinants  Determinants that would be difficult or 
unethical to modify 
Weight  Education 
Pre-pregnancy weight 
Antenatal weight gain 
Supplementation 
Infant sex 
Gestational age at birth (uncertain) 
Parity 
Maternal height (possibly in the long term) 
 
LBW  Pre-pregnancy weight 
Maternal weight gain 
Supplementation 
Parity 
Infant sex 
Gestational age at birth (uncertain) 
 
SGA  Pre-pregnancy weight 
Maternal weight gain 
Supplementation 
 
Parity 
 
Length  Pre-pregnancy weight 
Maternal weight gain 
Maternal height (possibly in the long term) 
Infant sex 
Gestational age at birth (uncertain) 
 
BMI  Pre-pregnancy weight 
Maternal weight gain 
Supplementation 
Parity 
Infant sex 
Gestational age at birth (uncertain) 
 
PI  Maternal weight gain  Parity 
Gestational age at birth (uncertain) 
 
LPI  Maternal weight gain  Parity 
 
HC  Maternal weight gain  Infant sex 
Gestational age at birth (uncertain) 
LBW: low birth weight; SGA: small for gestational age; BMI: body mass index; PI: ponderal index; LPI: low 
ponderal index; HC: head circumference 
Gestational duration was associated with most indicators of size at birth, but what predicts 
gestational duration and whether it can be successfully modified is governed by multiple 
factors. Maternal height is classified as a non-modifiable risk factor, although 30% of the 
participants were teenagers. Although extreme teenagers (<16 years) were taller than older 
counterparts, I observed that, although not significant, teenagers (<19 years) were shorter than 
older mothers. Maternal height had an independent association with birth weight and birth 
length. Delaying pregnancy could reduce the risk to some extent. All of the factors examined 
were easily obtainable at the time of antenatal visit except for gestational age. The estimate of 
gestational age used in the study was ultrasound-based and would not be available and 
accessible to all in Nepal. The other drawback is that the measurement of these variables has its    
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own inherent errors, especially gestational age and maternal anthropometry. The net effect is a 
reduction in the predictive accuracy. 
Table 9.7 summarizes studies of prediction models for size at birth based on known maternal 
determinants. I have compared eight studies which examined potential risk factors for abnormal 
birth weight and reported their predictive ability. The present study confirms earlier reports
230-
233 that size at birth is only partly explainable. Prospective hospital-based studies from 1966 in 
Baltimore to 2007 in Bangladesh reported that potential risk factors provided little explanatory 
power in prediction models for birth outcomes. The range of coefficients of determination was 
2.5-33% (except in a study by Etikan et al conducted in Turkey, which claimed to have a 
coefficient of determination of 59.8%. It included an extra variable, blood glucose level before 
and after ingestion of glucose load). 
A preliminary report of a study from India reported a low coefficient of determination of 13.2% 
for birth weight.
232 The final model for birth weight and LBW consisted of maternal weight on 
the third day after delivery, prematurity, birth order and maternal height. The model applied to 
both term and preterm infants. In contrast to our study, maternal weight gain was not included 
in the final prediction model. Considering the fact that our study used ultrasound-based 
gestation, it is not surprising to find the prediction power low in the Indian study. Our study 
could not confirm previous reports that low socioeconomic status and previous history of giving 
birth to a small infant were likely to affect infant size.
230 
One important and plausible prediction model for birth weight has an R
2 value of 33%.
233 This 
finding is consistent with ours despite the fact that the other study was conducted in term 
infants in a European population. It was similar in that the pregnancies were uncomplicated, but 
it involved a sample of only 262. Unlike the present study, Nahum examined the role of blood 
glucose screening in the third trimester, but did not consider maternal education. Glucose 
screening was not helpful in the prediction. Nahum’s equation claimed the prediction of birth 
weight to within 10.8% of actual birth weight.     
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I am unaware of previous analyses that have examined the prediction of other parameters of 
size using potential risk factors. In our study, the predictive accuracies were all lower than that 
for birth weight.    
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Table 9.7. Studies of predictors of size at birth based on maternal characteristics 
Study, date 
and 
location 
Maternal characteristics assessed  Design  N  Significant predictors in final model  Size at 
birth 
R
2  Inference 
Present 
study, 
Nepal 
Ethnicity, education, residence, 
socioeconomic status, systolic blood 
pressure, diastolic blood pressure, general 
antenatal illnesses, parity, prior history of 
giving birth to small infant, miscarriage, still 
birth, child death, maternal height, maternal 
weight, antenatal weight gain, hemoglobin 
status at enrolment, antenatal 
supplementation, maternal age, gestational 
duration, infant sex. 
Interaction: maternal age*parity. 
Hospital 
Prospective 
1048  Gestational age, maternal weight gain, 
infant sex, pre-pregnancy weight, parity, 
antenatal supplementation, maternal 
height, maternal education, 
 
Weight  32.7  Healthy population, singleton 
pregnancy, no gross congenital 
anomaly, no chronic maternal 
medical illness,  
19 variables explored, all 
measurable at booking  
 
Limitation 
Ultrasound based gestational 
age, factors not explored- 
psychological stress, work load, 
caloric intake and expenditure 
        Gestational duration, Infants gender, 
antenatal weight gain, maternal height, 
prior death of child 
Length  19   
        Gestational duration, antenatal weight 
gain, parity, pre-pregnancy weight, infant 
sex, antenatal supplementation 
 
BMI 
 
12.4 
 
 
        Antenatal weight gain, parity, gestational 
duration 
PI 
 
3.2 
 
 
        Gestational duration, infants gender, 
antenatal weight gain 
HC  18.6   
        Gestation, infant sex, antenatal weight 
gain, maternal weight at enrolment, 
antenatal micronutrient supplementation, 
Parity 
LBW     
        Antenatal weight gain, parity,  LPI     
        Prepregnancy weight, antenatal weight 
gain, parity, antenatal supplementation 
 
SGA 
   
               
Nahar 
2007
231 
Bangladesh 
Maternal weight, antenatal weight gain and 
body mass index at 3, 4, 5 ad 6 months of 
pregnancy, maternal height  
 
Community, 
longitudinal 
1104 
singleton 
healthy 
Maternal Weight at registration (3-5 
months) and at 9 months 
Weight  2.5 to 20  
 
Only 4 maternal anthropometric 
parameters explored    
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Study, date 
and 
location 
Maternal characteristics assessed  Design  N  Significant predictors in final model  Size at 
birth 
R
2  Inference 
Kutty 
2004
232 
India 
Maternal age, height, weight, weight gain, 
hemoglobin, blood pressure, weight post 
delivery 
Hospital, 
prospective 
1894  Maternal weight on 3
rd day after delivery, 
height, parity, gestational duration <38 w 
Weight 
 
13.7  Only 7 variables explored 
Important variables not 
explored: education, 
socioeconomic status, parity, 
infant sex  
          LBW     
 
Etikan 
2005
234 
Turkey 
Blood glucose level before and after 
ingestion of glucose load, age, body mass 
index, %of change in weight during 
pregnancy, height, gestational age, parity, 
fetal sex 
Hospital, 
retrospective 
300 term 
singleton 
healthy 
Gestational age, infant sex, body mass 
index, maternal height, blood glucose level 
Weight  59.8  Different: blood glucose level 
after glucose loading 
Limitation: Important variables 
not explored: maternal age, 
education, socioeconomic 
status 
 
Nahum 
1998
233 
California 
Maternal weight at 26 w, height, age, parity, 
third trimester glucose screening test value, 
obesity (body mass index at the start of the 
3
rd trimester), and gestational duration 
Hospital  262  Gestational age which affects male and 
female separately, maternal height*weight 
at 26w, parity*the rate of maternal 3
rd 
trimester pregnancy weight gain 
Weight  33  Important variables not 
explored: maternal 
socioeconomic status, 
education 
Breschi
235 
Ohio 
maternal height, BMI before pregnancy and 
at delivery, parity, week of delivery, fasting 
and 2-h plasma glucose concentrations, 
and male gender, maternal age, Smoking 
Hospital  503 
normal  
maternal height, BMI at baseline and 
delivery, 
parity, week of delivery, fasting and 2-h 
plasma glucose concentrations, and male 
gender 
Weight  26  Limitation: height and body 
mass index explored together, 
education and socioeconomic 
status not explored 
fasting and 2- hour plasma 
glucose concentration also 
explored 
 
Abernathy 
1966
230 
Baltimore 
Race, marital status, hospital type, 
socioeconomic status, height, parity, prior 
fetal and neonatal death, pre-pregnancy 
weight, hemoglobin, SBP, DBP, obstetric 
complications, placenta and cord condition, 
congenital anomaly,  
Interaction: maternal age*parity, (maternal 
age)
2*parity, age*illness, 
age*illness*socioeconomic status, sex, 
paternal age, maternal age, (age)
2, inter-
current illness 
Hospital 
prospective 
10000  Common to birth weight and length: 
race, hospital type, maternal height, prior 
fetal and neonatal death, maternal weight, 
Systolic blood pressure, obstetric 
complications, congenital anomaly, 
placental and cord condition, infant sex 
 
    Limitation: infants with 
congenital anomaly included 
Other variables explored: 
placental and cord condition 
included 
Different form current study: 
Maternal age, obstetric 
complications, maternal illness, 
hemoglobin status formed the 
final prediction model 
 
        Age*illness*social class, hemoglobin 
 
Weight  16 
 
 
        Parity, age
2*parity, age*illness, paternal 
age, maternal age*SES 
 
Length  7      
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Study, date 
and 
location 
Maternal characteristics assessed  Design  N  Significant predictors in final model  Size at 
birth 
R
2  Inference 
Abernathy 
1966
236 
Baltimore 
Gestation, maternal weight, parity, smoking, 
psychosomatic score, work, marital status, 
blood group, hemoglobin, hypertension, 
eclampsia, education, infant sex 
Interaction: sex*parity, sex*parity*maternal 
age, sex*maternal age, maternal age*parity, 
PSS*parity, PSS*smoking, PSS*gestation, 
PSS*parity*age, PSS*gestation; PSS*age, 
smoking*parity, smoking*age, 
smoking*age*parity 
Hospital 
prospective 
2700  gestation, gestation
2, smoking, parity, 
parity
2, sex, hemoglobin III, Hypertension 
II, eclampsia I, II, sex*parity 
Weight  24.03  Other variables explored: 
Psychosomatic score and blood 
group,  
 Different form current study: 
hypertension, eclampsia, 
hemoglobin and smoking in the 
final model; pre-pregnancy 
weight and maternal education 
not in the final model  
 PSS: Psychosomatic score; LBW: low birth weight; BMI: body mass index; PI: ponderal index; LPI: low ponderal index; SGA: Small for gestational age;   
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9.7.  Associations of size at birth with mortality, morbidity and malnutrition in 
childhood 
9.7.1.  General findings 
In a study where information on confounders was available, we investigated the association of 
size at birth with death, malnutrition and illness from birth to 2.5 years of age. We found that 
newborns of different sizes had varied risks for the outcomes investigated. Risks for mortality, 
morbidity and malnutrition were assessed against a range of classifications of size at birth. 
Newborn infants were classified using a) a single anthropometric index, b) a combination of 
two anthropometric indices, and c) a combination of three anthropometric indices. A simplified 
summary of the findings is presented in Table 9.8 and Table 9.9.   
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Table 9.8. Summary of significant increased odds ratios for mortality and childhood malnutrition on the basis of potential risk groups for size 
at birth 
  Proportion  Neonatal death  Infant death  Young child death  Stunting  Wasting  Underweight 
                           
LBW  22%  3.5  (1.4 – 8.9)  3.6  (1.6 – 7.9)  3.7  (1.7 – 7.8)  3.4  (2.2 – 5.3)  2.9  (1.5 – 5.6)  3.7  (2.5 – 5.5) 
LPI  68%                  2.2  (1.1 – 4.4)     
SGA  52%              2.4  (1.8 – 3.4)      3.1  (2.2 – 4.3) 
                           
LBW-LPI  20%  2.7  (1.0 – 6.8)  2.3  (0.9 – 1.0)  2.1  (1 – 4.6)  3.0  (1.9 – 4.6)  2.6  (1.4 – 5.1)  3.2  (2.1 – 4.8) 
LBW-API  2%          7.0  (2.3 – 21.4)  5.3   (1.1 – 25)      5.7  (1.7 – 19.2) 
LBW-SGA  19%      2.8  (1.3 – 6)  3.1  (1.5 – 6.3)  3.0  (1.9 – 4.7)  2.6  (1.4 – 5.0)  4.1
  (2.7 – 6.2) 
LBW-AGA  3%  5.7  (1.0 – 31.8)                     
LPI-SGA  41%              1.9  (1.4 – 2.7)  2.0  (1.1 – 3.6)  2.1  (1.5 – 2.9) 
API-SGA  10%              1.9  (1.0 – 3.2)      2.3  (1.3 – 3.8) 
                           
LBW-LPI-SGA  11%              2.6  (1.6 – 4.1)  2.6  (1.3 – 4.9)  3.6  (2.4 – 5.5) 
LBW-API-SGA  2%      6.5  (1.9 – 22)  8.1  (2.6 – 25)  11.3  (1.4 – 93)      7.8  (2.0 – 30.7) 
LBW-LPI-AGA  3%  6.6  (1.2 – 37.1)          5.2  (1.1 – 25)         
Values are OR (95% CI) 
 
 
Table 9.9 Summary of significant lowered odd ratios for mortality and childhood malnutrition on the basis of potential risk groups for size at 
birth 
  Proportion  Neonatal death  Infant death  Young child death  Stunting  Wasting  Underweight 
NBW-LPI                0.6  (0.4 – 0.8)      0.6  (0.5 – 0.9) 
NBW-API                    0.4  (0.2 – 1.2)  0.6  (0.5 – 0.9) 
NBW-AGA                0.4  (0.3 – 0.5)      0.4  (0.3 – 0.5) 
LPI_AGA                0.5  (0.3 – 0.7)      0.5  (0.3 – 0.7) 
API-AGA                        0.5  (0.3 – 0.7) 
NBW-LPI-AGA                0.4  (0.3 – 1.6)      0.5  (0.4 – 0.8) 
NBW-API-AGA                        0.5  (0.3 – 0.7) 
Values are OR (95% CI)    
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The chief findings for the effects of birth size on mortality were: (a) that LBW was a stronger 
single predictor than SGA and LPI, (b) that proportionate LBW infants were at greater risk of 
childhood death, (c) that appropriate for gestational age LBW infants were at greater risk of 
neonatal death, and (d) that proportionate LBW infants who were SGA were at greater risk of 
infant and childhood death. The most powerful predictors of neonatal mortality were LBW-AGA 
and LBW-LPI-AGA. For infant mortality, the most powerful predictor was LBW-API-SGA, and 
for childhood mortality it was LBW-API, with or without SGA. These associations were not 
explained by gestational duration, socioeconomic status, education level, maternal weight, 
antenatal supplementation, ethnicity, infant sex, maternal age, birth order or age of weaning. 
The incidences of neonatal, infant and young child deaths were high in the partly hospital-based 
study sample. The rates were 22, 35 and 39 per thousand for neonatal, infant and young child 
mortality respectively. The national mortality rates were 33, 48 and 61 for neonatal, infant and 
under five child mortality in the five years preceding the 2006 DHS
237. Our mortality rates were 
lower than national figures, possibly as a result of the care and attention that women and children 
received in the study. The previous finding that early neonatal deaths constitute the majority of 
neonatal deaths (and 75% of infant deaths) is supported by our study.  
A model that examined the relation between birth anthropometric parameters and survival showed 
no significant associations (see Figure 8.11). There are several possible reasons for this. As 
mentioned earlier, the sample size was small for mortality data. Sample size was calculated only for 
the antenatal multiple micronutrient supplementation study, whose main outcome was not 
mortality. Secondly, there are chances of data overlap. For example, birth weight, birth weight z-
score and ponderal index all involve birth weight and the chance of collinearity is increased. 
Thirdly, it could be true that the parameters we studied are actually not predictors of mortality. This 
warrants further study on the use of size at birth as a measure of survival.    
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A LBW classification put newborn infants into a mortality risk group better than SGA or LPI. More 
infants were categorized as SGA (52%) or LPI (68%) than LBW (22%). The benefits of this 
finding are that birth weight is already in use and adopting a single birth anthropometric category is 
practical in poor countries. The combinations of two anthropometric indices that were useful to 
define risk groups were proportionate LBW (child mortality), disproportionate LBW (neonatal, 
infant and child mortality), LBW-SGA (infant and child mortality) and LBW-AGA (neonatal 
mortality). 
The study suggested that if more than one anthropometric parameter was used, three groups were 
categorised as high risk, the most striking being the LBW-API group. This group had the highest 
risk for child mortality, as high as a 7-fold increase in deaths. The group made up 2% of infants. 
The other two groups which showed highest risk for mortality were LBW-SGA and LBW-LPI, for 
which the odds of mortality in infants and young children were 2-3 times higher. These groups each 
made up about 19% of infants. If one had to choose two anthropometric parameters for a risk 
category, the first choice would be PI and birth weight, not an SGA-based category. There are a 
number of reasons for this. First, PI is easier to calculate than SGA. It only requires measurements 
of birth weight and length. SGA requires more than just measurements, particularly the comparison 
of measurements against reference data or charts. This is next to impossible at the moment due to 
lack of trained human resources. Second, LBW-SGA (20%) and LBW-LPI (19%)  had the same 
prevalence and conferred similar risks for infant and young child mortality. Third, given the low 
prevalence and highest risk for mortality in young children, it might be economical to follow-up 
infants who are just LBW-API (2% and OR 7). 
The analysis of combinations of three anthropometric indices put two groups at highest risk: LBW-
API-SGA (prevalence 2%) and LBW-LPI-AGA (prevalence 3%). LBW-LPI-AGA infants had 7 
times higher odds of neonatal death and LBW-API-SGA had 7-8 times higher odds of infant or    
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young child death. The important finding here was that only 5% of newborn infants were in high 
risk groups, compared to 22% in a system based on LBW alone. 
In our study, size at birth conferred no higher risk for recalled illness in the first year of life. We 
have already discussed the lack of conviction behind these findings. A report from the Family 
Health Division documented the nationally representative prevalences of stunting, wasting and 
underweight as 48%, 11% and 47% respectively in children under three years of age for the year 
1996.
238 We found prevalences of 59%, 6% and 38% for stunting, wasting and underweight at 2.5 
years of age for 2005-06. Children in our study suffered more stunting, less wasting and less 
underweight compared to a national survey in 1996. The comparison shows that malnutrition 
among children is still markedly high ten years later.  
All the categories based on single anthropometric indices were associated with malnutrition. LBW 
infants were significantly stunted, wasted and underweight as young children. LPI infants were 
significantly wasted, and SGA infants were significantly stunted and underweight. It is difficult to 
identify the best predictor of stunting, wasting or underweight. However, it is worth using LBW 
because the prevalence is substantially lower and the risk of stunting, wasting and underweight was 
higher in the LBW group. This means that from a management point of view it is more 
administrable in the context of a poor country. The sensitivity, specificity and positive predictive 
value for LBW was 28%, 89% and 78% respectively for stunting; 42%, 80% and 12% for wasting; 
and 34%, 87% and 61% for underweight. The risk groups based on two anthropometric indices 
which had higher risk of all three types of malnutrition were LBW-LPI (19%), LPI-SGA (42%) and 
LBW-SGA (19%). The odds were highest for the LBW-SGA group (OR 3-4). 
It is interesting to note that with a classification based on birth weight and weight-for-gestational-
age, only one category, LBW-SGA, was at risk of later malnutrition. The prevalence of LBW-SGA 
was 19% and it had an odds ratio of 3-4 for stunting, wasting and underweight. As a predictor,    
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LBW-SGA had sensitivity, specificity and positive predictive value of 25%, 90% and 78% 
respectively for stunting, 37%, 82% and 12% for wasting and 77%, 92% and 64% for underweight 
respectively. 
With classifications based on birth weight and PI, two groups were high risk: LBW-API and LBW-
LPI. But LBW-API and LBW-LPI together are just LBW. Newborns who were LBW-API had the 
highest risk for stunting and underweight in childhood. The risk was 5 to 6 times higher than other 
newborns, but it had a very low sensitivity despite good specificity (3% and 92% respectively for 
stunting and 4% and 99% for underweight). The positive predictive values were 85%, and 75% 
respectively. The other category, LBW-LPI, had a 3-times higher risk for all forms of malnutrition. 
The sensitivity and specificity were 25% and 89% respectively for stunting, 36% and 82% for 
wasting and 30% and 88% for underweight. The positive predictive values were 77%, 11% and 
60% respectively for stunting, wasting and underweight. A classification based on PI and weight-
for-gestational-age had two groups at higher risk, API-SGA and LPI-SGA. But these are just 
equivalent to SGA. LPI-SGA newborns were more likely to be stunted, wasted and underweight 
and the risk was 2-fold. As a predictor, LPI-SGA had sensitivity, specificity and positive predictive 
values of 49%, 68% and 68% respectively for stunting, 57%, 59% and 8% for wasting and 53%, 
65% and 48% for underweight. Similarly, API-SGA had higher risk for stunting and underweight 
and the risk was 2-fold. The prevalence was 10%. The sensitivity, specificity and predictive value 
for stunting were 12%, 93% and 69% and for underweight were 14%, 93% and 53% respectively. 
When we examined combinations of three indices, three groups were at risk: LBW-LPI-SGA, 
LBW-API-SGA and LBW-LPI-AGA. Children born LBW-LPI-AGA (2%) were more likely to be 
stunted. The sensitivity, specificity and positive predictive value were 3%, 99% and 81%, 
respectively. LBW-API-SGA newborns (2%) were more likely to be stunted (OR 11) and 
underweight (OR 8). The sensitivity, specificity and positive predictive value were 3%, 100% and 
89% respectively for stunting and 4%, 99% and 78% for underweight. LBW-LPI-SGA children    
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(17%) had 3-4 times higher risk of becoming stunted, wasted and underweight. The sensitivity, 
specificity and positive predictive value were 22%, 90% and 76% respectively for stunting, 33%, 
84% and 12% for wasting and 28%, 90% and 62% for underweight. 
The findings suggest that groups based on LBW and LBW-SGA are a better choice than groups 
based on other combinations. The reasons for this are that (1) only one category is a high risk group 
for all forms of malnutrition and therefore easier for health workers to understand and apply in 
daily practice, (2) the sensitivity, specificity and positive predictive values were comparatively 
better, even if not ideal for screening purposes. Groups based on two indices were better predictors 
than groups based on three. They had higher sensitivity and specificity, the numbers of children 
falling into a risk group were similar, and the odds ratios for later malnutrition were higher. 
9.7.2.  Wider implications 
The risks of malnutrition and mortality varied across different categorisations of size at birth. The 
relationship between size at birth and later morbidity was not clarified by our analysis. Being LBW 
alone conferred higher risk for morality and malnutrition than LPI or SGA. However, SGA infants 
were at increased risk for stunting and underweight and LPI for childhood wasting.  The most 
powerful predictors of neonatal mortality were LBW-AGA and LBW-LPI-AGA. For infant 
mortality, the most powerful predictor was LBW-API-SGA, and for childhood mortality it was 
LBW-API, with or without SGA. We will attempt to generalize in rough terms about these 
categories. 
The key protective factor was to be born with normal birth weight. All categories with weight 
>2500g had significantly lower odds of malnutrition and mortality. LBW-AGA were mostly 
preterm.Most of them were immature fetuses who had grown normally so it is understandable that 
the initial months were the high risk period of survival. LBW-LPI-AGA infants were also mostly    
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preterm, but were the disproportionate subgroup. They had the highest odds of all for neonatal 
mortality. 
LBW-SGA infants were mostly term infants with IUGR. Their growth was compromised and they 
had a higher risk of subsequent malnutrition and death in childhood. On top of this, whether they 
were proportionate or disproportionate did not seem to affect their mortality (LBW-SGA with 
either LPI or API). So many of them were disproportionate, however, that this is easy to understand 
and highlights the need for studies with larger sample size.  
Size at birth independently predicted size in childhood. Most of the abnormal categories conferred 
higher odds of malnutrition in childhood. For example, newborn infants with disproportionate 
SGA, disproportionate LBW and LBW-SGA had similar significantly higher odds of stunting, 
wasting and underweight.  The key factor here was SGA: small babies end up small. Proportionate 
SGA and proportionate LBW infants had higher odds of stunting.  Preterm acutely malnourished 
infants (LBW-LPI-AGA) were more likely to be stunted in childhood if they survived the neonatal 
period. Proportionate LBW infants who were SGA (chronically malnourished term or preterm 
infants) were at greater risk of infant death, childhood death, stunting and underweight. 
The study confirms that LBW is a reasonable predictor of later mortality and malnutrition. Would 
there be a benefit in adding more indices? After extensive analysis, candidate categories include, 
for mortality, LBW-API, LBW-API-SGA and LBW-LPI-AGA; and, for malnutrition, LBW-SGA. 
Who are the infants represented by these categories? LBW-API infants are term or preterm, LBW-
API-SGA infants are symmetrically small (chronically growth restricted preterm or term), LBW-
LPI-AGA are acutely growth restricted preterm, and LBW-SGA are chronically growth restricted 
preterm or term. These categories are diverse, apart from the fact that they all include LBW. 
Introducing either PI or weight-for-gestational-age is likely to be a difficult task for Nepal’s health 
system, and we would require a simpler idea of risk groups to even consider it.    
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Chapter 10.   Conclusions 
This thesis began with three general obectives, which are presented once again. 
1)  Describing the distribution of different indicators of size at birth in a cohort of 
infants in Nepal. 
2)  Development of prediction models for different indicators of size at birth, and 
assessment of how useful they might be. 
3)  Looking at the outcomes in infants and young children of different classifications 
of size at birth. 
To our knowledge, none of these had been done well in Nepalese infants. In spite of studies of risk 
factors for size at birth, the usefulness of different potential predictors for prevention and public 
health intervention remained questionable. Likewise, the usefulness of different classifications of 
size at birth in predicting outcomes had not been investigated in depth and had not been used in 
practice. The quality of the data and the need for investigation enabled this in-depth study of size at 
birth.  
In our study of measurements of size at birth in semi-rural communities in Nepal, we found that the 
proportion of infants classified as having abnormal size was high (LBW, SGA, Low PI). Although 
LBW was common, the striking finding was the degree to which infants who would usually be 
classified as normal appeared to be small and disproportionate. This probably indicates that the 
majority of infants suffered intrauterine growth retardation due to acute or subacute malnutrition. If 
the hypothesis of association of wasting with adult onset disease is correct, this is an emergency 
situation that needs immediate action. We need to follow the infants born in the study into later    
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childhood if we are to answer the questions that arise. Will the excess of disproportionality be 
associated with physiological tendencies to insulin resistance, hyperlipidaemia and hypertension? 
The next step is to track the children as they go to school, and to add more complex measurements 
– body composition, blood tests – to the protocol. 
Our understanding of the etiology of abnormal size at birth is limited. Importantly, previously 
reported risk factors did not explain size at birth adequately. Only a few risk factors were shown to 
have independent associations with size at birth. We were unable to unravel the risk factors that are 
important but omitted from usual analyses, indicating that maybe we have reached the limit of 
usefulness for these sort of studies. This is especially important as research on risk factors for 
abnormal size at birth still seems to be prioritized, and it is possible that further work could be a 
waste of resources. Moreover, such studies may be of limited importance in terms of explaining 
observed size at birth and in the prevention and management of the problem.  
Given the fact that the potential risk factors explained a limited proportion of size at birth, 
reduction in the problem of abnormal size remains a difficult proposition. There are two ways to 
address the problem. The first approach is prevention of abnormal size at birth. Our findings 
suggest that most of the underlying determinants are not clear and known determinants explain only 
a small proportion of size at birth. This may explain why preventive measures have not led to 
remarkable improvement.
239;240 Furthermore, most of the risk factors are non-modifiable. The major 
modifiable determinants of size at birth are factors like maternal nutritional status: under-nutrition 
during childhood (maternal height), poor pre-conception nutritional status (pre-pregnancy weight), 
poor nutrition during pregnancy (gestational weight gain and antenatal supplementation). 
Nutritional status is compromised in situations of poverty and illiteracy, and these modifiable 
determinants should be the targets for public health intervention. However, the problem is likely to 
be preventable only to some extent through measures such as antenatal supplementation, nutrition 
improvement and behavior change.    
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A second approach is the management of abnormal size at birth to prevent adverse outcomes. 
Prediction of size at birth is only possible with a robust prediction model with high predictive 
accuracy. As discussed above, the predictive accuracy of maternal characteristic-based equations 
and ultrasound based equations were almost similar. However, in a situation where most 
pregnancies fall into the high-risk group and most of the population are poor, the management 
options are limited. Recent studies on risk factors have added little information to our 
understanding of causes or intervention and prevention efforts, and it is possible that the model is 
unlikely to improve. In the absence of a significant improvement in the model, it might be better to 
change the priority from risk factor studies to a focus on intervention measures. The failure to 
develop a robust prediction model using major determinants of abnormal size requires attention. 
Indeed, it warrants rethinking the necessity of further work on risk factors. Furthermore, It might be 
prudent to take a holistic view of known risk factors, focusing on modifiable factors like nutrition 
and education, all of which are linked with poverty. Addressing this single factor could be the best 
strategy to reduce the incidence of small size at birth. 
The third study confirmed associations of size at birth with neonatal, infant and child mortality. It 
also showed clear associations with malnutrition in childhood. The detailed analysis of the 
anthropometric parameters to correlate with adverse outcome showed that different combinations 
have different odds, making it difficult to choose the best group. From a public health intervention 
point of view in a poor country like Nepal, one might choose a few high risk groups based on 
applicability in a situation with limited human, time and financial resources. The implication is that 
we could prioritize intervention for a small group of infants, thus saving effort and cost and 
achieving important public health change. If one of the objectives of the study was to derive 
screening categories for either mortality or malnutrition, further studies with larger sample size are 
recommended. However, we feel it is unlikely that a combination of parameters will prove more 
useful than simple birth weight. We found that both ponderal index and weight-for-gestational age    
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showed particular associations with later outcomes in certain cases, but it is not clear that adding 
their assessment to current practice would help mothers and health workers to guard against future 
risk. 
The paradox of the thesis in this sense is that it set out to explain that size at birth is so much more 
than birth weight, but – after extensive analysis of good data – found that birth weight was 
probably the most useful predictor after all. Measurement of birth weight is by no means routine 
across Nepal, and it seems better to recommend efforts to improve routine weighing and 
classification of infants as low birth weight, than to recommend new activities which might dilute 
the likely impact. 
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Annex A. Research article 1 
Effects of antenatal multiple micronutrient supplementation on birth weight and gestational 
duration in Nepal: double-blind, randomized controlled trial. Lancet 2005; 365-62    
247 
 
    
248 
    
249 
    
250 
    
251 
    
252 
    
253 
 
    
254 
 
Annex B. Research article 2 
Effects of antenatal multiple micronutrient supplementation on children’s weight and size at 2 
years of age in Nepal; follow-up of a double blind randomized controlled trial. Lancet 2008; 
371:492 
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Antenatal information form (1 of 2) 
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Antenatal information form (2 of 2) 
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Home delivery form (1 of 2) 
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Home delivery form (2 of 2) 
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One month form  (2 of 2) 
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Nepali consent form    
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Annex E. Information given for ultrasound scan to eligible participants 
 
This scan allows to see inside the uterus. It is done to check how many weeks pregnant you are, the well 
being of the baby and how many babies you are pregnant with. It is painless and does not involve use of 
needles. It is harmless to the baby and your health. It uses sound. It does not use rays like in x-rays so can be 
done repeatedly. 
 
No strangers will be allowed to be in the room during the scan for privacy reason. It will be done in presence 
of your partner or mother in law or somebody you want to be present like a friend or sister. 
 
You should have a full bladder (6 glasses of water). You should loosen your cloth and expose your lower part 
of the abdomen. Gel will be applied to the abdomen. It is a sticky material. You might sometime feel 
discomfort when applying pressure to get the better and closer view. It might take 10 minutes to 20 minutes. It 
involves taking measurements, Once the process is done, gel will be wiped off your skin. I will share the 
results with you after finishing the procedure.  
 
Sometime you might need a second scan if the baby is very small or the baby is lying in awkward position. It 
will be arranged in your next antenatal visit.  
 
It is not always easy and possible to detect all congenital problems. We cannot be sure that the baby is 100 % 
free of congenital anomaly. There are still chances of missing some congenital anomalies. If we are not sure 
of the condition, we will refer you to the hospital radiologist for specialist scan. The cost of the scan will be 
refunded. 
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Annex F. Consent form for antenatal multiple micronutrient 
supplementation trial 
Consent Form 
 
Mother Infant Research Activities has for many years been conducting research in various districts of 
Nepal to improve the health of mothers and newborn babies, as well as to reduce illness and deaths, 
and is now starting a study with pregnant women who come to Janakpur Hospital, on the role of 
micronutrients in improving newborn infant health. The newborn babies of malnourished mothers are of 
low birth weight and diseased. Therefore, at the hospital, we are supplying iron and folic acid to prevent 
anaemia and micronutrient deficiency, and some women are supplied with other micronutrients as well 
as iron and folic acid. The Nepal Health Research Council and the Ministry of Health have given 
permission for us to conduct research comparing the role of multiple micronutrient supplementation for 
pregnant women with iron and folic acid tablet supplementation. Of the tablets we are giving you, some 
contain iron and folic acid, and the others contain iron and folic acid as well as some other minerals and 
vitamins, although we cannot tell which is which. For this 1200 pregnant women will be enrolled. This 
programme will also provide free services: 
 
1. Antenatal care examination every month and discussion of your state of health at home. 
2. Full predelivery care services 
3. Ultrasound scan to assess the age of the baby. 
4. Blood and urine examination as recommended by His Majesty's Government. 
5. Maternity care during and after the birth of the baby. 
6. Measurement of blood vitamin and mineral levels. 
7. Treatment for any problems arising from pregnancy or childbirth. 
8. Milk test after the baby is born. 
 
Whether or not to take part in this study is up to you and you may leave if you like. 
All information about participants will remain confidential. 
 
Besides this, if you have any problems or questions you can contact the following address. 
MIRA Janakpur Multiple Micronutrient Supplementation Study, Ramanand Chowk. Telephone 24032. 
I have understood all the information written on this consent form. 
I give my consent to take part in the study. 
 
Signature 
Name 
Address 
Date 
 
If the participant is unable to sign for herself, a witness may sign for her. 
The consent form has been read out in front of me (the woman has understood it) and it is true that she 
is willing to take part. 
Name of witness 
Date 
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Annex G. Verbal consent form 
 
Verbal consent form 
Mother Infant Research Activities has for many years been conducting research in various districts of Nepal to improve 
the health of mothers and newborn babies, as well as to reduce illness and deaths. It is now following up children at 2 
years of age born to mothers of antenatal micronutrient supplementation study conducted in Janakpur Hospital. This 
will include  
1.  short medical history of the children 
2.  nutritional and immunization history 
3.  history on developmental mile-stones 
4.  anthropometric measurements of children 
5.  anthropometric measurements of mothers   
6.  examination of mother’s blood 
It is your wish to choose not to participate. Everything will be confidential, and all the information will not be disclosed 
to anyone. You can ask any questions regarding this study.  
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Annex H. Team members  
Main study   
Hospital based staffs   
ANC  Yagya kumari Shrestha 
Durna Kumari Thapa 
Pushpa Baniya 
Laboratory 
 
Gunanand Sah 
Shyam Jha 
Birendra Kumar Yadav 
Obstetric and Gynaecology department 
 
Sunita yadav 
Sushila Karki 
Chandra MayaThapa 
Nayan Tara Sah 
Study room  Anjana Vaidya 
Field team   
  Mahottry team 
     Bechan Chaudhary 
Dhanusha VDC 
     Shiv Shanker Chave 
Dhanusha and Municipality team 
      Binaya Karki 
Follow up staffs   
Data  Anupa Regmi 
Filed team  
 
 
Team 1 
      Durna kumari Thapa (Anthropometric) 
      Shiv Shanker Chauve (Consent and Forms) 
Team 2 
      Chandra Maya Thapa (Anthropometric) 
      Gagan Kumar Chauve (Consent and Forms) 
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Annex I. Methods of data collection 
On booking in the antenatal 
clinic 
Ultrasound room  Delivery room  1 month postnatal 
interview 
2 year follow-up 
Introduction 
Address 
Menstrual history 
1
st scan at <20 weeks  Newborn Apgar Score  Infant morbidity  Maternal 
anthropometry 
Details of the study  Enrolment after consent if inclusion criteria 
fulfilled 
Newborn 
anthropometry 
Infant mortality  Child anthropometry 
Brief obstetric and gynaecological 
history 
Medical, Obstetric and Gynaecological 
history 
Congenital anomaly 
check 
Maternal morbidity  Child morbidity  
  Maternal anthropometry  Delivery events  Maternal mortality  Child mortality    
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Annex J. Composition of supplements 
Supplement 1  Supplement 2 
Iron 
Folic acid   
(60 mg) 
(400 mcg) 
 
Vitamin A   
Vitamin B1 
Vitamin B2 
Vitamin B6 
Vitamin B12 
Vitamin C             
Vitamin D   
Vitamin E   
Niacin 
Folic acid 
Iron 
Zinc 
Copper 
Selenium   
Iodine 
 
(800 mcg) 
(1.4 mg) 
(1.4 mg) 
(1.9 mg) 
(2.6 mcg) 
(70 mg) 
(5 mcg) 
(10 mg) 
(18 mg) 
(400 mcg) 
(30 mg) 
(15 mg) 
(2 mg) 
(65 mcg) 
(150 mcg) 
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Annex K. Principal components analysis 
The study used a score derived from the first component.  
Component loading of socioeconomic factors 
Variable  Principal component 
1 
Principal component 
2 
Principal component 
3 
Principal component 
4 
Principal component 
5 
Farming  .020  -.919  .177  -.025  -.055 
Salary  -.812  .444  .195  -.184  -.077 
Business  .841  .298  .189  -.157  -.023 
Daily wage  .160  -.004  -.803  .114  -.174 
Student  -.019  .043  .041  .966  .017 
Out of country  .031  .007  -.009  .019  .974 
Land ownership  .118  -.168  .573  .093  -.111 
Consumables  .156  .465  .529  .154  -.184 
           
Eigenvalue  1.534  1.445  1.211  1.032  1.022 
% of variation explained  19.181  18.062  15.134  12.897  12.772 
Cumulative % of variation 
explained 
19.181  37.243  52.377  65.274  78.046 
Extraction method: Principal Components Analysis.  
Rotation: Varimax with Kaiser Normalization. 
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Annex L. Studies comparing predictive accuracy of different estimation methods for birth weight 
Study and date  Methods   Accuracy  of estimation  Inference 
Chauhan 1998
228  Clinical/USS  Lower simple error and mean standardized absolute error for USS 
EFW  than Clinical EFW [mean (+/- Standard error)] 
Clinical simple error of (48.2 +/- 411 g) and standardized absolute error 
(130 +/- 122g/kg) 
USSl simple error for EFW (-6.6 +/- 381g) and standardized absolute 
error of (104 +/- 89g/kg) 
% of EFW that was predicted correctly within 10% of ABW 
   <2500 g (40% for clinical and 56% for USS) 
    2500-3999 g (60% for clinical and 58% for USS) 
    >4000 g (53% for clinical and 62% for USS) 
USS EFW is superior to clinical EFW in preterms 
 
Both methods have limited value in the estimation 
of actual birth weight and lie outside useful 
bandwidth (±10% of ABW) 
 
Chauhan 2000
241   USS biometric/clinical/USS 
soft tissue 
Areas under ROC curves (Area  ± Standard error) 
Clinical (0.72 ± 0.06)  
USS biometric (0.73 ± 0.06) 
USS soft tissues – 0.52 ±0.06 to 0.58 6 0.07 
USS soft tissue not superior to clinical or USS 
biometric methods 
Hendrix 2000
242  Clinical/USS 
(RCT) 
Clinical significantly more likely to be within 10% of actual weight (58%) 
than estimates derived from ultrasound examination  
At term clinical more predictive  
ROC curve showed similar predictive ability 
 
Nahum 2003 
227  Maternal/USS  USS 7.5 – 18.8% 
Maternal characteristics 10.4% 
Ultrasound no more accurate than maternal 
characteristics 
Halaska 2006
229   Maternal/ USS  % of birth weight predicted within 10% of ABW 
Maternal 
243- 63%  
Hadlock equation 
244 79%  
Halaska equation 75%  
Shepherd equation
245- 58% 
Nahum (maternal) comparable to shepherd 
Hadlock comparable to Halaska and more 
accurate 
 
ABW: Actual birth wight; EFW: Estimated Fetal Weight; RCT: Randomized controlled trial; ROC: Receiver operating characteristics; USS: Ultrasound scan   
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Annex M Prediction models 
The tables present odds ratios and 95% confidence interval 
Model I: Unadjusted 
Model II: Adjusted for significant confounders:  
Neonatal death: weight at enrolment 
Infant death: no significant confounders 
Child death: gestation at birth 
Stunting: parity, education, socioeconomic status, weight at enrolment, gestation at birth, age at weaning, age at follow up and frequency of illness 
Wasting: education and weight at enrolment 
Underweight: parity, education, socioeconomic status, weight at enrolment, gestation at birth, age at weaning and frequency of illness 
Illness during infancy 
Cough and fever: maternal age and education 
Diarrhoea and fever: ethnicity, supplementation and age at follow up 
Rash and fever: maternal age and education 
Frequency of illness: parity, education, socioeconomic status and infants gender 
Illness in the last fortnight 
Fever: parity, education, socioeconomic status, weight at enrolment and age at weaning 
Cough: parity, education, socioeconomic status, weight at enrolment, infants gender, age at weaning and age a follow up 
Difficulty breathing: parity, education, age at weaning and age at follow up 
Diarrhoea: parity, education, socioeconomic status, weight at enrolment, age at weaning and age at follow up 
Systolic Blood Pressure: maternal age and parity,  
Diastolic Blood Pressure: parity, ethnicity and education 
Model III: Adjusted for all possible confounders 
For neonatal deaths: Maternal age, parity, ethnicity, education, socioeconomic status, supplements, weight at enrolment, gestation at birth and infant sex 
For infant deaths and child deaths: All confounders for neonatal deaths plus age at weaning 
For malnutrition: All confounders for deaths plus age at weaning and frequency of illness 
For illness: All confounders for deaths plus age at follow up 
         
LBW  Model I  Model II  Model III 
Neonatal death  4.02 (1.75 – 9.22) p = 0.001  3.54 (1.53 – 8.24) p = 0.003  3.46 (1.36 – 8.85) p = 0.009 
Infant death  3.93 (1.95 – 7.91) p = 0.001  -  3.60 (1.63 – 7.93) p = 0.001 
Child death  3.93 (2.02 – 7.63) p = 0.001  3.75 (1.85 – 7.57) p = 0.001  3.66 (1.73 – 7.75) p = 0.001 
       
Stunting  3.03 (2.10 – 4.38) p = 0.001  3.53(2.28 – 5.44) p = 0.001  3.40 (2.19 – 5.30) p = 0.001 
Wasting  2.90 (1.65 – 5.10) p = 0.001  2.43 (1.37 – 4.31) p = 0.002  2.93 (1.53 – 5.59) p = 0.001 
Underweight  3.40 (2.45 – 4.72) p = 0.001  3.39 (2.31 – 4.98) p = 0.001  3.69 (2.47 – 5.50) p = 0.001 
       
Cough and fever during infancy  0.84 (0.48 – 1.81) p = 0.8  0.85 (0.44 – 1.67) p = 0.6  0.83 (0.40 – 1.72) p = 0.6 
Diarrhoea and fever during infancy  0.97 (0.68 – 1.36) p = 0.8  0.93 (0.38 – 2.19) p = 0.7  0.88 (0.60 – 1.29) p = 0.9 
Rash and fever during infancy  0.68 (0.39 – 1.17) p = 0.2  0.63 (0.36 – 1.09) p = 0.1  0.65 (0.36 – 1.17) p = 0.1 
Frequency of illness in the first year of life  1.23 (0.89 – 1.70) p = 0.2  1.25 (0.90 – 1.73) p = 0.2  1.31 (0.92 – 1.87) p = 0.1 
Fever in last 14 days  1.56 (1.13 – 2.16)) p = 0.007  1.48 (1.06 – 2.09) p = 0.02  1.57 (1.09 – 2.25) p = 0.02 
Diarrhoea in last 14 days  1.09 (0.69 – 1.72)  p = 0.7  1.06 (0.66 – 1.70) p = 0.8  1.05 (0.64 – 1.73) p = 0.8 
Cough in last 14 days  1.39 (1.00 – 1.92) p = 0.05  1.47 (1.04 – 2.08) p = 0.03  1.43 (0.99 – 2.05) p = 0.06 
Difficult breathing in 14 days  1.12 (0.62 – 1.20) p = 0.7  1.17 (0.64 – 2.13) p = 0.6  1.29 (0.68 – 2.46) p = 0.4 
Child systolic blood pressure   0.350 (-1.797 – 2.497) p = 0.8  -0.308 (-2.469 – 1.854) p = 0.8  -0.346 (-2.654 – 1.962) p = 0.8    
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Child diastolic blood pressure  2.004 (-0.104 – 4.112) p = 0.06  1.649 (-0.460 – 3.758) p = 0.1  1.246 (-1.004 – 3.497) p = 0.3 
 
 
SGA  Model I  Model II  Model III 
Neonatal death   1.21 (0.53 – 2.78) p = 0.7  1.00 (0.43 – 2.35) p = 1  1.11 (0.45 – 2.73) p = 0.8 
Infant death   1.28 (0.63 – 2.58) p = 0.5    1.34 (0.63 -2.85) p = 0.5 
Child death  1.39 (0.71 – 2.71) p = 0.4  1.57 (0.79 – 3.12) p = 0.2  1.67 (0.81 – 3.45) p = 0.2 
       
Stunting   2.31 (1.76 – 3.02) p = 0.001  2.50 (1.81 – 3.48) p = 0.001  2.42 (1.75 – 3.36) p = 0.001 
Wasting  1.81 (1.02 – 3.21) p = 0.04  1.43 (0.79 – 2.58) p = 0.2  1.56 (0.83 – 2.92) p = 0.2 
Underweight  2.70 (2.04 – 3.56) p = 0.001  2.98 (2.14 – 4.14) p = 0.001  3.05 (2.18 – 4.27) p = 0.001 
       
Cough and fever during infancy  0.97 (0.56 – 1.69) p = 0.9  0.93 (0.53 – 1.62) p = 0.8  1.10 (0.61 – 2.00) p = 0.8 
Diarrhoea and fever during infancy  1.01 (0.76 – 1.34) p = 0.9  0.96 (0.72 – 1.29) p = 0.8  0.94 (0.69 – 1.29) p = 0.7 
Rash and fever during infancy  1.22 (0.82 – 1.84) p = 0.3  1.18 (0.79 – 1.78) p = 0.4  1.23 (0.79 – 1.93) p = 0.4 
Frequency of illness in the first year of life  1.22 (0.94 – 1.59) p = 0.1  1.23 (0.94 – 1.60) p = 0.1  1.31 (0.98 – 1.75) p = 0.07 
Fever in last 14days  1.56 (1.19 – 2.06) p = 0.001  1.44 (1.08 – 1.93) p = 0.01  1.57 (1.16 – 2.13) p = 0.004 
Diarrhoea in last 14 days  1.32 (0.90 – 1.94) p = 0.2  1.17 (0.79 – 1.74) p = 0.4  1.19 (0.79 – 1.80) p = 0.4 
Cough in last 14 days  1.26 (0.96 – 1.65) p = 0.1  1.18 (0.89 – 1.58) p = 0.3  1.26 (0.94 – 1.71) p = 0.1 
Difficult breathing in 14 days  1.92 (1.15 – 3.20) p = 0.01  1.93 (1.15 – 3.26) p = 0.01  1.94 (1.11 – 3.37) p = 0.02 
Child systolic blood pressure   -0.140 (-1.898 – 1.619) p = 0.9  -0.412 (-2.177 – 1.352) p = 0.7  -0.584 (-2.456 – 1.288) p = 0.5 
Child diastolic blood pressure  -0.380 (-2.110 – 1.350) p = 0.7  -0.471 (-2.195 – 1.253) p = 0.6  -0.180 (-2.006– 1.647) p = 0.8 
 
 
 
 
 
LPI  Model I  Model II  Model III 
Neonatal death   1.38 (0.54 – 3.53) p = 0.5  1.31 (0.51 – 3.37) p = 0.6  1.26 (0.48 – 3.32) p = 0.6 
Infant death   1.07 (0.51 – 2.29) p = 0.9    0.98 (0.45 – 2.12) p = 1 
Child death  1.11 (0.54 – 2.27) p = 0.8  1.06 (0.51 – 2.17) p = 0.9  1.03 (0.49 – 2.16) p = 0.9 
       
Stunting   1.16 (0.87 – 1.54) p = 0.3  1.06 (0.77 – 1.46) p = 0.7  1.05 (0.76 – 1.45) p = 0.8 
Wasting   1.94 (0.98 – 3.82) p = 0.06  1.86 (0.94 – 3.69) p = 0.07  2.16 (1.05 – 4.44) p = 0.04 
Underweight   1.32 (0.99 – 1.77) p = 0.06  1.29 (0.93 – 1.79) p = 0.1  1.30 (0.94 – 1.82) p = 0.1 
       
Cough and fever during infancy  0.42 (0.20 – 0.88) p = 0.02  0.41 (0.20 – 0.86) p = 0.02  0.42 (0.20 – 0.88) p = 0.02 
Diarrhoea and fever during infancy  0.96 (0.71 – 1.30) p = 0.8  0.94 (0.69 – 1.28) p = 0.7  0.96 (0.70 – 1.32) p = 0.8 
Rash and fever during infancy  1.10 (0.71 – 1.71) p = 0.7  1.08 (0.69 – 1.67) p = 0.7  1.10 (0.70 – 1.72) p = 0.7 
Frequency of illness in the first year of life  1.18 (0.89 – 1.57) p = 0.2  1.19 (0.90 – 1.59) p = 0.2  1.18 (0.88 – 1.59) p = 0.3 
Fever in last 14days  0.94 (0.70 – 1.26) p = 0.7  0.90 (0.67 – 1.22) p = 0.5  0.88 (0.65 – 1.20) p = 0.4 
Diarrhoea in last 14 days  0.83 (0.55 – 1.23) p = 4  0.79 (0.53 – 1.19) p = 0.3  0.82 (0.54 – 1.24) p = 0.4 
Cough in last 14 days  0.88 (0.66 – 1.17) p = 0.4  0.84 (0.63 – 1.14) p = 0.3  0.83 (0.61 – 1.13) p = 0.2 
Difficult breathing in 14 days  1.0 (0.59 – 1.69) p = 1  1.01 (0.59 – 1.73) p = 1  0.97 (0.56 – 1.66) p = 0.9 
Child systolic blood pressure   -0.041 (-1.930 – 1.848) P = 1.0  -0.369 (-2.265 – 21.527) P = 0.7  -0.405 (-2.317 – 1.506) P = 0.7 
Child diastolic blood pressure  0.466 (-1.392 – 2.324) P = 0.6  0.348 (-1.504 –  2.200) P = 0.7  0.283  (-1.582 – 2.149) P = 0.8 
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LBW_LPI  Model I  Model II  Model III 
Neonatal death   3.31 (1.43 – 7.65) p = 0.005  2.93 (1.26 – 6.86) p = 0.01  2.65 (1.03 – 6.79) p = 0.04 
Infant death   2.76 (1.35 – 5.67) p = 0.005  -  2.26 (0.90 – 1.03) p = 0.05 
Child death   2.60 (1.31 – 5.14) p = 0.006  2.33 (1.13 – 4.81) p = 0.02  2.13 (0.98 – 4.59) p = 0.06 
       
Stunting  2.75 (1.88 – 4.03) p = 0.001  3.08 (1.98 – 4.79) p = 0.001  2.95 (1.89 – 4.63) p = 0.001 
Wasting   2.62 (1.47 – 4.66) p = 0.001  2.24 (1.24 – 4.01) p = 0.008  2.63 (1.37 – 5.07) p = 0.004 
Underweight   3.02 (2.15 – 4.25) p = 0.001  2.95 (1.99 – 4.37) p = 0.001  3.15 (2.09 – 4.75) p = 0.001 
       
Cough and fever during infancy  0.79 (0.41 – 1.54) p = 0.5  0.72 (0.37 – 1.41) p = 0.4  0.69 (0.34 – 1.42) p = 0.7 
Diarrhoea and fever during infancy  1.01 (0.70 – 1.45) p = 1  0.97 (0.67 – 1.40) p = 0.9  0.93 (0.63 – 1.38) p = 0.7 
Rash and fever during infancy  0.61 (0.34 – 1.10) p = 0.01  0.57 (0.31 – 1.02) p = 0.06  0.58 (0.31 – 1.07) p = 0.08 
Frequency of illness in the first year of life  1.25 (0.89 – 1.75) p = 0.2  1.27 (0.90 – 1.79) p = 0.2  1.35 (0.93 – 1.95) p = 0.1 
Fever in last 14days  1.48 (1.05 – 2.07) p = 0.02  1.41 (0.99 – 2.01) p = 0.06  1.46 (1.01 – 2.12) p = 0.05 
Diarrhoea in last 14 days  1.02 (0.63 – 1.65) p = 0.9  1.00 (0.61 – 1.65) p = 1  1.00 (0.60 – 1.68) p = 1 
Cough in last 14 days  1.30 (0.93 – 1.83) p = 0.1  1.38 (0.96 – 1.98) p = 0.08  1.34 (0.92 – 1.94) p =0.1 
Difficult breathing in 14 days  1.20 (0.66 – 2.17) p = 0.6  1.27 (0.69 – 2.34) p = 0.5  1.38 (0.71 – 2.65) p = 0.3 
Child systolic blood pressure   0.94 (-1.30 – 3.18) p = 0.4  0.24 (-2.02 – 2.50) p = 0.9  0.27 (-2.10 – 2.65) p = 0.8 
Child diastolic blood pressure  2.33 (0.13 – 4.53) p = 0.04  1.89 (-0.31 – 4.09) p = 0.09  1.51 (-0.80 – 3.83) p = 0.2 
 
 
 
 
 
LBW_API  Model I  Model II  Model III 
Neonatal death   3.78 (0.84 – 17.00) p = 0.08  3.17 (0.70 – 14.45) p = 0.1  3.46 (0.71 – 17.00) p = 0.1 
Infant death   5.87 (1.89 – 18. 18) p = 0.002    5.71 (0.90 – 1.03) p = 0.3 
Child death  6.95 (2.45 – 19.70) p = 0.001  5.98 (2.06 – 17.41) p = 0.001  7.04 (2.31 – 21.44) p = 0.001 
       
Stunting   4.04 ( 1.18- 13.89) p = 0.03  5.4 (1.13 – 25.89) p = 0.04  5.29  (1.11 – 25.34) p = 0.04 
Wasting   2.84 (0.81 – 10.00) p = 0.1  2.28 (0.63 – 8.24) p = 0.2  2.10 (0.54 – 8.17) p = 0.3 
Underweight   5.11 (1.84 – 14.18) p = 0.002  5.17 (1.58 – 16.93) p = 0.007  5.72 (1.70 – 19.21) p = 0.005 
       
Cough and fever during infancy  38927109 P=1  -   
Diarrhoea and fever during infancy  0.74 (0.29 – 1.91) p = 0.5  0.71 (0.27 – 1.86) p = 0.5  0.68 (0.26 – 1.79) p = 0.4 
Rash and fever during infancy  1.41 (0.40 – 4.91) p = 0.6  1.38 (0.39 – 4.83) p = 0.6  1.63 (0.45 – 5.89) p = 0.5 
Frequency of illness in the first year of life  0.96 (0.39 – 2.38) p = 0.9  0.95 (0.38 – 2.39) p = 0.9  0.92 (0.36 – 2.36) p = 0.9 
Fever in last 14days  1.66 (0.67 – 4.14) p = 0.3  1.54 (0.61 – 3.91) p = 0.4  1.62 (0.62 – 4.19) p = 0.3 
Diarrhoea in last 14 days  1.19 (0.34 – 4.14) p = 0.8  1.07 (0.30 – 3.79) p = 0.9  1.07 (0.29 – 3.93) p = 0.9 
Cough in last 14 days  1.62 (0.65 – 4.02) p = 0.3  1.62 (0.63 – 4.12) p = 0.3  1.55 (0.60 – 3.99) p = 0.4 
Difficult breathing in 14 days  0.00 (0.00 – 00) p = 0.1  -  - 
Child systolic blood pressure   -4.00 (-9.99 – 1.99) p =0.2  -4.17 (-10.14 – 1.81) p = 0.2  -4.30 (-10.36 – 1.76) p = 0.2 
Child diastolic blood pressure  -0.16 (-6.07 – 5.74) p = 1  -0.11 (-5.96 – 5.74) p = 1  -0.67 (-6.59 – 5.26) p = 0.8 
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NBW_LPI   Model I  Model II  Model III 
Neonatal death   0.47 (0.19 – 1.14) p = 0.1  0.49 (0.19 – 1.19) p = 0.1  0.55 (0.22 – 1.40) p = 0.2 
Infant death   0.45 (0.21 – 0.96) p = 0.04    0.51 (0.24 – 1.12) p = 0.09 
Child death  0.50 (0.25 – 1.00) p = 0.05  0.54 (0.26 – 1.09) p = 0.08  0.57 (0.28 – 1.19) p = 0.1 
       
Stunting   0.65 (0.50 – 0.84) p = 0.001  0.58 (0.43 – 0.79) p = 0.001  0.59 (0.43 – 0.80) p = 0.001 
Wasting   0.79 (0.46 – 1.37) p = 0.4  0.86 (0.49 – 1.49) p = 0.6  0.91 (0.50 – 1.65) p = 0.8 
Underweight   0.63 (0.48 – 0.82) p = 0.001  0.65 (0.48 – 0.88) p = 0.005  0.64 (0.47 – 0.88) p = 0.005 
       
Cough and fever during infancy  0.62 (0.35 – 1.09) p = 0.1  0.64 (0.36 – 1.13) p = 0.1  0.65 (0.36 – 1.17) p = 0.1 
Diarrhoea and fever during infancy  0.96 (0.72 – 1.27) p = 0.8  0.96 (0.72 – 1.29) p = 0.8  1.01 (0.75 – 1.36) p = 1 
Rash and fever during infancy  1.42 (0.95 – 2.14) p = 0.09  1.46 (0.97 – 2.19) p = 0.07  1.45 (0.95 – 2.21) p = 0.09 
Frequency of illness in the first year of life  1.01 (0.8 – 1.32) p = 0.9  1.01 (0.77 – 1.32) p = 1  0.96 (0.74 – 1.29) p = 0.9 
Fever in last 14days  0.74 (0.56 – 0.97) p = 0.03  0.74 (0.58 – 0.98) p = 0.04  0.71 (0.53 – 0.95) p = 0.02 
Diarrhoea in last 14 days  0.76 (0.58 – 0.99) p = 0.04  0.71 (0.53 – 0.94) p = 0.02  0.72 (0.54 – 0.96) p = 0.02 
Cough in last 14 days  0.89 (0.54 – 1.46) p = 0.6  0.87 (0.53 – 1.44) p = 0.6  0.81 (0.48 – 1.35) p = 0.8 
Difficult breathing in 14 days  0.83 (0.57 – 1.22) p = 0.3  0.81 (0.55 – 1.20) p = 0.3  0.84 (0.56 – 1.25) p = 0.4 
Child systolic blood pressure   -0.615 (-2.376 – 1.145) p = 0.5  -0.463 (-2.222 – 1.1296) p = 0.6  -0.514 (-2.312 – 1.284) p = 0.6 
Child diastolic blood pressure  -1.031 (-2.762 – 0.700) p = 0.2  -0.853 (-2.570 – 0.865) p = 0.3  -0.616 (-2.371 – 1.138) p = 0.5 
 
 
NBW_API  Model I  Model II  Model III 
Neonatal death   0.48 (0.16 – 1.44) p = 0.2  0.52 (0.18 – 1.55) p = 0.2  0.53 (0.17 – 1.61) p = 0.3 
Infant death  0.55 (0.23 – 1.36) p = 0.2  -  0.60 (0.24 – 1.51) p = 0.3 
Child death  0.48 (0.20 – 1.16) p = 0.1  0.51 (0.21 – 1.24) p = 0.1  0.50 (0.20 – 1.24) p = 0.1 
       
Stunting  0.77 (0.58 – 1.03) p = 0.08  0.83 (0.60 – 1.16) p = 0.3  0.85 (0.61 – 1.18) p = 0.3 
Wasting  0.39 (0.18 – 0.83) p = 0.01  0.41 (0.19 – 0.89) p = 0.02  0.35 (0.15 –  0.79) p = 0.01 
Underweight  0.64 (0.47 – 0.86) p = 0.004  0.65 (0.46 – 0.92) p = 0.01  0.64 (0.45 – 0.90) p = 0.01 
       
Cough and fever during infancy  2.13 (1.02 – 4.42) p = 0.04  2.19 (1.05 – 4.57) p = 0.04  2.18 (1.03 – 4.62) p = 0.04 
Diarrhoea and fever during infancy  1.05 (0.77 – 1.44) p = 0.8  1.08 (0.79 – 1.49) p = 0.6  1.06 (0.76 – 1.48) p = 0.7 
Rash and fever during infancy  0.90 (0.57 – 1.42) p = 0.7  0.92 (0.59 – 1.46) p = 0.7  0.90 (0.56 – 1.44) p = 0.7 
Frequency of illness in the first year of life  0.85 (0.64 – 1.14) p = 0.3  0.85 (0.63  - 1.14) p = 0.3  0.86 (0.63 – 1.16) p = 0.3 
Fever in last 14 days  1.02 (0.76 – 1.37) p = 0.9  1.07 (0.79 – 1.46) p = 0.7  1.09 (0.79 – 1.49) p = 0.6 
Diarrhoea in last 14 days  1.10 (0.81 – 1.47) p = 0.6  1.14 (0.84 – 1.55) p = 0.4  1.16 (0.85 – 1.59) p = 0.4 
Cough in last 14 days  1.20 (0.80 – 1.80) p = 0.4  1.27 (0.84 – 1.92) p = 0.3  1.22 (0.80 – 1.86) p = 0.4 
Difficult breathing in 14 days  1.12 (0.66 – 1.89) p = 0.7  1.10 (0.65 – 1.89) p = 0.7  1.13 (0.66 – 1.96) p = 0.7 
Child systolic blood pressure   0.497 (-1.436 – 2.430) p = 0.6  0.884 (-1.057 – 2.825) p = 0.4  0.937 (-1.028 – 2.903) p = 0.4 
Child diastolic blood pressure  -0.414 (-2.316 – 1.487) p = 0.7  -0.272 (-2..169 – 1.625) p = 0.8  -0.142 (-2.060 – 1.777) p = 0.9 
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LBW_SGA  Model I  Model II  Model III 
Neonatal death   2.78 (1.18 – 6.51) p = 0.02  2.40 (1.01 – 5.71) p = 0.05  2.15 (0.86 – 5.38) p = 0.1 
Infant death   3.17 (1.56 – 6.45) p = 0.001    2.79 (1.31 – 5.96) p = 0.008 
Child death   3.31 (1.69 – 6.47) p = 0.001  3.08 (1.56 – 6.08) p = 0.001  3.07 (1.50 – 6.30) p = 0.002 
       
Stunting   2.92 (1.98 – 4.31) p = 0.001  3.25 (2.09 – 5.07) p = 0.001  3.01 (1.92 – 4.70) P = 0.001 
Wasting   2.75 (1.54 – 4.92) p = 0.001  2.31 (1.27 – 4.17) p = 0.006  2.63 (1.39 – 4.97) p = 0.003 
Underweight   3.83 (2.71 – 5.43) p = 0.001  3.80 (2.56 – 5.63) p = 0.001  4.08 (2.71 – 6.15) p = 0.001 
       
Cough and fever during infancy  1.16 (0.55 – 2.41) p = 0.7  1.08 (0.52 – 2.28) p = 0.8  1.14 (0.52 – 2.47) p = 0.8 
Diarrhoea and fever during infancy  1.04 (0.72 – 1.50) p = 0.8  1.02 (0.70 – 1.47) p = 0.9  0.99 (0.67 – 1.47) p = 0.9 
Rash and fever during infancy  0.81 (0.47 – 1.41) p = 0.5  0.77 (0.44 – 1.34) p = 0.4  0.80 (0.45 – 1.41) p = 0.4 
Frequency of illness in the first year of life  1.28 (0.91 – 1.79) p = 0.2  1.31 (0.93 – 1.84) p = 0.1  1.39 (0.97 – 1.99) p = 0.08 
Fever in last 14days  1.70 (1.21 – 2.38) p = 0.002  1.64 (1.15 – 2.33) p = 0.006  1.73 (1.20 – 2.49) p = 0.003 
Diarrhoea in last 14 days  1.19 (0.74 – 1.89) p = 0.5  1.13 (0.70 – 1.82) p = 0.6  1.12 (0.68 – 1.85) p = 0.7 
Cough in last 14 days  1.37 (0.97 – 1.92) p = 0.07  1.44 (1.00 – 2.06) p =0.05  1.43 (0.99 – 2.06) p = 0.06 
Difficult breathing in 14 days  1.21 (0.66 – 2.19) p = 0.5  1.26 (0.68 – 2.32) p = 0.5  1.36 (0.72 – 2.58) p = 0.4 
Child systolic blood pressure   0.338 (-1.914 – 2.590) p = 0.8  -0.004 (-2.260 – 2.251) p = 1  -0.26 (-2.59 – 2.08) p = 0.8 
Child diastolic blood pressure  1.631 (-0.582 – 3.844) p = 0.2  1.293 (-0.910 – 3.497) p = 0.3  1.032 (-1.243 – 3.308) p = 0.4 
 
 
 
 
 
LBW_AGA  Model I  Model II  Model III 
Neonatal death   5.52 (1.55 – 10.71) p = 0.008  5.43 (1.51 – 10.57) p = 0.01  5.69 (1.02 – 31.83)  p = 0.05 
Infant death   3.89 (1.11- 13.66) p = 0.03    2.30 (0.47 – 11.24) p = 0.3 
Child death   3.41 (0.98 – 11.93) p = 0.05  2.20 (0.48 – 10.10 ) p = 0.3  1.64 (0.35 – 7.85) p = 0.5 
       
Stunting  2.57 (0.94 – 6.98) p = 0.07  2.33 (0.69 – 7.84) p = 0.2  3.28 (0.85 – 12.69) p = 0.09 
Wasting  2.47 (0.71 – 8.57) p = 0.2  2.32 (0.66 – 8.19) p = 0.2  2.18 (0.49 – 9.72) p = 0.3 
Underweight   1.07 (0.46 – 2.51) p = 0.9  0.65 (0.23 – 1.78) p = 0.4  0.65 (0.23 – 1.81) p = 0.4 
       
Cough and fever during infancy  0.41 (0.12 – 1.42) p = 0.2  0.33 (0.09 – 1.18) p = 0.09  0.18 (0.04 – 0.79) p = 0.02 
Diarrhoea and fever during infancy  0.67 (0.29 – 1.56) p = 0.4  0.60 (0.25 – 1.41) p = 0.2  0.45 (0.17 – 1.19) p = 0.1 
Rash and fever during infancy  ----  ---  ----- 
Frequency of illness in the first year of life  0.88 (0.38 – 2.05) p = 0.7  0.84 (0.35 – 1.98) p = 0.7  0.66 (0.25 – 1.73) p = 0.4 
Fever in last 14days  0.80 (0.33 – 1.97) p = 0.6  0.66 (0.25 – 1.74) p = 0.4  0.51 (0.18 – 1.44) p = 0.2 
Cough in last 14 days  1.39 (0.60 – 3.21) p = 0.4  1.39 (0.57 – 3.93) p = 0.5  1.02 (0.39 – 2.66) p = 1 
Difficult breathing in 14 days  0.54 (0.07 – 4.06) p = 0.6  0.57 (0.07 – 4.37) p = 0.6  0.61 (0.07 – 5.18) p = 0.6 
Diarrhoea in last 14 days  0.60 (0.14 – 2.58) p = 0.5  0.65 (0.15 – 2.89) p = 0.7  0.56 (0.12 – 2.70) p = 0.5 
Child systolic blood pressure   -0.051 (-5.657 – 5.556) p = 1  -0.626 (-6.224 – 4.973) p = 0.8  -1.088 (-7.176 – 4.999) p = 0.7 
Child diastolic blood pressure  3.353 (-2.158 – 8.864) p = 0.2  2.900 (-2.570 – 8.371) p = 0.3  1.418 (-4.521 – 7.358) p = 0.6 
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NBW_AGA  Model I  Model II  Model III 
Neonatal death   0.52 (0.21 – 1.28) p = 0.2  0.62 (0.25 – 1.55) p = 0.3  0.60 (0.23 – 1.53) p = 0.3 
Infant death  0.59 (0.28 - 1.22) p = 0.2    0.63 (0.29 – 1.37) p = 0.2 
Child death  0.56 (0.28 – 1.13) p = 0.1  0.55 (0.27 – 1.12) p = 0.1  0.54 (0.26 – 1.14) p = 0.1 
       
Stunting  0.39 (0.30 – 0.52) p = 0.001  0.39 (0.28 – 0.53) p = 0.001  0.39 (0.28 – 0.54) p = 0.001 
Wasting  0.47 (0.26 – 0.86) p = 0.01  0.60 (0.32 – 1.10) p = 0.1  0.57 (0.30 – 1.08) p = 0.08 
Underweight  0.36 (0.27 -0.48) p = 0.001  0.36 (0.26 – 0.50) p = 0.001  0.35 (0.25 –  0.49) p = 0.001 
       
Cough and fever during infancy  1.17 (0.67 – 2.04) p = 0.6  1.25 (0.71 – 2.2) p = 0.4  1.10 (0.61 – 1.99) p = 0.8 
Diarrhoea and fever during infancy  1.04 (0.78 – 1.38) p = 0.8  1.1 (0.82 – 1.47) p = 0.5  1.14 (0.84 – 1.56) p = 0.4 
Rash and fever during infancy  0.92 (0.61 – 1.38) p = 0.7  0.96 (0.64 – 1.45) p = 0.8  0.92 (0.59 – 1.43) p = 0.7 
Frequency of illness in the first year of life  0.83 (0.64 – 1.08) p = 0.2  0.83 (0.63 – 1.08) p = 0.2  0.80 (0.60 – 1.07) p = 0.1 
Fever in last 14 days  0.65 (0.49 – 0.86) p = 0.002  0.72 (0.54 – 0.96) p=0.03  0.69 (0.51 – 0.92) p = 0.01 
Diarrhoea in last 14 days  0.79 (0.54 – 1.16) p = 0.2  0.88 (0.59 – 1.32) p = 0.6  0.88 (0.59 – 1.33) p = 0.6 
Cough in last 14 days  0.77 (0.59 – 1.01) p = 0.06  0.82 (0.61 – 1.09) p = 0.2  0.80 (0.59 – 1.07) p = 0.1 
Difficult breathing in 14 days  0.54 (0.32 – 0.91) p =0.02  0.54 (0.32 – 0.91) p = 0.02  0.54 (0.31 – 0.94) p = 0.03 
Child systolic blood pressure (n=902)  0.145 (-1.618 – 1.909) p = 0.9  0.526 (-1.251 – 2.304) p = 0.6  0.670 (-1.178 – 2.518) p = 0.5 
Child diastolic blood pressure  0.050 (-1.684 – 1.785) p = 1  0.186 (-1.551 – 1.923) p = 0.8  0.044 (-1.760 – 1.848) p = 1 
 
 
 
 
NBW_SGA  Model I  Model II  Model III 
Neonatal death   0.43 (0.14 – 1.27) p =0.1  0.39 (0.13 – 1.16) p = 0.09  0.45 (0.14 – 1.44) p = 0.2 
Infant death   0.37 (0.14 – 0.97) p = 0.04  -  0.40 (0.14 – 1.10) p = 0.07 
Child death   0.40 (0.17 – 0.97) p = 0.04  0.46 (0.18 – 1.14) p = 0.09  0.49 (0.19 – 1.25) p = 0.1 
       
Stunting   1.32 (0.99 – 1.75) p = 0.06  1.28 (0.91 – 1.80) p = 0.2  1.31(0.93– 1.85 p = 0.1 
Wasting   0.79 (0.43 – 1.45) p = 0.4  0.69 (0.37 – 1.27) p = 0.2  0.65 (0.32 – 1.28) p = 0.2 
Underweight   1.15 (0.87 – 1.53) p = 0.3  1.20 (0.86 – 1.68) p = 0.3  1.20 (0.85 – 1.69) p = 0.3 
       
Cough and fever during infancy  0.88 (0.50 – 1.57) p = 0.7  0.88 (0.49 – 1.56) p = 0.7  1.02 (0.54 – 1.93) p = 1 
Diarrhoea and fever during infancy  0.98 (0.73 – 1.33) p = 0.9  0.95 (0.70 – 1.29) p = 0.7  0.94 (0.67 – 1.31) p = 0.7 
Rash and fever during infancy  1.42 (0.94 – 2.15) p = 0.1  1.42 (0.93 – 2.15) p = 0.1  1.48 (0.93 – 2.35) p = 0.09 
Frequency of illness in the first year of life  1.06 (0.80 – 1.41) p = 0.7  1.05 (0.79 – 1.39) p =0.8  1.07 (0.78 – 1.46) p = 0.7 
Fever in last 14days  1.13 (0.85 – 1.51) p = 0.4  1.05 (0.78 – 1.41) p = 0.8  1.10 (0.80 – 1.52) p = 0.6 
Cough in last 14 days  1.04 (0.78 – 1.39) p = 0.8  0.93 (0.69 – 1.26) p = 0.7  1.00 (0.72 – 1.39) p = 0.1 
Difficult breathing in last 14 days  1.73 (1.05 – 2.83) p = 0.03  1.68 (1.02 – 2.78) p = 0.04  1.62 (0.93 – 2.82) p = 0.09 
Cough in 14 days  1.21 (0.81 – 1.80) p = 0.4  1.09 (0.73 – 1.63) p = 0.7  1.12 (0.72 – 1.74) p = 0.6 
Child systolic blood pressure   -0.39 (-2.27 – 1.48) p = 0.7  -0.38 (-2.25 – 1.49) p = 0.7  -0.49 (-2.53 – 1.54) p = 0.6 
Child diastolic blood pressure  -1.56 (-3.41 – 0.28) P = 0.1  -1.42 (-0.33 – 0.41) P = 0.1  -0.99 (-2.98 – 0.99) P = 0.3 
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LPI_SGA  Model I  Model II  Model III 
Neonatal death  1.29 (0.57 – 2.96) p = 0.5  1.14 (0.49 – 2.62) p = 0.8  1.15 (0.48 – 2.75) p = 0.8 
Infant death   1.16 (0.58 – 2.33) p = 0.7  -  1.15 (0.55 – 2.38) p = 0.7 
Child death  1.18 (0.61 – 2.29) p = 0.6  1.28 (0.66 – 2.50) p = 0.5  1.29 (0.64 -2.58) p = 0.5 
       
Stunting  1.99 (1.51 – 2.62) p = 0.001  2.01 (1.46 – 2.77) p = 0.001  1.92 (1.39 – 2.66) p = 0.001 
Wasting   1.96 (1.12 – 3.42) p = 0.02  1.68 (0.95 – 3.00) p = 0.07  1.99 (1.10 – 3.61) p = 0.02 
Underweight   2.05 (1.56 – 2.70) p = 0.001  2.14 (1.56 – 2.94) p = 0.001  2.13 (1.54 – 2.93) p = 0.001 
       
Cough and fever during infancy  0.80 (0.46 – 1.39) p = 0.4  0.76 (0.44 – 1.34) p = 0.3  0.85 (0.47 – 1.52) p = 0.6 
Diarrhoea and fever during infancy  1.00 (0.75 – 1.33) p = 0.9  0.95 (0.71 – 1.28) p = 0.9  0.96 (0.70 – 1.30) p = 0.8 
Rash and fever during infancy  0.98 (0.65 – 1.48) p = 0.9  0.95 (0.63 – 1.44) p = 0.8  0.95 (0.61 – 1.46) p = 1 
Frequency of illness in the first year of life  1.23 (0.94 – 1.60) p = 0.1  1.25 (0.95 – 1.64) p = 0.1  1.30 (0.97 – 1.73) p = 0.08 
Fever in last 14days  1.39 (1.06 – 1.84) p = 0.02  1.33 (0.99 – 1.77) p = 0.06  1.37 (1.02 – 1.84) p = 0.04 
Diarrhoea in last 14 days  1.15 (0.78 – 1.69) p = 0.5  1.06 (0.72 – 1.57) p = 0.8  1.05 (0.70 – 1.57) p = 0.8 
Cough in last 14 days  1.11 (0.84 – 1.46) p = 0.5  1.09 (0.82 – 1.45) p = 0.6  1.11 (0.83 – 1.50)  p = 0.4 
Difficult breathing in 14 days  1.48 (0.91 – 2.43) p = 0.1  1.54 (0.93 – 2.54) p = 0.09  1.46 (0.87 – 2.46) p = 0.2 
Child systolic blood pressure  0.12 (-1.67 – 1.67) p = 0.9  -0.21  (-2.00 – 1.59) p = 0.8  -0.32 (-2.17 – 1.53) p = 0.7 
Child diastolic blood pressure  0.19 (-1.57 – 1.95) p = 0.8  0.04 (-1.71 – 1.79) p = 1.0  0.24 (-1.57 – 2.05) p = 0.8 
 
 
 
 
 
LPI_AGA  Model I  Model II  Model III 
Neonatal death   1.01 (0.40 – 2.60) p = 1   1.15 (0.44 – 3.0) p = 0.8  1.1 (0.40 – 2.98 ) p = 0.9  
Infant death  0.94 (0.42 – 2.11) p = 0.9  -  0.86 (0.36 – 2.06) p = 0.7 
Child death  o.94 ( 0.43 – 2.02) p = 0.9   0.80 (0.37 – 1.77) p = 0.6  0.79 (0.35 – 1.80) p = 0.6 
       
Stunting  0.51 (0.38 – 0.69) p = 0.001  0.45 (0.32 – 0.64) p = 0.001  0.47 (0.33 – 0.67) p = 0.001 
Wasting  0.79 (0.41 – 1.53) p = 0.5  0.94 (0.48 – 1.84) p = 0.9  0.89 (0.44 – 1.79) p = 0.7 
Underweight  0.52 (0.38 – 0.72) p = 0.001  0.48 (0.33 – 0.70) p = 0.001  0.49 (0.34 – 0.72) p = 0.001 
       
Cough and fever during infancy  0.62 (0.35 – 1.1) p = 0.1  0.63 (0.35 – 1.14) p = 0.1  0.53 (0.28 – 1.00) p = 0.05 
Diarrhoea and fever during infancy  0.99 (0.71 – 1.36) p = 0.8  1.01 (0.73 – 1.41) p = 0.9  1.05 (0.74 – 1.48) p = 0.8 
Rash and fever during infancy  1.09 (0.69 – 1.72) p = 0.7  1.10 (0.70 – 1.75) p = 0.7  1.12 (0.69 – 1.82) p = 0.7 
Frequency of illness in the first year of life  0.92 (0.68 – 1.25) p = 0.6  0.91 (0.67 – 1.23) p = 0.6  0.85 (0.62 – 1.18) p = 0.3 
Fever in last 14 days  0.61 (0.44 – 0.84)) p = 0.003  0.62 (0.45 – 0.87) p = 0.006  0.57 (0.40 – 0.81) p = 0.002 
Diarrhoea in last 14 days  0.57 (0.30 – 1.08)  p = 0.08  0.55 (0.29 – 1.05) p = 0.07  0.54 (0.27 – 1.06) p = 0.07 
Cough in last 14 days  0.77 (0.56 – 1.05) p = 0.1  0.75 (0.54 – 1.04) p = 0.09  0.71 (0.50 – 1.00) p = 0.05 
Difficult breathing in 14 days  0.64 (0.40 – 1.03) p = 0.07  0.68 (0.42 – 1.10) p = 0.1  0.71 (0.43 – 1.18) p = 0.2 
Child systolic blood pressure   -0.043 (-2.051 – 1.966) p = 1  -0.022 (-2.033 – 1.989) p = 1  0.070 (-2.031 – 2.171) p = 1 
Child diastolic blood pressure  0.288 (-1.688 – 2.264) p = 0.8  0.313 (-1.651 – 2.277) p = 0.8  0.001 (-2.048 – 2.051) p = 1 
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API_SGA  Model I  Model II  Model III 
Neonatal death   0.82 (0.19 – 2.53) p = 0.8  0.71 (0.16 – 3.07) p = 0.6  0.92 (0.20 – 4.17) p = 0.9 
Infant death   1.27 (0.44 – 3.71) p = 0.7  -  1.46 (0.48 – 4.43) p = 0.5 
Child death   1.45 (0.55 – 3.83) p = 0.5  1.63 (0.61 – 4.33)  p = 0.3  1.87 (0.67 – 5.16) p = 0.2 
       
Stunting   1.64 (1.02 – 2.633) p = 0.04  1.78 (1.02 - 3.09) p = 0.04  1.85 (1.05 – 3.24) p = 0.03 
Wasting   0.73 (0.26 – 2.08) p = 0.6  0.58 (0.20 – 1.68 p = 0.6  0.41 (0.12 – 1.40) p = 0.2 
Underweight   2.03 (1.31 – 3.16) p = 0.002  2.06 (1.24 – 3.42) p = 0.005  2.27 (1.34 – 3.82) p = 0.002 
       
Cough and fever during infancy  2.77 (0.66 – 11.59) p = 0.2  2.75 (0.66 – 11.54) p = 0.2  3.18 (0.75 – 13.52) p = 0.2 
Diarrhoea and fever during infancy  1.06 (0.65 – 1.72) p = 0.8  1.05 (0.64 – 1.72) p = 0.9  0.99 (0.59 – 1.65) p = 1 
Rash and fever during infancy  1.71 (0.94 – 3.10) p = 0.08  1.69 (0.92 – 3.08) p = 0.09  1.81 (0.97 – 3.39) p = 0.06 
Frequency of illness in the first year of life  1.04 (0.67 – 1.63) p = 0.9  1.00 (0.64 – 1.57) p = 1.0  1.05 (0.66 – 1.68) p = 0.8 
Fever in last 14days  1.33 (0.85 – 2.09) p = 0.2  1.20 (0.74 – 1.91) p = 0.4  1.31 (0.81 – 2.11) p = 0.3 
Diarrhoea in last 14 days  1.37 (0.76 – 2.47) p = 0.3  1.21 (0.66 – 2.21) p = 0.5  1.25 (0.67 – 2.32) p = 0.5 
Cough in last 14 days  1.36 (0.87 – 2.13) p = 0.2  1.19 (0.75 – 1.90) p = 0.5  1.31 (0.81 – 2.11) p = 0.3 
Difficult breathing in 14 days  1.67 (0.82 – 3.39) p = 0.2  1.57 (0.76 – 3.23) p = 0.2  1.49 (0.71 – 3.15) p = 0.3 
Child systolic blood pressure   -0.76 (-3.74 – 2.22) p = 0.6  -0.63 (-3.61 – 2.34) p = 0.7  -0.70 (-3.72 – 2.33) p =0.7 
Child diastolic blood pressure  -1.49 (-4.42 – 1.43) p = 0.4  -1.40 (-4.30 – 1.51) p = 0.4  -1.06 (-4.01 -  1.90) p = 0.5 
 
 
 
 
 
 
 
API_AGA  Model I  Model II  Model III 
Neonatal death   0.74 (0.25 – 2.21) p = 0.6  0.85 (0.28 – 2.55) p = 0.8  0.76 (0.25 – 2.37) p = 0.6 
Infant death  0.82 (0.33 – 2.02) p = 0.7    0.85 (0.34 – 2.17) p = 0.7 
Child death  0.71 (0.29 – 1.72) p = 0.4  0.71 (0.29 – 1.73) p = 0.45  0.67 (0.27 – 1.70) p = 0.4 
       
Stunting  0.67 (0.49 0 – 0.91) p = 0.01  0.71 (0.50 – 1.02) p = 0.07  0.72 (0.50 – 1.03) p = 0.07 
Wasting  0.51 (0.23-1.14) p = 0.1  0.60 (0.26-1.36) p = 0.2  0.58 (0.25-1.34) p = 0.2 
Underweight  0.48 (0.34 – 0.68) p = 0.001  0.49 (0.33 – 0.72) p = 0.001  0.45 (0.30 – 0.68) p = 0.001 
       
Cough and fever during infancy  1.93 (0.86 – 4.34) p = 0.1  2.00 (0.89 – 4.53) p = 0.09  1.86 (0.81 – 4.29) p =0.1 
Diarrhoea and fever during infancy  1 (0.71- 1.41) p = 1  1.03 (0.72 – 1.46) p = 0.9  1.02 (0.71 – 1.47) p = 0.9 
Rash and fever during infancy  0.66 (0.38 – 1.14) p = 0.1  0.68 (0.39 – 1.18) p = 0.2  0.64 (0.36 – 1.12) p = 0.1 
Frequency of illness in the first year of life  0.81 (0.59 – 1.12) p = 0.2  0.82 (0.60 – 1.14) p = 0.2  0.81 (0.57 – 1.13) p = 0.2 
Fever in last 14 days  0.93 (0.67 – 1.30) p = 0.7  1.03 (0.73 – 1.46) p = 0.9  1.01 (0.71 – 1.44) p = 1 
Diarrhoea in last 14 days  1.10 (0.70 – 1.73) p = 0.7  1.24 (0.78 – 1.96) p = 0.4  1.16 (0.72 – 1.86) p = 0.6 
Cough in last 14 days  1.00 (0.72 – 1.39) p = 1  1.12 (0.80 – 1.59) p = 0.5  1.09 (0.77 – 1.55) p = 0.7 
Difficult breathing in 14 days  0.72 (0.38 – 1.38) p = 0.3  0.74 (0.38 – 1.42) p = 0.4  0.80 (0.41 – 1.57) p = 0.5 
Child systolic blood pressure   0.469 (-1.663 – 2.600) p = 0.6  0.861 (-1.289 – 3.011) p = 0.4  0.941 (-1.238 – 3.120) p = 0.4 
Child diastolic blood pressure  0.305 (-1.792 – 2.402) p = 0.8  0.453 (-1.648 – 2.553) p = 0.7  0.359 (-1.768 – 2.486) p = 0.7 
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LBW_LPI_AGA  Model I  Model II  Model III 
Neonatal death   6.26 (1.74 – 22.48) p = 0.005  6.09 (1.68 – 22.08) p = 0.006  6.55 (1.16 – 37.06) p = 0.03 
Infant death  4.28 (1.21 – 15.14) p = 0.02    2.52 (0.51 – 12.38) p = 0.3 
Child death   3.76 (1.07 – 13.22) p = 0.04  2.50 (0.55 – 11.33) p = 0.2  1.82 (0.38 – 8.75) p = 0.5 
       
Stunting   3.02 (1.0 – 9.6) p = 0.05  3.27 (0.85 – 12.57) p = 0.08  5.17 (1.06 – 25.16) p = 0.04 
Wasting   1.67 (0.38 – 7.36) p = 0.5  1.56 (0.35 – 7.01) p= 0.6  1.25 (2.32 – 6.73) p = 0.8 
Underweight   1.02 (0.42 – 2.49) p = 1  0.62 (0.22 – 1.80) p = 0.4  0.63 (0.21 – 1.85) p = 0.4 
       
Cough and fever during infancy  0.37 (0.10 – 1.28) p = 0.1  0.29 (0.08 – 1.03) p = 0.06  0.15 (0.03 – 0.68) p = 0.01 
Diarrhoea and fever during infancy  0.70 (0.29 – 1.70) p = 0.4  0.63 (0.26 – 1.56) p = 0.3  0.48 (0.18 – 1.31) p = 0.2 
Rash and fever during infancy  0.00 (0.00 - .) p = 1  -  - 
Frequency of illness in the first year of life  0.86 (0.35 – 2.10) p = 0.8  0.80 (0.32 – 1.96) p = 0.6  0.66 (0.24 – 1.81) p = 0.4 
Fever in last 14days  0.73 (0.28 – 1.90) p = 0.5  0.56 (0.20 – 1.60) p = 0.3  0.44 (0.15 – 1.34) p = 0.2 
Diarrhoea in last 14 days  0.66 (0.15 – 2.86) p = 0.6  0.73 (0.16 – 3.26) p = 0.7  0.67 (0.14 – 3.27) p = 0.6 
Cough in last 14 days  1.64 (0.69 – 3.91) p = 0.3  1.64 (0.65 – 4.14) p = 0.3  1.25 (0.46 – 3.38) p = 0.7 
Difficult breathing in 14 days  0.62 (0.60 – 4.51) p = 0.6  0.58 (0.07 – 4.51) p = 0.6  0.63 (0.07 – 5.43) p = 0.7 
Child systolic blood pressure   0.457 (-5.404 – 6.317) p = 0.9  -0.555 (-6.417 – 5.307) p = 0.9  -0.430 (-6.743 – 5.882) p = 0.9 
Child diastolic blood pressure  4.509 (-1.248 – 10.267) p = 0.1  4.145 (-1.575 – 9.865) p = 0.2  2.775 (-3.38 – 8.932) p = 0.4 
 
 
 
 
 
 
LBW_API_SGA  Model I  Model II  Model III 
Neonatal death   4.34 (0.96 – 19.67) p = 0.06  3.55 (0.77 – 16.30) p = 0.1  4.08 (0.82 – 20. 19) p = 0.09 
Infant death   6.54 (2.09 – 20.45) p = 0.03    6.46 (1.93 – 21.60) p = 0.002 
Child death   7.80 (2.72 – 22.31) p = 0.001  6.89 (2.38 – 19.98) p = 0.001  8.09 (2.64 – 24.78) p = 0.001 
       
Stunting   5.75 (1.31 – 25.15) p = 0.02  11.60 (1.39 – 96.77) p = 0.02  11.26 (1.35 – 93.71) p = 0.03 
Wasting   1.99 (0.45 – 8.89) p = 0.4  1.55 (0.34 – 7.10) p = 0.6  1.47 (0.30 – 7.11) p = 0.6 
Underweight   6.01 (1.96 – 18.42) p = 0.002  6.82 (1.80 – 25.91) p = 0.005  7.82 (1.99 – 30.74) p = 0.003 
       
Cough and fever during infancy  -     
Diarrhoea and fever during infancy  0.79 (0.29 – 2.15) p = 0.6  0.79 (0.28 – 2.19) p = 0.6  0.73 (0.26 – 2.06) p = 0.6 
Rash and fever during infancy  1.62 (0.46 – 5.75) p = 0.5  1.57 (0.44 – 5.59) p = 0.5  1.88 (0.51 – 6.89) p = 0.3 
Frequency of illness in the first year of life  0.94 (0.36 – 2.46) p = 0.9  0.90 (0.34 – 2.38) p = 0.8  0.93 (0.35 – 2.50) p = 0.9 
Fever in last 14days  1.65 (0.63 – 4.32) p = 0.3  1.45 (0.54 – 3.88) p = 0.5  1.59 (0.58 – 4.31) p = 0.4 
Diarrhoea in last 14 days  2.04 (0.78 – 5.34) p = 0.1  1.99 (0.74 – 5.36) p = 0.2  1.98 (0.73 – 5.37) p = 0.2 
Cough in last 14 days  1.36 (0.39 – 4.81) p = 0.6  1.21 (0.34 – 4.35) p = 0.8  1.26 (0.34 – 4.70) p = 0.7 
Difficult breathing in 14 days  -  -  - 
Child systolic blood pressure   -3.868 (-10.183 – 2.446) p = 0.2  -3.944 (-10.241 – 2.352) p = 0.2  -4.011 (-10.368 – 2.346) p = 0.2 
Child diastolic blood pressure  0.835 (-5.381 – 7.051) p = 0.8  1.036 (-5.119 – 7.191) p = 0.7  0.578 (-5.630 – 6.786) p = 0.9 
    
296 
 
LBW_API_AGA  Model I  Model II  Model III 
Neonatal death 1048  -  -  - 
Infant death 953 (totalfup)  -  -  - 
Child death 953  -  -  - 
       
Stunting 915  0.70 (0.04 – 11.23) p = 0.8  0.34 (0.02 – 5.69) p = 0.5  0.36 (0.02 – 6.14) p = 0.5 
Wasting 915  15.91 (0.98 – 257.81) p = 0.05  15.58 (0.92 – 264.63) p = 0.06  10.27 (0.49 – 215.12) p = 0.1 
Underweight 915  1.66 (0.10 – 26.65) p = 0.7  0.99 (0.06 – 16.98) p = 1  0.92 (0.05 – 15.99) p = 1 
       
Cough and fever during infancy  1E+008 (0.00 - .) p = 1  -  - 
Diarrhoea and fever during infancy  0.43 (0.03 – 6.01) p = 0.6  0.31 (0.02 – 5.04) p = 0.4  0.34 (0.02 – 5.88) p = 0.5 
Rash and fever during infancy  -  -  - 
Frequency of illness in the first year of life  1.06 (0.07 – 16.96) p = 1  1.41 (0.09 – 22.97) p = 0.8  0.87 (0.05 – 14.93) p = 0.9 
Fever in last 14days  1.84 (0.12 – 29.53) p = 0.7  2.66 (0.16 – 43.90) p = 0.5  1.94 (0.12 – 32.87) p = 0.7 
Diarrhoea in last 14 days  -  -  - 
Cough in last 14 days  -  -  - 
Difficult breathing in 14 days  -  -  - 
Child systolic blood pressure (n=902)  -4.80 (-23.59 – 13.99) p = 0.6  -5.798 (-24.52 – 12.92) p = 0.5  -6.21 (-25.22 – 12.80) p = 0.5 
Child diastolic blood pressure  -8.42 (-26.90 – 10.06) p = 0.4  -9.632 (-27.91 – 8.65) p = 0.3  -11.1 (-29.61 – 7.45) p = 0.2 
 
 
 
 
 
 
 
LBW_LPI_SGA  Model I  Model II  Model III 
Neonatal death   2.23 (0.90 – 5.51) p = 0.08  1.95 (0.78 – 4.86) p = 0.2  1.66 (0.63 – 4.36) p = 0.3 
Infant death   2.18 (1.02 – 4.67) p = 0.05    1.82 (0.81 – 4.08) p = 0.2 
Child death   2.13 (1.03 – 4.40) p = 0.04  1.98 (0.95 – 4.12) p = 0.07  1.87 (0.87 – 4.03) p = 0.1 
       
Stunting   2.60 (1.75 – 3.89) p = 0.001  2.82 (1.79 – 4.42) p = 0.001  2.58 (1.64 – 4.07) p = 0.001 
Wasting   2.64 (1.46 – 4.77) p = 0.001  2.23 (1.22 – 4.09) p = 0.01  2.56 (1.34 – 4.90) p = 0.004 
Underweight   3.44 (2.40 – 4.94) p = 0.001  3.40 (2.26 – 5.11) p = 0.001  3.59 (2.35 – 5.48) p = 0.001 
       
Cough and fever during infancy  1 (0.48 – 2.08) p = 1  0.93 (0.44 – 1.96) p = 0.9  0.97 (0.45 – 2.10) p = 0.9 
Diarrhoea and fever during infancy  1.06 (0.72 – 1.56) p = 0.8  1.03 (0.70 – 1.53) p = 0.9  1.02 (0.68 – 1.54) p = 0.9 
Rash and fever during infancy  0.73 (0.41 – 1.32) p = 0.3  0.69 (0.38 – 1.26) p = 0.3  0.70 (0.38 – 1.29) p = 0.3 
Frequency of illness in the first year of life  1.30 (0.91 – 1.85) p = 0.2  1.34 (0.94 – 1.92) p = 0.1  1.44 (0.99 – 2.09) p = 0.06 
Fever in last 14days  1.62 (1.14 – 2.31) p = 0.008  1.59 (1.10 – 2.29) p = 0.01  1.66 (1.14 – 2.42) p = 0.009 
Diarrhoea in last 14 days  1.08 (0.66 – 1.78) p = 0.8  1.05 (0.63 – 1.75) p = 0.9  1.05 (0.62 – 1.77) p = 0.9 
Cough in last 14 days  1.24 (0.87 – 1.78) p = 0.2  1.33 (0.91 – 1.93) p = 0.1  1.31 (0.90 – 1.93) p = 0.2 
Difficult breathing in 14 days  1.28 (0.69 – 2.36) p = 0.4  1.37 (0.73 – 2.57) p = 0.3  1.43 (0.74 – 2.76) p = 0.3 
Child systolic blood pressure   0.992 (-1.365 -3.349) p = 0.4  0.373 (-1.989 – 2.735) p = 0.8  0.368 (-2.056 – 2.793) p = 0.8 
Child diastolic blood pressure  1.919 (-0.397 – 4.235) p = 0.1  1.486 (-0.819 – 3.791) p = 0.2  1.251 (-1.113 – 3.616) p = 0.3 
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NBW_LPI_AGA  Model I  Model II  Model III 
Neonatal death   0.50 (0.15 – 1.68) p = 0.3  0.56 (0.16 – 1.92) p = 0.4  0.58 (0.17 – 2.02) p = 0.4 
Infant death   0.57 (0.22 – 1.50) p  = 0.3    0.61 (0.23 – 1.63) p = 0.3 
Child death   0.62 (0.26 – 1.51) p = 0.3  0.60 (0.25 – 1.45) p = 0.3  0.62 (0.25 – 1.55) p = 0.3 
       
Stunting  0.44 (0.33 – 0.60) p = 0.001  0.41 (0.29 – 0.59) p = 0.001  0.42 (0.29 – 0.60) p = 0.001 
Wasting   0.70 (0.35 – 1.41) p = 0.70  0.85 (0.41 – 1.73) p = 0.7  0.81 (0.39 – 1.69) p = 0.6 
Underweight   0.51 (0.36 – 0.71) p = 0.001  0.52 (0.36 – 0.76) p = 0.001  0.53 (0.36 – 0.78) p = 0.001 
       
Cough and fever during infancy  0.73 (0.40 – 1.38) p = 0.3  0.76 (0.42 – 1.40) p = 0.4  0.68 (0.36 – 1.29) p = 0.2 
Diarrhoea and fever during infancy  0.98 (0.71 – 1.37) p =  0.9  1.03 (0.73 – 1.45) p = 0.9  1.08 (0.76 – 1.54) p = 0.7 
Rash and fever during infancy  1.28 (0.82 – 2.02) p = 0.3  1.33 (0.84 – 2.09) p = 0.2  1.34 (0.84 – 2.16) p = 0.2 
Frequency of illness in the first year of life  0.94 (0.69 – 1.28) p = 0.7  0.94 (0.69 – 1.28) p = 0.7  0.90 (0.65 – 1.25) p = 0.9 
Fever in last 14days  0.61 (0.44 – 0.86) p = 0.004  0.64 (0.46 – 0.91) p = 0.01  0.61 (0.43 – 0.88) p = 0.007 
Diarrhoea in last 14 days  0.65 (0.40 – 1.05) p = 0.08  0.68 (0.41 – 1.11) p = 0.1  0.72 (0.43 – 1.20) p = 0.7 
Cough in last 14 days  0.70 (0.50 – 0.97) p = 0.03  0.69 (0.49 – 0.97) p = 0.03  0.68 (0.48 – 0.96) p = 0.03 
Difficult breathing in 14 days  0.57 (0.30 – 1.11) p = 0.09  0.56 (0.29 – 1.09) p = 0.09  0.54 (0.27 – 1.08) p = 0.08 
Child systolic blood pressure   -0.18 (-2.24 – 1.89) p = 0.9  -0.009 (-2.075 – 2.057) p = 0.9  0.065 (-2.052 – 2.182) p = 1 
Child diastolic blood pressure  -0.206 (-2.232 – 1.820) p = 0.8  -0.104 (-2.122 – 1.913) p = 0.9  -0.232 (-2.297 – 1.833) p = 0.8 
 
 
 
 
 
NBW_API_SGA  Model I  Model II  Model III 
Neonatal death   -  -  - 
Infant death   -  -  - 
Child death   -  -  - 
       
Stunting   1.29 (0.77 – 2.14) p = 1.29  1.34 (0.74 – 2.42) p = 0.3  1.40 (0.77 – 2.56) p = 0.3 
Wasting   0.44 (0.11 – 1.84) p = 0.44  0.35 (0.08 – 1.50) p = 0.4  0.17 (0.02 – 1.25) p = 0.08 
Underweight   1.53 (0.94 – 2.50) p = 0.09  1.54 (0.88 – 2.72) p = 0.1  1.65 (0.92 – 2.95) p = 0.09 
       
Cough and fever during infancy  2.18 (0.52 – 9.13) p = 0.3  2.15 (0.51 – 9.07) p = 0.3  2.55 (0.59 – 10.97) p = 0.2 
Diarrhoea and fever during infancy  1.12 (0.65 – 1.95) p = 0.7  1.11 (0.64 – 1.95) p = 0.7  1.06 (0.60 – 1.89) p = 0.8 
Rash and fever during infancy  1.68 (0.87 – 3.25) p = 0.1  1.68 (0.87 – 3.26) p = 0.1  1.73 (0.87 – 3.46) p = 0.1 
Frequency of illness in the first year of life  1.06 (0.65 – 1.74) p = 0.8  1.02 (0.62 – 1.69) p = 0.9  1.08 (0.64 – 1.82) p = 0.8 
Fever in last 14days  1.25 (0.76 – 2.05) p = 0.4  1.13 (0.68 – 1.89) p = 0.6  1.23 (0.73 – 2.10) p = 0.4 
Diarrhoea in last 14 days  1.34 (0.70 – 2.57) p = 0.4  1.18 (0.61 – 2.30) p = 0.6  1.24 (0.62 – 2.48) p = 0.6 
Cough in last 14 days  1.21 (0.73 – 1.99) p = 0.5  1.03 (0.61 – 1.74) p = 0.9  1.16 (0.68 – 1.98) p = 0.6 
Difficult breathing in 14 days  2.18 (1.06 – 4.46) p = 0.03  2.03 (0.97 – 4.22) p = 0.06  1.92 (0.89 – 4.16) p = 0.1 
Child systolic blood pressure   0.206 (-3.095 – 3.508) p = 0.9  0.381 (-2.915 – 3.676) p = 0.8  0.345 (-3.040 – 3.729) p = 0.8 
Child diastolic blood pressure  -1.956 (-5.202 – 1.289) p = 0.2  -1.884 (-5.101 – 1.333) p = 0.3  -1.368 (-4.669 – 1.934) p = 0.4 
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NBW_LPI_SGA  Model I  Model II  Model III 
Neonatal death   0.65 (0.22 – 1.92) p = 0.4  0.61 (0.21 – 1.81) p = 0.4  0.70 (0.22 – 2.23) p = 0.6 
Infant death   0.54 (0.21 – 1.42) p = 0.2    0.62 (0.26 – 1.68) p = 0.3 
Child death   0.59 (0.24 – 1.43) p = 0.24  0.68 (0.27 – 1.69) p = 0.4  0.72 (0.28 – 1.83) p = 0.5 
       
Stunting   1.28 (0.94 – 1.75) p = 0.1  1.20 (0.84 – 1.72) p = 0.3  1.22 (0.85 – 1.75) p = 0.3 
Wasting   0.94 (0.50 – 1.79) p = 0.9  0.87 (0.46 – 1.66) p = 0.7  0.99 (0.50 – 1.96) p = 1 
Underweight   1.00 (0.73 – 1.37) p = 1  1.03 (0.73 – 1.47) p = 0.9  1.00 (0.70 – 1.44) p = 0.9 
       
Cough and fever during infancy  0.77 (0.42 – 1.42) p = 0.4  0.77 (0.42 – 1.41) p = 0.4  0.86 (0.45 – 1.64) p = 0.6 
Diarrhoea and fever during infancy  0.92 (0.67 – 1.28) p = 0.6  0.89 (0.64 – 1.24) p = 0.5  0.90 (0.63 – 1.27) p = 0.5 
Rash and fever during infancy  1.21 (0.77 – 1.89) p = 0.4  1.20 (0.76 – 1.89) p = 0.4  1.18 (0.73 – 1.91) p = 0.5 
Frequency of illness in the first year of life  1.06 (0.78 – 1.44) p = 0.7  1.06 (0.78 – 1.44) p = 0.7  1.06 (0.76 – 1.47) p = 0.7 
Fever in last 14days  1.06 (0.77 – 1.45) p = 0.7  1.01 (0.73 – 1.39) p = 1  1.02 (0.73 – 1.43) p = 0.9 
Diarrhoea in last 14 days  1.11 (0.72 – 1.70) p = 0.6  1.03 (0.67 – 1.59) p = 0.9  1.03 (0.65 – 1.62) p = 0.9 
Cough in last 14 days  0.97 (0.72 – 1.33) p = 0.9  0.91 (0.66 – 1.26) p = 0.6  0.94 (0.67 – 1.32) p = 0.7 
Difficult breathing in 14 days  1.34 (0.79 – 2.29) p = 0.3  1.33 (0.77 – 2.30) p = 0.3  1.23 (0.70 – 2.18) p = 0.5 
Child systolic blood pressure   -0.449 (-2.484 – 1.586) p = 0.7  0.411 (-2.445 – 1.624) p = 0.7  -0.568 (-2.696 – 1.560) p = 0.6 
Child diastolic blood pressure  -1.013 (-3.014 – 0.987) p = 0.3  -0.862 (-2.848 – 1.125) p = 0.4  -0.449 (-2.526 – 1.627) p = 0.7 
 
 
 
 
NBW_API_AGA  Model I  Model II  Model III 
Neonatal death   0.76 (0.26 – 2.25) p = 0.6  0.87 (0.29 – 2.60) p = 0.8  0.78 (0.25 – 2.44) p = 0.7 
Infant death  0.83 (0.34 – 2.06) p = 0.7    0.87 (0.34 – 2.22) p = 0.8 
Child death  0.72 (0.30 – 1.75) p = 0.5  0.73 (0.30 – 1.79) p = 0.5  0.69 (0.27 – 1.75) p = 0.4 
       
Stunting  0.67 (0.49 – 0.92) p = 0.01  0.73 (0.51 – 1.05) p = 0.08  0.73 (0.51 – 1.05) p = 0.09 
Wasting  0.42 (0.18 – 1.0) p = 0.05  0.50 (0.21 – 1.20) p = 0.1  0.49 (0.20 – 1.19) p = 0.1 
Underweight  0.47 (0.33 – 0.67) p = 0.001  0.48 (0.32 – 0.71) p = 0.001  0.45 (0.30 – 0.68) p = 0.001 
       
Cough and fever during infancy  1.89 (0.84 – 4.26) p = 0.1  1.97 (0.87 – 4.44) p = 0.1  1.83 (0.79 – 4.23) p = 0.1 
Diarrhoea and fever during infancy  1.00 (0.71 – 1.42) p = 1  1.04 (0.73 – 1.49) p = 0.8  1.04 (0.72 – 1.50) p = 0.8 
Rash and fever during infancy  0.66 (0.38 – 1.14) p = 0.1  0.68 (0.40 – 1.18) p = 0.2  0.65 (0.37 – 1.14) p = 0.1 
Frequency of illness in the first year of life  0.81 (0.59 – 1.12) p = 0.2  0.82 (0.59 – 1.13) p = 0.2  0.81 (0.57 – 1.14) p = 0.2 
Fever in last 14 days  0.92 (0.66 – 1.28) p = 0.6  1.01 (0.72 – 1.43) p = 0.9  1 (0.70 – 1.42) p = 1 
Diarrhoea in last 14 days  1.02 (0.73 – 1.41) p = 0.9  1.14 (0.81 – 1.61) p = 0.5  1.11 (0.78 – 1.58) p = 0.6 
Cough in last 14 days  1.11 (0.71 – 1.74) p = 0.7  1.25 (0.79 – 1.99) p = 0.3  1.18 (0.73 – 1.90) p = 0.5 
Difficult breathing in 14 days  0.74 (0.39 – 1.40) p = 0.4  0.74 (0.38 – 1.43) p = 0.4  0.81 (0.41 – 1.58) p = 0.5 
Child systolic blood pressure   0.586 (-1.553 – 2.724) p = 0.6  1.002 (-1.156 – 3.159) p = 0.4  1.088 (-1.099 – 3.274) p = 0.3 
Child diastolic blood pressure  0.477 (-1.657 – 2.551) p = 0.7  0.617 (-1.490 – 2.725) p = 0.6  0.538 (-1.596 – 2.673) p = 0.6    
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